public class BannerAnnotate {
static void init0() {
a0 = new int[] {
0,17,5,/*tumor*/
0,54,38,/*adenomatous polyposis coli (APC) tumor*/
0,159,18,/*colorectal cancers*/
1,1064,18,/*dystrophic chicken*/
1,1232,36,/*familial hypertrophic cardiomyopathy*/
1,1359,18,/*dystrophic muscles*/
2,17,30,/*familial adenomatous polyposis*/
3,4,21,/*ataxia telangiectasia*/
3,34,28,/*familial and sporadic cancer*/
3,68,21,/*ataxia telangiectasia*/
3,91,3,/*A-T*/
3,343,3,/*A-T*/
3,392,13,/*breast cancer*/
3,521,5,/*T-PLL*/
3,488,31,/*T cell prolymphocytic leukaemia*/
3,913,6,/*tumour*/
3,1554,3,/*A-T*/
4,1673,20,/*bile acid metabolism*/
5,65,36,/*paroxysmal nocturnal haemoglobinuria*/
6,56,16,/*dental anomalies*/
6,522,15,/*Turner syndrome*/
6,539,27,/*Beckwith-Wiedemann syndrome*/
6,568,15,/*Marfan syndrome*/
6,585,25,/*Treacher Collins syndrome*/
6,612,23,/*cleidocranial dysplasia*/
6,641,20,/*cleft lip and palate*/
9,53,12,/*glomus tumor*/
9,67,13,/*Glomus tumors*/
9,104,6,/*tumors*/
9,156,6,/*tumors*/
9,222,32,/*hereditary glomus jugulare tumor*/
9,564,5,/*tumor*/
9,920,5,/*tumor*/
9,1357,5,/*tumor*/
9,1593,5,/*tumor*/
9,1614,13,/*glomus tumors*/
10,54,16,/*breast carcinoma*/
10,167,26,/*sporadic breast carcinomas*/
10,278,17,/*breast carcinomas*/
10,355,17,/*breast carcinomas*/
11,131,31,/*hereditary neuralgic amyotrophy*/
11,164,3,/*HNA*/
11,180,45,/*autosomal dominant recurrent focal neuropathy*/
11,240,15,/*brachial plexus*/
11,273,3,/*HNA*/
12,48,24,/*neurofibromatosis type 2*/
12,87,21,/*retinal abnormalities*/
13,39,21,/*Coffin-Lowry syndrome*/
13,62,3,/*CLS*/
13,68,21,/*Coffin-Lowry syndrome*/
13,91,3,/*CLS*/
13,102,17,/*X-linked disorder*/
13,137,18,/*facial dysmorphism*/
13,157,19,/*digit abnormalities*/
13,181,30,/*severe psychomotor retardation*/
13,213,3,/*CLS*/
13,348,3,/*CLS*/
13,400,3,/*CLS*/
13,1430,3,/*CLS*/
14,53,19,/*volunteer deficient*/
15,68,21,/*human prostate cancer*/
15,370,15,/*prostate cancer*/
15,1021,15,/*prostate cancer*/
15,1518,5,/*tumor*/
15,1737,5,/*tumor*/
15,1770,12,/*LNCaP tumors*/
15,1825,6,/*tumors*/
15,2083,6,/*tumors*/
15,2108,15,/*parental tumors*/
15,2711,15,/*prostate cancer*/
17,7,11,/*nephropathy*/
17,33,19,/*Lesch-Nyhan disease*/
18,30,12,/*iris atrophy*/
18,47,8,/*glaucoma*/
18,72,9,/*Glaucomas*/
18,103,9,/*blindness*/
18,145,27,/*retinal ganglion cell death*/
18,276,9,/*glaucomas*/
18,306,30,/*anterior segment abnormalities*/
18,345,27,/*pigment dispersion syndrome*/
18,374,3,/*PDS*/
18,383,12,/*iris atrophy*/
18,584,8,/*glaucoma*/
18,642,18,/*pigment dispersion*/
18,665,12,/*iris atrophy*/
18,844,8,/*glaucoma*/
18,949,18,/*pigment dispersion*/
18,1134,3,/*PDS*/
18,1361,18,/*pigment production*/
18,1498,18,/*pigment dispersion*/
19,12,14,/*G6PD-deficient*/
19,162,51,/*glucose 6-phosphate dehydrogenase (G6PD) deficiency*/
19,525,14,/*G6PD deficient*/
19,1293,15,/*G6PD deficiency*/
19,1547,14,/*G6PD-deficient*/
20,1377,43,/*glucose toxicity and diabetes complications*/
21,50,15,/*colon carcinoma*/
21,166,13,/*colon cancers*/
21,310,13,/*colon cancers*/
21,369,9,/*melanomas*/
21,380,16,/*medulloblastomas*/
21,398,15,/*prostate cancer*/
21,418,37,/*gastric and hepatocellular carcinomas*/
21,558,7,/*TCF/LEF*/
21,1154,12,/*colon-cancer*/
21,1545,10,/*neoplastic*/
22,26,14,/*von Willebrand*/
22,88,31,/*type IID von Willebrand disease*/
22,180,14,/*von Willebrand*/
22,262,31,/*type IID von Willebrand disease*/
22,1424,31,/*type IID von Willebrand disease*/
23,0,27,/*Coexisting carcinoid tumors*/
23,31,67,/*familial adenomatous polyposis-associated upper intestinal adenomas*/
23,100,29,/*Upper gastrointestinal polyps*/
23,134,22,/*extraintestinal tumors*/
23,197,30,/*familial adenomatous polyposis*/
23,229,3,/*FAP*/
23,244,16,/*carcinoid tumors*/
23,309,17,/*colonic neoplasms*/
23,331,18,/*ulcerative colitis*/
23,414,3,/*FAP*/
23,444,3,/*FAP*/
23,466,16,/*carcinoid tumors*/
23,507,17,/*duodenal adenomas*/
23,547,19,/*carcinoid neoplasms*/
23,717,16,/*carcinoid tumors*/
23,763,19,/*intestinal adenomas*/
25,0,28,/*Familial Mediterranean fever*/
25,41,26,/*Mycobacterium tuberculosis*/
25,119,28,/*Familial mediterranean fever*/
25,149,3,/*FMF*/
25,258,11,/*amyloidosis*/
25,301,27,/*immunological abnormalities*/
25,358,26,/*Mycobacterium tuberculosis*/
25,432,3,/*FMF*/
25,580,3,/*FMF*/
25,971,9,/*granuloma*/
25,1169,12,/*tuberculosis*/
25,1222,3,/*FMF*/
25,1290,12,/*tuberculosis*/
25,1691,12,/*tuberculosis*/
25,1708,3,/*FMF*/
25,1765,11,/*amyloidosis*/
25,1819,3,/*FMF*/
26,233,18,/*dyslipoproteinemia*/
26,412,23,/*coronary artery disease*/
27,82,12,/*Prader-Willi*/
28,24,15,/*hemochromatosis*/
28,61,15,/*Hemochromatosis*/
28,78,2,/*HH*/
28,298,24,/*juvenile hemochromatosis*/
28,324,2,/*JH*/
28,491,15,/*hemochromatosis*/
28,759,15,/*hemochromatosis*/
28,840,15,/*hemochromatosis*/
28,981,2,/*HH*/
29,84,18,/*IIb hyperlipidemia*/
29,175,23,/*type IIb hyperlipidemic*/
29,2165,23,/*type IIb hyperlipidemic*/
30,1315,19,/*gastrulation defect*/
31,74,27,/*Duchenne muscular dystrophy*/
31,155,27,/*Duchenne muscular dystrophy*/
31,184,3,/*DMD*/
31,190,3,/*DMD*/
31,963,3,/*DMD*/
31,1088,3,/*DMD*/
31,1133,19,/*greater abnormality*/
32,0,15,/*Maternal disomy*/
32,20,21,/*Prader-Willi syndrome*/
32,240,21,/*Prader-Willi syndrome*/
32,264,3,/*PWS*/
32,326,3,/*PWS*/
32,553,3,/*PWS*/
32,893,3,/*PWS*/
32,990,3,/*PWS*/
32,1238,15,/*Maternal disomy*/
32,1769,3,/*PWS*/
32,1887,3,/*PWS*/
34,0,39,/*X-linked nonspecific mental retardation*/
34,231,27,/*X-linked mental retardation*/
34,268,20,/*speech abnormalities*/
35,51,7,/*lipomas*/
35,142,7,/*lipomas*/
35,719,6,/*lipoma*/
37,42,20,/*macular degeneration*/
38,0,3,/*MED*/
38,49,29,/*multiple epiphyseal dysplasia*/
38,158,29,/*multiple epiphyseal dysplasia*/
38,189,3,/*MED*/
38,261,3,/*MED*/
38,396,3,/*MED*/
38,405,20,/*multilayered patella*/
38,427,13,/*brachydactyly*/
38,499,21,/*diastrophic dysplasia*/
38,522,5,/*DTDST*/
39,69,26,/*pure fundus flavimaculatus*/
40,51,7,/*obesity*/
40,78,21,/*Prader-Willi syndrome*/
41,28,18,/*Fragile X Syndrome*/
41,48,18,/*Fragile X Syndrome*/
41,68,3,/*FXS*/
41,103,18,/*mental retardation*/
41,126,26,/*neuropsychiatric disorders*/
41,460,38,/*neuropsychiatric variables problematic*/
41,747,29,/*neuropsychiatric dysfunctions*/
41,1247,40,/*attention-deficit hpyeractivity disorder*/
41,1289,4,/*ADHD*/
41,1296,17,/*avoidant disorder*/
41,1315,33,/*pervasive developmental disorders*/
41,1350,17,/*anziety disorders*/
41,1369,14,/*mood disorders*/
41,1389,32,/*schizotypal personality disorder*/
42,0,6,/*Cancer*/
42,31,9,/*psoriasis*/
42,190,23,/*nonmelanoma skin cancer*/
42,235,28,/*cutaneous malignant melanoma*/
42,307,16,/*malignant tumors*/
42,547,9,/*psoriasis*/
42,841,4,/*PUVA*/
42,847,6,/*Cancer*/
42,1062,11,/*skin cancer*/
42,1090,16,/*internal cancers*/
42,1166,6,/*cancer*/
42,1221,20,/*basal cell carcinoma*/
42,1274,11,/*skin cancer*/
42,1300,20,/*noncutaneous cancers*/
42,1429,6,/*cancer*/
43,72,18,/*myotonic dystrophy*/
43,215,29,/*congenital myotonic dystrophy*/
43,339,17,/*muscular weakness*/
43,361,9,/*hypotonia*/
43,413,20,/*respiratory distress*/
43,485,26,/*generalized arthrogryposis*/
43,625,18,/*myotonic dystrophy*/
43,927,74,/*longitudinal evaluation of the cognitive deficit detected no deterioration*/
43,1068,22,/*ventricular dilatation*/
43,1118,20,/*cognitive impairment*/
43,1349,22,/*cerebral abnormalities*/
43,1410,17,/*myoencephalopathy*/
44,0,12,/*Microcephaly*/
44,150,23,/*congenital microcephaly*/
44,175,8,/*seizures*/
44,243,18,/*mental retardation*/
44,263,2,/*MR*/
44,493,37,/*known cortical malformation syndromes*/
44,676,10,/*pachygyria*/
44,979,32,/*autosomal recessive microcephaly*/
44,1139,31,/*neuronal proliferation disorder*/
46,84,19,/*Burkitt's lymphomas*/
46,154,4,/*FHIT*/
46,217,10,/*carcinomas*/
46,1497,18,/*Burkitt's lymphoma*/
46,1567,18,/*Epstein-Barr virus*/
47,127,28,/*syndrome of infantile spasms*/
47,157,14,/*hypsarrhythmia*/
47,177,18,/*mental retardation*/
47,197,13,/*West syndrome*/
47,235,8,/*epilepsy*/
47,329,13,/*West syndrome*/
47,349,28,/*X-linked recessive condition*/
47,496,28,/*syndrome of infantile spasms*/
47,992,18,/*adrenal hypoplasia*/
47,1042,25,/*X-linked infantile spasms*/
47,1252,54,/*syndromic or non-syndromic X-linked mental retardation*/
47,1360,22,/*neuroaxonal processing*/
48,537,20,/*ataxia telangectasia*/
48,721,5,/*tumor*/
48,1472,6,/*cancer*/
48,1573,6,/*cancer*/
48,2247,6,/*cancer*/
49,239,16,/*T-cell leukemias*/
49,260,9,/*lymphomas*/
49,1387,14,/*leukemogenesis*/
50,0,21,/*Loss of the ARF tumor*/
50,79,26,/*radiation hypersensitivity*/
50,649,21,/*ataxia telangiectasia*/
50,878,3,/*ARF*/
50,1034,9,/*lymphomas*/
50,1143,3,/*ARF*/
51,66,30,/*familial adenomatous polyposis*/
51,211,30,/*familial adenomatous polyposis*/
51,243,3,/*FAP*/
51,476,3,/*FAP*/
51,614,14,/*colonic polyps*/
52,150,14,/*hyperlipidemia*/
52,257,22,/*coronary heart disease*/
52,297,20,/*hypercholesterolemia*/
52,369,23,/*combined hyperlipidemia*/
52,413,22,/*coronary heart disease*/
52,825,14,/*hyperlipidemia*/
52,935,14,/*hyperlipidemia*/
52,1554,11,/*arachidonic*/
52,1914,14,/*hyperlipidemia*/
53,120,18,/*pulmonary diseases*/
53,324,6,/*cancer*/
53,526,6,/*cancer*/
53,723,15,/*lung malignancy*/
53,749,20,/*pulmonary conditions*/
53,1179,7,/*smokers*/
54,105,21,/*Ataxia telangiectasia*/
54,128,2,/*AT*/
54,521,2,/*AT*/
54,744,12,/*AT-LCLs/homo*/
54,1026,6,/*cancer*/
54,1184,6,/*cancer*/
54,1299,6,/*cancer*/
54,1324,2,/*AT*/
55,12,17,/*Angelman syndrome*/
56,75,27,/*Duchenne muscular dystrophy*/
56,127,27,/*Duchenne muscular dystrophy*/
56,536,27,/*Duchenne muscular dystrophy*/
58,18,20,/*Desbuquois dysplasia*/
58,215,18,/*skeletal dysplasia*/
58,245,20,/*Desbuquois dysplasia*/
58,327,22,/*generalized osteopenia*/
58,408,51,/*flattening of the long bones, broad proximal femora*/
58,634,20,/*Desbuquois dysplasia*/
58,694,33,/*minor spondylo-articular problems*/
58,791,14,/*growth failure*/
58,810,37,/*severe spondylo-articular deformities*/
58,851,20,/*Desbuquois dysplasia*/
58,940,20,/*Desbuquois dysplasia*/
58,1010,42,/*abnormalities of the diastrophic dysplasia*/
58,1154,20,/*Desbuquois dysplasia*/
58,1205,27,/*spondylo-articular problems*/
58,1313,20,/*Desbuquois dysplasia*/
60,67,35,/*paroxysmal nocturnal hemoglobinuria*/
60,104,35,/*Paroxysmal nocturnal hemoglobinuria*/
60,141,3,/*PNH*/
60,151,20,/*hematologic disorder*/
60,257,42,/*glycosylphosphatidylinositol (GPI) anchors*/
60,1194,3,/*PNH*/
60,1380,3,/*PNH*/
60,1430,15,/*aplastic anemia*/
60,1709,3,/*PNH*/
61,293,50,/*autosomal dominant nocturnal frontal lobe epilepsy*/
61,350,15,/*low-voltage EEG*/
61,467,41,/*autosomal dominant nocturnal frontal lobe*/
61,1026,21,/*idiopathic epilepsies*/
62,31,43,/*glucose-6-phosphate dehydrogenase-deficient*/
62,131,18,/*hyperbilirubinemia*/
62,274,53,/*glucose-6-phosphate dehydrogenase (G-6-PD) deficiency*/
62,397,9,/*hemolysis*/
62,599,18,/*Gilbert's syndrome*/
62,645,18,/*hyperbilirubinemia*/
62,743,17,/*G-6-PD deficiency*/
62,835,18,/*hyperbilirubinemia*/
62,1463,18,/*hyperbilirubinemia*/
62,2134,18,/*hyperbilirubinemia*/
62,2208,18,/*hyperbilirubinemia*/
62,2758,27,/*neonatal hyperbilirubinemia*/
62,2930,18,/*hyperbilirubinemia*/
63,85,17,/*diabetes mellitus*/
63,107,8,/*deafness*/
63,117,41,/*Thiamine-responsive megaloblastic anaemia*/
63,181,15,/*Rogers syndrome*/
63,275,21,/*megaloblastic anaemia*/
63,298,17,/*diabetes mellitus*/
63,320,22,/*sensorineural deafness*/
63,160,4,/*TRMA*/
63,1283,13,/*TRMA syndrome*/
64,0,15,/*Phenylketonuria*/
64,126,15,/*phenylketonuria*/
64,299,3,/*PKU*/
64,1193,3,/*PKU*/
65,110,28,/*Pelizaeus-Merzbacher disease*/
65,140,28,/*Pelizaeus-Merzbacher disease*/
65,170,3,/*PMD*/
65,180,14,/*leukodystrophy*/
65,292,3,/*PMD*/
65,519,3,/*PMD*/
65,849,3,/*PMD*/
66,1,31,/*Glucose-galactose malabsorption*/
66,99,31,/*glucose-galactose malabsorption*/
66,132,3,/*GGM*/
66,162,3,/*GGM*/
66,172,28,/*autosomal recessive disorder*/
66,252,9,/*diarrhoea*/
66,274,3,/*GGM*/
67,15,28,/*familial hemiplegic migraine*/
67,158,28,/*Familial hemiplegic migraine*/
67,188,3,/*FHM*/
67,218,2,/*HC*/
67,197,19,/*hemicrania continua*/
67,298,16,/*cyclic syndromes*/
67,384,2,/*HC*/
67,443,16,/*cyclic syndromes*/
68,57,31,/*X-linked dilated cardiomyopathy*/
68,90,4,/*XLDC*/
68,120,15,/*genetic disease*/
68,148,40,/*Duchenne and Becker muscular dystrophies*/
68,230,4,/*XLDC*/
69,52,18,/*diabetes insipidus*/
69,124,44,/*Familial neurohypophysial diabetes insipidus*/
69,189,22,/*vasopressin deficiency*/
69,530,8,/*PC12/PC2*/
70,683,12,/*Wilms' tumor*/
71,0,24,/*Maternal phenylketonuria*/
71,174,15,/*phenylketonuria*/
71,206,23,/*intellectual disability*/
71,245,24,/*congenital malformations*/
71,191,3,/*PKU*/
71,347,3,/*PKU*/
71,528,3,/*PKU*/
71,687,3,/*PKU*/
71,755,3,/*PKU*/
71,829,3,/*PKU*/
71,1117,3,/*PKU*/
71,1297,3,/*PKU*/
71,1347,21,/*maternal PKU syndrome*/
71,1567,3,/*PKU*/
71,1623,13,/*MPKU syndrome*/
72,58,5,/*tumor*/
72,90,6,/*glioma*/
72,192,5,/*tumor*/
72,243,6,/*glioma*/
72,330,5,/*tumor*/
72,655,14,/*retinoblastoma*/
72,842,5,/*tumor*/
72,945,6,/*glioma*/
72,1017,14,/*tumorigenicity*/
72,1127,6,/*glioma*/
72,1168,6,/*glioma*/
72,1264,12,/*glioblastoma*/
72,1366,6,/*tumors*/
72,1456,6,/*glioma*/
73,0,17,/*Visual impairment*/
73,55,13,/*choroideremia*/
73,79,13,/*Choroideremia*/
73,94,3,/*CHM*/
73,103,37,/*X-linked recessive hereditary disease*/
73,160,23,/*chorioretinal dystrophy*/
73,220,3,/*CHM*/
73,374,3,/*CHM*/
73,438,3,/*CHM*/
73,581,3,/*CHM*/
73,988,3,/*CHM*/
73,1193,3,/*CHM*/
73,1644,3,/*CHM*/
75,38,20,/*adrenoleukodystrophy*/
75,106,20,/*adrenoleukodystrophy*/
75,446,39,/*childhood cerebral adrenoleukodystrophy*/
75,493,21,/*adrenomyeloneuropathy*/
75,525,15,/*Addison disease*/
77,52,27,/*neurodegenerative disorders*/
77,171,20,/*Huntington's disease*/
77,193,2,/*HD*/
77,239,36,/*dentatorubral-pallidoluysian atrophy*/
77,303,2,/*HD*/
77,277,5,/*DRPLA*/
77,559,2,/*HD*/
77,631,2,/*HD*/
77,1037,2,/*HD*/
77,1375,20,/*neuronal dysfunction*/
77,1440,2,/*HD*/
78,196,20,/*Huntington's disease*/
78,232,20,/*Huntington's disease*/
78,254,2,/*HD*/
78,263,26,/*neurodegenerative disorder*/
78,407,2,/*HD*/
78,1607,2,/*HD*/
80,0,20,/*Cognitive impairment*/
80,45,18,/*myotonic dystrophy*/
80,86,18,/*Myotonic dystrophy*/
80,106,2,/*DM*/
80,123,21,/*multisystemic disease*/
80,179,32,/*cardiac and cognitive impairment*/
80,426,20,/*Cognitive impairment*/
80,578,24,/*neuromuscular impairment*/
80,688,2,/*DM*/
80,747,21,/*spinal muscle atrophy*/
80,844,4,/*WAIS*/
80,770,3,/*SMA*/
80,809,33,/*Wechsler Adult Intelligence Scale*/
80,882,2,/*DM*/
80,905,3,/*SMA*/
80,1042,4,/*WAIS*/
80,1107,4,/*SADS*/
80,1055,50,/*Schedule for Affective Disorders and Schizophrenia*/
80,1149,2,/*DM*/
80,1258,2,/*DM*/
80,1459,2,/*DM*/
80,1523,4,/*WAIS*/
80,1582,2,/*DM*/
80,1624,2,/*DM*/
80,1792,2,/*DM*/
80,1901,2,/*DM*/
80,2038,24,/*neuromuscular impairment*/
81,0,23,/*Familial gastric cancer*/
81,121,23,/*familial gastric cancer*/
81,262,23,/*familial gastric cancer*/
81,329,23,/*familial gastric cancer*/
81,408,14,/*gastric cancer*/
81,578,23,/*familial gastric cancer*/
81,633,14,/*gastric cancer*/
81,749,14,/*gastric cancer*/
81,858,23,/*familial gastric cancer*/
81,989,23,/*familial gastric cancer*/
81,1052,14,/*gastric cancer*/
81,1155,24,/*Familial gastric cancers*/
81,1266,24,/*sporadic gastric cancers*/
81,1322,23,/*familial gastric cancer*/
83,15,16,/*Pendred syndrome*/
83,33,22,/*autoimmune thyroiditis*/
83,61,13,/*simple goiter*/
83,90,16,/*Pendred syndrome*/
83,163,15,/*familial goiter*/
83,183,19,/*congenital deafness*/
83,326,37,/*congenital sensorineural hearing loss*/
83,365,6,/*goiter*/
83,414,16,/*Pendred syndrome*/
83,652,17,/*thyroid disorders*/
83,679,23,/*Hashimoto's thyroiditis*/
83,876,16,/*Pendred syndrome*/
83,894,22,/*autoimmune thyroiditis*/
83,922,13,/*simple goiter*/
84,45,27,/*Duchenne muscular dystrophy*/
84,110,26,/*Sensorineural hearing loss*/
84,172,30,/*inherited muscular dystrophies*/
84,369,27,/*Duchenne muscular dystrophy*/
86,0,54,/*Autosomal dominant neurohypophyseal diabetes insipidus*/
86,131,54,/*Autosomal dominant neurohypophyseal diabetes insipidus*/
86,188,5,/*ADNDI*/
86,202,17,/*inherited disease*/
86,459,18,/*diabetes insipidus*/
86,597,5,/*ADNDI*/
86,1092,42,/*attenuated posterior pituitary bright spot*/
87,19,27,/*hypertrophic cardiomyopathy*/
87,89,56,/*very-long-chain acyl-coenzyme A dehydrogenase deficiency*/
87,147,66,/*Very-long-chain acyl-coenzyme A dehydrogenase ( VLCAD ) deficiency*/
87,367,16,/*VLCAD deficiency*/
87,434,27,/*hypertrophic cardiomyopathy*/
87,464,12,/*hepatomegaly*/
87,479,14,/*encephalopathy*/
87,500,9,/*hypotonia*/
87,542,16,/*VLCAD deficiency*/
87,1077,16,/*VLCAD deficiency*/
87,1165,14,/*cardiomyopathy*/
88,65,17,/*breast carcinomas*/
88,193,5,/*tumor*/
88,228,13,/*breast cancer*/
88,348,17,/*breast carcinomas*/
88,418,5,/*tumor*/
88,491,17,/*breast carcinomas*/
88,690,17,/*breast carcinomas*/
88,758,5,/*tumor*/
88,803,17,/*breast carcinomas*/
88,905,5,/*tumor*/
88,926,17,/*breast carcinomas*/
88,997,6,/*tumors*/
88,1078,17,/*breast carcinomas*/
88,1140,17,/*breast carcinomas*/
88,1348,5,/*tumor*/
88,1465,13,/*breast cancer*/
89,55,21,/*ataxia-telangiectasia*/
89,261,21,/*ataxia-telangiectasia*/
89,284,3,/*A-T*/
89,337,28,/*autosomal recessive syndrome*/
89,413,6,/*cancer*/
89,424,22,/*coronary heart disease*/
89,659,3,/*A-T*/
89,973,3,/*A-T*/
89,1044,3,/*A-T*/
90,83,14,/*osteoarthritis*/
90,184,11,/*osteophytes*/
90,230,14,/*osteoarthritis*/
90,246,2,/*OA*/
90,413,11,/*osteophytes*/
90,483,39,/*malignant and benign mesenchymal tumors*/
90,768,2,/*OA*/
91,100,24,/*Wiskott-Aldrich syndrome*/
91,180,24,/*Wiskott-Aldrich syndrome*/
91,206,3,/*WAS*/
91,248,16,/*thrombocytopenia*/
91,266,6,/*eczema*/
91,277,17,/*immune deficiency*/
91,310,3,/*WAS*/
91,338,25,/*intracerebral hemorrhages*/
91,677,3,/*WAS*/
91,745,3,/*WAS*/
91,781,24,/*Wiskott-Aldrich syndrome*/
91,1090,3,/*WAS*/
91,1141,3,/*WAS*/
91,1502,3,/*WAS*/
91,1622,3,/*WAS*/
92,0,18,/*Myotonic dystrophy*/
92,133,18,/*Myotonic dystrophy*/
92,153,2,/*DM*/
92,249,22,/*Cardiovascular disease*/
92,320,2,/*DM*/
92,386,2,/*DM*/
92,641,2,/*DM*/
92,1455,21,/*cardiac contractility*/
92,1515,2,/*DM*/
93,86,5,/*tumor*/
93,162,23,/*familial ovarian cancer*/
93,420,13,/*ovarian tumor*/
93,445,23,/*familial ovarian cancer*/
93,573,5,/*tumor*/
93,660,5,/*tumor*/
93,1860,5,/*tumor*/
94,0,12,/*Microcephaly*/
94,14,14,/*microphthalmia*/
94,30,19,/*congenital cataract*/
94,51,13,/*optic atrophy*/
94,66,13,/*short stature*/
94,81,9,/*hypotonia*/
94,128,22,/*cerebral malformations*/
94,173,14,/*micro syndrome*/
94,281,9,/*hypotonia*/
94,292,16,/*spastic diplegia*/
94,310,12,/*microcephaly*/
94,324,14,/*microphthalmia*/
94,340,19,/*congenital cataract*/
94,361,13,/*optic atrophy*/
94,376,6,/*ptosis*/
94,384,14,/*kyphoscoliosis*/
94,400,13,/*short stature*/
94,422,18,/*mental retardation*/
94,446,22,/*cerebral malformations*/
95,30,25,/*von Hippel-Lindau disease*/
95,99,31,/*von Hippel-Lindau (VHL) disease*/
95,141,5,/*tumor*/
95,342,3,/*VHL*/
95,703,3,/*VHL*/
95,995,3,/*VHL*/
95,1244,22,/*VHL gene abnormalities*/
96,0,16,/*Kniest dysplasia*/
96,68,16,/*Kniest dysplasia*/
96,97,16,/*chondrodysplasia*/
96,368,9,/*blindness*/
96,673,16,/*Kniest dysplasia*/
98,159,13,/*breast cancer*/
98,183,6,/*tumors*/
98,220,37,/*breast sarcoma cancer family syndrome*/
98,733,5,/*tumor*/
98,1183,13,/*breast cancer*/
98,1206,7,/*cancers*/
98,1248,21,/*breast sarcoma cancer*/
99,156,28,/*metachromatic leukodystrophy*/
99,250,28,/*metachromatic leukodystrophy*/
99,280,3,/*MLD*/
99,510,3,/*MLD*/
99,1356,3,/*MLD*/
99,1876,15,/*ARSA deficiency*/
100,64,18,/*colorectal cancers*/
100,135,6,/*tumors*/
100,245,18,/*colorectal cancers*/
100,378,5,/*tumor*/
100,414,17,/*pancreatic cancer*/
100,467,27,/*Juvenile Polyposis Syndrome*/
100,496,3,/*JPS*/
100,683,18,/*colorectal cancers*/
100,718,6,/*tumors*/
100,915,6,/*tumors*/
100,1035,6,/*tumors*/
100,1438,6,/*tumors*/
100,1677,18,/*colorectal cancers*/
100,1884,17,/*Hereditary cancer*/
101,57,29,/*X-linked adrenoleukodystrophy*/
101,88,29,/*X-linked adrenoleukodystrophy*/
101,119,5,/*X-ALD*/
101,143,26,/*neurodegenerative disorder*/
101,394,5,/*X-ALD*/
101,587,5,/*X-ALD*/
101,598,31,/*peroxisome biogenesis disorders*/
101,788,5,/*X-ALD*/
101,847,5,/*X-ALD*/
101,1024,41,/*impaired peroxisomal beta-oxidation alone*/
101,1301,5,/*X-ALD*/
101,1853,5,/*X-ALD*/
101,1869,36,/*peroxisomal beta-oxidation disorders*/
103,82,42,/*inherited canine conotruncal heart defects*/
103,954,30,/*DiGeorge and related syndromes*/
104,56,20,/*retinal degeneration*/
104,155,20,/*retinal degeneration*/
104,237,24,/*intrinsic genetic defect*/
104,380,16,/*subretinal space*/
105,122,10,/*cystinuria*/
105,143,10,/*Cystinuria*/
105,422,10,/*Cystinuria*/
105,850,10,/*cystinuria*/
106,0,30,/*Trocar implantation metastasis*/
106,75,14,/*ovarian cancer*/
106,187,30,/*trocar implantation metastasis*/
106,285,23,/*advanced ovarian cancer*/
106,356,23,/*advanced ovarian cancer*/
106,408,14,/*ovarian cancer*/
106,551,23,/*implantation metastasis*/
106,1061,5,/*tumor*/
106,1084,5,/*tumor*/
106,1107,13,/*maximal tumor*/
106,1180,16,/*metastatic tumor*/
106,1198,14,/*residual tumor*/
106,1637,25,/*abdominal wall metastasis*/
106,1908,38,/*abdominal wall implantation metastasis*/
106,2238,14,/*ovarian cancer*/
107,28,26,/*adenovirus-mediated cancer*/
107,240,6,/*cancer*/
107,604,5,/*tumor*/
107,847,6,/*cancer*/
107,897,21,/*intraperitoneal tumor*/
107,1009,6,/*cancer*/
107,1332,5,/*tumor*/
107,1582,6,/*tumors*/
107,1792,5,/*tumor*/
107,2040,22,/*intraperitoneal tumors*/
107,2099,18,/*intrapleural tumor*/
108,470,7,/*LEF/TCF*/
109,0,31,/*Schwartz-Jampel syndrome type 2*/
109,36,24,/*Stuve-Wiedemann syndrome*/
109,181,24,/*Schwartz-Jampel syndrome*/
109,208,3,/*SJS*/
109,217,8,/*myotonia*/
109,230,18,/*skeletal dysplasia*/
109,341,24,/*Stuve-Wiedemann syndrome*/
109,368,3,/*SWS*/
109,392,10,/*campomelia*/
109,417,18,/*skeletal dysplasia*/
109,679,3,/*SWS*/
109,751,3,/*SWS*/
109,808,22,/*neuromuscular disorder*/
109,838,29,/*congenital joint contractures*/
109,921,12,/*hyperthermia*/
109,984,41,/*campomelic-metaphyseal skeletal dysplasia*/
109,1229,14,/*bone dysplasia*/
109,1297,3,/*SWS*/
109,1392,3,/*SWS*/
110,14,26,/*hereditary hemochromatosis*/
110,98,26,/*hereditary hemochromatosis*/
110,126,2,/*HH*/
110,170,25,/*understandable enthusiasm*/
110,197,2,/*HH*/
110,368,44,/*secondary cirrhosis, diabetes, heart failure*/
110,428,9,/*arthritis*/
110,701,2,/*HH*/
110,819,2,/*HH*/
112,38,24,/*myelodysplastic syndrome*/
112,67,26,/*acute myelogenous leukemia*/
112,288,17,/*refractory anemia*/
112,311,6,/*excess*/
112,337,10,/*basophilia*/
112,364,26,/*acute myelogenous leukemia*/
112,392,3,/*AML*/
112,402,12,/*eosinophilia*/
112,441,21,/*eosinophilic leukemia*/
112,464,3,/*AEL*/
112,671,3,/*AEL*/
112,745,3,/*AML*/
112,1075,3,/*AML*/
112,1083,3,/*AEL*/
112,1414,3,/*AML*/
112,1540,24,/*hematologic malignancies*/
113,86,17,/*Angelman syndrome*/
113,131,8,/*albinism*/
113,165,26,/*global developmental delay*/
113,413,8,/*albinism*/
113,502,9,/*nystagmus*/
113,795,17,/*Angelman syndrome*/
114,623,19,/*embryonic lethality*/
116,558,9,/*fragile X*/
119,81,34,/*hyperinsulinemic fatty Zucker rats*/
119,580,16,/*hyperinsulinemia*/
119,790,33,/*hyperinsulinemic fatty Zucker rat*/
119,2413,34,/*fatty hyperinsulinemic Zucker rats*/
120,146,21,/*ataxia telangiectasia*/
120,177,15,/*genetic disease*/
120,210,32,/*extreme sensitivity to radiation*/
121,151,48,/*ptosis, epicanthal folds, depressed nasal bridge*/
121,234,9,/*hirsutism*/
122,506,45,/*immunodeficiency, X-linked agammaglobulinemia*/
122,553,3,/*XLA*/
123,0,35,/*Crystal structure of the PTEN tumor*/
123,142,5,/*tumor*/
123,187,7,/*cancers*/
123,202,42,/*hereditary cancer predisposition syndromes*/
123,772,18,/*glioblastoma tumor*/
124,50,39,/*premalignant lesions of the oral mucosa*/
124,181,48,/*oral premalignant lesions and normal oral mucosa*/
124,345,28,/*oral dysplastic leukoplakias*/
124,775,62,/*basal layer of the floor of the mouth and the tongue epithelia*/
124,1133,3,/*LGD*/
124,1160,9,/*dysplasia*/
124,1204,3,/*HGD*/
124,1221,9,/*dysplasia*/
124,1179,23,/*high grade leukoplakias*/
124,1104,27,/*low grade oral leukoplakias*/
124,1702,20,/*dysplastic epithelia*/
125,44,32,/*Angelman syndrome-like phenotype*/
126,142,27,/*Duchenne muscular dystrophy*/
126,171,3,/*DMD*/
126,302,9,/*diaphragm*/
126,329,3,/*DMD*/
126,423,19,/*muscle degeneration*/
126,549,9,/*diaphragm*/
128,4,23,/*von Hippel-Lindau tumor*/
128,140,23,/*von Hippel-Lindau tumor*/
128,182,3,/*VHL*/
128,231,31,/*clear-cell renal cell carcinoma*/
128,265,3,/*RCC*/
128,276,3,/*VHL*/
128,314,25,/*von Hippel-Lindau disease*/
128,475,43,/*von Hippel-Lindau disease-associated tumors*/
128,566,3,/*VHL*/
128,688,3,/*VHL*/
128,769,3,/*RCC*/
128,1132,3,/*VHL*/
128,1266,3,/*VHL*/
128,1394,3,/*VHL*/
128,1497,3,/*RCC*/
128,1698,3,/*VHL*/
128,1856,25,/*von Hippel-Lindau disease*/
128,1886,3,/*RCC*/
129,107,43,/*glucose-6-phosphate dehydrogenase-deficient*/
129,168,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
129,249,7,/*malaria*/
129,424,17,/*G6PD deficiencies*/
129,517,14,/*G6PD-deficient*/
129,632,15,/*G6PD deficiency*/
129,760,5,/*tumor*/
129,928,3,/*A/T*/
129,1032,14,/*G6PD-deficient*/
129,1200,14,/*G6PD-deficient*/
129,1287,14,/*G6PD-deficient*/
129,1747,7,/*malaria*/
129,1837,14,/*G6PD-deficient*/
129,1975,14,/*G6PD-deficient*/
130,121,26,/*Hereditary hemochromatosis*/
130,149,2,/*HH*/
130,165,28,/*autosomal-recessive disorder*/
130,231,2,/*HH*/
130,1262,2,/*HH*/
131,73,21,/*polyglutamine disease*/
131,96,32,/*Polyglutamine (polygln) diseases*/
131,144,37,/*inherited neurodegenerative disorders*/
131,587,52,/*spinocerebellar ataxia type 3/Machado-Joseph disease*/
131,641,8,/*SCA3/MJD*/
131,895,16,/*SCA3/MJD disease*/
132,190,2,/*RB*/
132,1007,8,/*RB tumor*/
134,57,19,/*Bedlington terriers*/
134,78,16,/*Copper toxicosis*/
134,109,13,/*liver disease*/
134,143,19,/*Bedlington terriers*/
134,229,14,/*Wilson disease*/
134,335,14,/*Wilson disease*/
134,374,23,/*canine copper toxicosis*/
134,1608,22,/*copper storage disease*/
135,0,21,/*Peripheral neuropathy*/
135,68,28,/*Pelizaeus-Merzbacher disease*/
135,98,3,/*PMD*/
135,108,23,/*dysmyelinating disorder*/
135,344,3,/*PMD*/
135,439,10,/*neuropathy*/
136,54,35,/*dominant non-syndromic hearing loss*/
136,188,12,/*hearing loss*/
136,294,8,/*deafness*/
136,351,8,/*deafness*/
136,588,26,/*sensorineural hearing loss*/
136,1566,22,/*non-syndromic deafness*/
137,0,24,/*Orofaciodigital syndrome*/
137,26,6,/*type I*/
137,99,24,/*orofaciodigital syndrome*/
138,56,21,/*ataxia-telangiectasia*/
138,126,16,/*genetic disorder*/
138,143,21,/*ataxia-telangiectasia*/
138,167,3,/*A-T*/
138,597,3,/*A-T*/
138,988,3,/*A-T*/
139,82,36,/*Paroxysmal nocturnal haemoglobinuria*/
139,565,36,/*paroxysmal nocturnal haemoglobinuria*/
139,811,36,/*paroxysmal nocturnal haemoglobinuria*/
140,174,17,/*matrix deficiency*/
141,305,19,/*embryonic lethality*/
141,757,52,/*X-linked recessive Emery-Dreifuss muscular dystrophy*/
141,834,9,/*Ce-emerin*/
141,930,19,/*embryonic lethality*/
141,1657,33,/*Emery-Dreifuss muscular dystrophy*/
142,23,6,/*cancer*/
142,159,6,/*Cancer*/
142,301,6,/*cancer*/
142,515,16,/*inherited tumors*/
142,736,6,/*cancer*/
142,956,6,/*cancer*/
142,1125,6,/*cancer*/
142,1677,21,/*breast/ovarian cancer*/
142,1845,6,/*cancer*/
142,2063,6,/*cancer*/
142,2260,6,/*cancer*/
142,2319,6,/*cancer*/
142,2383,6,/*cancer*/
143,96,22,/*aortic atherosclerosis*/
143,355,15,/*atherosclerosis*/
143,1576,11,/*LCAT-Tg HDL*/
143,1774,15,/*atherosclerosis*/
143,1849,15,/*atherosclerosis*/
143,1923,7,/*LCAT-Tg*/
144,39,25,/*alveolar rhabdomyosarcoma*/
144,100,35,/*Pediatric alveolar rhabdomyosarcoma*/
145,374,2,/*IV*/
145,599,2,/*IV*/
146,56,16,/*colorectal tumor*/
146,247,29,/*colorectal premalignant polyp*/
146,281,9,/*carcinoma*/
146,540,14,/*Colonic polyps*/
146,568,5,/*tumor*/
146,673,27,/*hereditary cancer syndromes*/
146,746,14,/*sporadic tumor*/
146,984,12,/*colon cancer*/
147,0,69,/*Molecular defects leading to human complement component C6 deficiency*/
147,101,34,/*Complement component C6 deficiency*/
147,202,24,/*meningococcal meningitis*/
147,304,10,/*meningitis*/
147,324,20,/*neisserial infection*/
149,0,27,/*Gastric and duodenal polyps*/
149,119,5,/*tumor*/
149,206,20,/*pancreatic carcinoma*/
149,492,8,/*adenomas*/
149,513,15,/*adenocarcinomas*/
149,780,44,/*inflammatory polyps in the glandular stomach*/
149,1115,6,/*polyps*/
149,1143,15,/*juvenile polyps*/
149,1435,27,/*familial juvenile polyposis*/
150,36,34,/*hormone-refractory prostate cancer*/
150,72,15,/*Prostate cancer*/
150,289,15,/*prostate cancer*/
150,376,48,/*untreated and hormone-refractory prostate cancer*/
150,1055,2,/*AR*/
150,1198,7,/*cancers*/
150,1429,34,/*hormone-refractory prostate cancer*/
150,1667,34,/*hormone-refractory prostate cancer*/
151,85,18,/*fragile-X syndrome*/
151,105,18,/*Fragile-X syndrome*/
151,261,28,/*fragile-X mental retardation*/
152,32,6,/*cancer*/
153,332,6,/*tumors*/
155,331,6,/*cancer*/
155,421,60,/*colon, rectal, breast, melanoma, bladder and ovarian cancers*/
155,538,6,/*cancer*/
155,987,6,/*tumour*/
155,1147,34,/*breast, ovarian and rectal tumours*/
155,1531,34,/*breast, ovarian and rectal tumours*/
156,35,20,/*Li-Fraumeni syndrome*/
156,67,14,/*gastric cancer*/
157,23,23,/*colorectal adenomatosis*/
157,50,30,/*familial adenomatous polyposis*/
157,199,8,/*adenomas*/
157,278,3,/*FAP*/
157,651,3,/*FAP*/
157,715,23,/*colorectal adenomatosis*/
157,863,19,/*colorectal adenomas*/
157,1429,8,/*adenomas*/
157,1510,11,/*colon sigma*/
157,1566,8,/*adenomas*/
157,1672,21,/*Colorectal carcinomas*/
158,59,8,/*migraine*/
158,466,2,/*DZ*/
158,958,8,/*DZ-pairs*/
159,31,6,/*McLeod*/
159,65,2,/*XS*/
159,109,15,/*McLeod syndrome*/
159,135,27,/*X-linked recessive disorder*/
159,211,28,/*haematopoietic abnormalities*/
159,353,6,/*McLeod*/
159,397,3,/*DMD*/
159,508,3,/*DMD*/
159,749,3,/*DMD*/
159,774,2,/*XS*/
160,73,24,/*Wiskott-Aldrich syndrome*/
160,141,24,/*Wiskott-Aldrich syndrome*/
160,171,24,/*Wiskott-Aldrich syndrome*/
160,197,3,/*WAS*/
160,215,33,/*X-linked immunodeficiency disease*/
160,276,24,/*Wiskott-Aldrich syndrome*/
160,368,3,/*WAS*/
160,1078,24,/*Wiskott-Aldrich syndrome*/
161,407,6,/*G6PD A*/
161,430,14,/*G6PD deficient*/
161,806,17,/*enzyme deficiency*/
163,25,15,/*hemochromatosis*/
163,195,26,/*hereditary hemochromatosis*/
163,420,15,/*hemochromatosis*/
165,453,3,/*OAT*/
166,28,8,/*melanoma*/
166,654,3,/*TAM*/
166,1217,3,/*TAM*/
166,1418,20,/*tamoxifen resistance*/
168,28,25,/*pancreatic adenocarcinoma*/
168,143,25,/*pancreatic adenocarcinoma*/
168,238,25,/*familial cancer syndromes*/
168,340,17,/*pancreatic cancer*/
168,380,26,/*hereditary cancer syndrome*/
168,554,6,/*cancer*/
168,638,25,/*pancreatic adenocarcinoma*/
168,1659,17,/*pancreatic cancer*/
168,1730,19,/*early-onset disease*/
168,1861,17,/*pancreatic cancer*/
170,0,38,/*Type II human complement C2 deficiency*/
170,143,40,/*Type II complement protein C2 deficiency*/
170,331,3,/*MHC*/
};
}
static void init1() {
a1 = new int[] {
170,381,20,/*Type I C2 deficiency*/
170,440,18,/*Type II deficiency*/
170,665,21,/*Type II C2 deficiency*/
170,1075,2,/*C2*/
172,775,3,/*TSD*/
172,734,39,/*temperature-dependent sex determination*/
173,5,24,/*Schmid-Fraccaro syndrome*/
173,75,48,/*bilateral colobomatous malformations of the uvea*/
173,144,17,/*anorectal atresia*/
173,192,26,/*Schmid-Fraccaro's syndrome*/
173,231,16,/*cat eye syndrome*/
174,14,26,/*hereditary hemochromatosis*/
174,145,26,/*hereditary hemochromatosis*/
174,257,30,/*hemochromatosis-associated HFE*/
174,2045,26,/*hereditary hemochromatosis*/
176,84,26,/*bipolar affective disorder*/
176,175,16,/*Bipolar Disorder*/
176,438,9,/*bipolar I*/
176,510,10,/*bipolar II*/
176,449,3,/*BPI*/
176,522,4,/*BPII*/
176,1258,13,/*schizophrenia*/
176,1276,16,/*bipolar disorder*/
177,37,18,/*male breast cancer*/
177,168,13,/*breast cancer*/
177,254,13,/*breast cancer*/
177,348,18,/*male breast cancer*/
177,453,13,/*breast cancer*/
177,468,2,/*BC*/
177,993,2,/*BC*/
177,1113,13,/*breast cancer*/
177,1173,2,/*BC*/
177,1314,2,/*BC*/
178,36,21,/*ataxia-telangiectasia*/
178,151,28,/*autosomal recessive disorder*/
178,180,21,/*ataxia-telangiectasia*/
178,204,3,/*A-T*/
178,288,3,/*A-T*/
178,1045,3,/*A-T*/
178,1104,3,/*A-T*/
178,1559,3,/*A-T*/
179,97,7,/*cancers*/
179,239,6,/*cancer*/
179,261,23,/*primary lung carcinomas*/
179,324,5,/*tumor*/
179,614,9,/*cancerous*/
179,667,34,/*cancers of colon, ovary, and liver*/
179,818,21,/*colorectal carcinomas*/
179,848,17,/*ovarian carcinoma*/
179,989,6,/*cancer*/
179,1138,27,/*insulin resistant disorders*/
181,46,25,/*alveolar rhabdomyosarcoma*/
181,80,16,/*pediatric cancer*/
181,106,16,/*rhabdomyosarcoma*/
182,0,29,/*Retino-vascular malformations*/
183,895,23,/*anterior-posterior axis*/
185,440,25,/*alveolar rhabdomyosarcoma*/
186,26,17,/*colorectal tumors*/
186,159,18,/*colorectal cancers*/
186,301,3,/*APC*/
186,384,30,/*familial adenomatous polyposis*/
186,416,3,/*FAP*/
186,505,10,/*FAP tumors*/
186,694,17,/*colorectal cancer*/
186,730,7,/*cancers*/
186,767,3,/*APC*/
186,892,17,/*colorectal tumors*/
186,996,18,/*colorectal cancers*/
186,1053,6,/*tumors*/
186,1272,3,/*APC*/
186,1288,17,/*colorectal tumors*/
186,1320,3,/*FAP*/
186,1432,12,/*allelic loss*/
186,1454,6,/*tumors*/
186,1681,3,/*APC*/
187,93,28,/*Familial Mediterranean fever*/
187,123,3,/*FMF*/
187,134,27,/*autosomal recessive disease*/
187,200,9,/*serositis*/
187,372,3,/*FMF*/
187,473,3,/*FMF*/
187,756,3,/*FMF*/
187,786,3,/*FMF*/
187,1213,3,/*FMF*/
188,0,18,/*Myotonic dystrophy*/
188,126,18,/*myotonic dystrophy*/
188,146,2,/*DM*/
188,787,2,/*DM*/
188,930,2,/*DM*/
189,81,13,/*breast cancer*/
189,239,5,/*tumor*/
189,680,13,/*breast cancer*/
189,1200,6,/*cancer*/
190,111,14,/*Leigh syndrome*/
190,127,40,/*Succinate dehydrogenase (SDH) deficiency*/
190,196,14,/*Leigh syndrome*/
190,212,2,/*LS*/
190,422,2,/*LS*/
190,429,14,/*SDH deficiency*/
190,478,2,/*LS*/
190,485,14,/*SDH deficiency*/
190,1575,35,/*deficiencies in complex II activity*/
190,1678,2,/*LS*/
191,223,43,/*neoplastic transformation and tumorigenesis*/
191,614,20,/*abnormal cell growth*/
191,1480,33,/*proteolytic feedback-control loop*/
192,78,23,/*sporadic hepatoblastoma*/
192,103,14,/*Hepatoblastoma*/
192,119,2,/*HB*/
192,160,5,/*tumor*/
192,370,39,/*familial adenomatous polyposis syndrome*/
192,777,6,/*cancer*/
192,888,2,/*HB*/
192,1356,2,/*HB*/
193,115,9,/*arthritis*/
193,126,26,/*Collagen-induced arthritis*/
193,154,3,/*CIA*/
193,189,24,/*autoimmune polyarthritis*/
193,253,20,/*rheumatoid arthritis*/
193,348,20,/*rheumatoid arthritis*/
193,526,9,/*arthritis*/
193,614,24,/*Ab-mediated inflammation*/
193,642,3,/*CIA*/
193,787,54,/*congenic for deficiency of the C5 complement component*/
193,1150,12,/*C5-deficient*/
193,1281,25,/*Ab-triggered inflammation*/
193,1334,20,/*autoimmune arthritis*/
194,78,13,/*breast cancer*/
194,106,13,/*Breast Cancer*/
194,189,13,/*breast cancer*/
194,300,13,/*breast cancer*/
194,333,13,/*Breast Cancer*/
194,427,24,/*ovarian or other cancers*/
194,703,21,/*breast-ovarian cancer*/
194,854,13,/*breast cancer*/
194,1664,13,/*breast cancer*/
194,1938,13,/*breast cancer*/
195,54,28,/*breast and/or ovarian cancer*/
195,137,13,/*breast cancer*/
195,406,13,/*breast cancer*/
195,649,6,/*cancer*/
195,927,13,/*breast cancer*/
195,1194,25,/*breast and ovarian cancer*/
195,1242,13,/*breast cancer*/
196,516,36,/*hereditary breast and ovarian cancer*/
197,111,13,/*C9 deficiency*/
197,1259,13,/*C9 deficiency*/
197,1419,19,/*bacterial infection*/
198,27,43,/*familial juvenile hyperuricemic nephropathy*/
198,79,24,/*underexcretion-type gout*/
198,175,43,/*Familial juvenile hyperuricemic nephropathy*/
198,244,26,/*autosomal-dominant disease*/
198,288,33,/*underexcretion-type hyperuricemia*/
198,323,4,/*gout*/
198,333,21,/*chronic renal failure*/
198,220,4,/*FJHN*/
198,400,38,/*underexcretion-type hyperuricemia/gout*/
200,69,6,/*autism*/
200,269,6,/*autism*/
200,834,6,/*autism*/
201,72,21,/*ataxia telangiectasia*/
201,124,21,/*ataxia telangiectasia*/
202,92,13,/*Schizophrenia*/
202,327,13,/*schizophrenia*/
203,15,32,/*adenomatous polyposis coli tumor*/
203,171,12,/*colon cancer*/
203,208,35,/*familial adenomatous polyposis coli*/
203,245,3,/*FAP*/
203,295,19,/*colorectal adenomas*/
203,319,10,/*carcinomas*/
203,370,12,/*colon cancer*/
203,413,5,/*tumor*/
203,442,3,/*APC*/
203,485,12,/*colon tumors*/
203,547,5,/*tumor*/
203,670,35,/*colonic epithelial cell homeostasis*/
203,798,3,/*APC*/
203,1097,18,/*APC-mediated tumor*/
203,1145,3,/*FAP*/
203,1336,17,/*colorectal cancer*/
203,1428,7,/*cancers*/
204,42,24,/*fallopian tube carcinoma*/
204,95,24,/*Fallopian tube carcinoma*/
204,134,32,/*ovarian and peritoneal carcinoma*/
204,290,32,/*ovarian and peritoneal carcinoma*/
204,343,19,/*gynecologic cancers*/
204,388,24,/*fallopian tube carcinoma*/
204,437,17,/*ovarian carcinoma*/
204,643,31,/*ovarian or peritoneal carcinoma*/
204,694,21,/*fallopian tube cancer*/
204,768,32,/*abnormality in the breast cancer*/
205,4,33,/*Emery-Dreifuss muscular dystrophy*/
205,693,33,/*Emery-Dreifuss muscular dystrophy*/
205,729,4,/*EMDM*/
205,879,4,/*EDMD*/
206,450,28,/*postnatal growth retardation*/
206,565,24,/*retarded bone maturation*/
206,773,12,/*clinodactyly*/
206,932,23,/*Silver-Russell syndrome*/
206,957,3,/*SRS*/
206,1399,28,/*trisomy 7 in chorionic villi*/
206,1595,48,/*postnatal growth retardation anda facial gestalt*/
207,765,12,/*fetal anemia*/
207,884,12,/*fetal anemia*/
207,964,6,/*McLeod*/
207,1067,18,/*muscular dystrophy*/
207,1090,19,/*nerve abnormalities*/
209,85,15,/*Gaucher disease*/
209,102,15,/*Gaucher disease*/
209,250,18,/*glucocerebrosidase*/
209,597,22,/*type 1 Gaucher disease*/
209,714,15,/*Gaucher disease*/
209,1374,15,/*Gaucher disease*/
209,1503,15,/*Gaucher disease*/
209,1582,24,/*perinatal lethal disease*/
210,73,19,/*embryonic lethality*/
210,379,21,/*ataxia telangiectasia*/
210,402,2,/*AT*/
210,409,20,/*pleiotropic disorder*/
210,447,21,/*radiation sensitivity*/
210,1101,19,/*embryonic lethality*/
211,44,28,/*metachromatic leukodystrophy*/
211,295,28,/*metachromatic leukodystrophy*/
211,325,3,/*MLD*/
211,893,3,/*MLD*/
211,1062,3,/*MLD*/
211,1308,19,/*motor deterioration*/
211,1395,17,/*gait disturbances*/
211,1469,22,/*swallowing, dysarthria*/
211,1493,6,/*tremor*/
211,1505,9,/*nystagmus*/
211,1598,22,/*psychotic disturbances*/
212,0,14,/*Retinoblastoma*/
212,39,2,/*Rb*/
212,199,13,/*breast cancer*/
212,503,14,/*retinoblastoma*/
212,547,2,/*Rb*/
212,652,2,/*Rb*/
212,869,5,/*tumor*/
212,929,5,/*tumor*/
213,239,12,/*galactosemia*/
214,171,12,/*RSH syndrome*/
214,191,36,/*autosomal recessive genetic disorder*/
214,255,39,/*multi-organ developmental abnormalities*/
214,296,37,/*dysmorphic facies, limb malformations*/
214,338,18,/*mental retardation*/
215,33,28,/*postmenopausal breast cancer*/
215,123,13,/*breast cancer*/
215,184,13,/*breast cancer*/
215,326,28,/*postmenopausal breast cancer*/
215,394,13,/*breast cancer*/
215,900,24,/*breast and other cancers*/
215,1429,13,/*breast cancer*/
215,1520,28,/*postmenopausal breast cancer*/
215,1556,13,/*breast cancer*/
216,173,7,/*malaria*/
216,286,25,/*deficient enzyme activity*/
216,339,7,/*malaria*/
216,1043,2,/*LD*/
217,31,6,/*tumour*/
217,112,6,/*tumour*/
217,151,26,/*prostate and other cancers*/
217,1450,15,/*prostate cancer*/
217,1581,24,/*advanced prostate cancer*/
217,1698,15,/*prostate cancer*/
218,86,28,/*familial Mediterranean fever*/
218,116,28,/*Familial Mediterranean fever*/
218,146,3,/*FMF*/
218,244,3,/*FMF*/
218,290,5,/*fever*/
218,372,17,/*renal amyloidosis*/
218,402,2,/*AA*/
218,390,10,/*associated*/
218,513,11,/*amyloidosis*/
218,530,3,/*FMF*/
218,757,3,/*FMF*/
218,803,3,/*FMF*/
220,31,14,/*Wilson disease*/
220,91,14,/*Wilson disease*/
220,107,3,/*WND*/
221,32,53,/*deficiency of the second component of complement (C2)*/
221,90,27,/*discoid lupus erythematosus*/
221,136,59,/*hereditary deficiency of the second component of complement*/
221,200,27,/*discoid lupus erythematosus*/
221,245,28,/*systemic lupus erythematosus*/
221,335,10,/*arthralgia*/
221,347,23,/*Transient renal disease*/
221,419,8,/*seizures*/
221,1216,13,/*C2 deficiency*/
221,1300,13,/*C2 deficiency*/
221,1393,13,/*C2 deficiency*/
221,1680,12,/*C3-deficient*/
221,1710,19,/*lupus erythematosus*/
222,0,20,/*Huntington's disease*/
222,203,20,/*Huntington's disease*/
222,225,2,/*HD*/
222,570,2,/*HD*/
223,100,23,/*lumbosacral spinal cord*/
223,380,16,/*lumbosacral cord*/
224,212,16,/*rhabdomyosarcoma*/
224,230,3,/*RMS*/
224,236,12,/*solid tumors*/
224,357,3,/*RMS*/
224,455,3,/*RMS*/
224,489,6,/*BCL-XL*/
224,572,3,/*RMS*/
224,623,6,/*BCL-XL*/
224,1195,5,/*tumor*/
225,2003,37,/*stimulus-specific regulation of tumor*/
226,72,25,/*breast and ovarian cancer*/
226,99,26,/*Breast and ovarian cancers*/
226,265,13,/*breast cancer*/
226,439,6,/*cancer*/
226,509,25,/*breast and ovarian cancer*/
226,620,24,/*breast or ovarian cancer*/
226,681,13,/*breast cancer*/
226,789,14,/*ovarian cancer*/
226,1092,14,/*ovarian cancer*/
226,1281,14,/*ovarian cancer*/
226,1364,25,/*breast and ovarian cancer*/
226,1456,13,/*breast cancer*/
226,1537,25,/*breast or ovarian cancers*/
226,1625,13,/*breast cancer*/
226,1687,24,/*breast or ovarian cancer*/
226,1778,14,/*ovarian cancer*/
226,1924,25,/*breast and ovarian cancer*/
227,188,37,/*autosomal dominant inherited syndrome*/
227,229,36,/*benign familial neonatal convulsions*/
227,267,4,/*BFNC*/
227,627,27,/*benign neonatal convulsions*/
227,730,8,/*seizures*/
228,0,20,/*Pyoderma gangrenosum*/
228,39,29,/*autoimmune haemolytic anaemia*/
228,73,21,/*complement deficiency*/
228,118,20,/*pyoderma gangrenosum*/
228,140,2,/*PG*/
228,177,17,/*systemic diseases*/
228,267,29,/*autoimmune haemolytic anaemia*/
228,319,46,/*congenital deficiency of complement factors C2*/
229,84,15,/*retinal atrophy*/
229,162,15,/*retinal atrophy*/
229,213,19,/*hereditary diseases*/
229,383,20,/*retinitis pigmentosa*/
229,1925,18,/*Labrador Retriever*/
229,2113,18,/*Labrador Retriever*/
229,2275,18,/*Labrador Retriever*/
230,86,17,/*Tay-Sachs disease*/
230,142,17,/*Tay-Sachs disease*/
230,161,3,/*TSD*/
230,171,30,/*recessively inherited disorder*/
230,231,12,/*A deficiency*/
230,357,3,/*TSD*/
230,886,3,/*TSD*/
230,1000,3,/*TSD*/
231,16,18,/*fragile X syndrome*/
231,97,18,/*Fragile X syndrome*/
231,142,28,/*inherited mental retardation*/
231,1196,18,/*fragile X syndrome*/
231,1317,19,/*developmental delay*/
231,1341,21,/*learning difficulties*/
233,0,9,/*Fragile X*/
233,169,18,/*fragile X syndrome*/
233,389,23,/*triplet repeat diseases*/
233,1315,18,/*fragile X syndrome*/
235,174,20,/*retinal degeneration*/
235,300,20,/*retinitis pigmentosa*/
236,0,26,/*Proximal myotonic myopathy*/
236,148,17,/*myotonic myopathy*/
236,286,18,/*myotonic dystrophy*/
236,306,2,/*DM*/
236,311,2,/*DM*/
236,1316,22,/*parent-offspring pairs*/
236,1611,2,/*DM*/
236,1681,2,/*DM*/
236,1701,5,/*PROMM*/
237,96,3,/*FAP*/
237,155,17,/*colorectal cancer*/
237,227,17,/*colorectal cancer*/
237,300,30,/*familial adenomatous polyposis*/
237,333,3,/*FAP*/
237,625,3,/*APC*/
237,650,17,/*colorectal cancer*/
237,722,3,/*FAP*/
237,741,17,/*colorectal cancer*/
237,955,3,/*FAP*/
237,1085,17,/*colorectal cancer*/
237,1237,3,/*FAP*/
237,1661,3,/*FAP*/
237,1677,17,/*colorectal cancer*/
238,878,19,/*thrombotic symptoms*/
238,1096,17,/*PROC gene lesions*/
239,32,14,/*Wilson disease*/
239,175,14,/*Wilson disease*/
239,191,3,/*WND*/
239,1582,3,/*WND*/
239,1703,3,/*WND*/
239,1840,3,/*WND*/
240,0,21,/*Adenomatous polyposis*/
240,156,31,/*classical adenomatous polyposis*/
240,189,3,/*FAP*/
240,224,14,/*attenuated FAP*/
240,240,4,/*AFAP*/
240,349,9,/*polyposis*/
240,461,21,/*adenomatous polyposis*/
240,1182,6,/*tumors*/
240,1461,3,/*FAP*/
240,1582,3,/*APC*/
241,88,13,/*Down syndrome*/
241,165,6,/*AML-M7*/
241,212,13,/*Down syndrome*/
241,446,13,/*Down syndrome*/
241,561,3,/*AML*/
241,689,3,/*AML*/
242,112,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
242,196,19,/*enzyme deficiencies*/
242,696,14,/*G6PD-deficient*/
242,1209,14,/*G6PD-deficient*/
243,67,21,/*Prader-Willi syndrome*/
243,154,21,/*Prader-Willi syndrome*/
243,177,3,/*PWS*/
243,186,17,/*Angelman syndrome*/
243,205,2,/*AS*/
243,280,3,/*PWS*/
243,441,20,/*congenital anomalies*/
243,466,18,/*mental retardation*/
243,838,3,/*PWS*/
244,59,25,/*growth hormone deficiency*/
244,242,34,/*isolated growth hormone deficiency*/
244,278,4,/*IGHD*/
244,519,4,/*IGHD*/
244,1663,4,/*IGHD*/
245,46,11,/*hypokalemic*/
245,152,39,/*familial hypokalemic periodic paralysis*/
245,573,26,/*hereditary muscle diseases*/
245,616,8,/*myotonia*/
245,1604,8,/*HypoPP-2*/
245,1707,8,/*myotonia*/
247,620,25,/*atherogenic lipid profile*/
248,43,21,/*ataxia-telangiectasia*/
248,130,16,/*genetic disorder*/
248,147,21,/*ataxia-telangiectasia*/
248,170,3,/*A-T*/
248,442,3,/*A-T*/
248,573,3,/*A-T*/
248,851,3,/*A-T*/
248,1185,3,/*A-T*/
249,188,41,/*autosomal recessive nonsyndromic deafness*/
249,1070,6,/*DFNB10*/
249,1213,16,/*genetic diseases*/
250,1000,23,/*Drosophila melanogaster*/
250,1276,19,/*embryonic lethality*/
250,1738,13,/*Down syndrome*/
252,78,18,/*Zellweger syndrome*/
252,123,39,/*Zellweger cerebro-hepato-renal syndrome*/
252,175,19,/*congenital disorder*/
252,424,32,/*peroxisomal biogenesis disorders*/
252,1059,18,/*Zellweger syndrome*/
253,0,14,/*Ovarian cancer*/
253,202,13,/*breast cancer*/
253,235,14,/*ovarian cancer*/
253,381,14,/*tumourigenesis*/
253,722,7,/*cancers*/
253,742,13,/*breast cancer*/
253,852,36,/*hereditary breast and ovarian cancer*/
253,999,14,/*ovarian cancer*/
253,1302,25,/*hereditary ovarian cancer*/
253,1354,13,/*breast cancer*/
253,1535,15,/*cancer syndrome*/
255,81,18,/*myotonic dystrophy*/
255,128,18,/*myotonic dystrophy*/
255,149,2,/*DM*/
255,270,2,/*DM*/
255,447,2,/*DM*/
255,764,2,/*DM*/
255,1261,18,/*myotonic dystrophy*/
256,108,21,/*embryonic development*/
256,134,13,/*tumorigenesis*/
256,385,5,/*tumor*/
256,581,7,/*cancers*/
257,844,5,/*tumor*/
258,84,18,/*insulin resistance*/
258,114,19,/*Friedreich's ataxia*/
258,135,2,/*FA*/
258,145,27,/*autosomal recessive disease*/
258,278,26,/*Impaired glucose tolerance*/
258,332,2,/*FA*/
258,369,8,/*diabetes*/
258,521,2,/*FA*/
258,630,8,/*diabetes*/
258,738,2,/*FA*/
258,793,2,/*FA*/
258,856,32,/*parameters of glucose metabolism*/
258,1340,18,/*insulin resistance*/
258,1452,8,/*diabetes*/
259,56,28,/*oral squamous cell carcinoma*/
259,126,38,/*Adenomatous Polyposis Coli (APC) tumor*/
259,331,28,/*oral squamous cell carcinoma*/
259,361,4,/*OSCC*/
259,395,3,/*APC*/
259,652,6,/*cancer*/
259,776,3,/*APC*/
259,853,3,/*APC*/
260,63,41,/*Echinococcus granulosus hydatid infection*/
260,260,39,/*Echinococcus granulosus hydatid disease*/
260,470,12,/*C5-deficient*/
260,949,11,/*eosinophils*/
260,1115,12,/*C5-deficient*/
260,1231,12,/*C5-deficient*/
262,53,42,/*hereditary non-polyposis colorectal cancer*/
262,214,42,/*hereditary non-polyposis colorectal cancer*/
262,258,5,/*HNPCC*/
262,371,5,/*HNPCC*/
262,580,28,/*hereditary colorectal cancer*/
262,620,30,/*familial adenomatous polyposis*/
262,694,5,/*HNPCC*/
262,772,21,/*Amsterdam II criteria*/
262,947,20,/*colorectal neoplasia*/
262,1360,5,/*HNPCC*/
262,2015,5,/*HNPCC*/
263,308,29,/*smooth eye and head movements*/
263,390,30,/*smooth tracking head movements*/
263,1395,28,/*smooth pursuit eye movements*/
263,1582,28,/*smooth pursuit eye movements*/
264,92,28,/*metachromatic leukodystrophy*/
264,215,53,/*classical late infantile metachromatic leukodystrophy*/
264,271,3,/*MLD*/
264,387,2,/*GS*/
264,591,3,/*MLD*/
264,1324,3,/*MLD*/
264,1478,3,/*MLD*/
264,1597,13,/*MLD-like ARSA*/
264,1881,2,/*GS*/
265,17,31,/*hereditary progressive dystonia*/
265,82,3,/*HPD*/
265,105,24,/*dopa-responsive dystonia*/
265,292,20,/*tyrosine hydroxylase*/
265,354,3,/*HPD*/
265,381,24,/*dopa-responsive dystonia*/
265,490,31,/*hereditary progressive dystonia*/
265,523,3,/*HPD*/
266,117,35,/*inherited breast and ovarian cancer*/
266,733,6,/*tumour*/
267,0,35,/*Familial adenomatous polyposis coli*/
267,185,35,/*familial adenomatous polyposis coli*/
267,222,3,/*FAP*/
267,336,3,/*FAP*/
267,1191,6,/*cancer*/
267,1226,3,/*FAP*/
268,0,24,/*Dopa-responsive dystonia*/
268,259,31,/*recessive hyperphenylalaninemia*/
268,292,3,/*HPA*/
268,314,24,/*dopa-responsive dystonia*/
268,340,3,/*DRD*/
268,404,8,/*dystonia*/
269,43,35,/*paroxysmal nocturnal hemoglobinuria*/
269,108,35,/*Paroxysmal nocturnal hemoglobinuria*/
269,145,3,/*PNH*/
269,255,42,/*glycosylphosphatidylinositol (GPI) anchors*/
269,494,28,/*deficiencies of specific GPI*/
269,1384,18,/*GPI anchor deficit*/
269,1406,3,/*PNH*/
270,141,2,/*HC*/
270,458,19,/*infectious diseases*/
270,788,2,/*HC*/
271,67,19,/*Lesch-Nyhan disease*/
271,88,64,/*Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency*/
271,168,13,/*hyperuricemia*/
271,210,27,/*neurological manifestations*/
271,264,20,/*Lesch-Nyhan syndrome*/
271,565,34,/*deficiency of erythrocyte activity*/
271,606,13,/*hyperuricemia*/
271,624,4,/*gout*/
271,641,19,/*Lesch-Nyhan disease*/
271,1499,15,/*HPRT deficiency*/
272,175,29,/*type 1 von Willebrand disease*/
272,206,3,/*VWD*/
272,663,3,/*VWD*/
272,1373,3,/*VWD*/
272,1397,10,/*type 1 VWD*/
272,1621,3,/*VWD*/
273,31,16,/*torsion dystonia*/
273,219,27,/*hereditary torsion dystonia*/
273,248,2,/*TD*/
273,375,24,/*dopa-responsive dystonia*/
273,401,3,/*DRD*/
273,470,2,/*TD*/
273,607,4,/*NDRD*/
273,577,28,/*non-dopa-responsive dystonia*/
273,824,4,/*NDRD*/
273,957,2,/*TD*/
273,1110,3,/*DRD*/
273,1118,4,/*NDRD*/
274,28,51,/*autosomal dominant hereditary gingival fibromatosis*/
274,116,32,/*Hereditary gingival fibromatosis*/
274,201,12,/*oral disease*/
274,231,22,/*enlargement of gingiva*/
274,150,3,/*HGF*/
274,825,32,/*hereditary gingival fibromatosis*/
275,59,18,/*myotonic dystrophy*/
275,94,18,/*Myotonic dystrophy*/
275,128,27,/*autosomal dominant disorder*/
275,795,48,/*abnormality of human myotonic muscular dystrophy*/
275,845,2,/*DM*/
275,1240,15,/*DMPK deficiency*/
275,1270,22,/*Na channel abnormality*/
275,1296,2,/*DM*/
276,94,20,/*colorectal carcinoma*/
276,198,20,/*colorectal carcinoma*/
276,283,7,/*tumours*/
276,417,18,/*colonic carcinomas*/
276,554,7,/*tumours*/
276,729,10,/*carcinomas*/
276,965,20,/*cancer-related death*/
276,1497,21,/*colorectal carcinomas*/
276,1609,3,/*III*/
277,52,27,/*autosomal dominant cataract*/
277,111,28,/*autosomal dominant cataracts*/
277,141,4,/*ADCs*/
277,477,3,/*ADC*/
277,1041,46,/*pulverulent opacities in the embryonal nucleus*/
277,1129,51,/*radial opacities in the posterior embryonal nucleus*/
277,1231,3,/*ADC*/
278,133,12,/*Prader-Willi*/
278,199,21,/*Prader-Willi syndrome*/
278,234,27,/*neurodevelopmental disorder*/
280,353,16,/*thyroid diseases*/
280,381,14,/*thyroid cancer*/
280,400,25,/*congenital hypothyroidism*/
280,796,3,/*TSH*/
280,1159,3,/*TSH*/
281,1054,9,/*G2 damage*/
282,107,26,/*hereditary hemochromatosis*/
282,286,26,/*hereditary hemochromatosis*/
282,726,15,/*hemochromatosis*/
282,743,11,/*Camaschella*/
283,33,37,/*idiopathic sporadic cerebellar ataxia*/
283,142,25,/*autosomal dominant ataxia*/
283,175,19,/*Friedreich's ataxia*/
283,254,29,/*idiopathic cerebellar ataxias*/
283,343,30,/*spinocerebellar ataxia types 1*/
283,479,26,/*idiopathic sporadic ataxia*/
283,661,18,/*symptomatic ataxia*/
283,948,4,/*SCA8*/
283,1001,4,/*SCA2*/
283,1155,26,/*idiopathic sporadic ataxia*/
283,1323,17,/*idiopathic ataxia*/
283,1400,17,/*cerebellar ataxia*/
283,1486,15,/*sporadic ataxia*/
283,1577,19,/*Friedreich's ataxia*/
284,110,23,/*end-stage renal disease*/
284,435,23,/*end-stage renal disease*/
284,460,4,/*ESRD*/
284,812,4,/*ESRD*/
284,1560,4,/*ESRD*/
284,2412,4,/*ESRD*/
284,2598,4,/*ESRD*/
284,2612,5,/*CA/GT*/
284,2966,4,/*ESRD*/
285,221,23,/*cardiovascular diseases*/
286,0,4,/*DMSO*/
286,25,15,/*bacterial death*/
286,134,20,/*Huntington's disease*/
286,156,2,/*HD*/
286,413,20,/*Huntington's disease*/
286,578,2,/*HD*/
286,587,15,/*Bacterial death*/
286,1083,4,/*DMSO*/
287,579,39,/*chronic nonspherocytic hemolytic anemia*/
287,687,15,/*G6PD deficiency*/
287,1392,15,/*G6PD deficiency*/
288,170,15,/*Gaucher disease*/
288,255,23,/*glucocerebrosidase gene*/
289,71,40,/*esophagogastric junction adenocarcinomas*/
289,516,13,/*tumorigenesis*/
289,541,7,/*cancers*/
289,566,26,/*esophageal adenocarcinomas*/
289,696,3,/*APC*/
289,732,40,/*esophagogastric junction adenocarcinomas*/
289,936,15,/*adenocarcinomas*/
289,1017,6,/*tumors*/
289,1324,20,/*colorectal carcinoma*/
289,1392,39,/*esophagogastric junction adenocarcinoma*/
290,67,21,/*breast/ovarian cancer*/
290,218,21,/*breast/ovarian cancer*/
290,324,32,/*hereditary breast/ovarian cancer*/
290,974,23,/*breast and ovary cancer*/
290,1070,7,/*cancers*/
290,1081,20,/*prostate and stomach*/
290,1201,13,/*breast cancer*/
290,1458,13,/*breast cancer*/
290,1599,13,/*breast cancer*/
290,1748,13,/*breast cancer*/
291,116,25,/*alveolar rhabdomyosarcoma*/
291,202,12,/*solid tumors*/
291,357,25,/*alveolar rhabdomyosarcoma*/
291,1050,25,/*alveolar rhabdomyosarcoma*/
292,91,15,/*Phenylketonuria*/
292,108,3,/*PKU*/
292,117,28,/*autosomal recessive disorder*/
292,158,47,/*deficiency of hepatic phenylalanine hydroxylase*/
292,507,15,/*phenylketonuria*/
293,1,24,/*Schwartz-Jampel syndrome*/
293,26,26,/*chondrodystrophic myotonia*/
294,22,19,/*Friedreich's ataxia*/
294,86,19,/*Friedreich's ataxia*/
294,107,4,/*FRDA*/
294,119,46,/*autosomal recessive neurodegenerative disorder*/
294,279,19,/*Friedreich's ataxia*/
294,394,19,/*Friedreich's ataxia*/
294,453,4,/*FRDA*/
294,603,19,/*Friedreich's ataxia*/
294,842,4,/*FRDA*/
294,889,19,/*Friedreich's ataxia*/
295,202,16,/*genetic disorder*/
295,236,41,/*congenital malformation of the great toes*/
295,504,3,/*FOP*/
295,876,3,/*FOP*/
295,995,3,/*FOP*/
295,1735,3,/*FOP*/
295,2185,3,/*FOP*/
296,112,39,/*autosomal dominant retinitis pigmentosa*/
296,153,4,/*adRP*/
297,18,18,/*muscular dystrophy*/
297,52,25,/*Becker muscular dystrophy*/
297,189,16,/*dystrophinopathy*/
297,289,22,/*dilated cardiomyopathy*/
297,320,14,/*cardiomyopathy*/
297,437,15,/*muscle weakness*/
297,749,16,/*Dystrophinopathy*/
297,817,14,/*cardiomyopathy*/
297,911,22,/*dilated cardiomyopathy*/
297,973,22,/*dilated cardiomyopathy*/
297,997,15,/*muscle weakness*/
298,163,25,/*breast and ovarian cancer*/
298,241,5,/*tumor*/
298,1422,5,/*tumor*/
299,1,28,/*Familial Mediterranean fever*/
299,62,3,/*FMF*/
299,71,19,/*hereditary disorder*/
299,108,14,/*periodic fever*/
299,127,37,/*acute abdominal, chest, or joint pain*/
299,184,11,/*amyloidosis*/
299,233,14,/*kidney failure*/
299,299,3,/*FMF*/
299,471,11,/*amyloidosis*/
301,42,8,/*interact*/
301,92,36,/*hereditary breast and ovarian cancer*/
301,726,13,/*breast cancer*/
301,808,6,/*tumour*/
302,25,49,/*very long-chain acyl-CoA dehydrogenase deficiency*/
302,200,57,/*very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency*/
302,266,25,/*hypoketotic hypoglycaemia*/
302,333,12,/*hepatomegaly*/
302,527,16,/*VLCAD deficiency*/
302,574,49,/*very long-chain acyl-CoA dehydrogenase deficiency*/
302,836,12,/*hepatomegaly*/
303,0,20,/*Color vision defects*/
303,27,32,/*central serous chorioretinopathy*/
303,107,32,/*central serous chorioretinopathy*/
303,272,2,/*VA*/
303,257,13,/*visual acuity*/
303,141,3,/*CSC*/
303,594,3,/*CSC*/
303,619,19,/*color vision defect*/
303,828,19,/*color vision defect*/
303,893,19,/*color vision defect*/
303,1009,19,/*color vision defect*/
304,65,9,/*leiomyoma*/
304,164,18,/*mesenchymal tumors*/
304,303,10,/*leiomyomas*/
304,632,10,/*leiomyomas*/
304,764,6,/*tumors*/
304,1274,9,/*leiomyoma*/
305,67,25,/*breast and ovarian cancer*/
305,172,36,/*hereditary breast and ovarian cancer*/
305,319,21,/*hospital-based cancer*/
305,978,6,/*cancer*/
307,15,19,/*acute polyarthritis*/
307,80,19,/*acute polysynovitis*/
307,104,23,/*vasculitis-like changes*/
307,178,22,/*Neisseria meningitidis*/
307,226,23,/*chronic meningococcemia*/
307,377,9,/*meningism*/
307,509,10,/*vasculitis*/
307,559,19,/*acute polysynovitis*/
307,611,19,/*bacterial infection*/
307,649,9,/*Neisseria*/
307,669,21,/*Neisseria gonorrhoeae*/
307,764,22,/*Neisseria meningitidis*/
307,788,12,/*meningococci*/
307,962,19,/*acute polyarthritis*/
308,0,28,/*Familial Mediterranean fever*/
308,30,28,/*Familial Mediterranean fever*/
308,60,3,/*FMF*/
308,86,31,/*hereditary inflammatory disease*/
308,169,5,/*fever*/
308,179,9,/*serositis*/
308,318,3,/*FMF*/
308,612,3,/*FMF*/
308,643,21,/*chronic renal failure*/
308,814,11,/*amyloidosis*/
308,1058,11,/*amyloidosis*/
309,286,38,/*congenital lysosomal storage disorders*/
309,467,3,/*HAE*/
309,505,3,/*HAE*/
309,695,3,/*HAE*/
309,746,3,/*HAE*/
309,958,30,/*mucopolysaccharidosis type VII*/
309,1400,38,/*congenital lysosomal storage disorders*/
310,40,27,/*craniometaphyseal dysplasia*/
310,154,27,/*AR spondylocostal dysplasia*/
310,277,23,/*craniotubular dysplasia*/
310,302,3,/*CTD*/
310,722,3,/*CTD*/
310,780,30,/*AR craniometaphyseal dysplasia*/
310,812,3,/*CMD*/
310,818,3,/*CMD*/
310,827,3,/*CTD*/
310,862,2,/*AD*/
310,842,18,/*autosomal dominant*/
310,984,3,/*CMD*/
310,1144,2,/*AD*/
310,1394,27,/*AR spondylocostal dysplasia*/
310,1423,2,/*SD*/
310,1690,2,/*SD*/
311,35,8,/*glaucoma*/
311,125,19,/*Open angle glaucoma*/
311,146,3,/*OAG*/
311,880,3,/*AAD*/
311,862,16,/*age at diagnosis*/
311,1069,3,/*AAD*/
311,1606,14,/*GLC1I glaucoma*/
312,35,26,/*hereditary prostate cancer*/
312,63,3,/*HPC*/
312,119,18,/*late-onset disease*/
312,171,26,/*hereditary prostate cancer*/
312,199,3,/*HPC*/
312,271,4,/*HPCX*/
312,537,4,/*HPCX*/
312,562,23,/*Finnish prostate cancer*/
312,767,3,/*HPC*/
312,805,15,/*prostate cancer*/
312,938,4,/*HPCX*/
312,991,4,/*HPCX*/
312,1358,17,/*HPCX-linked cases*/
312,1636,27,/*HPCX-linked prostate cancer*/
313,73,25,/*breast and ovarian cancer*/
313,135,25,/*breast and ovarian cancer*/
313,239,36,/*hereditary breast and ovarian cancer*/
313,810,21,/*cancer predisposition*/
313,925,25,/*breast and ovarian cancer*/
314,23,34,/*familial hemolytic uremic syndrome*/
314,257,25,/*hemolytic uremic syndrome*/
314,419,16,/*Familial HUS/TTP*/
314,1583,24,/*deficiencies in factor H*/
314,1629,68,/*autosomal-dominant and autosomal-recessive hemolytic uremic syndrome*/
315,1168,2,/*HD*/
315,1282,2,/*HD*/
315,1154,12,/*heteroduplex*/
315,1652,2,/*CE*/
315,1982,2,/*HD*/
316,239,31,/*nonsyndromic hearing impairment*/
316,638,46,/*cochlea and vestibule of human fetal inner ear*/
316,1052,17,/*brain, eye, limb,*/
316,1735,21,/*inner-ear dysfunction*/
317,91,23,/*Langer-Giedion syndrome*/
317,207,23,/*Langer-Giedion syndrome*/
317,453,27,/*osteoprotegerin, syndecan-2*/
317,657,23,/*Langer-Giedion syndrome*/
317,685,37,/*trichorhinophalangeal syndrome type I*/
317,928,14,/*Cohen syndrome*/
317,955,18,/*Klip-Feil syndrome*/
317,984,29,/*hereditary spastic paraplegia*/
317,1048,18,/*myoclonic epilepsy*/
318,111,52,/*X-linked recessive Emery-Dreifuss muscular dystrophy*/
318,165,6,/*X-EDMD*/
318,739,52,/*autosomal dominant Emery-Dreifuss muscular dystrophy*/
318,793,7,/*AD-EDMD*/
319,19,4,/*HDM2*/
319,105,5,/*tumor*/
319,353,5,/*tumor*/
319,716,21,/*ataxia telangiectasia*/
319,739,2,/*AT*/
319,776,2,/*AT*/
319,977,4,/*HDM2*/
319,1044,4,/*HDM2*/
320,24,8,/*Borrelia*/
320,136,24,/*Wiskott-Aldrich syndrome*/
320,211,22,/*multisystemic disorder*/
320,504,11,/*borreliosis*/
320,1143,24,/*Wiskott-Aldrich Syndrome*/
320,1347,24,/*Wiskott-Aldrich Syndrome*/
320,1743,12,/*phagocytosis*/
321,158,26,/*Wolfram (DIDMOAD) syndrome*/
321,191,46,/*autosomal recessive neurodegenerative disorder*/
321,253,35,/*insulin-dependent diabetes mellitus*/
321,293,25,/*progressive optic atrophy*/
321,1121,16,/*Wolfram syndrome*/
321,1529,51,/*psychiatric, behavioral and emotional abnormalities*/
322,92,5,/*tumor*/
322,204,16,/*familial cancers*/
322,882,20,/*pancreatic carcinoma*/
322,1288,15,/*BRCA2-deficient*/
322,1501,13,/*breast cancer*/
322,1807,5,/*tumor*/
323,43,20,/*cardiac dysfunctions*/
323,98,33,/*Emery-Dreifuss muscular dystrophy*/
323,138,27,/*inherited muscular disorder*/
323,263,18,/*joint contractures*/
323,287,14,/*cardiomyopathy*/
323,752,15,/*muscle weakness*/
323,771,19,/*joint abnormalities*/
323,837,26,/*altered motor coordination*/
323,1176,17,/*emerin deficiency*/
323,1219,20,/*cardiac dysfunctions*/
323,1266,22,/*fragility of myonuclei*/
324,26,23,/*bilateral breast cancer*/
324,69,23,/*bilateral breast cancer*/
324,153,13,/*breast cancer*/
324,317,23,/*bilateral breast cancer*/
324,371,13,/*breast cancer*/
324,487,13,/*right tumours*/
324,519,37,/*premenopausal bilateral breast cancer*/
324,976,13,/*breast cancer*/
324,1483,6,/*tumour*/
324,1527,13,/*breast cancer*/
324,1679,23,/*bilateral breast cancer*/
326,84,24,/*Complement C7 deficiency*/
326,156,23,/*meningococcal infection*/
326,208,13,/*C7 deficiency*/
326,311,13,/*C7 deficiency*/
326,398,24,/*meningococcal meningitis*/
326,906,12,/*C7-deficient*/
327,90,18,/*Myotonic dystrophy*/
327,111,2,/*DM*/
327,229,2,/*DM*/
327,748,2,/*DM*/
328,215,31,/*X-linked juvenile retinoschisis*/
329,80,9,/*leiomyoma*/
329,91,17,/*Uterine leiomyoma*/
329,112,26,/*benign smooth-muscle tumor*/
329,191,8,/*neoplasm*/
329,265,39,/*rearranged in benign mesenchymal tumors*/
329,321,10,/*leiomyomas*/
329,566,9,/*leiomyoma*/
329,1021,9,/*leiomyoma*/
330,53,14,/*Cowden disease*/
330,72,24,/*Bannayan-Zonana syndrome*/
330,155,6,/*tumour*/
330,427,52,/*sporadic breast , brain , prostate and kidney cancer*/
330,530,22,/*endometrial carcinomas*/
330,555,18,/*malignant melanoma*/
330,578,15,/*thyroid tumours*/
330,686,14,/*Cowden disease*/
330,703,2,/*CD*/
330,743,3,/*BZS*/
330,752,30,/*Ruvalcaba-Riley-Smith syndrome*/
330,825,2,/*CD*/
330,847,3,/*BZS*/
330,955,2,/*CD*/
330,1249,2,/*CD*/
330,1338,2,/*CD*/
330,1625,3,/*BZS*/
330,1854,2,/*CD*/
330,1874,3,/*BZS*/
330,1956,3,/*BZS*/
330,2024,2,/*CD*/
330,2168,2,/*CD*/
330,2185,14,/*breast disease*/
330,2472,24,/*malignant breast disease*/
330,2770,40,/*breast , skin and gastrointestinal tract*/
330,2902,2,/*CD*/
332,52,25,/*congenital hypothyroidism*/
332,86,25,/*congenital hypothyroidism*/
332,113,2,/*CH*/
332,126,34,/*total iodide organification defect*/
332,162,4,/*TIOD*/
332,428,9,/*anomalous*/
332,1151,32,/*unilateral preauricular skin tag*/
333,1043,23,/*intracellular IFN-gamma*/
334,33,18,/*myotonic dystrophy*/
334,84,23,/*bilateral optic atrophy*/
334,126,18,/*myotonic dystrophy*/
334,146,18,/*Myotonic dystrophy*/
334,171,27,/*autosomal dominant disorder*/
334,545,18,/*myotonic dystrophy*/
334,716,35,/*bilateral pallor of the optic disks*/
334,905,18,/*myotonic dystrophy*/
334,971,18,/*myotonic dystrophy*/
334,1035,23,/*bilateral optic atrophy*/
334,1072,13,/*Optic atrophy*/
334,1134,18,/*myotonic dystrophy*/
335,232,29,/*skeletal dysplasia conditions*/
335,281,16,/*lethal disorders*/
335,299,23,/*achondrogenesis type 1B*/
335,335,23,/*atelosteogenesis type 2*/
335,374,20,/*non-lethal disorders*/
335,396,21,/*diastrophic dysplasia*/
335,419,3,/*DTD*/
335,428,39,/*recessive multiple epiphyseal dysplasia*/
};
}
static void init2() {
a2 = new int[] {
335,469,4,/*rMED*/
335,360,3,/*AO2*/
335,324,5,/*ACG1B*/
335,1275,4,/*rMED*/
335,1317,3,/*DTD*/
335,1587,3,/*DTD*/
336,165,12,/*hemophilia B*/
337,1414,8,/*hepatoma*/
338,41,10,/*HPC2/ELAC2*/
338,69,36,/*familial or sporadic prostate cancer*/
338,147,10,/*HPC2/ELAC2*/
338,162,15,/*prostate cancer*/
338,321,26,/*hereditary prostate cancer*/
338,349,3,/*HPC*/
338,441,3,/*HPC*/
338,512,10,/*HPC2/ELAC2*/
338,562,3,/*HPC*/
338,585,24,/*sporadic prostate cancer*/
338,1035,3,/*HPC*/
338,1336,15,/*prostate cancer*/
338,1484,15,/*prostate cancer*/
338,1939,15,/*prostate cancer*/
338,2203,15,/*prostate cancer*/
338,2359,15,/*prostate cancer*/
339,257,34,/*serotonin-related mental disorders*/
339,301,10,/*depression*/
339,757,16,/*mental disorders*/
339,1108,16,/*mental disorders*/
340,52,24,/*optic nerve malformation*/
340,171,30,/*systemic developmental defects*/
340,321,24,/*optic nerve malformation*/
340,491,35,/*congenital optic nerve malformation*/
340,1015,22,/*optic nerve hypoplasia*/
340,1701,24,/*optic nerve malformation*/
341,84,24,/*Wolf-Hirschhorn syndrome*/
341,114,19,/*congenital glaucoma*/
341,135,24,/*Wolf-Hirschhorn syndrome*/
341,165,22,/*developmental disorder*/
341,308,24,/*Wolf-Hirschhorn syndrome*/
341,337,20,/*early onset glaucoma*/
341,384,24,/*Wolf-Hirschhorn syndrome*/
341,413,20,/*early onset glaucoma*/
341,437,16,/*ocular anomalies*/
341,482,8,/*glaucoma*/
341,560,24,/*Wolf-Hirschhorn syndrome*/
341,648,8,/*glaucoma*/
341,714,15,/*Wolf-Hirschhorn*/
341,790,8,/*glaucoma*/
341,1014,8,/*glaucoma*/
341,1302,24,/*Wolf-Hirschhorn syndrome*/
341,1331,20,/*early onset glaucoma*/
341,1453,19,/*congenital glaucoma*/
342,1,39,/*Autoimmune lymphoproliferative syndrome*/
342,41,4,/*ALPS*/
344,43,25,/*myotonic dystrophy type 1*/
344,70,3,/*DM1*/
344,79,25,/*myotonic dystrophy type 1*/
344,106,3,/*DM1*/
344,299,3,/*DM1*/
344,399,3,/*DM1*/
344,1198,3,/*DM1*/
344,1325,3,/*DM1*/
344,1421,3,/*DM1*/
345,416,7,/*tumoral*/
345,1062,6,/*cancer*/
346,588,22,/*congenital abnormality*/
347,61,24,/*Wiskott-Aldrich syndrome*/
347,91,24,/*Wiskott-Aldrich syndrome*/
347,117,3,/*WAS*/
347,128,25,/*X-linked immunodeficiency*/
347,342,3,/*WAS*/
348,72,13,/*breast cancer*/
348,197,35,/*familial breast and ovarian cancers*/
348,399,36,/*hereditary breast and ovarian cancer*/
348,507,26,/*breast and ovarian cancers*/
348,544,13,/*breast cancer*/
348,852,13,/*breast cancer*/
348,891,14,/*ovarian cancer*/
348,1500,25,/*breast and ovarian cancer*/
348,1632,13,/*breast cancer*/
349,27,18,/*myotonic dystrophy*/
349,109,18,/*myotonic dystrophy*/
349,129,2,/*DM*/
349,226,2,/*DM*/
349,580,24,/*putamen, globus pallidus*/
349,609,8,/*thalamus*/
349,875,19,/*muscular disability*/
349,896,13,/*brain atrophy*/
349,1084,2,/*DM*/
350,105,26,/*bipolar affective disorder*/
350,159,26,/*Bipolar affective disorder*/
350,188,4,/*BPAD*/
350,269,9,/*hypomania*/
350,415,4,/*BPAD*/
350,553,4,/*BPAD*/
350,661,4,/*BPAD*/
350,705,17,/*genetic disorders*/
350,773,20,/*psychiatric disorder*/
350,946,4,/*BPAD*/
350,1520,4,/*BPAD*/
351,137,22,/*Dominant optic atrophy*/
351,161,3,/*DOA*/
351,202,23,/*inherited optic atrophy*/
352,53,15,/*hemochromatosis*/
352,77,26,/*Hereditary hemochromatosis*/
352,202,15,/*hemochromatosis*/
352,647,27,/*nonfamilial hemochromatosis*/
352,1646,13,/*iron overload*/
353,89,6,/*anemia*/
353,100,15,/*hemochromatosis*/
353,358,24,/*abnormal iron metabolism*/
353,426,15,/*iron deficiency*/
353,469,15,/*hemochromatosis*/
353,1369,15,/*iron deficiency*/
354,205,5,/*tumor*/
354,246,6,/*tumors*/
354,435,6,/*cancer*/
354,640,6,/*cancer*/
354,1786,6,/*tumors*/
354,2148,5,/*tumor*/
355,0,46,/*Autosomal dominant primary hyperparathyroidism*/
355,51,18,/*jaw tumor syndrome*/
355,86,16,/*renal hamartomas*/
355,107,21,/*cystic kidney disease*/
355,186,16,/*renal hamartomas*/
355,204,49,/*Hereditary hyperparathyroidism-jaw tumor syndrome*/
355,256,6,/*HPT-JT*/
355,271,26,/*autosomal dominant disease*/
355,420,15,/*HPT-JT syndrome*/
355,471,21,/*cystic kidney disease*/
355,584,15,/*HPT-JT syndrome*/
355,624,13,/*renal lesions*/
355,709,2,/*JT*/
355,784,2,/*JT*/
355,879,25,/*polycystic kidney disease*/
355,1230,28,/*multiple endocrine neoplasia*/
355,1803,9,/*jaw tumor*/
355,1819,17,/*parathyroid tumor*/
355,1866,16,/*renal hamartomas*/
355,2060,5,/*tumor*/
356,37,15,/*Crohn's disease*/
356,268,15,/*Crohn's disease*/
356,285,2,/*CD*/
356,915,2,/*CD*/
356,1735,18,/*late onset disease*/
357,59,33,/*autoimmune hematologic cytopenias*/
357,549,39,/*autoimmune lymphoproliferative syndrome*/
357,1287,24,/*hematologic autoimmunity*/
358,71,23,/*amelogenesis imperfecta*/
358,264,41,/*local hypoplastic amelogenesis imperfecta*/
358,307,4,/*AIH2*/
358,514,41,/*local hypoplastic amelogenesis imperfecta*/
358,557,2,/*AI*/
358,1009,20,/*local hypoplastic AI*/
358,1142,2,/*AI*/
358,1216,20,/*local hypoplastic AI*/
358,1269,2,/*AI*/
358,1421,4,/*AIH2*/
359,334,29,/*familial hypercholesterolemia*/
359,365,2,/*FH*/
359,418,30,/*polygenic hypercholesterolemia*/
359,855,2,/*FH*/
359,908,2,/*FH*/
359,1012,2,/*FH*/
360,26,16,/*Cat-Eye syndrome*/
360,44,16,/*Cat-Eye syndrome*/
360,62,3,/*CES*/
360,147,20,/*coloboma of the iris*/
360,205,3,/*CES*/
360,687,29,/*iris coloboma, anal anomalies*/
360,721,23,/*pre-auricular anomalies*/
360,853,18,/*mental retardation*/
360,911,18,/*Mental retardation*/
360,1026,17,/*mentally retarded*/
362,11,25,/*hyperalphalipoproteinemia*/
363,213,25,/*autism-spectrum disorders*/
363,255,6,/*autism*/
363,310,17,/*Angelman syndrome*/
363,467,8,/*autistic*/
363,905,6,/*autism*/
363,954,17,/*Angelman syndrome*/
364,411,21,/*embryonic spinal cord*/
365,9,35,/*paroxysmal nocturnal hemoglobinuria*/
365,75,57,/*glycosyl-phosphatidyl-inositol-anchored protein-deficient*/
365,159,23,/*deficient hematopoiesis*/
365,184,35,/*Paroxysmal nocturnal hemoglobinuria*/
365,221,3,/*PNH*/
365,582,23,/*intravascular hemolysis*/
365,925,3,/*PNH*/
365,1016,3,/*PNH*/
365,1058,15,/*aplastic anemia*/
365,1075,2,/*AA*/
365,1165,3,/*PNH*/
365,1193,15,/*aplastic anemia*/
365,1388,3,/*PNH*/
365,1720,35,/*aplastic and hemolytic types of PNH*/
365,1768,21,/*hematopoietic failure*/
365,1793,3,/*PNH*/
365,1885,3,/*PNH*/
365,1996,27,/*autoimmune hemolytic anemia*/
365,2067,3,/*PNH*/
365,2086,15,/*reticulocytosis*/
365,2221,23,/*deficient hematopoiesis*/
366,26,18,/*myotonic dystrophy*/
366,46,18,/*Myotonic dystrophy*/
366,67,2,/*DM*/
366,78,26,/*autosomal dominant disease*/
366,203,45,/*infertility and congenital myotonic dystrophy*/
366,251,3,/*CDM*/
366,283,2,/*DM*/
366,414,2,/*DM*/
366,486,2,/*DM*/
366,524,2,/*DM*/
366,697,2,/*DM*/
366,939,2,/*DM*/
366,1004,2,/*DM*/
366,1020,2,/*DM*/
366,1094,2,/*DM*/
367,335,3,/*DAI*/
367,312,21,/*diffuse axonal injury*/
367,534,11,/*head injury*/
367,1454,3,/*DAI*/
367,2021,3,/*SEP*/
367,2197,3,/*DAI*/
368,0,37,/*Prothrombotic inherited abnormalities*/
368,103,10,/*thrombosis*/
368,117,26,/*inflammatory bowel disease*/
368,182,15,/*thromboembolism*/
368,228,26,/*inflammatory bowel disease*/
368,291,49,/*prothrombotic inherited coagulation abnormalities*/
368,363,10,/*thrombosis*/
368,433,26,/*inflammatory bowel disease*/
368,475,17,/*venous thrombosis*/
368,519,26,/*inflammatory bowel disease*/
368,558,10,/*thrombosis*/
368,591,26,/*inflammatory bowel disease*/
368,641,17,/*venous thrombosis*/
368,724,17,/*venous thrombosis*/
368,1041,26,/*inflammatory bowel disease*/
368,1132,26,/*inflammatory bowel disease*/
368,1208,26,/*inflammatory bowel disease*/
368,1236,2,/*NS*/
368,1317,26,/*inflammatory bowel disease*/
368,1385,26,/*inflammatory bowel disease*/
368,1491,26,/*inflammatory bowel disease*/
368,1834,26,/*inflammatory bowel disease*/
368,1907,15,/*thrombotic risk*/
370,64,12,/*hearing loss*/
370,81,24,/*neurological dysfunction*/
370,172,40,/*syndromic and non-syndromic hearing loss*/
370,767,12,/*hearing loss*/
371,55,16,/*hemolytic anemia*/
371,82,41,/*glucosephosphate dehydrogenase deficiency*/
371,152,15,/*DG6F deficiency*/
371,207,27,/*neinatal hyperbilirubinemia*/
371,459,8,/*jaundice*/
371,472,15,/*deep dark urine*/
371,489,18,/*Partial deficiency*/
372,106,28,/*autoimmune encephalomyelitis*/
372,136,41,/*Experimental autoimmune encephalomyelitis*/
372,179,3,/*EAE*/
372,207,18,/*multiple sclerosis*/
372,227,2,/*MS*/
372,1837,32,/*autoimmune demyelinating disease*/
373,533,5,/*tumor*/
373,988,36,/*Cowden and Bannayan-Zonana syndromes*/
373,1080,26,/*breast and thyroid cancers*/
373,1947,11,/*hyperplasia*/
373,1964,5,/*tumor*/
374,35,19,/*Friedreich's ataxia*/
374,65,19,/*Friedreich's ataxia*/
374,86,4,/*FRDA*/
374,132,33,/*hereditary spinocerebellar ataxia*/
374,167,3,/*SCA*/
374,179,46,/*autosomal recessive neurodegenerative disorder*/
374,389,3,/*SCA*/
374,438,4,/*FRDA*/
374,767,6,/*ataxia*/
375,1744,36,/*neonatal alloimmune thrombocytopenia*/
375,1784,23,/*posttransfusion purpura*/
376,44,15,/*phenylketonuria*/
376,81,15,/*Phenylketonuria*/
376,98,3,/*PKU*/
376,129,36,/*inborn errors of metabolic disorders*/
376,176,3,/*PKU*/
376,188,18,/*mental retardation*/
376,532,3,/*PKU*/
376,621,3,/*PKU*/
378,92,22,/*aspartylglycosaminuria*/
378,116,22,/*Aspartylglycosaminuria*/
378,140,3,/*AGU*/
378,155,25,/*lysosomal storage disease*/
378,199,61,/*deficiency of the lysosomal enzyme, glycosylasparaginase (GA)*/
378,418,18,/*Epstein-Barr virus*/
378,438,3,/*EBV*/
379,20,29,/*congenital myotonic dystrophy*/
379,52,29,/*Congenital myotonic dystrophy*/
379,92,17,/*autosomal disease*/
379,271,14,/*arthrogryposis*/
379,287,9,/*hypotonia*/
379,298,53,/*facial diplegia, respiratory and feeding difficulties*/
379,353,43,/*Clinical and electrical myotonic discharges*/
379,457,29,/*congenital myotonic dystrophy*/
379,526,9,/*hypotonia*/
379,537,23,/*diaphragmatic paralysis*/
379,562,15,/*facial diplegia*/
380,0,21,/*Ataxia telangiectasia*/
380,40,9,/*leukaemia*/
380,54,8,/*lymphoma*/
380,64,21,/*Ataxia telangiectasia*/
380,87,2,/*AT*/
380,160,21,/*neuronal degeneration*/
380,228,6,/*cancer*/
380,257,2,/*AT*/
380,280,6,/*cancer*/
380,319,21,/*Lymphoid malignancies*/
380,358,2,/*AT*/
380,411,18,/*Hodgkin's lymphoma*/
380,431,22,/*non-Hodgkin's lymphoma*/
380,476,9,/*leukaemia*/
380,491,2,/*AT*/
380,1298,2,/*AT*/
380,1349,13,/*breast cancer*/
380,1435,2,/*AT*/
380,1467,15,/*thymic lymphoma*/
380,1557,19,/*lymphoid malignancy*/
380,1594,2,/*AT*/
380,1631,8,/*lymphoma*/
380,1643,13,/*Atm deficient*/
380,1763,28,/*sporadic lymphoid malignancy*/
380,1880,19,/*lymphoid malignancy*/
380,2032,5,/*T-PLL*/
380,2105,20,/*mantle cell lymphoma*/
380,2127,3,/*MCL*/
380,1999,31,/*T cell prolymphocytic leukaemia*/
380,2235,21,/*lymphoid malignancies*/
380,2501,21,/*lymphoid malignancies*/
380,2570,6,/*tumour*/
380,2745,2,/*AT*/
381,66,16,/*vascular disease*/
381,86,12,/*hemodialysis*/
381,299,15,/*atherosclerosis*/
381,413,12,/*hemodialysis*/
381,461,15,/*atherosclerosis*/
381,672,29,/*atherosclerotic complications*/
381,709,12,/*hemodialysis*/
381,766,16,/*vascular disease*/
381,1061,16,/*vascular disease*/
381,1582,16,/*vascular disease*/
381,1880,16,/*vascular disease*/
381,1900,12,/*hemodialysis*/
382,1512,21,/*alveolar preneoplasia*/
382,2207,10,/*neoplastic*/
383,88,15,/*Phenylketonuria*/
383,294,42,/*phenylalanine hydroxylase (PAH) deficiency*/
383,412,25,/*classical phenylketonuria*/
383,680,5,/*tumor*/
383,731,15,/*phenylketonuria*/
383,748,13,/*short stature*/
383,1229,24,/*contiguous gene syndrome*/
383,1394,15,/*phenylketonuria*/
384,35,15,/*prostate cancer*/
384,205,23,/*prostate carcinogenesis*/
384,346,6,/*cancer*/
384,483,15,/*prostate cancer*/
384,604,26,/*hereditary prostate cancer*/
384,632,3,/*HPC*/
384,735,15,/*prostate cancer*/
384,1246,3,/*HPC*/
384,1324,3,/*HPC*/
384,1423,24,/*putative prostate cancer*/
384,1957,15,/*prostate cancer*/
385,25,3,/*MJD*/
385,87,22,/*Machado-Joseph Disease*/
385,136,22,/*Machado-Joseph Disease*/
385,160,3,/*MJD*/
385,171,45,/*autosomal dominant neurodegenerative disorder*/
385,347,22,/*Machado-Joseph Disease*/
385,804,3,/*MJD*/
385,955,3,/*MJD*/
385,1696,3,/*MJD*/
387,35,28,/*Angeles variant galactosemia*/
387,137,12,/*galactosemia*/
387,1792,12,/*galactosemia*/
388,81,42,/*non-syndromic autosomal recessive deafness*/
388,442,53,/*congenital autosomal recessive sensorineural deafness*/
388,899,8,/*deafness*/
390,0,34,/*Metastatic carcinomatous cirrhosis*/
390,39,21,/*hepatic hemosiderosis*/
390,164,32,/*ductal carcinoma of the breast 3*/
390,320,13,/*liver failure*/
390,339,19,/*portal hypertension*/
390,552,34,/*metastatic carcinomatous cirrhosis*/
390,633,21,/*hepatic hemosiderosis*/
390,754,34,/*cirrhosis-associated hemosiderosis*/
390,949,9,/*cirrhosis*/
391,113,19,/*racemase deficiency*/
391,137,38,/*malabsorption and vitamin K deficiency*/
391,1858,21,/*racemase deficiencies*/
391,1947,12,/*K deficiency*/
391,2013,35,/*cases of unexplicable malabsorption*/
393,23,35,/*Prader-Willi and Angelman syndromes*/
393,208,21,/*Prader-Willi syndrome*/
393,231,3,/*PWS*/
393,247,17,/*Angelman syndrome*/
393,266,2,/*AS*/
393,488,3,/*PWS*/
393,495,2,/*AS*/
393,854,3,/*PWS*/
393,861,2,/*AS*/
393,966,6,/*PWS/AS*/
393,1084,6,/*PWS/AS*/
393,1338,6,/*PWS/AS*/
393,1799,6,/*PWS/AS*/
394,18,5,/*tumor*/
394,109,18,/*metastatic ability*/
394,131,15,/*prostate cancer*/
394,293,15,/*prostate cancer*/
394,599,15,/*prostate tumors*/
394,656,18,/*prostate neoplasms*/
394,742,6,/*cancer*/
394,1040,4,/*SCID*/
394,1521,15,/*prostate cancer*/
394,1606,6,/*tumors*/
394,1750,15,/*prostate cancer*/
395,81,15,/*cystic fibrosis*/
395,145,15,/*Cystic fibrosis*/
395,162,2,/*CF*/
395,170,28,/*autosomal recessive disorder*/
395,1143,8,/*myalgias*/
395,1232,8,/*myalgias*/
395,1242,5,/*fever*/
395,1454,8,/*myalgias*/
395,2158,14,/*viral shedding*/
395,2361,6,/*fevers*/
395,2372,8,/*myalgias*/
396,227,37,/*hereditary breast and ovarian cancers*/
397,114,5,/*tumor*/
397,151,7,/*cancers*/
397,302,6,/*cancer*/
397,730,14,/*ovarian tumors*/
397,925,6,/*cancer*/
398,212,3,/*ALS*/
398,181,29,/*amyotrophic lateral sclerosis*/
398,376,3,/*ALS*/
398,419,3,/*ALS*/
398,855,18,/*pseudobulbar palsy*/
398,878,31,/*abnormal posterior tibial nerve*/
398,1138,3,/*ALS*/
398,1208,18,/*pseudobulbar palsy*/
398,1288,3,/*ALS*/
399,18,9,/*fragile X*/
399,81,9,/*fragile X*/
399,135,28,/*inherited mental retardation*/
400,514,30,/*disorder ataxia telangiectasia*/
400,546,2,/*AT*/
400,1419,2,/*AT*/
401,25,24,/*G6PD molecular evolution*/
401,54,19,/*malarial resistance*/
401,256,18,/*malarial infection*/
401,301,16,/*G6PD and malaria*/
401,785,7,/*malaria*/
402,94,8,/*dystonia*/
402,119,12,/*parkinsonism*/
402,133,8,/*Dystonia*/
402,147,17,/*movement disorder*/
402,382,20,/*early onset dystonia*/
402,470,17,/*dystonic symptoms*/
402,575,3,/*EOP*/
402,683,8,/*dystonia*/
402,721,3,/*EOP*/
402,817,20,/*early onset dystonia*/
402,842,18,/*myoclonic features*/
402,1162,14,/*onset dystonia*/
403,0,28,/*Familial Mediterranean fever*/
403,72,3,/*FMF*/
403,312,3,/*FMF*/
403,477,3,/*FMF*/
403,1522,3,/*FMF*/
404,494,23,/*Vibrio parahaemolyticus*/
405,21,23,/*type II Gaucher disease*/
405,112,15,/*Gaucher disease*/
405,129,2,/*GD*/
405,160,26,/*lysosomal storage diseases*/
405,315,34,/*progression of neurologic symptoms*/
405,545,10,/*type II GD*/
405,782,2,/*GD*/
405,853,10,/*type II GD*/
405,901,2,/*GD*/
405,1011,2,/*GD*/
405,1165,10,/*type II GD*/
406,78,21,/*mucolipidosis type IV*/
406,141,16,/*mucolipidosis IV*/
406,159,5,/*ML IV*/
406,807,5,/*ML IV*/
408,0,19,/*Frataxin deficiency*/
408,147,17,/*Friedreich ataxia*/
408,275,17,/*Friedreich ataxia*/
408,294,35,/*loss of dorsal root ganglia neurons*/
408,612,19,/*embryonic carcinoma*/
408,905,19,/*frataxin deficiency*/
408,1010,19,/*Frataxin deficiency*/
408,1643,19,/*frataxin deficiency*/
409,917,5,/*tumor*/
410,82,34,/*autosomal dominant Alport syndrome*/
410,121,21,/*hypercholesterolaemia*/
410,156,15,/*Alport syndrome*/
410,173,2,/*AS*/
410,280,13,/*renal failure*/
410,295,22,/*sensorineural deafness*/
410,326,20,/*ocular abnormalities*/
410,478,2,/*AS*/
410,708,39,/*AS-phenotype plus hypercholesterolaemia*/
410,784,17,/*Fechtner syndrome*/
410,803,2,/*FS*/
410,914,2,/*AS*/
410,1708,18,/*collagen disorders*/
412,305,20,/*hemorrhagic syndrome*/
413,11,18,/*GM2 gangliosidosis*/
414,288,5,/*tumor*/
414,1021,15,/*cranial ganglia*/
414,1302,22,/*anterior telencephalon*/
415,1271,8,/*C3/C4/C5*/
416,50,15,/*phenylketonuria*/
416,124,15,/*phenylketonuria*/
416,141,3,/*PKU*/
416,253,3,/*PKU*/
416,442,3,/*PKU*/
416,613,3,/*PKU*/
416,663,24,/*background abnormalities*/
417,255,21,/*ataxia-telangiectasia*/
418,62,22,/*Peutz-Jeghers syndrome*/
418,442,22,/*Peutz-Jeghers syndrome*/
418,466,3,/*PJS*/
418,536,20,/*unusual disturbances*/
418,774,3,/*PJS*/
419,0,29,/*Congenital myotonic dystrophy*/
419,121,29,/*congenital myotonic dystrophy*/
419,737,18,/*myotonic dystrophy*/
419,841,18,/*myotonic dystrophy*/
420,344,5,/*C5-C9*/
421,25,22,/*von Willebrand disease*/
421,49,22,/*von Willebrand disease*/
421,73,3,/*VWD*/
421,90,39,/*autosomally inherited bleeding disorder*/
421,206,3,/*VWD*/
421,260,28,/*deficiency of von Willebrand*/
421,515,3,/*VWD*/
421,739,15,/*genetic lesions*/
421,874,3,/*VWD*/
421,915,10,/*type 1 VWD*/
421,1074,10,/*type 1 VWD*/
422,310,27,/*type I protein C deficiency*/
422,1983,13,/*thrombophilia*/
423,175,6,/*cancer*/
423,576,18,/*leukotriene (LT)B4*/
424,32,20,/*retinal degeneration*/
424,85,20,/*retinal degeneration*/
424,156,20,/*retinal degeneration*/
424,224,30,/*recessive retinitis pigmentosa*/
425,1943,25,/*quantitative deficiencies*/
426,1,20,/*Lesch-Nyhan syndrome*/
427,65,13,/*C7 deficiency*/
427,166,28,/*total or subtotal deficiency*/
427,247,13,/*C7 deficiency*/
427,315,31,/*combined total deficiency of C7*/
427,371,28,/*systemic lupus erythematosus*/
427,831,13,/*C7 deficiency*/
427,853,34,/*combined subtotal C6/C7 deficiency*/
427,985,24,/*meningococcal meningitis*/
427,1716,13,/*C7 deficiency*/
428,274,22,/*Prader-Willi syndromes*/
428,766,20,/*developmental delays*/
428,790,17,/*autistic features*/
429,59,9,/*Solar UVA*/
429,187,11,/*skin cancer*/
429,453,3,/*UVA*/
430,65,8,/*leukemia*/
430,565,8,/*leukemia*/
431,309,13,/*galactosaemic*/
431,390,14,/*breast feeding*/
431,447,13,/*galactosaemia*/
431,625,13,/*galactosaemic*/
432,102,16,/*lethal dysplasia*/
432,274,31,/*extremities, voluminous cranium*/
432,310,14,/*polyhydramnios*/
432,368,23,/*platyspondylic dwarfism*/
432,397,32,/*short extremities, narrow thorax*/
432,501,32,/*progressive respiratory distress*/
433,46,16,/*synovial sarcoma*/
433,106,16,/*Synovial sarcoma*/
433,128,17,/*mesenchymal tumor*/
433,409,16,/*synovial sarcoma*/
433,610,16,/*synovial sarcoma*/
433,949,15,/*biphasic tumors*/
433,1584,6,/*tumors*/
433,1707,17,/*synovial sarcomas*/
433,1937,17,/*monophasic tumors*/
433,2045,16,/*synovial sarcoma*/
434,86,27,/*Duchenne muscular dystrophy*/
434,115,3,/*DMD*/
434,269,3,/*DMD*/
435,70,17,/*breast carcinomas*/
435,152,36,/*hereditary breast and ovarian cancer*/
435,300,16,/*sporadic cancers*/
435,466,15,/*ovarian cancers*/
435,484,15,/*Epigenetic loss*/
435,1014,19,/*breast malignancies*/
435,1127,40,/*benign breast , invasive lobular cancers*/
435,1172,27,/*low-grade ductal carcinomas*/
435,1292,17,/*ductal carcinomas*/
435,1420,14,/*breast cancers*/
436,127,13,/*Wilms' tumors*/
436,170,12,/*Wilms' tumor*/
436,184,2,/*WT*/
436,1296,14,/*pseudodiploidy*/
436,1360,17,/*WT1 abnormalities*/
437,509,12,/*macrocephaly*/
437,580,12,/*micrognathia*/
437,598,23,/*psychomotor retardation*/
437,692,26,/*trisomy 1q42-qter syndrome*/
438,26,20,/*pseudoachondroplasia*/
438,51,38,/*spondyloepiphyseal dysplasia congenita*/
438,124,38,/*spondyloepiphyseal dysplasia congenita*/
438,202,24,/*short-limb short stature*/
438,164,4,/*SEDC*/
438,528,18,/*skeletal dysplasia*/
439,269,24,/*postnatal growth failure*/
439,295,12,/*microcephaly*/
439,315,19,/*dysmorphic features*/
439,339,31,/*psychomotor developmental delay*/
440,0,44,/*Glucose 6-phosphate dehydrogenase deficiency*/
440,49,18,/*sickle cell anemia*/
440,242,18,/*sickle cell anemia*/
440,262,2,/*SS*/
440,408,14,/*G6PD deficient*/
440,661,14,/*G6PD-deficient*/
440,772,20,/*G6PD-normal subjects*/
440,817,19,/*sickle cell disease*/
440,862,6,/*anemia*/
440,1036,15,/*G6PD deficiency*/
440,1055,18,/*sickle cell anemia*/
440,1191,2,/*SS*/
441,0,33,/*Epileptogenic brain malformations*/
441,208,8,/*epilepsy*/
441,371,17,/*agyria-pachygyria*/
441,556,13,/*Lissencephaly*/
441,587,29,/*predominant gyral abnormality*/
441,766,3,/*SBH*/
441,826,4,/*XLIS*/
441,736,28,/*subcortical band heterotopia*/
441,879,4,/*XLIS*/
441,1005,4,/*XLIS*/
441,1079,33,/*Autosomal recessive lissencephaly*/
441,1118,21,/*cerebellar hypoplasia*/
441,1230,13,/*lissencephaly*/
441,1256,19,/*developmental delay*/
441,1280,16,/*infantile spasms*/
441,1352,18,/*mental retardation*/
441,1376,8,/*epilepsy*/
441,1416,54,/*X-linked bilateral periventricular nodular heterotopia*/
441,1472,4,/*BPNH*/
441,1498,4,/*BPNH*/
441,1594,14,/*focal epilepsy*/
441,1810,18,/*Tuberous sclerosis*/
441,1830,2,/*TS*/
441,1960,2,/*TS*/
441,1968,8,/*epilepsy*/
441,2033,2,/*TS*/
441,2053,5,/*cleft*/
441,2114,14,/*focal epilepsy*/
441,2147,19,/*Familial occurrence*/
441,2420,14,/*schizencephaly*/
441,2658,70,/*autosomal recessive, X-linked dominant, X-linked recessive inheritance*/
442,0,28,/*Familial Mediterranean fever*/
442,30,3,/*FMF*/
442,46,11,/*amyloidosis*/
442,122,28,/*Familial Mediterranean fever*/
442,152,3,/*FMF*/
442,163,28,/*autosomal recessive disorder*/
442,233,5,/*fever*/
442,243,9,/*serositis*/
442,254,17,/*Renal amyloidosis*/
442,382,3,/*FMF*/
442,400,11,/*amyloidosis*/
442,522,11,/*amyloidosis*/
442,559,3,/*FMF*/
442,675,11,/*proteinuria*/
442,737,18,/*nephrotic syndrome*/
442,774,19,/*renal insufficiency*/
442,795,3,/*CRI*/
442,990,18,/*nephrotic syndrome*/
442,1037,11,/*proteinuria*/
442,1163,13,/*renal failure*/
442,1178,4,/*ESRF*/
442,1522,11,/*Amyloidosis*/
442,1570,3,/*FMF*/
442,1627,13,/*renal disease*/
442,1676,11,/*proteinuria*/
442,1702,18,/*nephrotic syndrome*/
442,1778,18,/*nephrotic syndrome*/
442,1815,11,/*proteinuria*/
442,1987,3,/*CRI*/
442,2008,3,/*FMF*/
442,2023,11,/*amyloidosis*/
443,0,41,/*Inflammatory eye, skin, and bowel disease*/
443,45,17,/*spondyloarthritis*/
443,178,40,/*inflammatory disease of the spine/joints*/
443,248,22,/*ankylosing spondylitis*/
443,272,2,/*AS*/
443,277,9,/*psoriasis*/
443,288,6,/*iritis*/
443,296,26,/*inflammatory bowel disease*/
443,324,3,/*IBD*/
443,434,2,/*AS*/
443,703,2,/*AS*/
443,744,2,/*AS*/
443,778,11,/*spondylitis*/
443,836,2,/*AS*/
443,886,2,/*AS*/
443,988,2,/*AS*/
443,1135,6,/*iritis*/
443,1301,14,/*spinal disease*/
443,1487,11,/*co-diseases*/
443,1517,3,/*IBD*/
443,1522,6,/*iritis*/
443,1533,2,/*AS*/
443,1578,2,/*AS*/
443,1600,3,/*IBD*/
443,1605,9,/*psoriasis*/
443,1619,6,/*iritis*/
443,1737,2,/*AS*/
443,1798,2,/*AS*/
443,1815,6,/*iritis*/
443,1938,28,/*gastroenterological diseases*/
443,2058,2,/*AS*/
443,2166,21,/*inflammatory disorder*/
443,2203,29,/*enteropathic spondylarthritis*/
443,2327,23,/*inflammatory conditions*/
443,2362,9,/*psoriasis*/
443,2376,6,/*iritis*/
443,2418,2,/*AS*/
443,2473,2,/*AS*/
443,2507,3,/*IBD*/
443,2575,2,/*AS*/
444,164,21,/*breast-ovarian cancer*/
444,256,6,/*tumors*/
444,318,5,/*tumor*/
444,431,6,/*tumors*/
447,71,34,/*Angioimmunoblastic T-cell lymphoma*/
447,107,4,/*AITL*/
447,145,36,/*lymph nodes, spleen, and bone marrow*/
447,479,4,/*AITL*/
447,559,29,/*reactive lymphoid hyperplasia*/
447,1000,4,/*AITL*/
447,1025,4,/*AITL*/
447,1109,27,/*PTL or reactive hyperplasia*/
447,1219,4,/*AITL*/
447,1445,5,/*tumor*/
447,1467,4,/*AITL*/
447,1645,4,/*AITL*/
448,54,36,/*neonatal alloimmune thrombocytopenia*/
448,274,24,/*Wiskott-Aldrich syndrome*/
448,369,36,/*neonatal alloimmune thrombocytopenia*/
448,407,4,/*NAIT*/
448,902,4,/*NAIT*/
449,168,6,/*cancer*/
449,199,16,/*chemosensitivity*/
449,695,5,/*tumor*/
449,808,16,/*chemosensitivity*/
449,1079,13,/*breast cancer*/
450,30,3,/*WAS*/
450,64,24,/*Wiskott-Aldrich syndrome*/
450,90,24,/*Wiskott-Aldrich syndrome*/
450,116,3,/*WAS*/
450,134,25,/*immunodeficiency disorder*/
450,177,19,/*recurrent infection*/
450,198,6,/*eczema*/
450,210,21,/*microthrombocytopenia*/
450,233,3,/*WAS*/
450,313,3,/*WAS*/
450,367,3,/*WAS*/
450,422,15,/*bloody diarrhea*/
450,439,6,/*eczema*/
450,451,27,/*persistent thrombocytopenia*/
450,484,15,/*small platelets*/
450,561,3,/*WAS*/
451,44,24,/*breast or ovarian cancer*/
451,395,13,/*breast cancer*/
451,483,21,/*breast/ovarian cancer*/
451,1177,25,/*breast and ovarian cancer*/
451,1340,13,/*breast cancer*/
451,1486,13,/*breast cancer*/
452,13,14,/*pilomatricomas*/
453,104,16,/*fish-eye disease*/
453,458,16,/*fish-eye disease*/
453,477,3,/*FED*/
453,748,3,/*FED*/
453,1186,3,/*FED*/
454,39,15,/*Rieger Syndrome*/
454,86,24,/*Axenfeld-Rieger syndrome*/
454,143,27,/*autosomal dominant disorder*/
454,196,24,/*anterior segment defects*/
454,222,8,/*glaucoma*/
454,236,21,/*extraocular anomalies*/
454,308,15,/*Rieger syndrome*/
454,388,24,/*Axenfeld-Rieger syndrome*/
454,476,24,/*Axenfeld-Rieger syndrome*/
454,890,15,/*Rieger syndrome*/
454,937,24,/*Axenfeld-Rieger syndrome*/
454,1129,24,/*Axenfeld-Rieger syndrome*/
454,1339,24,/*Axenfeld-Rieger syndrome*/
454,1444,24,/*Axenfeld-Rieger syndrome*/
455,68,24,/*Wiskott-Aldrich Syndrome*/
455,129,24,/*Wiskott-Aldrich syndrome*/
455,155,3,/*WAS*/
455,164,27,/*X-linked recessive disorder*/
455,213,43,/*primary progressive T cell immunodeficiency*/
455,307,6,/*eczema*/
455,319,16,/*thrombocytopenia*/
455,536,3,/*WAS*/
455,1462,3,/*WAS*/
455,1732,3,/*WAS*/
456,143,36,/*neonatal alloimmune thrombocytopenia*/
456,269,36,/*neonatal alloimmune thrombocytopenia*/
456,307,4,/*NAIT*/
457,20,14,/*Norrie disease*/
457,36,2,/*ND*/
457,69,2,/*ND*/
457,159,14,/*Norrie disease*/
457,176,2,/*ND*/
457,234,2,/*ND*/
457,279,2,/*ND*/
457,593,2,/*ND*/
457,700,27,/*retinal ganglion cell layer*/
457,995,2,/*ND*/
457,1114,40,/*X-linked recessive neurological disorder*/
458,40,21,/*ataxia-telangiectasia*/
458,72,25,/*sporadic T-cell leukaemia*/
458,99,21,/*Ataxia-telangiectasia*/
458,123,3,/*A-T*/
458,241,6,/*cancer*/
458,261,19,/*lymphoid neoplasias*/
458,312,3,/*A-T*/
458,471,5,/*T-PLL*/
458,561,3,/*A-T*/
458,677,3,/*A-T*/
458,728,9,/*leukaemia*/
458,1090,3,/*A-T*/
458,1183,6,/*tumour*/
458,1235,9,/*leukaemia*/
458,1303,6,/*tumour*/
458,1365,5,/*B-NHL*/
458,1544,7,/*tumours*/
458,1668,6,/*tumour*/
459,0,37,/*Childhood cerebellar hemangioblastoma*/
459,92,23,/*von Hippel-Lindau tumor*/
459,218,16,/*hemangioblastoma*/
459,281,17,/*von Hippel-Lindau*/
459,343,27,/*cerebellar hemangioblastoma*/
459,412,17,/*von Hippel-Lindau*/
459,477,25,/*von Hippel-Lindau disease*/
459,534,17,/*von Hippel-Lindau*/
459,728,5,/*tumor*/
459,778,17,/*von Hippel-Lindau*/
459,810,36,/*Solitary cerebellar hemangioblastoma*/
459,914,23,/*von Hippel-Lindau tumor*/
459,976,16,/*hemangioblastoma*/
459,1098,23,/*von Hippel-Lindau tumor*/
460,317,34,/*type III protein S (PS) deficiency*/
460,678,2,/*PS*/
461,137,17,/*colorectal cancer*/
461,167,13,/*neuroblastoma*/
461,298,17,/*colorectal cancer*/
461,612,13,/*neuroblastoma*/
462,156,18,/*fragile X syndrome*/
462,737,9,/*fragile X*/
462,892,9,/*fragile X*/
462,1221,18,/*fragile X syndrome*/
463,244,26,/*familial breast carcinomas*/
463,338,17,/*breast carcinomas*/
463,451,17,/*breast carcinomas*/
463,747,10,/*carcinomas*/
463,1109,16,/*breast carcinoma*/
463,1170,14,/*poor prognosis*/
464,165,21,/*Prader-Willi syndrome*/
464,211,21,/*Prader-Willi syndrome*/
464,234,3,/*PWS*/
464,519,3,/*PWS*/
464,593,3,/*PWS*/
464,785,3,/*PWS*/
464,884,3,/*PWS*/
464,941,2,/*AT*/
464,925,14,/*adipose tissue*/
464,1148,3,/*PWS*/
464,1476,2,/*AT*/
464,1586,3,/*PWS*/
464,1643,3,/*PWS*/
464,1759,3,/*PWS*/
464,1825,7,/*obesity*/
464,1836,3,/*PWS*/
464,1845,26,/*leptin receptor deficiency*/
465,96,25,/*mucopolysaccharidosis IVA*/
465,123,25,/*Mucopolysaccharidosis IVA*/
465,151,7,/*MPS IVA*/
465,167,46,/*autosomal recessive lysosomal storage disorder*/
465,507,7,/*MPS IVA*/
465,786,7,/*MPS IVA*/
466,114,5,/*tumor*/
466,308,21,/*ataxia telangiectasia*/
467,23,15,/*Gaucher disease*/
467,66,15,/*Gaucher disease*/
467,127,18,/*glucocerebrosidase*/
467,210,16,/*glucosylceramide*/
467,320,15,/*Gaucher disease*/
467,592,22,/*type 3 Gaucher disease*/
467,834,15,/*Gaucher disease*/
467,965,15,/*Gaucher disease*/
468,82,26,/*Papillon-Lef  vre syndrome*/
468,115,44,/*autosomal recessive palmoplantar keratoderma*/
469,0,29,/*Partial cerebellar hypoplasia*/
469,48,21,/*Prader-Willi syndrome*/
469,108,21,/*Prader-Willi syndrome*/
469,131,3,/*PWS*/
469,529,3,/*PWS*/
469,687,21,/*Prader-Willi syndrome*/
469,733,3,/*PWS*/
469,795,3,/*PWS*/
469,803,19,/*brain abnormalities*/
470,0,44,/*Glucose-6-phosphate dehydrogenase deficiency*/
470,90,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
470,148,30,/*X-linked hemolytic enzymopathy*/
470,347,14,/*G6PD deficient*/
470,415,14,/*G6PD deficient*/
470,491,24,/*chronic myeloid leukemia*/
470,517,3,/*CML*/
470,540,15,/*G6PD deficiency*/
470,730,9,/*hemolysis*/
470,949,15,/*G6PD deficiency*/
470,1122,15,/*G6PD deficiency*/
470,1162,37,/*multi-lineage clonal marrow disorders*/
471,41,3,/*VHL*/
471,53,29,/*sporadic renal cell carcinoma*/
471,172,25,/*von Hippel-Lindau disease*/
471,199,3,/*VHL*/
471,266,19,/*renal tumorigenesis*/
471,314,30,/*sporadic renal cell carcinomas*/
471,534,3,/*VHL*/
471,657,3,/*VHL*/
471,780,3,/*VHL*/
471,850,3,/*VHL*/
471,977,14,/*clear-cell RCC*/
471,1022,3,/*VHL*/
471,1275,5,/*tumor*/
471,1322,5,/*tumor*/
471,1378,21,/*lymph node metastasis*/
471,1416,3,/*VHL*/
471,1464,4,/*RCCs*/
471,1605,9,/*VHL tumor*/
474,59,42,/*hereditary non-polyposis colorectal cancer*/
474,133,42,/*hereditary non-polyposis colorectal cancer*/
474,178,5,/*HNPCC*/
474,330,17,/*colorectal cancer*/
474,621,17,/*absence of cancer*/
476,53,13,/*breast cancer*/
476,145,21,/*ataxia telangiectasia*/
476,168,3,/*A-T*/
476,199,13,/*breast cancer*/
476,229,3,/*A-T*/
476,324,13,/*breast cancer*/
476,584,13,/*breast cancer*/
476,1039,13,/*breast cancer*/
476,1567,13,/*breast cancer*/
476,1670,13,/*breast cancer*/
477,1,49,/*Very-long-chain acyl-CoA dehydrogenase deficiency*/
478,68,17,/*diabetes mellitus*/
478,90,13,/*optic atrophy*/
478,105,16,/*Wolfram syndrome*/
478,124,16,/*Wolfram syndrome*/
478,143,3,/*WFS*/
478,169,46,/*autosomal recessive neurodegenerative disorder*/
478,250,35,/*insulin-dependent diabetes mellitus*/
478,464,3,/*WFS*/
478,653,3,/*WFS*/
479,95,26,/*hereditary hemochromatosis*/
479,124,2,/*HH*/
479,825,2,/*HH*/
479,974,2,/*HH*/
479,1077,6,/*cancer*/
480,98,47,/*digenic-recessive familial hypercholesterolemia*/
480,911,48,/*autosomal-dominant familial hypercholesterolemia*/
480,1186,3,/*ARH*/
481,63,17,/*familial aniridia*/
481,138,8,/*aniridia*/
481,150,23,/*panocular eye condition*/
481,191,15,/*iris hypoplasia*/
481,230,34,/*anterior and posterior eye defects*/
481,276,11,/*poor vision*/
481,360,17,/*familial aniridia*/
481,480,8,/*aniridia*/
};
}
static void init3() {
a3 = new int[] {
481,510,8,/*aniridic*/
483,53,59,/*malnutrition-modulated diabetes, insulin-dependent diabetes*/
483,118,40,/*non-insulin- dependent diabetes mellitus*/
483,188,35,/*Insulin-dependent diabetes mellitus*/
483,236,18,/*polygenic disorder*/
483,225,4,/*IDDM*/
483,930,40,/*malnutrition-modulated diabetes mellitus*/
483,972,4,/*MMDM*/
483,983,39,/*non-insulin-dependent diabetes mellitus*/
483,1024,5,/*NIDDM*/
483,1175,5,/*NIDDM*/
483,1593,5,/*NIDDM*/
483,1663,8,/*diabetes*/
483,1683,4,/*LADA*/
483,1988,4,/*MMDM*/
483,2278,4,/*MMDM*/
483,2334,4,/*MMDM*/
483,2440,4,/*MMDM*/
483,2675,5,/*NIDDM*/
484,16,3,/*VHL*/
484,75,35,/*non-papillary renal cell carcinomas*/
484,147,3,/*VHL*/
484,178,30,/*sporadic renal cell carcinomas*/
484,301,3,/*VHL*/
484,386,2,/*HD*/
484,458,35,/*non-papillary renal cell carcinomas*/
484,516,33,/*chromophobe renal cell carcinomas*/
484,568,35,/*non-papillary renal cell carcinomas*/
484,668,2,/*HD*/
484,738,21,/*renal cell carcinomas*/
484,779,28,/*papillary renal cell tumours*/
484,812,21,/*ten renal oncocytomas*/
484,958,3,/*VHL*/
484,983,7,/*tumours*/
484,1070,3,/*VHL*/
484,1129,34,/*non-papillary renal cell carcinoma*/
485,47,11,/*arrhythmias*/
485,62,25,/*myotonic dystrophy type 1*/
485,145,16,/*Cardiac myopathy*/
485,179,23,/*conduction disturbances*/
485,207,11,/*arrhythmias*/
485,236,37,/*neurologic disease myotonic dystrophy*/
485,333,18,/*myotonic dystrophy*/
485,601,18,/*myotonic dystrophy*/
485,721,19,/*muscular disability*/
485,818,10,/*arrhythmia*/
485,1306,3,/*QRS*/
485,1650,16,/*cardiac myopathy*/
485,1670,18,/*myotonic dystrophy*/
486,0,3,/*VHL*/
486,48,15,/*renal carcinoma*/
486,71,20,/*Renal cell carcinoma*/
486,127,29,/*von Hippel-Lindau (VHL) tumor*/
486,204,6,/*tumors*/
486,494,14,/*pVHL-deficient*/
487,0,22,/*Van der Woude syndrome*/
487,24,22,/*Van der Woude syndrome*/
487,48,3,/*VWS*/
487,59,40,/*autosomal dominant craniofacial syndrome*/
487,142,15,/*congenital pits*/
487,201,20,/*cleft lip, or palate*/
487,252,3,/*VWS*/
488,0,16,/*Vascular defects*/
488,21,22,/*sensorineural deafness*/
488,64,14,/*Norrie disease*/
488,80,14,/*Norrie disease*/
488,101,27,/*X-linked recessive syndrome*/
488,132,9,/*blindness*/
488,143,8,/*deafness*/
488,157,18,/*mental retardation*/
488,388,12,/*hearing loss*/
488,421,8,/*deafness*/
489,56,28,/*Pelizaeus-Merzbacher disease*/
489,86,28,/*Pelizaeus-Merzbacher disease*/
489,116,3,/*PMD*/
489,131,23,/*X-linked leukodystrophy*/
489,463,3,/*PMD*/
489,485,3,/*PMD*/
489,1348,3,/*PMD*/
490,398,25,/*retinoblastoma (Rb) tumor*/
491,190,21,/*psychiatric disorders*/
491,635,19,/*impulsive disorders*/
491,1088,16,/*bipolar disorder*/
492,350,17,/*steroid synthesis*/
493,0,39,/*Autoimmune lymphoproliferative syndrome*/
493,92,21,/*monoclonal gammopathy*/
493,163,39,/*autoimmune lymphoproliferative syndrome*/
493,204,4,/*ALPS*/
493,284,15,/*lymphadenopathy*/
493,301,12,/*splenomegaly*/
493,329,20,/*bacterial infections*/
493,387,23,/*pneumococcal meningitis*/
493,682,21,/*monoclonal gammopathy*/
493,1060,21,/*monoclonal gammopathy*/
493,1125,4,/*ALPS*/
493,1324,4,/*ALPS*/
494,56,37,/*autosomal dominant hearing impairment*/
494,172,50,/*autosomal dominant nonsyndromic hearing impairment*/
494,224,5,/*DFNA2*/
495,65,24,/*Saethre-Chotzen syndrome*/
495,102,25,/*craniosynostosis syndrome*/
495,145,31,/*craniofacial and limb anomalies*/
495,318,26,/*craniosynostosis syndromes*/
495,626,24,/*Saethre-Chotzen syndrome*/
495,762,16,/*craniosynostosis*/
495,1092,19,/*Developmental delay*/
495,1366,16,/*craniosynostosis*/
496,52,16,/*bipolar disorder*/
496,588,16,/*bipolar disorder*/
496,606,4,/*BP-I*/
496,836,13,/*schizophrenia*/
496,893,21,/*psychiatric disorders*/
497,17,15,/*phenylketonuria*/
497,34,25,/*Classical phenylketonuria*/
497,62,3,/*PKU*/
497,74,28,/*autosomal recessive disorder*/
497,115,47,/*deficiency of hepatic phenylalanine hydroxylase*/
497,222,3,/*PKU*/
497,1035,3,/*PKU*/
498,8,15,/*Opsonic defects*/
499,69,24,/*Wiskott-Aldrich syndrome*/
499,99,24,/*Wiskott-Aldrich Syndrome*/
499,125,3,/*WAS*/
499,136,35,/*X-linked recessive immunodeficiency*/
499,212,3,/*WAS*/
499,264,6,/*eczema*/
499,272,16,/*thrombocytopenia*/
499,300,16,/*immunodeificency*/
499,520,3,/*WAS*/
500,36,18,/*growth retardation*/
500,98,35,/*immune defects, and thymic lymphoma*/
500,189,21,/*ataxia-telangiectasia*/
500,573,21,/*ataxia-telangiectasia*/
500,650,15,/*growth-retarded*/
500,730,15,/*meiotic failure*/
500,1313,9,/*lymphomas*/
500,1389,3,/*ATM*/
500,1557,5,/*tumor*/
501,4,11,/*Wilms tumor*/
501,127,11,/*Wilms tumor*/
501,786,16,/*Frasier syndrome*/
502,1641,20,/*catalytic efficiency*/
503,47,13,/*breast cancer*/
503,105,18,/*male breast cancer*/
503,210,23,/*breast / ovarian cancer*/
503,314,30,/*breast and / or ovarian cancer*/
503,435,23,/*breast / ovarian cancer*/
503,584,13,/*breast cancer*/
503,720,13,/*breast cancer*/
503,793,6,/*cancer*/
503,819,14,/*ovarian cancer*/
503,901,18,/*male breast cancer*/
503,945,23,/*breast / ovarian cancer*/
504,603,5,/*tumor*/
504,967,6,/*glioma*/
505,41,24,/*Wiskott-Aldrich syndrome*/
505,67,3,/*WAS*/
505,175,3,/*WAS*/
505,199,24,/*Wiskott-Aldrich syndrome*/
505,225,3,/*WAS*/
505,258,3,/*WAS*/
505,431,3,/*WAS*/
505,544,3,/*WAS*/
505,969,3,/*WAS*/
505,1569,3,/*WAS*/
505,1677,3,/*WAS*/
506,0,8,/*Aniridia*/
506,22,13,/*WAGR syndrome*/
506,70,11,/*hypospadias*/
506,83,8,/*Aniridia*/
506,117,13,/*WAGR syndrome*/
506,132,12,/*Wilms tumour*/
506,146,8,/*aniridia*/
506,156,23,/*genitourinary anomalies*/
506,185,18,/*mental retardation*/
506,286,13,/*WAGR syndrome*/
506,325,11,/*hypospadias*/
506,654,12,/*Wilms tumour*/
506,716,13,/*WAGR syndrome*/
506,749,11,/*hypospadias*/
506,876,4,/*WAGR*/
506,959,6,/*tumour*/
506,995,8,/*aniridia*/
506,1034,14,/*WAGR anomalies*/
507,0,27,/*Inherited thrombocytopenias*/
507,79,27,/*Inherited thrombocytopenias*/
507,691,26,/*familial thrombocytopenias*/
507,974,27,/*inherited thrombocytopenias*/
507,1250,15,/*Wiskott-Aldrich*/
507,1270,25,/*Bernard-Soulier syndromes*/
507,1399,19,/*May-Hegglin anomaly*/
507,1445,17,/*Epstein syndromes*/
507,1549,16,/*thrombocytopenia*/
507,1629,27,/*inherited thrombocytopenias*/
507,2238,14,/*such disorders*/
509,52,25,/*hereditary retinoblastoma*/
509,152,45,/*familial or sporadic bilateral retinoblastoma*/
510,70,15,/*hyperlipidaemia*/
510,206,15,/*hyperlipidaemia*/
510,251,15,/*hyperlipidaemia*/
511,4,23,/*von Hippel-Lindau tumor*/
511,94,25,/*von Hippel-Lindau disease*/
511,126,3,/*VHL*/
511,168,13,/*renal cancers*/
511,215,3,/*VHL*/
511,248,5,/*tumor*/
511,365,12,/*renal cancer*/
511,613,3,/*VHL*/
511,800,3,/*VHL*/
511,872,23,/*clear-cell renal cancer*/
511,1064,3,/*VHL*/
511,1069,3,/*VHL*/
511,1186,3,/*VHL*/
511,1297,3,/*VHL*/
511,1386,24,/*VHL-mediated renal tumor*/
512,26,16,/*rhabdomyosarcoma*/
512,44,16,/*Rhabdomyosarcoma*/
512,62,3,/*RMS*/
512,72,28,/*family of soft tissue tumors*/
512,252,36,/*embryonal (ERMS) and alveolar (ARMS)*/
512,385,4,/*ARMS*/
512,831,4,/*ARMS*/
512,842,4,/*ERMS*/
512,971,5,/*tumor*/
512,1017,5,/*tumor*/
512,1066,4,/*ERMS*/
512,1075,4,/*ARMS*/
512,1273,4,/*MDM2*/
512,1335,4,/*ARMS*/
512,1359,4,/*ERMS*/
512,1512,4,/*ARMS*/
512,1521,4,/*ERMS*/
513,271,26,/*hereditary hemochromatosis*/
513,299,2,/*HH*/
513,382,2,/*HH*/
513,994,14,/*iron-poor diet*/
513,1274,15,/*iron deficiency*/
513,1319,14,/*genetic defect*/
514,48,17,/*myasthenia gravis*/
515,19,17,/*Alstr  m syndrome*/
515,80,17,/*Alstr  m syndrome*/
515,382,17,/*Alstr  m syndrome*/
515,410,28,/*autosomal recessive disorder*/
515,473,23,/*pigmentary degeneration*/
515,498,26,/*sensorineural hearing loss*/
515,526,7,/*obesity*/
515,535,39,/*non-insulin-dependent diabetes mellitus*/
515,580,19,/*chronic nephropathy*/
515,647,13,/*hyperglycemia*/
515,666,15,/*hyperinsulinism*/
515,706,28,/*autosomal recessive disorder*/
515,765,9,/*Blindness*/
515,776,39,/*hearing loss, complications of diabetes*/
515,821,13,/*renal failure*/
515,941,13,/*renal failure*/
516,0,12,/*Wilms' tumor*/
516,148,11,/*Wilms tumor*/
516,556,21,/*pseudohermaphroditism*/
516,581,20,/*Denys-Drash syndrome*/
517,0,19,/*Friedreich's ataxia*/
517,56,19,/*Friedreich's ataxia*/
517,97,16,/*inherited ataxia*/
517,145,22,/*deficiency of frataxin*/
517,275,19,/*Friedreich's ataxia*/
517,491,19,/*frataxin deficiency*/
517,662,19,/*frataxin deficiency*/
517,819,19,/*Friedreich's ataxia*/
517,900,41,/*recessive or sporadic degenerative ataxia*/
517,965,19,/*Friedreich's ataxia*/
517,1048,19,/*Friedreich's ataxia*/
517,1103,15,/*tendon reflexes*/
517,1389,19,/*Friedreich's ataxia*/
517,1513,19,/*axonal degeneration*/
518,104,21,/*ataxia-telangiectasia*/
518,128,2,/*AT*/
518,350,2,/*AT*/
518,405,17,/*gamma-irradiation*/
518,1093,13,/*growth defect*/
518,1154,2,/*AT*/
520,78,13,/*breast cancer*/
520,381,6,/*tumors*/
520,468,5,/*tumor*/
520,495,13,/*breast cancer*/
520,604,5,/*tumor*/
520,630,13,/*breast cancer*/
520,729,13,/*breast cancer*/
520,818,14,/*breast cancers*/
520,894,13,/*breast cancer*/
520,1050,14,/*breast cancers*/
520,1164,13,/*breast cancer*/
520,1522,14,/*breast cancers*/
520,1584,13,/*breast cancer*/
520,1663,21,/*breast carcinogenesis*/
521,40,28,/*spondyloepiphyseal dysplasia*/
521,173,55,/*autosomal dominant form of spondyloepiphyseal dysplasia*/
521,230,3,/*SED*/
521,252,13,/*short stature*/
521,287,24,/*degenerative arthropathy*/
521,703,3,/*SED*/
521,910,29,/*multiple epiphyseal dysplasia*/
521,962,3,/*SED*/
523,93,29,/*X-linked adrenoleukodystrophy*/
523,147,29,/*X-linked adrenoleukodystrophy*/
523,178,5,/*X-ALD*/
523,224,5,/*X-ALD*/
523,286,5,/*CCALD*/
523,357,21,/*adrenomyeloneuropathy*/
523,380,3,/*AMN*/
523,392,3,/*AMN*/
523,438,3,/*CNS*/
523,443,26,/*adrenoleukomyeloneuropathy*/
523,471,4,/*ALMN*/
523,496,3,/*AMN*/
523,600,21,/*glutathione synthesis*/
523,643,17,/*neurodegeneration*/
523,691,3,/*CBS*/
523,662,27,/*Cystathionine beta-synthase*/
523,742,3,/*CBS*/
523,926,5,/*X-ALD*/
523,1043,3,/*AMN*/
523,1085,17,/*CNS demyelination*/
523,1104,5,/*CCALD*/
523,1113,4,/*ALMN*/
523,1214,5,/*X-ALD*/
523,1237,17,/*CNS demyelination*/
523,1380,5,/*X-ALD*/
524,24,13,/*Van der Woude*/
524,461,22,/*Van der Woude syndrome*/
524,485,3,/*VWS*/
524,563,47,/*autosomal dominant form of cleft lip and palate*/
524,616,8,/*lip pits*/
524,667,19,/*cleft lip or palate*/
524,688,28,/*Popliteal pterygium syndrome*/
524,718,3,/*PPS*/
524,804,26,/*skin and genital anomalies*/
524,1027,3,/*VWS*/
524,1128,3,/*VWS*/
524,1184,3,/*PPS*/
525,37,13,/*C9 deficiency*/
525,101,12,/*C9-deficient*/
525,694,13,/*C9 deficiency*/
525,977,16,/*deficiency of C9*/
525,1074,13,/*C9 deficiency*/
526,1994,16,/*neuropathic pain*/
527,341,44,/*Deficiency of terminal complement components*/
527,500,23,/*inherited C9 deficiency*/
527,559,13,/*C9 deficiency*/
527,666,13,/*C9 deficiency*/
527,1007,13,/*C9 deficiency*/
528,221,6,/*tumour*/
528,365,6,/*tumour*/
528,1386,6,/*tumour*/
529,67,37,/*chronic obstructive pulmonary disease*/
529,420,37,/*chronic obstructive pulmonary disease*/
529,536,3,/*DBS*/
529,1245,15,/*deficient alpha*/
529,1468,3,/*DBS*/
530,81,30,/*cerebrotendinous xanthomatosis*/
531,75,54,/*autosomal dominant neurohypophyseal diabetes insipidus*/
531,131,54,/*Autosomal dominant neurohypophyseal diabetes insipidus*/
531,187,5,/*ADNDI*/
531,200,17,/*inherited disease*/
531,240,46,/*deficiency of the hormone arginine vasopressin*/
531,476,5,/*ADNDI*/
531,684,5,/*ADNDI*/
531,1630,5,/*ADNDI*/
532,92,30,/*chromatin remodeling complexes*/
533,105,48,/*deficiency of the second component of complement*/
533,257,48,/*deficiency of the second component of complement*/
533,456,13,/*C2 deficiency*/
533,516,13,/*C2 deficiency*/
533,609,13,/*C2 deficiency*/
533,743,13,/*C2 deficiency*/
533,761,5,/*HLA-B*/
533,1344,26,/*Factor B and C2 deficiency*/
533,1473,13,/*C2 deficiency*/
533,1515,13,/*C2 deficiency*/
533,1693,13,/*C2 deficiency*/
534,54,26,/*breast and stomach cancers*/
534,82,14,/*Stomach cancer*/
534,118,27,/*cancer in the global cancer*/
534,216,36,/*hereditary diffuse gastric carcinoma*/
534,336,14,/*stomach cancer*/
534,491,14,/*stomach cancer*/
534,620,13,/*breast cancer*/
534,711,13,/*breast cancer*/
534,783,6,/*cancer*/
534,917,16,/*malignant tumour*/
534,1253,14,/*stomach cancer*/
534,1419,7,/*cancers*/
535,75,18,/*Fragile X syndrome*/
536,106,21,/*Ataxia-telangiectasia*/
536,129,3,/*A-T*/
536,141,27,/*autosomal recessive disease*/
536,186,39,/*neurological and immunological symptoms*/
536,227,16,/*radiosensitivity*/
536,248,6,/*cancer*/
536,271,3,/*A-T*/
536,452,3,/*A-T*/
536,740,3,/*A-T*/
536,1023,3,/*A-T*/
536,1209,3,/*A-T*/
536,1384,3,/*A-T*/
537,59,19,/*Partington syndrome*/
537,193,27,/*X-linked mental retardation*/
537,222,4,/*XLMR*/
537,339,10,/*dysarthria*/
537,748,21,/*neurological features*/
537,796,18,/*mental retardation*/
537,816,10,/*dysarthria*/
537,828,22,/*facial muscle weakness*/
537,859,18,/*dysdiadochokinesis*/
537,879,23,/*slow dystonic movements*/
537,946,6,/*ataxia*/
537,956,22,/*spasticity of the legs*/
537,1353,2,/*DM*/
538,0,44,/*Mitochondrial fatty acid oxidation disorders*/
538,196,46,/*Carnitine/acylcarnitine translocase deficiency*/
538,294,14,/*sudden cardiac*/
538,491,12,/*hepatomegaly*/
538,505,23,/*persistent hypoglycemia*/
538,530,12,/*hypocalcemia*/
538,544,12,/*hyperkalemia*/
538,796,53,/*Medium chain acyl CoA dehydrogenase (MCAD) deficiency*/
538,903,14,/*sudden cardiac*/
538,1273,5,/*MCADD*/
538,1288,20,/*Carnitine deficiency*/
538,1386,7,/*dyspnea*/
538,1423,22,/*parental consanguinity*/
538,1494,23,/*cardiac decompensations*/
538,1519,12,/*hepatomegaly*/
538,1533,6,/*anemia*/
538,1541,21,/*generalized hypotonia*/
539,82,30,/*mucopolysaccharidosis type VII*/
539,153,25,/*mucopolysaccharidosis VII*/
539,180,7,/*MPS VII*/
539,189,12,/*Sly syndrome*/
539,218,32,/*deficiency of beta-glucuronidase*/
539,381,7,/*MPS VII*/
539,755,7,/*MPS VII*/
539,910,3,/*MPS*/
539,1393,7,/*MPS VII*/
540,112,21,/*breast/ovarian cancer*/
540,211,28,/*breast and/or ovarian cancer*/
540,458,13,/*breast cancer*/
540,651,21,/*breast/ovarian cancer*/
540,794,28,/*breast and/or ovarian cancer*/
540,922,9,/*neoplasms*/
540,1324,13,/*breast cancer*/
540,1576,24,/*breast or ovarian cancer*/
540,1691,13,/*breast cancer*/
541,12,17,/*von hippel-lindau*/
541,165,17,/*Hemangioblastomas*/
541,233,31,/*von Hippel-Lindau (VHL) disease*/
541,184,3,/*HBs*/
541,285,15,/*VHL-related HBs*/
541,322,9,/*VHL tumor*/
541,409,3,/*VHL*/
541,611,6,/*tumors*/
541,754,6,/*tumors*/
541,1007,2,/*HB*/
541,1057,3,/*VHL*/
541,1279,15,/*VHL-related HBs*/
541,1304,3,/*VHL*/
541,1390,3,/*VHL*/
541,1419,15,/*VHL-related HBs*/
541,1530,15,/*VHL-related HBs*/
541,1581,3,/*VHL*/
541,1703,3,/*VHL*/
542,104,21,/*hyperphenylalaninemia*/
542,127,21,/*Hyperphenylalaninemia*/
542,150,3,/*HPA*/
542,165,39,/*deficiency of phenylalanine hydroxylase*/
542,306,14,/*PAH deficiency*/
542,521,29,/*BH4-responsive PAH deficiency*/
543,124,52,/*Traditional risk factors for coronary artery disease*/
543,178,3,/*CAD*/
543,227,3,/*CAD*/
543,306,3,/*CAD*/
543,673,3,/*CAD*/
543,681,27,/*hyperapobetalipoproteinemia*/
543,710,32,/*familial combined hyperlipidemia*/
543,777,25,/*dyslipidemic hypertension*/
543,808,10,/*syndrome X*/
543,824,18,/*metabolic syndrome*/
543,937,18,/*insulin resistance*/
543,960,15,/*intra-abdominal*/
543,1064,20,/*atherogenic syndrome*/
543,2001,18,/*insulin resistance*/
543,2377,23,/*metabolic abnormalities*/
543,3156,15,/*atherosclerosis*/
543,3433,3,/*HDL*/
543,3441,20,/*hypertriglyceridemia*/
543,3651,3,/*CAD*/
543,3729,24,/*LDL and the dyslipidemia*/
544,37,20,/*senile retinoschisis*/
545,22,28,/*Pelizaeus-Merzbacher disease*/
546,22,28,/*recurrent panlymphocytopenia*/
546,263,3,/*ICL*/
546,299,16,/*immunodeficiency*/
546,228,33,/*Idiopathic CD4+ T lymphocytopenia*/
546,417,3,/*ICL*/
546,422,33,/*chronic mucocutaneous candidiasis*/
546,511,16,/*ulcerous lesions*/
546,457,3,/*CMC*/
547,49,18,/*endometrial cancer*/
547,211,22,/*endometrial carcinomas*/
547,235,3,/*ECs*/
547,435,3,/*APC*/
547,556,22,/*endometrial carcinomas*/
547,593,35,/*endometrioid endometrial carcinomas*/
547,630,4,/*EECs*/
547,872,3,/*RAS*/
547,1219,3,/*APC*/
547,1845,3,/*RAS*/
548,78,28,/*metachromatic leukodystrophy*/
548,109,28,/*Metachromatic leukodystrophy*/
548,139,3,/*MLD*/
548,150,25,/*inherited storage disease*/
548,186,29,/*deficiency of arylsulfatase A*/
548,345,3,/*MLD*/
548,396,3,/*MLD*/
548,462,9,/*adult MLD*/
548,1025,3,/*MLD*/
549,1,18,/*Huntinton's chorea*/
549,31,18,/*hereditary disease*/
551,36,13,/*breast cancer*/
551,175,13,/*breast cancer*/
551,275,13,/*breast cancer*/
551,333,13,/*breast cancer*/
551,589,13,/*breast cancer*/
551,718,14,/*ovarian cancer*/
551,1066,13,/*breast cancer*/
551,1226,13,/*breast cancer*/
551,1440,13,/*breast cancer*/
551,1612,13,/*breast cancer*/
551,1975,13,/*breast cancer*/
551,2054,13,/*breast cancer*/
552,31,12,/*Wilms tumour*/
552,108,12,/*Wilms tumour*/
552,122,2,/*WT*/
553,117,10,/*haemolysis*/
553,652,14,/*G6PD-deficient*/
553,1052,14,/*G6PD-deficient*/
554,65,15,/*Fabry's disease*/
554,94,15,/*Fabry's disease*/
554,116,63,/*X-linked recessive inborn error of glycosphingolipid catabolism*/
554,274,22,/*microvascular diseases*/
554,461,15,/*Fabry's disease*/
554,544,15,/*Fabry's disease*/
554,864,15,/*Fabry's disease*/
554,1031,15,/*Fabry's disease*/
554,1081,15,/*Fabry's disease*/
554,1209,14,/*kidney disease*/
555,100,25,/*hyperalphalipoproteinemia*/
555,142,52,/*cholesteryl ester transfer protein (CETP) deficiency*/
555,216,25,/*hyperalphalipoproteinemia*/
555,243,4,/*HALP*/
555,285,15,/*CETP deficiency*/
555,317,4,/*HALP*/
555,458,4,/*HALP*/
555,853,4,/*HALP*/
555,1049,4,/*HALP*/
555,1103,4,/*HALP*/
555,1393,4,/*HALP*/
555,1412,4,/*HALP*/
555,1732,15,/*CETP deficiency*/
555,1768,4,/*HALP*/
555,1787,15,/*CETP deficiency*/
556,0,26,/*Nijmegen breakage syndrome*/
556,468,13,/*malignancies.*/
556,482,26,/*Nijmegen breakage syndrome*/
556,514,26,/*recessive genetic disorder*/
556,559,42,/*elevated sensitivity to ionizing radiation*/
557,0,26,/*Kelley-Seegmiller syndrome*/
557,45,66,/*complete hypoxanthine-guanine phosphoribosyltransferase deficiency*/
557,134,64,/*hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiency*/
557,219,13,/*hyperuricemia*/
557,234,25,/*uric acid nephrolithiasis*/
557,271,4,/*gout*/
557,293,14,/*HPRT deficient*/
557,388,24,/*neurological dysfunction*/
557,414,4,/*HRND*/
557,433,26,/*neurological manifestation*/
557,535,20,/*Lesch-Nyhan syndrome*/
557,574,34,/*choreoathetosis or self-mutilation*/
557,669,4,/*gout*/
557,715,19,/*Lesch Nyhan disease*/
557,881,21,/*neurologic impairment*/
557,1004,15,/*HPRT deficiency*/
557,1078,15,/*G6PD deficiency*/
557,1289,13,/*megaloblastyc*/
558,655,17,/*AT-like" disorder*/
559,636,27,/*Beckwith-Wiedemann syndrome*/
559,717,23,/*Russell-Silver syndrome*/
559,1259,27,/*Beckwith-Wiedemann syndrome*/
559,1304,31,/*Prader-Willi/Angelman syndromes*/
559,1353,23,/*Russell-Silver syndrome*/
559,1406,25,/*hereditary osteodystrophy*/
560,0,49,/*Deficiency of the seventh component of complement*/
560,80,23,/*complement deficiencies*/
560,242,32,/*systemic meningococcal infection*/
560,483,12,/*C7-deficient*/
560,675,21,/*complement deficiency*/
560,791,21,/*complement deficiency*/
560,904,21,/*meningococcal disease*/
560,935,18,/*serious infections*/
561,48,21,/*ataxia-telangiectasia*/
561,107,21,/*ataxia-telangiectasia*/
561,131,3,/*A-T*/
561,266,3,/*A-T*/
561,485,3,/*A-T*/
561,836,17,/*cerebellar ataxia*/
561,1019,3,/*A-T*/
561,1111,3,/*A-T*/
562,408,22,/*skeletal abnormalities*/
562,452,46,/*bowing of the long bones with prominent joints*/
562,510,16,/*spinal deformity*/
562,680,75,/*injury to the tongue and limbs, absent corneal reflexes and a smooth tongue*/
562,937,16,/*spinal deformity*/
562,1304,22,/*skeletal abnormalities*/
562,1366,21,/*neurological symptoms*/
562,1403,12,/*dysautonomia*/
563,19,7,/*malaria*/
563,60,7,/*Malaria*/
563,71,18,/*widespread disease*/
563,347,18,/*malaria infections*/
563,421,7,/*malaria*/
563,841,16,/*clearing malaria*/
563,959,7,/*malaria*/
565,156,15,/*iron deficiency*/
565,621,15,/*hemochromatosis*/
565,2199,15,/*iron deficiency*/
566,46,22,/*Peutz-Jeghers syndrome*/
566,73,11,/*canceration*/
566,111,22,/*Peutz-Jeghers syndrome*/
566,135,3,/*PJS*/
566,146,38,/*autosomal dominantly inherited disease*/
566,238,5,/*tumor*/
566,340,3,/*PJS*/
566,482,4,/*FHIT*/
566,495,3,/*PJS*/
566,557,3,/*PJS*/
566,1096,3,/*PJS*/
566,1781,3,/*PJS*/
566,1897,4,/*FHIT*/
566,2020,26,/*PJS and their cancerations*/
567,162,6,/*gonads*/
567,208,21,/*pituitary gonadotroph*/
567,644,15,/*adrenal failure*/
568,161,26,/*cancer-associated diseases*/
568,188,21,/*ataxia-telangiectasia*/
568,214,20,/*Li-Fraumeni syndrome*/
568,399,21,/*radiation sensitivity*/
568,860,6,/*tumour*/
568,1548,7,/*tumours*/
569,47,33,/*HCV-related chronic liver disease*/
569,85,12,/*liver cancer*/
569,450,13,/*liver disease*/
569,480,6,/*cancer*/
569,490,9,/*hepatitis*/
569,502,14,/*virus-infected*/
569,745,17,/*chronic hepatitis*/
569,767,9,/*cirrhosis*/
569,784,24,/*hepatocellular carcinoma*/
569,810,3,/*HCC*/
569,1235,13,/*liver disease*/
569,1311,3,/*HCC*/
569,1388,3,/*HCC*/
569,1449,9,/*cirrhosis*/
569,1485,2,/*PM*/
569,1588,19,/*hepatitis/cirrhosis*/
569,1467,16,/*poor metabolizer*/
569,1988,3,/*HCC*/
569,2000,12,/*HCV-infected*/
570,810,18,/*Circular dichroism*/
571,45,6,/*cancer*/
571,73,5,/*HNPCC*/
571,123,42,/*Hereditary non-polyposis colorectal cancer*/
571,167,5,/*HNPCC*/
571,178,40,/*inherited cancer predisposition syndrome*/
571,373,3,/*CRC*/
571,708,3,/*CRC*/
571,716,6,/*cancer*/
571,1235,6,/*cancer*/
571,1372,6,/*cancer*/
571,1400,5,/*HNPCC*/
571,1592,16,/*increased cancer*/
572,120,14,/*Wilson disease*/
572,277,14,/*Wilson disease*/
572,293,2,/*WD*/
572,329,2,/*WD*/
572,523,2,/*WD*/
572,698,2,/*WD*/
573,0,53,/*A new syndrome of "spondylo-epi-metaphyseal dysplasia*/
573,87,14,/*bone dysplasia*/
573,155,34,/*spondylo-meta-epiphyseal dysplasia*/
573,241,20,/*metatropic dysplasia*/
573,342,19,/*Facial malformation*/
574,11,28,/*metachromatic leukodystrophy*/
574,167,28,/*metachromatic leukodystrophy*/
574,208,3,/*MLD*/
574,246,3,/*MLD*/
574,360,3,/*MLD*/
574,678,19,/*spastic paraparesis*/
574,701,17,/*cerebellar ataxia*/
574,720,18,/*mental disturbance*/
574,901,43,/*schizophrenia-like behavioral abnormalities*/
574,946,18,/*social dysfunction*/
574,970,14,/*mental decline*/
574,986,18,/*but motor deficits*/
574,1338,28,/*metachromatic leukodystrophy*/
575,185,22,/*ovarian-specific tumor*/
575,502,3,/*RHA*/
575,486,14,/*RNA helicase A*/
576,93,17,/*Frasier syndromes*/
576,275,16,/*Frasier syndrome*/
576,499,23,/*End-stage renal disease*/
576,601,3,/*DMS*/
576,629,20,/*glomerular sclerosis*/
576,651,4,/*FSGS*/
576,524,4,/*ESRD*/
576,572,27,/*diffuse mesangial sclerosis*/
576,726,6,/*tumors*/
576,745,13,/*Wilms' tumors*/
576,769,12,/*tissue tumor*/
576,787,17,/*bladder papilloma*/
576,814,14,/*gonadoblastoma*/
576,830,13,/*Wilms' tumors*/
576,970,16,/*Frasier syndrome*/
576,1430,3,/*DMS*/
576,1547,11,/*nephropathy*/
576,1578,13,/*Wilms' tumors*/
577,22,12,/*hemophilia B*/
578,24,29,/*obsessive-compulsive disorder*/
578,55,3,/*OCD*/
578,101,29,/*Obsessive-compulsive disorder*/
578,132,3,/*OCD*/
578,142,27,/*chronic psychiatric disease*/
578,254,3,/*OCD*/
578,358,3,/*OCD*/
578,980,17,/*speech impairment*/
578,1201,20,/*neurologic disorders*/
579,11,18,/*myotonic dystrophy*/
579,69,18,/*Myotonic dystrophy*/
579,89,2,/*DM*/
579,185,18,/*myotonic dystrophy*/
579,339,2,/*DM*/
579,506,21,/*cognitive dysfunction*/
579,531,2,/*DM*/
579,758,19,/*synaptic plasticity*/
579,1335,21,/*cognitive dysfunction*/
579,1373,2,/*DM*/
580,46,29,/*X-linked adrenoleukodystrophy*/
580,77,29,/*X-linked adrenoleukodystrophy*/
580,112,26,/*neurodegenerative disorder*/
580,233,21,/*adrenomyeloneuropathy*/
580,260,15,/*Addison disease*/
580,804,29,/*X-linked adrenoleukodystrophy*/
580,1328,29,/*X-linked adrenoleukodystrophy*/
581,650,8,/*gorillas*/
581,1022,23,/*chemosensory dependence*/
583,966,6,/*testis*/
584,18,25,/*von Hippel-Lindau disease*/
584,99,17,/*von Hippel-Lindau*/
584,119,3,/*VHL*/
584,254,3,/*VHL*/
584,306,50,/*retinal , cerebellar and spinal haemangioblastomas*/
584,359,20,/*renal cell carcinoma*/
584,384,17,/*phaeochromocytoma*/
584,446,3,/*VHL*/
584,470,29,/*sporadic renal cell carcinoma*/
584,504,17,/*haemangioblastoma*/
584,622,3,/*VHL*/
584,1049,3,/*VHL*/
584,1128,3,/*VHL*/
584,1431,3,/*VHL*/
584,1546,3,/*VHL*/
584,1646,3,/*VHL*/
584,1725,3,/*VHL*/
585,153,21,/*ataxia telangiectasia*/
585,401,21,/*ataxia telangiectasia*/
585,433,23,/*paradoxically deficient*/
586,110,15,/*Canavan disease*/
586,127,15,/*Canavan disease*/
586,147,24,/*inherited leukodystrophy*/
586,601,15,/*Canavan disease*/
586,1489,17,/*enzyme deficiency*/
586,1802,15,/*Canavan disease*/
587,0,32,/*Familial hypobetalipoproteinemia*/
587,90,32,/*familial hypobetalipoproteinemia*/
587,124,4,/*FHBL*/
587,217,4,/*FHBL*/
588,24,17,/*Friedreich ataxia*/
588,113,4,/*FRDA*/
588,124,17,/*Friedreich ataxia*/
588,225,4,/*FRDA*/
589,358,15,/*hemochromatosis*/
589,1508,15,/*hemochromatosis*/
589,1822,15,/*hemochromatosis*/
590,0,33,/*Emery-Dreifuss muscular dystrophy*/
590,72,33,/*Emery-Dreifuss muscular dystrophy*/
590,107,4,/*EDMD*/
590,118,36,/*neuromuscular degenerative condition*/
590,174,22,/*dilated cardiomyopathy*/
590,201,25,/*cardiac conduction defect*/
590,377,20,/*muscular dystrophies*/
590,830,4,/*EDMD*/
590,1039,4,/*EDMD*/
591,10,30,/*familial adenomatous polyposis*/
591,42,3,/*FAP*/
591,61,31,/*classical adenomatous polyposis*/
591,141,6,/*cancer*/
591,255,30,/*familial adenomatous polyposis*/
591,287,3,/*FAP*/
591,389,3,/*FAP*/
591,508,3,/*FAP*/
591,615,3,/*FAP*/
591,860,22,/*fundic gland polyposis*/
591,925,3,/*APC*/
591,972,8,/*osteomas*/
591,1041,29,/*FAP-associated hepatoblastoma*/
591,1074,15,/*medullablastoma*/
591,1238,35,/*hereditary mixed polyposis syndrome*/
591,1275,4,/*HMPS*/
591,1497,18,/*colorectal cancers*/
591,1546,3,/*APC*/
591,1887,6,/*cancer*/
592,44,46,/*familial heterozygous hypobetalipoproteinaemia*/
592,161,37,/*steatorrhoea and vitamin E deficiency*/
592,220,33,/*familial hypobetalipoproteinaemia*/
592,255,4,/*FHBL*/
592,516,33,/*familial hypobetalipoproteinaemia*/
592,651,17,/*failure to thrive*/
592,809,32,/*delay neurological complications*/
593,0,15,/*Phenylketonuria*/
593,245,3,/*PKU*/
593,695,3,/*PKU*/
594,12,31,/*dermatofibrosarcoma protuberans*/
594,54,6,/*tumors*/
594,124,31,/*Dermatofibrosarcoma protuberans*/
594,269,5,/*tumor*/
594,157,2,/*DP*/
594,821,6,/*tumors*/
594,1078,5,/*tumor*/
594,1410,2,/*DP*/
594,2181,12,/*Bednar tumor*/
594,2201,24,/*superficial fibrosarcoma*/
594,2260,2,/*DP*/
594,2287,2,/*DP*/
594,2760,2,/*DP*/
595,79,39,/*atorvastatin therapy in type 2 diabetes*/
595,550,8,/*diabetes*/
596,111,22,/*dilated cardiomyopathy*/
596,271,22,/*dilated cardiomyopathy*/
596,389,22,/*dilated cardiomyopathy*/
596,533,15,/*muscle myopathy*/
596,722,30,/*atrial/ventricular arrhythmias*/
596,769,10,/*quadriceps*/
596,787,8,/*myopathy*/
596,879,23,/*neuromuscular disorders*/
596,912,21,/*cardiac abnormalities*/
597,261,25,/*breast and ovarian cancer*/
597,348,7,/*cancers*/
597,425,5,/*tumor*/
597,689,16,/*Brca1-deficiency*/
597,1694,7,/*cancers*/
598,8,19,/*malignant lymphomas*/
598,45,20,/*rheumatoid arthritis*/
598,128,20,/*rheumatoid arthritis*/
598,150,2,/*RA*/
598,180,19,/*malignant lymphomas*/
598,281,19,/*malignant lymphomas*/
598,384,19,/*malignant lymphomas*/
598,433,2,/*RA*/
598,500,19,/*malignant lymphomas*/
598,523,2,/*RA*/
598,646,17,/*rheumatic disease*/
598,936,6,/*cancer*/
598,1032,19,/*malignant lymphomas*/
598,1243,2,/*RA*/
598,1268,19,/*malignant lymphomas*/
598,1483,18,/*Hodgkin's lymphoma*/
598,1567,2,/*RA*/
598,1635,19,/*malignant lymphomas*/
598,1756,19,/*malignant lymphomas*/
599,209,8,/*melanoma*/
599,1039,17,/*melanoma-affected*/
599,1387,15,/*French melanoma*/
599,1625,8,/*melanoma*/
600,38,18,/*myotonic dystrophy*/
600,92,18,/*Myotonic dystrophy*/
600,116,20,/*dystrophia myotonica*/
600,139,2,/*DM*/
600,152,39,/*autosomal dominant multisystem disorder*/
600,359,2,/*DM*/
600,478,38,/*hereditary adult neuromuscular disease*/
600,1019,2,/*DM*/
600,1486,2,/*DM*/
601,29,41,/*autosomal recessive juvenile parkinsonism*/
601,87,5,/*tumor*/
601,158,5,/*tumor*/
601,669,14,/*ovarian tumors*/
601,1044,5,/*tumor*/
601,1063,5,/*tumor*/
601,1161,13,/*ovarian tumor*/
601,1536,6,/*cancer*/
601,1742,5,/*tumor*/
602,12,15,/*afibrinogenemia*/
603,750,13,/*iron overload*/
603,767,15,/*iron deficiency*/
603,868,30,/*iron overload, iron deficiency*/
604,72,21,/*embryonic spinal cord*/
604,201,21,/*embryonic spinal cord*/
604,752,28,/*Deleted in Colorectal Cancer*/
604,852,28,/*dorsal embryonic spinal cord*/
604,782,3,/*DCC*/
604,1331,21,/*embryonic spinal cord*/
605,16,17,/*Tay-Sachs disease*/
605,53,17,/*Tay-Sachs Disease*/
605,72,3,/*TSD*/
605,83,46,/*autosomal recessive neurodegenerative disorder*/
605,131,3,/*TSD*/
606,24,24,/*immunodeficiency disease*/
606,53,6,/*cancer*/
607,47,35,/*paroxysmal nocturnal hemoglobinuria*/
607,87,35,/*paroxysmal nocturnal hemoglobinuria*/
607,124,3,/*PNH*/
607,378,20,/*bacterial infections*/
607,829,18,/*chemotactic defect*/
607,916,3,/*PNH*/
607,1107,29,/*deficiency of the overall PNH*/
607,1167,19,/*bacterial infection*/
608,13,43,/*glucose-6-phosphate dehydrogenase-deficient*/
608,210,49,/*glucose-6-phosphate dehydrogenase (G6PD) activity*/
608,1167,15,/*G6PD deficiency*/
609,26,14,/*renal diseases*/
609,57,25,/*antiphospholipid syndrome*/
609,217,25,/*antiphospholipid syndrome*/
609,244,3,/*APS*/
609,292,3,/*APS*/
609,316,33,/*thrombotic vascular complications*/
609,409,3,/*APS*/
609,448,18,/*glomerulonephritis*/
609,483,3,/*APS*/
609,569,24,/*vascular APS nephropathy*/
609,839,3,/*APS*/
609,894,15,/*APS nephropathy*/
609,971,24,/*vascular APS nephropathy*/
609,1236,14,/*renal symptoms*/
609,1313,19,/*acute renal failure*/
609,1448,11,/*Proteinuria*/
609,1512,18,/*nephrotic syndrome*/
609,1931,19,/*acute renal failure*/
609,2035,23,/*end-stage renal failure*/
609,2148,14,/*renal diseases*/
609,2195,3,/*APS*/
610,33,16,/*HIV-1 viral load*/
610,277,26,/*determinants of viral load*/
610,405,16,/*HIV-1 viral load*/
610,557,12,/*HIV infected*/
610,596,26,/*gravidity, gestational age*/
610,624,19,/*malaria parasitemia*/
610,1932,16,/*HIV-1 viral load*/
610,2086,22,/*advanced HIV infection*/
610,2149,13,/*HIV infection*/
612,86,25,/*hepatocellular carcinomas*/
612,119,7,/*cancers*/
612,221,18,/*broad-range tumour*/
612,356,12,/*colon cancer*/
612,373,13,/*breast cancer*/
612,465,6,/*tumour*/
612,678,6,/*cancer*/
612,778,25,/*hepatocellular carcinomas*/
612,1114,25,/*hepatocellular carcinomas*/
613,52,30,/*spinocerebellar ataxia types 1*/
613,201,22,/*spinocerebellar ataxia*/
613,225,3,/*SCA*/
613,294,3,/*SCA*/
613,507,4,/*SCA7*/
613,622,29,/*progressive cerebellar ataxia*/
613,779,3,/*SCA*/
613,872,4,/*SCA2*/
613,890,4,/*SCA3*/
613,912,4,/*SCA7*/
613,971,6,/*ataxia*/
613,989,4,/*SCA6*/
613,1047,9,/*hypotonia*/
613,1061,13,/*optic atrophy*/
613,1079,18,/*SCA1; hyporeflexia*/
613,1102,4,/*SCA2*/
613,1136,8,/*dystonia*/
613,1149,4,/*SCA3*/
613,1159,20,/*macular degeneration*/
613,1184,4,/*SCA7*/
613,1224,4,/*SCA2*/
613,1237,4,/*SCA3*/
613,1254,4,/*SCA6*/
613,1373,12,/*parkinsonism*/
613,1390,20,/*urinary incontinence*/
};
}
static void init4() {
a4 = new int[] {
613,1691,3,/*SCA*/
613,1818,12,/*parkinsonism*/
614,22,20,/*Lesch-Nyhan syndrome*/
614,97,20,/*Lesch-Nyhan syndrome*/
614,119,3,/*LNS*/
614,146,82,/*deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) and clinically*/
614,246,23,/*self-injurious behavior*/
614,274,15,/*nephrolithiasis*/
614,1698,3,/*LNS*/
615,76,5,/*tumor*/
615,101,17,/*colorectal cancer*/
615,217,5,/*tumor*/
615,240,20,/*colorectal carcinoma*/
615,490,5,/*tumor*/
615,725,40,/*colorectal cell lines and primary tumors*/
615,802,17,/*colorectal tumors*/
615,924,6,/*tumors*/
615,1135,9,/*MSS tumor*/
615,1218,17,/*colorectal tumors*/
615,1290,5,/*tumor*/
617,266,14,/*hyperammonemia*/
617,282,4,/*CPSI*/
618,154,5,/*tumor*/
618,198,6,/*tumors*/
618,880,22,/*positive feedback loop*/
619,64,8,/*dystonia*/
620,0,63,/*Autosomal dominant familial neurohypophyseal diabetes insipidus*/
620,65,63,/*Autosomal dominant familial neurohypophyseal diabetes insipidus*/
620,130,6,/*adFNDI*/
621,34,21,/*ataxia-telangiectasia*/
621,133,21,/*ataxia-telangiectasia*/
621,157,2,/*AT*/
621,592,2,/*AT*/
621,720,2,/*AT*/
622,0,15,/*Coats' syndrome*/
622,51,8,/*glaucoma*/
622,71,15,/*Coats' syndrome*/
622,130,8,/*glaucoma*/
622,188,8,/*eye pain*/
622,409,44,/*inferior yellow exudative retinal detachment*/
622,459,30,/*retinal vascular abnormalities*/
622,501,14,/*Coats' disease*/
622,663,15,/*Coats' syndrome*/
623,65,50,/*autosomal dominant nocturnal frontal lobe epilepsy*/
623,242,50,/*autosomal dominant nocturnal frontal lobe epilepsy*/
623,294,6,/*ADNFLE*/
623,1195,6,/*ADNFLE*/
623,1361,6,/*ADNFLE*/
624,0,24,/*Maternal phenylketonuria*/
624,236,34,/*cognitive and behavioural outcomes*/
624,798,24,/*congenital abnormalities*/
624,1646,25,/*poorer cognitive outcomes*/
624,1740,3,/*PKU*/
624,1851,3,/*PKU*/
624,1967,3,/*PKU*/
624,2034,3,/*PKU*/
625,42,33,/*Pelizaeus-Merzbacher-like disease*/
625,77,28,/*Pelizaeus-Merzbacher disease*/
625,107,3,/*PMD*/
625,116,33,/*Pelizaeus-Merzbacher-like disease*/
625,151,4,/*PMLD*/
625,248,3,/*PMD*/
625,258,17,/*X-linked disorder*/
625,305,4,/*PMLD*/
625,316,29,/*autosomal recessive condition*/
625,411,29,/*complex neurological syndrome*/
625,645,8,/*PMD/PMLD*/
626,69,22,/*ankylosing spondylitis*/
626,264,22,/*ankylosing spondylitis*/
626,288,2,/*AS*/
626,654,2,/*AS*/
626,1032,2,/*AS*/
626,1182,2,/*AS*/
626,1899,2,/*AS*/
626,2199,2,/*AS*/
628,43,17,/*Friedreich Ataxia*/
628,153,17,/*Friedreich Ataxia*/
628,172,4,/*FRDA*/
628,195,16,/*inherited ataxia*/
628,693,4,/*FRDA*/
628,1183,4,/*FRDA*/
629,95,20,/*retinitis pigmentosa*/
629,321,29,/*retinal degenerative diseases*/
629,361,39,/*autosomal dominant retinitis pigmentosa*/
629,402,4,/*ADRP*/
630,14,37,/*autosomal dominant myotonia congenita*/
630,108,37,/*Autosomal dominant myotonia congenita*/
631,42,21,/*ataxia-telangiectasia*/
631,152,21,/*ataxia-telangiectasia*/
631,176,3,/*A-T*/
631,241,28,/*autosomal recessive syndrome*/
631,461,3,/*A-T*/
631,476,6,/*cancer*/
631,628,3,/*A-T*/
631,655,3,/*A-T*/
631,736,13,/*X-irradiation*/
631,852,3,/*A-T*/
631,1105,3,/*A-T*/
631,1214,29,/*familial and sporadic cancers*/
631,1316,5,/*tumor*/
632,81,28,/*familial Mediterranean fever*/
632,283,28,/*familial Mediterranean fever*/
632,313,3,/*FMF*/
632,657,3,/*FMF*/
632,1693,3,/*FMF*/
633,89,18,/*muscular dystrophy*/
633,331,18,/*muscular dystrophy*/
633,394,27,/*Duchenne muscular dystrophy*/
633,423,3,/*DMD*/
633,429,25,/*Becker muscular dystrophy*/
633,456,3,/*BMD*/
633,466,29,/*congenital muscular dystrophy*/
633,497,3,/*CMD*/
633,1306,3,/*DMD*/
633,1314,3,/*CMD*/
633,1392,15,/*dystrophic mice*/
633,1560,3,/*DMD*/
633,1568,3,/*CMD*/
633,1585,17,/*advanced fibrosis*/
633,1896,15,/*muscle fibrosis*/
634,150,20,/*retinal degeneration*/
634,1628,25,/*photoreceptor dystrophies*/
635,29,22,/*Van der Woude syndrome*/
635,104,22,/*Van der Woude syndrome*/
635,128,3,/*VWS*/
635,139,39,/*autosomal-dominant oral facial disorder*/
635,346,3,/*VWS*/
635,857,3,/*VWS*/
636,449,3,/*NBS*/
636,1265,3,/*CPT*/
637,40,16,/*Wolfram syndrome*/
637,58,31,/*nonsyndromic hearing impairment*/
637,91,17,/*diabetes mellitus*/
637,114,19,/*psychiatric disease*/
637,293,36,/*autosomal recessive Wolfram syndrome*/
637,334,65,/*autosomal dominant low frequency sensorineural hearing impairment*/
637,401,6,/*LFSNHI*/
637,515,17,/*diabetes mellitus*/
637,575,20,/*psychiatric diseases*/
637,597,16,/*Wolfram syndrome*/
637,679,18,/*diabetes insipidus*/
637,699,17,/*diabetes mellitus*/
637,718,13,/*optic atrophy*/
637,737,8,/*deafness*/
637,747,16,/*Wolfram syndrome*/
637,977,8,/*DFNA6/14*/
637,1240,16,/*Wolfram syndrome*/
637,1261,6,/*LFSNHI*/
638,0,26,/*Adenomatous polyposis coli*/
638,96,15,/*gastric cancers*/
638,116,17,/*precursor lesions*/
638,344,30,/*distal gastric adenocarcinomas*/
638,422,6,/*cancer*/
638,437,21,/*intestinal metaplasia*/
638,460,2,/*IM*/
638,773,6,/*cancer*/
638,903,14,/*adenocarcinoma*/
638,1020,17,/*gastric carcinoma*/
638,1051,20,/*Abnormalities of APC*/
638,1206,18,/*neoplastic process*/
638,1357,14,/*gastric cancer*/
638,1413,32,/*carcinoma and noninvolved mucosa*/
638,1849,14,/*gastric cancer*/
638,1879,10,/*carcinomas*/
638,2034,20,/*Diffuse-type cancers*/
638,2151,6,/*cancer*/
638,2251,5,/*tumor*/
638,2566,6,/*tumors*/
638,2590,3,/*APC*/
638,2700,9,/*carcinoma*/
639,0,17,/*Colorectal cancer*/
639,65,18,/*colorectal tumours*/
639,216,30,/*familial adenomatous polyposis*/
639,274,27,/*sporadic colorectal tumours*/
639,948,18,/*colorectal tumours*/
639,1116,7,/*tumours*/
639,1338,13,/*colon cancers*/
639,1517,21,/*colorectal carcinomas*/
640,23,11,/*nephropathy*/
640,59,11,/*nephropathy*/
640,108,4,/*TBMN*/
640,72,34,/*Thin basement membrane nephropathy*/
640,293,9,/*hematuria*/
640,312,34,/*proteinuria, normal renal function*/
640,427,9,/*hematuria*/
640,542,16,/*renal impairment*/
640,697,16,/*renal impairment*/
640,717,4,/*TBMN*/
640,808,4,/*FSGS*/
640,840,18,/*glomerulonephritis*/
640,891,24,/*X-linked Alport syndrome*/
640,931,20,/*coincidental disease*/
640,772,34,/*focal segmental glomerulosclerosis*/
640,977,4,/*TBMN*/
640,1138,35,/*autosomal-recessive Alport syndrome*/
640,1202,4,/*TBMN*/
640,1415,22,/*coincidental hematuria*/
640,1622,24,/*X-linked Alport syndrome*/
640,1732,9,/*hematuria*/
640,1743,24,/*X-linked Alport syndrome*/
640,1888,11,/*retinopathy*/
641,793,56,/*salivary glands, pancreas, biliary tract and gallbladder*/
642,24,34,/*autosomal dominant distal myopathy*/
642,128,17,/*Distal myopathies*/
642,223,16,/*muscle disorders*/
642,934,17,/*proximal weakness*/
642,1107,33,/*idiopathic dilated cardiomyopathy*/
642,2011,14,/*cardiomyopathy*/
643,379,20,/*retinal degeneration*/
643,491,39,/*autosomal dominant retinitis pigmentosa*/
643,532,4,/*adRP*/
644,0,9,/*Fragile X*/
645,40,20,/*Huntington's disease*/
646,122,23,/*childhood kidney cancer*/
646,148,12,/*Wilms tumour*/
646,163,2,/*WT*/
646,313,13,/*Wilms tumours*/
646,387,20,/*Denys-Drash syndrome*/
646,410,17,/*renal nephropathy*/
646,430,15,/*gonadal anomaly*/
646,466,2,/*WT*/
646,560,30,/*juvenile granulosa cell tumour*/
646,629,36,/*desmoplastic small round cell tumour*/
646,688,22,/*acute myeloid leukemia*/
647,29,28,/*paediatric and adult cancers*/
647,59,14,/*Retinoblastoma*/
647,75,2,/*RB*/
647,87,48,/*familial adenomatous polyposis/colorectal cancer*/
647,137,3,/*FAP*/
647,258,6,/*cancer*/
647,266,14,/*Retinoblastoma*/
647,381,2,/*RB*/
647,621,2,/*RB*/
647,706,17,/*Colorectal cancer*/
647,863,3,/*FAP*/
647,973,12,/*colon cancer*/
647,1216,17,/*colorectal cancer*/
647,1251,3,/*DCC*/
647,1450,7,/*tumours*/
647,1466,2,/*RB*/
648,21,17,/*atypical myopathy*/
648,78,3,/*DM1*/
648,103,3,/*DM1*/
648,123,25,/*Myotonic dystrophy type 1*/
648,150,3,/*DM1*/
648,161,38,/*autosomal dominant inheritable disease*/
648,316,17,/*atypical myopathy*/
648,379,3,/*DM1*/
648,425,3,/*DM1*/
648,541,8,/*myopathy*/
648,588,3,/*DM1*/
648,648,3,/*DM1*/
649,31,25,/*breast and ovarian cancer*/
649,150,30,/*breast and / or ovarian cancer*/
649,185,6,/*tumour*/
649,204,17,/*breast carcinomas*/
649,335,6,/*cancer*/
649,645,6,/*cancer*/
649,697,13,/*breast cancer*/
649,933,7,/*tumours*/
649,1114,17,/*breast carcinomas*/
650,161,30,/*familial adenomatous polyposis*/
650,193,3,/*FAP*/
651,1,30,/*Familial adenomatous polyposis*/
651,184,14,/*genetic defect*/
651,215,30,/*familial adenomatous polyposis*/
651,635,21,/*adenomatous polyposis*/
652,39,12,/*Wilms' tumor*/
652,171,12,/*Wilms' tumor*/
652,222,20,/*congenital disorders*/
652,278,27,/*Beckwith-Wiedemann syndrome*/
652,412,5,/*tumor*/
652,185,2,/*WT*/
652,743,5,/*tumor*/
653,312,17,/*colorectal cancer*/
653,335,3,/*FAP*/
653,340,30,/*Familial Adenomatous Polyposis*/
653,376,5,/*HNPCC*/
653,383,42,/*Hereditary Non-polyposis Colorectal Cancer*/
653,491,17,/*colorectal cancer*/
653,569,18,/*colorectal cancers*/
653,597,3,/*FAP*/
653,779,6,/*cancer*/
653,864,17,/*colorectal cancer*/
653,934,5,/*HNPCC*/
653,1069,15,/*Dukes' A cancer*/
653,1130,6,/*polyps*/
653,1260,3,/*FAP*/
653,1320,3,/*FAP*/
654,275,20,/*deficiency of enzyme*/
654,498,25,/*chronic hemolytic disease*/
655,78,7,/*cancers*/
655,147,16,/*familial cancers*/
655,576,14,/*retinoblastoma*/
655,636,24,/*wider range of neoplasms*/
655,672,13,/*breast cancer*/
655,761,12,/*Wilms' tumor*/
655,775,17,/*neurofibromatosis*/
655,830,17,/*colorectal cancer*/
655,1120,6,/*cancer*/
655,1152,12,/*Wilms' tumor*/
655,1218,13,/*breast cancer*/
656,57,15,/*Becker myopathy*/
656,164,27,/*X-linked muscular dystrophy*/
656,193,7,/*DMD/BMD*/
656,573,7,/*DMD/BMD*/
657,33,28,/*Familial mediterranean fever*/
657,200,5,/*fever*/
657,210,14,/*abdominal pain*/
657,674,11,/*amyloidosis*/
657,770,20,/*gonadic disturbances*/
657,837,18,/*particular disease*/
658,1128,15,/*virus infection*/
660,107,16,/*SAP-1 deficiency*/
660,350,28,/*metachromatic leukodystrophy*/
660,825,15,/*murine leukemia*/
660,992,16,/*SAP-1 deficiency*/
662,53,27,/*Duchenne muscular dystrophy*/
662,103,27,/*Duchenne muscular dystrophy*/
662,132,3,/*DMD*/
663,0,38,/*Duchenne and Becker muscular dystrophy*/
663,86,27,/*Duchenne muscular dystrophy*/
663,115,3,/*DMD*/
663,124,25,/*Becker muscular dystrophy*/
663,151,3,/*BMD*/
663,257,7,/*DMD/BMD*/
663,586,3,/*DMD*/
663,611,3,/*BMD*/
663,699,3,/*DMD*/
663,708,21,/*dystrophin deficiency*/
663,985,16,/*muscular atrophy*/
663,1003,19,/*congenital myopathy*/
663,1036,58,/*deficiency and unclassified limb-girdle muscular dystrophy*/
663,1198,7,/*DMD/BMD*/
665,57,27,/*Duchenne muscular dystrophy*/
665,110,27,/*Duchenne muscular dystrophy*/
665,139,3,/*DMD*/
665,176,28,/*immunostaining abnormalities*/
665,459,3,/*DMD*/
665,690,3,/*DMD*/
665,741,3,/*DMD*/
666,12,27,/*Duchenne muscular dystrophy*/
668,42,35,/*idiopathic ventricular fibrillation*/
668,79,24,/*Ventricular fibrillation*/
668,131,13,/*sudden deaths*/
668,333,35,/*idiopathic ventricular fibrillation*/
668,371,3,/*IVF*/
668,399,3,/*IVF*/
668,561,12,/*sudden death*/
668,615,3,/*IVF*/
668,652,3,/*IVF*/
668,970,3,/*IVF*/
669,11,26,/*congenital afibrinogenemia*/
672,24,3,/*DMD*/
672,111,34,/*Duchenne/Becker muscular dystrophy*/
673,34,18,/*Huntington disease*/
673,233,18,/*Huntington disease*/
673,913,18,/*Huntington disease*/
674,0,18,/*Huntington disease*/
674,79,18,/*inherited diseases*/
674,432,18,/*Huntington disease*/
674,703,18,/*Huntington disease*/
676,0,20,/*X-linked dystrophies*/
676,118,33,/*Emery-Dreifuss muscular dystrophy*/
676,153,4,/*EDMD*/
676,250,27,/*Duchenne muscular dystrophy*/
676,279,3,/*DMD*/
677,149,14,/*retinoblastoma*/
678,16,44,/*glucose-6-phosphate dehydrogenase deficiency*/
679,58,22,/*anomalous color vision*/
680,31,17,/*sporadic aniridia*/
680,398,8,/*aniridia*/
680,577,8,/*aniridia*/
680,752,8,/*aniridia*/
680,827,8,/*aniridia*/
681,74,15,/*G6PD deficiency*/
681,188,15,/*G6PD deficiency*/
681,575,13,/*anomaloscopic*/
681,676,15,/*G6PD deficiency*/
681,917,15,/*G6PD deficiency*/
682,31,25,/*velocardiofacial syndrome*/
682,118,25,/*Velocardiofacial syndrome*/
682,145,4,/*VCFS*/
682,174,22,/*developmental disorder*/
682,214,22,/*craniofacial anomalies*/
682,241,25,/*conotruncal heart defects*/
682,273,4,/*VCFS*/
682,544,4,/*VCFS*/
682,1073,4,/*VCFS*/
683,52,17,/*pancreatic cancer*/
683,132,30,/*familial adenomatous polyposis*/
683,210,40,/*sporadic tumors of the colon and stomach*/
683,316,6,/*tumors*/
683,428,10,/*carcinomas*/
683,440,25,/*hepatocellular carcinomas*/
683,471,19,/*cancers of the lung*/
683,524,6,/*tumors*/
683,790,18,/*pancreatic cancers*/
685,22,27,/*Duchenne muscular dystrophy*/
685,119,27,/*Duchenne muscular dystrophy*/
685,148,3,/*DMD*/
685,235,3,/*DMD*/
686,0,39,/*Autosomal dominant retinitis pigmentosa*/
688,22,23,/*intravascular hemolysis*/
688,64,15,/*G6PD deficiency*/
690,81,19,/*isovaleric acidemia*/
691,102,15,/*phenylketonuria*/
691,142,15,/*phenylketonuria*/
691,159,3,/*PKU*/
691,242,3,/*PKU*/
691,439,13,/*microcephalic*/
691,470,20,/*congenital anomalies*/
691,492,18,/*esophageal atresia*/
691,622,31,/*intrauterine growth retardation*/
691,709,6,/*length*/
691,847,3,/*PKU*/
691,960,28,/*enlarged cerebral ventricles*/
691,1199,3,/*PKU*/
691,1242,3,/*PKU*/
691,1386,3,/*PKU*/
692,42,25,/*vitreoretinochoroidopathy*/
692,136,44,/*autosomal dominant vitreoretinochoroidopathy*/
693,502,13,/*koro syndrome*/
695,68,24,/*hereditary breast cancer*/
695,156,17,/*breast carcinomas*/
695,234,23,/*familial breast cancers*/
695,445,6,/*tumors*/
695,548,6,/*tumors*/
695,630,6,/*tumors*/
695,691,6,/*tumors*/
695,808,13,/*breast cancer*/
695,890,7,/*tumoral*/
695,1114,23,/*sporadic breast cancers*/
695,1219,17,/*ductal carcinomas*/
695,1277,12,/*BRCA1 tumors*/
695,2012,12,/*BRCA1 tumors*/
695,2040,6,/*tumors*/
695,2254,24,/*hereditary breast cancer*/
696,0,25,/*Maple syrup urine disease*/
696,231,25,/*Maple syrup urine disease*/
696,258,4,/*MSUD*/
696,270,41,/*autosomal recessive inborn error disorder*/
696,486,22,/*neurometabolic disease*/
696,933,4,/*MSUD*/
697,25,24,/*Saethre-Chotzen syndrome*/
697,131,24,/*Saethre-Chotzen syndrome*/
697,167,48,/*autosomal dominant condition of craniosynostosis*/
697,220,14,/*limb anomalies*/
697,571,24,/*Saethre-Chotzen syndrome*/
697,860,18,/*coronal synostosis*/
697,881,13,/*brachycephaly*/
697,939,6,/*ptosis*/
697,948,13,/*hypertelorism*/
697,964,16,/*broad great toes*/
697,987,12,/*clinodactyly*/
697,1428,33,/*craniofacial and limb development*/
698,143,33,/*FRAXE mental retardation syndrome*/
698,347,14,/*FRAXE syndrome*/
698,379,18,/*fragile X syndrome*/
698,429,18,/*mental retardation*/
698,555,14,/*FRAXE syndrome*/
698,749,15,/*Drosophila FMR2*/
698,1537,20,/*retardation disorder*/
699,106,17,/*Kennedy's disease*/
699,128,45,/*autosomal dominant neurodegenerative diseases*/
699,334,26,/*essential cellular process*/
699,431,20,/*vesicular structures*/
699,694,17,/*isolated axoplasm*/
700,90,19,/*Friedreich's ataxia*/
701,35,28,/*GM2 gangliosidosis variant B*/
701,296,28,/*GM2 gangliosidosis variant B*/
701,592,18,/*GM2 gangliosidosis*/
701,1004,28,/*GM2 gangliosidosis variant B*/
702,91,18,/*myotonic dystrophy*/
702,134,18,/*Myotonic dystrophy*/
702,155,2,/*DM*/
702,571,2,/*DM*/
702,1257,2,/*DM*/
703,82,26,/*Adenomatous polyposis coli*/
703,120,5,/*tumor*/
703,155,24,/*colorectal tumorigenesis*/
703,110,3,/*APC*/
703,616,17,/*colorectal cancer*/
703,793,3,/*APC*/
704,38,23,/*bilateral coats disease*/
704,130,23,/*bilateral Coats disease*/
704,1110,13,/*Coats disease*/
704,1171,84,/*abnormalities of retinal vascular and hypoperfusion of choroidial vascular in macula*/
705,4,18,/*fragile X syndrome*/
705,501,18,/*fragile X syndrome*/
705,734,25,/*myotonic dystrophy type 1*/
705,1010,12,/*Dicer enzyme*/
705,1187,9,/*fragile X*/
705,1369,9,/*fragile X*/
706,378,3,/*FHA*/
707,75,20,/*hypercholesterolemic*/
707,301,20,/*hypercholesterolemic*/
708,0,28,/*Familial Mediterranean fever*/
708,112,28,/*Familial Mediterranean Fever*/
708,142,3,/*FMF*/
708,153,34,/*autoinflammatory periodic disorder*/
708,1666,3,/*FMF*/
709,15,52,/*N-acetylgalactosamine-6-sulfate sulfatase deficiency*/
709,136,17,/*Morquio A disease*/
709,155,25,/*Mucopolysaccharidosis IVA*/
709,187,28,/*autosomal recessive disorder*/
709,228,55,/*deficiency of N-acetylgalactosamine-6-sulfate sulfatase*/
709,731,51,/*liver, kidney, spleen, heart, brain and bone marrow*/
709,1281,2,/*KS*/
710,251,30,/*cerebrotendinous xanthomatosis*/
710,283,3,/*CTX*/
710,549,3,/*CTX*/
710,643,3,/*CTX*/
710,683,17,/*Corneal dystrophy*/
710,856,3,/*CTX*/
710,1051,3,/*CTX*/
711,193,5,/*tumor*/
711,279,37,/*benign and malignant gastric diseases*/
712,20,26,/*hereditary prostate cancer*/
712,57,26,/*Hereditary prostate cancer*/
712,85,3,/*HPC*/
712,243,3,/*HPC*/
712,296,3,/*HPC*/
712,645,20,/*primary brain cancer*/
712,863,3,/*HPC*/
712,937,3,/*HPC*/
713,6,24,/*Wiskott-Aldrich syndrome*/
713,89,24,/*Wiskott-Aldrich syndrome*/
713,115,3,/*WAS*/
713,124,25,/*X-linked thrombocytopenia*/
713,151,3,/*XLT*/
713,174,29,/*chronic microthrombocytopenia*/
713,221,16,/*immunodeficiency*/
713,270,3,/*WAS*/
713,1370,7,/*WAS/XLT*/
713,1684,16,/*thrombocytopenia*/
713,1702,16,/*immunodeficiency*/
713,1720,17,/*atopic dermatitis*/
713,1739,33,/*autoimmune and malignant diseases*/
714,21,13,/*breast cancer*/
714,62,21,/*ataxia-telangiectasia*/
714,166,21,/*ataxia-telangiectasia*/
714,452,25,/*breast and ovarian cancer*/
714,823,6,/*tumour*/
714,1370,6,/*tumour*/
714,1515,4,/*HDM2*/
715,23,14,/*retinoblastoma*/
715,182,14,/*retinoblastoma*/
715,513,14,/*retinoblastoma*/
716,48,49,/*very-long-chain Acyl-CoA dehydrogenase deficiency*/
716,193,24,/*hyper-creatine kinasemia*/
716,256,7,/*pyrexia*/
716,268,48,/*persistent hypertonicity of the cervical muscles*/
716,368,15,/*muscle weakness*/
716,733,57,/*very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency*/
716,802,16,/*VLCAD deficiency*/
717,57,15,/*phenylketonuria*/
717,350,15,/*phenylketonuria*/
717,367,3,/*PKU*/
717,433,3,/*PKU*/
717,564,3,/*PKU*/
717,574,3,/*PKU*/
717,583,26,/*mild hyperphenylalaninemia*/
717,882,3,/*PKU*/
717,906,3,/*PKU*/
717,929,3,/*MHP*/
717,1083,3,/*PKU*/
717,1269,3,/*PKU*/
717,1310,3,/*PKU*/
717,1867,3,/*PKU*/
717,1970,3,/*PKU*/
718,193,52,/*Machado-Joseph disease/spinocerebellar ataxia type 3*/
718,249,26,/*neurodegenerative disorder*/
719,152,22,/*Adeno-associated virus*/
719,176,3,/*AAV*/
719,291,22,/*neuroendocrine disease*/
719,499,26,/*central diabetes insipidus*/
719,546,18,/*growth retardation*/
719,583,17,/*deficiency of AVP*/
719,527,3,/*CDI*/
719,856,10,/*hypertonic*/
719,1507,23,/*neuroendocrine diseases*/
720,41,18,/*prostate carcinoma*/
720,124,15,/*Prostate cancer*/
720,171,11,/*male cancer*/
720,405,19,/*prostate carcinomas*/
720,504,19,/*prostate carcinomas*/
720,998,5,/*tumor*/
720,1042,24,/*prostatic adenocarcinoma*/
720,1161,23,/*prostate adenocarcinoma*/
720,1569,25,/*prostate adenocarcinoma 1*/
720,1609,5,/*tumor*/
720,1636,18,/*prostate carcinoma*/
720,1748,24,/*prostatic adenocarcinoma*/
721,102,14,/*leukodystrophy*/
721,130,16,/*spastic diplegia*/
721,152,21,/*peripheral neuropathy*/
721,367,14,/*leukodystrophy*/
721,894,6,/*clefts*/
721,1288,27,/*dysmyelination in disorders*/
722,48,16,/*Brugada syndrome*/
722,81,17,/*atrial standstill*/
722,184,23,/*ventricular arrhythmias*/
722,218,16,/*Brugada syndrome*/
722,239,27,/*congenital long QT syndrome*/
722,293,16,/*Brugada syndrome*/
722,386,58,/*atrial standstill and spontaneous ventricular fibrillation*/
722,791,23,/*ventricular arrhythmias*/
723,110,5,/*tumor*/
723,325,19,/*embryonic lethality*/
724,25,25,/*von Hippel-Lindau disease*/
724,59,16,/*renal carcinomas*/
724,135,20,/*Renal cell carcinoma*/
724,157,3,/*RCC*/
724,395,4,/*RCCs*/
724,479,17,/*von Hippel-Lindau*/
724,498,3,/*VHL*/
724,680,34,/*dialysis-specific renal carcinomas*/
724,806,11,/*VHL disease*/
724,997,3,/*VHL*/
724,1072,7,/*tumours*/
724,1090,3,/*VHL*/
724,1199,10,/*carcinomas*/
724,1240,23,/*end-stage renal disease*/
724,1353,9,/*carcinoma*/
724,1391,27,/*dialysis-specific carcinoma*/
724,1430,3,/*VHL*/
724,1490,10,/*VHL tumour*/
724,1541,20,/*clear cell carcinoma*/
724,1618,3,/*VHL*/
725,79,25,/*Becker muscular dystrophy*/
725,115,38,/*Duchenne and Becker muscular dystrophy*/
725,155,3,/*DMD*/
725,163,3,/*BMD*/
725,282,3,/*DMD*/
725,1212,3,/*DMD*/
725,1316,7,/*DMD/BMD*/
725,1347,3,/*DMD*/
725,1426,3,/*DMD*/
725,1466,3,/*BMD*/
725,1582,3,/*DMD*/
725,1653,3,/*DMD*/
726,45,20,/*lesch-nyhan syndrome*/
726,67,76,/*Complete hypoxanthine-guanine phosphoribosyl-transferase ( HPRT ) deficiency*/
726,169,20,/*Lesch-Nyhan syndrome*/
726,241,34,/*compulsive self-injurious behavior*/
726,401,20,/*Lesch-Nyhan syndrome*/
726,599,15,/*HPRT-deficiency*/
726,945,15,/*APRT deficiency*/
726,963,24,/*additional abnormalities*/
726,1220,20,/*Lesch-Nyhan syndrome*/
727,41,21,/*Prader-Willi syndrome*/
727,108,21,/*Prader-Willi syndrome*/
727,131,3,/*PWS*/
727,197,7,/*obesity*/
727,231,19,/*respiratory failure*/
727,328,25,/*death or critical illness*/
727,401,3,/*PWS*/
727,578,24,/*Hypothalamic dysfunction*/
727,824,21,/*adrenal insufficiency*/
727,878,3,/*PWS*/
727,987,19,/*central hypersomnia*/
727,1035,3,/*PWS*/
727,1075,16,/*critical illness*/
727,1178,3,/*PWS*/
727,1269,3,/*PWS*/
728,129,6,/*growth*/
728,140,18,/*mental retardation*/
728,160,19,/*cerebral dysgenesis*/
728,181,17,/*eye malformations*/
728,206,12,/*hearing loss*/
728,746,42,/*eye anterior chamber developmental defects*/
728,833,28,/*ophthalmologic abnormalities*/
728,874,52,/*haploinsufficiency of the transcription factor FOXC1*/
729,131,28,/*epidermolytic hyperkeratosis*/
729,161,28,/*Epidermolytic hyperkeratosis*/
729,200,42,/*autosomal dominant inherited skin disorder*/
729,731,28,/*epidermolytic hyperkeratosis*/
729,1017,24,/*palmoplantar keratoderma*/
729,1531,28,/*epidermolytic hyperkeratosis*/
729,1745,28,/*epidermolytic hyperkeratosis*/
730,62,5,/*X-ALD*/
731,0,18,/*Multiple sclerosis*/
731,154,18,/*multiple sclerosis*/
731,174,2,/*MS*/
731,314,2,/*MS*/
731,705,2,/*MS*/
732,21,22,/*episodic ataxia type 2*/
732,108,15,/*episodic ataxia*/
732,237,15,/*episodic ataxia*/
732,1016,6,/*ataxia*/
732,1059,18,/*progressive ataxia*/
732,1137,20,/*interictal nystagmus*/
732,1322,6,/*ataxia*/
732,1421,8,/*epilepsy*/
732,1489,15,/*episodic ataxia*/
733,129,18,/*Fragile X syndrome*/
733,173,17,/*mental impairment*/
733,301,28,/*fragile X mental retardation*/
734,98,17,/*neurofibromatosis*/
734,130,27,/*benign and malignant tumors*/
734,283,40,/*malignant peripheral nerve sheath tumors*/
734,325,6,/*MPNSTs*/
734,414,6,/*tumors*/
734,629,6,/*tumors*/
734,778,19,/*LOH-positive tumors*/
734,1463,26,/*Microsatellite instability*/
734,1491,3,/*MSI*/
734,1815,6,/*tumors*/
734,1963,14,/*genetic defect*/
735,1324,12,/*galactosemic*/
735,1475,12,/*galactosemic*/
735,1699,12,/*galactosemic*/
736,33,26,/*pseudorheumatoid dysplasia*/
736,65,11,/*hypoplastic*/
736,132,38,/*progressive pseudorheumatoid dysplasia*/
736,172,5,/*PPsRD*/
736,326,32,/*weather-dependent articular pain*/
736,396,20,/*hypoplasia/dysplasia*/
736,535,87,/*rectangular shape of the lumbar spinal canal, progressive narrowing of the joint spaces*/
736,633,23,/*synovial chondromatosis*/
736,830,15,/*bone dysplasias*/
736,860,29,/*spondyloepiphyseal dysplasias*/
736,910,18,/*spondylarthropathy*/
736,930,29,/*juvenile rheumatoid arthritis*/
736,964,14,/*osteoarthritis*/
737,216,26,/*distinct epilepsy syndrome*/
738,53,20,/*abetalipoproteinemia*/
738,98,20,/*Abetalipoproteinemia*/
738,120,3,/*ABL*/
738,135,27,/*autosomal recessive disease*/
738,382,3,/*ABL*/
738,790,20,/*abetalipoproteinemic*/
739,1,21,/*Prader-Willi syndrome*/
739,59,21,/*Prader-Willi syndrome*/
739,82,3,/*PWS*/
739,112,16,/*genetic disorder*/
739,364,3,/*PWS*/
739,457,3,/*PWS*/
739,601,3,/*PWS*/
739,701,3,/*PWS*/
739,723,3,/*PML*/
739,831,3,/*PWS*/
739,1208,3,/*PWS*/
739,1455,3,/*PWS*/
739,1601,3,/*PWS*/
739,1825,3,/*PWS*/
739,1881,3,/*PWS*/
739,1969,3,/*PWS*/
740,73,16,/*vascular density*/
740,212,29,/*Duchenne's muscular dystrophy*/
740,243,3,/*DMD*/
740,330,3,/*DMD*/
740,496,3,/*FMD*/
740,849,3,/*FMD*/
740,910,26,/*decreased vascular density*/
740,1179,21,/*dystrophin deficiency*/
740,1242,21,/*Dystrophin deficiency*/
740,1347,3,/*FMD*/
740,1394,22,/*low arteriolar density*/
740,1520,16,/*genetic diseases*/
740,1578,3,/*DMD*/
741,0,43,/*X-linked spondyloepiphyseal dysplasia tarda*/
741,138,43,/*X-linked spondyloepiphyseal dysplasia tarda*/
741,229,17,/*skeletal disorder*/
741,369,33,/*absence of systemic complications*/
742,171,2,/*HP*/
742,1655,16,/*malignant tumors*/
742,1673,13,/*inflammations*/
742,1688,19,/*autoimmune diseases*/
742,1709,16,/*allergic illness*/
743,82,18,/*colorectal cancers*/
743,153,18,/*colorectal cancers*/
743,185,5,/*tumor*/
743,370,6,/*cancer*/
743,449,18,/*colorectal cancers*/
743,599,17,/*colorectal cancer*/
743,770,18,/*colorectal cancers*/
743,928,17,/*colorectal cancer*/
743,1083,5,/*tumor*/
743,1343,18,/*colorectal cancers*/
744,136,23,/*inherited breast cancer*/
744,234,13,/*breast cancer*/
744,322,22,/*familial breast cancer*/
744,357,33,/*inherited breast / ovarian cancer*/
744,459,23,/*inherited breast cancer*/
744,988,13,/*breast cancer*/
744,1056,18,/*male breast cancer*/
744,1259,13,/*breast cancer*/
744,1767,24,/*hereditary breast cancer*/
745,15,14,/*prostate tumor*/
745,62,12,/*Wilms' tumor*/
745,124,15,/*prostate cancer*/
745,232,15,/*Prostate cancer*/
745,372,2,/*AI*/
745,350,20,/*androgen independent*/
745,480,5,/*tumor*/
745,512,2,/*AI*/
745,533,5,/*tumor*/
745,563,20,/*LNCaP prostate tumor*/
745,780,15,/*prostate cancer*/
745,1084,5,/*tumor*/
745,1251,12,/*LNCaP tumors*/
745,1344,12,/*small tumors*/
745,1428,6,/*tumors*/
745,1493,16,/*WT1-LNCaP tumors*/
745,1590,5,/*tumor*/
745,1676,11,/*LNCaP tumor*/
746,0,13,/*C5 deficiency*/
746,151,13,/*C5 deficiency*/
746,253,20,/*Chronic inflammation*/
746,709,12,/*C5 deficient*/
746,1071,13,/*C5 deficiency*/
746,1126,13,/*C5 deficiency*/
748,1378,27,/*breast and prostate cancers*/
749,91,17,/*Friedreich ataxia*/
749,110,17,/*Friedreich ataxia*/
749,129,4,/*FRDA*/
749,152,17,/*hereditary ataxia*/
749,243,4,/*FRDA*/
749,672,4,/*FRDA*/
749,877,4,/*FRDA*/
749,1094,4,/*FRDA*/
749,1387,4,/*FRDA*/
751,0,23,/*Posterior scalp defects*/
751,27,14,/*Opitz syndrome*/
751,156,22,/*posterior scalp defect*/
751,288,14,/*Opitz syndrome*/
754,22,12,/*galactosemia*/
755,27,26,/*Papillon-Lef  vre syndrome*/
755,55,25,/*prepubertal periodontitis*/
755,86,24,/*aggressive periodontitis*/
755,213,26,/*Papillon-Lef  vre syndrome*/
755,244,29,/*autosomal recessive condition*/
755,291,22,/*palmoplantar keratosis*/
755,338,13,/*periodontitis*/
755,418,25,/*prepubertal periodontitis*/
755,576,13,/*periodontitis*/
755,744,3,/*PLS*/
755,903,3,/*PLS*/
755,1203,24,/*aggressive periodontitis*/
755,1312,13,/*periodontitis*/
755,1614,25,/*prepubertal periodontitis*/
755,1732,3,/*PLS*/
755,1775,25,/*prepubertal periodontitis*/
755,1928,25,/*prepubertal periodontitis*/
755,2055,3,/*PLS*/
756,77,35,/*autoimmune type 1 diabetes mellitus*/
756,252,24,/*type 1 diabetes mellitus*/
757,464,12,/*galactosemia*/
757,1600,12,/*galactosemia*/
758,259,25,/*BRCA1 breast cancer tumor*/
758,1225,15,/*BRCA1-deficient*/
759,4,18,/*fragile X syndrome*/
759,203,28,/*fragile X mental retardation*/
759,271,9,/*fragile X*/
759,646,28,/*neurobiology of the syndrome*/
759,771,19,/*synaptic plasticity*/
760,70,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
760,134,31,/*X-linked hereditary enzymopathy*/
760,657,4,/*ARMS*/
761,82,20,/*fundus albipunctatus*/
761,108,30,/*sectorial retinitis pigmentosa*/
761,220,20,/*fundus albipunctatus*/
761,260,20,/*fundus albipunctatus*/
761,332,30,/*sectorial retinitis pigmentosa*/
762,0,11,/*Amyloidosis*/
762,15,28,/*familial Mediterranean fever*/
762,138,28,/*Familial mediterranean fever*/
762,168,3,/*FMF*/
762,178,29,/*recessively inherited disease*/
762,245,5,/*fever*/
762,252,41,/*abdominal, articular and/or thoracic pain*/
762,346,17,/*renal amyloidosis*/
762,553,11,/*amyloidosis*/
762,568,3,/*FMF*/
762,887,3,/*FMF*/
762,905,11,/*amyloidosis*/
762,924,3,/*FMF*/
762,945,11,/*amyloidosis*/
762,1076,11,/*amyloidosis*/
762,1113,3,/*FMF*/
762,1210,11,/*amyloidosis*/
762,1283,3,/*FMF*/
762,1441,11,/*amyloidosis*/
762,1564,11,/*amyloidosis*/
762,1627,11,/*amyloidosis*/
763,0,24,/*Abnormal brain structure*/
763,40,22,/*Van der Woude syndrome*/
763,64,22,/*Van der Woude syndrome*/
763,88,3,/*VWS*/
763,99,27,/*autosomal dominant disorder*/
763,141,23,/*cleft lip and/or palate*/
763,169,8,/*lip pits*/
763,273,3,/*VWS*/
763,302,32,/*abnormalities in brain structure*/
763,380,3,/*VWS*/
763,483,3,/*VWS*/
763,509,3,/*VWS*/
763,654,3,/*VWS*/
763,729,3,/*VWS*/
763,878,3,/*VWS*/
763,987,3,/*VWS*/
763,1191,28,/*neurodevelopmental disorders*/
763,1270,3,/*VWS*/
764,52,37,/*hereditary hemorrhagic telangiectasia*/
764,101,38,/*Hereditary hemmorrhagic telangiectasia*/
764,141,3,/*HHT*/
764,149,26,/*Osler-Rendu-Weber syndrome*/
764,183,26,/*autosomal dominant disease*/
764,227,27,/*arteriovenous malformations*/
765,0,26,/*Glycerol kinase deficiency*/
765,135,12,/*glyceroluria*/
765,1257,12,/*glyceroluria*/
765,1387,13,/*GK deficiency*/
765,1402,3,/*GKD*/
765,1428,12,/*glyceroluria*/
765,1474,12,/*glyceroluria*/
765,1651,3,/*GKD*/
766,18,6,/*tumors*/
766,28,25,/*von Hippel-Lindau disease*/
766,63,31,/*Von Hippel-Lindau (VHL) disease*/
766,100,38,/*hereditary multiple-neoplasia syndrome*/
766,170,30,/*Endolymphatic sac (ELS) tumors*/
766,255,11,/*VHL disease*/
766,349,17,/*inner ear disease*/
766,429,11,/*VHL disease*/
766,489,3,/*VHL*/
766,701,11,/*VHL disease*/
766,956,11,/*VHL disease*/
766,1024,11,/*VHL disease*/
766,1102,10,/*ELS tumors*/
766,1189,11,/*ELS lesions*/
766,1202,12,/*Hearing loss*/
766,1272,14,/*vestibulopathy*/
766,1288,14,/*aural fullness*/
766,1353,9,/*ELS tumor*/
766,1398,22,/*vestibular dysfunction*/
766,1517,10,/*ELS tumors*/
766,1541,17,/*pheochromocytomas*/
766,1576,11,/*VHL disease*/
766,1626,11,/*VHL disease*/
766,1895,12,/*hearing loss*/
766,2004,11,/*VHL disease*/
766,2048,9,/*ELS tumor*/
766,2108,3,/*VHL*/
766,2163,6,/*tumors*/
766,2201,11,/*VHL disease*/
766,2276,11,/*VHL disease*/
766,2318,25,/*endolymphatic dysfunction*/
766,2359,11,/*VHL disease*/
766,2456,50,/*discrete neoplastic process on the human inner ear*/
766,2521,10,/*ELS tumors*/
766,2584,3,/*ELS*/
766,2637,3,/*ELS*/
767,174,16,/*immune complexes*/
767,263,28,/*auto/immune complex diseases*/
767,362,20,/*auto-immune diseases*/
767,778,23,/*complement deficiencies*/
767,1098,21,/*complement deficiency*/
769,1324,14,/*retinal layers*/
770,31,10,/*ochronosis*/
770,87,12,/*Alkaptonuria*/
770,110,29,/*hereditary metabolic disorder*/
770,381,22,/*Ochronotic arthropathy*/
770,535,26,/*degenerative joint disease*/
770,578,26,/*articular space narrowing,*/
770,609,14,/*bony sclerosis*/
770,664,22,/*ochronotic arthropathy*/
770,712,20,/*sclera discoloration*/
770,742,12,/*arthroplasty*/
770,844,12,/*arthroplasty*/
770,1089,45,/*electro-analgesia of associated low back pain*/
770,1466,22,/*ochronotic arthropathy*/
770,1508,24,/*total joint arthroplasty*/
771,169,20,/*Cold thyroid nodules*/
771,191,4,/*CTNs*/
771,2184,3,/*NIS*/
772,92,18,/*hypofibrinogenemia*/
772,140,18,/*hypofibrinogenemia*/
773,108,26,/*vaccine-associated sarcoma*/
773,143,26,/*vaccine-associated sarcoma*/
773,171,3,/*VAS*/
773,416,3,/*VAS*/
773,484,3,/*VAS*/
773,537,19,/*feline fibrosarcoma*/
773,558,3,/*FSA*/
773,670,3,/*VAS*/
773,855,3,/*VAS*/
773,978,10,/*VAS tumors*/
773,1140,3,/*VAS*/
773,1420,5,/*tumor*/
774,48,13,/*Lowe syndrome*/
774,67,34,/*oculocerebrorenal syndrome of Lowe*/
774,103,4,/*OCRL*/
774,138,17,/*X-linked disorder*/
774,179,50,/*abnormalities of eyes, nervous system, and kidneys*/
774,256,4,/*OCRL*/
775,16,6,/*autism*/
775,24,6,/*Autism*/
};
}
static void init5() {
a5 = new int[] {
775,307,6,/*cancer*/
775,318,13,/*Down syndrome*/
775,470,6,/*Autism*/
775,557,6,/*autism*/
775,635,23,/*developmental disorders*/
775,828,6,/*Autism*/
775,866,32,/*pervasive developmental disorder*/
775,900,3,/*PDD*/
775,949,16,/*Mental Disorders*/
775,1185,3,/*PDD*/
775,1199,17,/*autistic disorder*/
775,1218,17,/*Asperger disorder*/
775,1237,23,/*disintegrative disorder*/
775,1266,3,/*PDD*/
775,1398,6,/*autism*/
775,1557,6,/*autism*/
775,1723,15,/*cytomegalovirus*/
775,1883,6,/*autism*/
775,1891,8,/*Epilepsy*/
775,1951,6,/*autism*/
775,2027,6,/*Autism*/
775,2049,18,/*tuberous sclerosis*/
775,2080,18,/*fragile X syndrome*/
775,2208,25,/*cytogenetic abnormalities*/
775,2264,18,/*tuberous sclerosis*/
775,2292,18,/*fragile X syndrome*/
775,2420,6,/*autism*/
775,2432,18,/*heritable disorder*/
775,2484,3,/*ASD*/
775,2657,18,/*X-linked disorders*/
775,3448,6,/*autism*/
775,4010,6,/*autism*/
775,4531,6,/*autism*/
775,4654,6,/*autism*/
775,4752,6,/*autism*/
775,4902,6,/*autism*/
775,5275,6,/*autism*/
775,5618,19,/*dysmorphic features*/
775,5639,20,/*congenital anomalies*/
775,5661,18,/*mental retardation*/
775,6007,6,/*autism*/
775,6168,25,/*chromosomal abnormalities*/
775,6474,6,/*autism*/
775,6641,6,/*autism*/
776,137,17,/*colorectal cancer*/
776,156,3,/*CRC*/
776,192,30,/*familial adenomatous polyposis*/
776,224,3,/*FAP*/
776,233,41,/*hereditary nonpolyposis colorectal cancer*/
776,276,5,/*HNPCC*/
776,344,3,/*CRC*/
776,461,3,/*CRC*/
776,538,6,/*polyps*/
776,639,30,/*attenuated polypotic syndromes*/
776,828,18,/*low-risk syndromes*/
776,953,17,/*colorectal cancer*/
776,1035,3,/*APC*/
776,1447,17,/*colorectal cancer*/
776,1753,17,/*colorectal cancer*/
777,30,22,/*aspartylglucosaminuria*/
777,100,22,/*aspartylglucosaminuria*/
777,124,3,/*AGU*/
777,245,45,/*autosomal recessive lysosomal storage disease*/
777,302,25,/*dysmorphic facial gestalt*/
777,429,3,/*AGU*/
777,491,18,/*dysmorphic gestalt*/
777,515,13,/*hypertelorism*/
777,837,3,/*AGU*/
777,919,3,/*AGU*/
778,29,18,/*myotonic dystrophy*/
778,104,18,/*myotonic dystrophy*/
778,124,2,/*DM*/
778,312,2,/*DM*/
778,500,2,/*DM*/
779,92,13,/*breast cancer*/
779,120,6,/*tumour*/
779,229,22,/*sporadic breast cancer*/
779,318,16,/*sporadic tumours*/
779,609,13,/*breast cancer*/
779,738,17,/*ductal carcinomas*/
779,924,7,/*tumours*/
779,1135,18,/*high-grade tumours*/
779,1301,7,/*tumours*/
779,1450,11,/*poor tumour*/
779,1627,13,/*breast cancer*/
780,48,39,/*autoimmune lymphoproliferative syndrome*/
780,452,39,/*autoimmune lymphoproliferative syndrome*/
780,494,4,/*ALPS*/
780,598,4,/*ALPS*/
780,798,12,/*splenomegaly*/
780,815,15,/*lymphadenopathy*/
781,43,25,/*Hemolytic Uremic Syndrome*/
781,215,25,/*Hemolytic Uremic Syndrome*/
781,242,3,/*HUS*/
781,667,3,/*HUS*/
782,59,15,/*Gaucher disease*/
782,134,15,/*Gaucher disease*/
782,170,16,/*sphingolipidosis*/
782,428,15,/*Gaucher disease*/
782,829,15,/*Gaucher disease*/
782,1695,15,/*Gaucher disease*/
783,4,5,/*tumor*/
783,194,5,/*tumor*/
783,227,25,/*malignant rhabdoid tumors*/
783,1732,14,/*retinoblastoma*/
784,17,10,/*thrombosis*/
784,74,20,/*protein S deficiency*/
784,304,31,/*hereditary protein S deficiency*/
784,708,17,/*pancreatic cancer*/
784,740,16,/*advanced disease*/
785,50,18,/*Myotonic dystrophy*/
785,70,3,/*DM1*/
785,80,22,/*neuromuscular disorder*/
785,169,18,/*myotonic dystrophy*/
785,281,18,/*myotonic dystrophy*/
785,312,4,/*DMWD*/
785,441,18,/*myotonic dystrophy*/
785,1063,4,/*DMWD*/
786,17,20,/*Lesch-Nyhan syndrome*/
786,55,20,/*Lesch-Nyhan syndrome*/
786,77,3,/*LNS*/
786,506,18,/*muscular hypotonia*/
786,735,3,/*LNS*/
788,56,15,/*hepatoblastomas*/
788,198,15,/*hepatoblastomas*/
788,215,14,/*Hepatoblastoma*/
788,256,22,/*malignant liver tumors*/
788,468,14,/*hepatoblastoma*/
788,528,5,/*tumor*/
788,745,15,/*hepatoblastomas*/
788,943,15,/*hepatoblastomas*/
788,1006,14,/*hepatoblastoma*/
788,1094,5,/*tumor*/
788,1281,14,/*hepatoblastoma*/
788,1453,15,/*hepatoblastomas*/
788,1569,6,/*tumors*/
788,1637,15,/*hepatoblastomas*/
788,1774,15,/*hepatoblastomas*/
788,1863,14,/*hepatoblastoma*/
788,2136,14,/*hepatoblastoma*/
788,2300,14,/*hepatoblastoma*/
789,28,36,/*non-syndromic sensorineural deafness*/
789,66,4,/*DFN2*/
789,73,31,/*Non-syndromic X-linked deafness*/
789,131,8,/*deafness*/
789,191,23,/*hereditary hearing loss*/
789,244,31,/*non-syndromic X-linked deafness*/
789,380,46,/*congenital profound sensorineural hearing loss*/
789,489,36,/*non-syndromic sensorineural deafness*/
789,527,4,/*DFN2*/
789,746,4,/*DFN2*/
790,73,25,/*deficiency of this enzyme*/
790,204,8,/*melanoma*/
790,275,19,/*deficiency of hex A*/
790,349,17,/*Tay-Sachs disease*/
790,369,3,/*TSD*/
790,753,3,/*TSD*/
790,992,3,/*TSD*/
790,1136,3,/*TSD*/
791,85,36,/*steroid-sensitive nephrotic syndrome*/
791,135,18,/*Nephrotic syndrome*/
791,155,2,/*NS*/
791,189,11,/*proteinuria*/
791,202,15,/*hypoalbuminemia*/
791,219,5,/*edema*/
791,230,14,/*hyperlipidemia*/
791,246,36,/*Steroid-resistant nephrotic syndrome*/
791,284,4,/*SRNS*/
791,402,23,/*end-stage renal disease*/
791,427,4,/*ESRD*/
791,493,12,/*Wilms' tumor*/
791,598,12,/*Wilms' tumor*/
791,612,2,/*WT*/
791,620,32,/*urinary or genital malformations*/
791,869,36,/*steroid-sensitive nephrotic syndrome*/
791,907,4,/*SSNS*/
791,1488,33,/*urinary and genital malformations*/
791,1595,24,/*bilateral gonadoblastoma*/
791,1820,21,/*genital abnormalities*/
791,1940,12,/*Wilms' tumor*/
792,50,14,/*ovarian cancer*/
792,370,14,/*ovarian cancer*/
792,647,14,/*ovarian cancer*/
792,750,14,/*ovarian cancer*/
792,890,14,/*ovarian cancer*/
792,990,14,/*ovarian cancer*/
792,1295,14,/*ovarian cancer*/
793,0,22,/*Aspartylglucosaminuria*/
793,48,22,/*Aspartylglucosaminuria*/
793,73,3,/*AGU*/
793,360,3,/*AGU*/
793,568,3,/*AGU*/
794,55,3,/*APC*/
794,199,9,/*polyposis*/
794,414,15,/*Dutch polyposis*/
794,553,9,/*polyposis*/
794,722,3,/*APC*/
794,758,9,/*polyposis*/
794,945,38,/*classic familial adenomatous polyposis*/
794,985,3,/*FAP*/
794,1010,8,/*adenomas*/
794,1045,3,/*APC*/
794,1240,3,/*FAP*/
794,1255,3,/*APC*/
794,1312,9,/*polyposis*/
794,1626,3,/*FAP*/
794,1686,20,/*attenuated polyposis*/
795,75,15,/*genetic disease*/
795,145,16,/*genetic disorder*/
795,708,27,/*X-linked immunodeficiencies*/
796,38,15,/*prostate cancer*/
796,79,15,/*prostate cancer*/
796,383,15,/*prostate cancer*/
796,452,15,/*prostate cancer*/
796,520,6,/*cancer*/
796,814,15,/*prostate cancer*/
796,1335,15,/*prostate cancer*/
797,53,25,/*hemolytic uremic syndrome*/
797,206,19,/*acute renal disease*/
797,288,36,/*idiopathic hemolytic uremic syndrome*/
797,327,3,/*HUS*/
797,367,21,/*homozygous deficiency*/
797,640,21,/*homozygous deficiency*/
797,727,36,/*underlying defect for the deficiency*/
797,805,23,/*heterozygous deficiency*/
797,894,2,/*FH*/
797,906,19,/*Factor H deficiency*/
797,938,21,/*complement deficiency*/
797,976,3,/*HUS*/
797,1020,2,/*FH*/
797,1068,14,/*idiopathic HUS*/
799,63,18,/*prostate carcinoma*/
799,172,15,/*Prostate cancer*/
799,219,21,/*cancer-related deaths*/
799,377,15,/*prostate cancer*/
799,532,38,/*bloodroot plant Sanguinaria canadensis*/
799,962,18,/*prostate carcinoma*/
799,1062,15,/*prostate cancer*/
799,1564,15,/*prostate cancer*/
799,2115,18,/*prostate carcinoma*/
799,2355,15,/*prostate cancer*/
799,2485,15,/*prostate cancer*/
800,0,25,/*Congenital analbuminaemia*/
800,103,25,/*Congenital analbuminaemia*/
800,198,25,/*placental and body oedema*/
800,262,28,/*autosomal recessive disorder*/
800,587,24,/*congenital analbuminemia*/
800,646,13,/*lipodystrophy*/
800,664,21,/*hypercholesterolaemia*/
800,707,15,/*atherosclerosis*/
800,780,18,/*hypercoagulability*/
800,800,42,/*osteoporosis, respiratory tract infections*/
800,844,31,/*intrauterine growth retardation*/
800,880,18,/*intrauterine death*/
800,973,25,/*Congenital analbuminaemia*/
801,0,26,/*Glycerol kinase deficiency*/
801,126,35,/*isolated glycerol kinase deficiency*/
801,163,3,/*GKD*/
801,985,13,/*hypoglycaemic*/
801,1255,3,/*GKD*/
801,1451,12,/*isolated GKD*/
801,1480,13,/*hypoglycaemia*/
802,0,71,/*Transfer of glycosylphosphatidylinositol-anchored proteins to deficient*/
802,111,35,/*paroxysmal nocturnal hemoglobinuria*/
802,151,35,/*paroxysmal nocturnal hemoglobinuria*/
802,188,3,/*PNH*/
802,505,16,/*hemolytic anemia*/
802,975,3,/*PNH*/
802,1522,3,/*PNH*/
803,203,19,/*developmental delay*/
803,224,10,/*ichthyosis*/
803,236,63,/*hypogonadism, limb shortness, hypoplasia of the corpus callosum*/
803,1149,25,/*contiguous gene syndromes*/
803,1288,16,/*chondrodysplasia*/
803,1401,18,/*growth retardation*/
803,1424,19,/*developmental delay*/
803,1468,35,/*atrophy of the cerebral hemispheres*/
804,121,20,/*macular pigmentation*/
804,723,30,/*different macular pigmentation*/
804,758,16,/*narrow age range*/
804,855,20,/*macular pigmentation*/
804,1108,10,/*brown-eyed*/
804,1600,14,/*non-Asian eyes*/
805,15,21,/*Prader-Willi syndrome*/
805,103,21,/*maternal heterodisomy*/
805,141,12,/*Prader-Willi*/
805,286,6,/*PWS/AS*/
805,596,6,/*PWS/AS*/
807,66,30,/*glycosylasparaginase-deficient*/
807,149,22,/*Aspartylglycosaminuria*/
807,173,3,/*AGU*/
807,191,57,/*deficient enzymatic activity of glycosylasparaginase (GA)*/
807,388,3,/*AGU*/
807,411,3,/*AGU*/
807,469,15,/*glycoasparagine*/
807,644,3,/*AGU*/
807,687,3,/*AGU*/
807,819,3,/*AGU*/
807,1008,3,/*AGU*/
807,1298,3,/*AGU*/
807,1509,3,/*AGU*/
807,1649,3,/*AGU*/
808,34,17,/*fragment assembly*/
808,435,17,/*fragment assembly*/
808,486,23,/*FragmentGluer assembler*/
809,29,17,/*Friedreich ataxia*/
809,61,17,/*Friedreich ataxia*/
809,85,48,/*autosomal recessive trinucleotide-repeat disease*/
809,192,4,/*FRDA*/
809,616,17,/*Friedreich ataxia*/
809,907,17,/*Friedreich ataxia*/
810,532,13,/*haemophilia B*/
810,572,27,/*X-linked recessive disorder*/
810,1064,24,/*severe bleeding disorder*/
811,25,24,/*hereditary breast cancer*/
811,107,13,/*breast cancer*/
811,261,24,/*hereditary breast cancer*/
811,406,24,/*hereditary breast cancer*/
811,489,25,/*hereditary breast cancers*/
811,591,35,/*hereditary breast or ovarian cancer*/
811,694,13,/*breast cancer*/
811,793,24,/*breast or ovarian cancer*/
811,985,17,/*hereditary cancer*/
811,1437,24,/*hereditary breast cancer*/
811,1597,24,/*hereditary breast cancer*/
812,31,39,/*congenital contractural syndrome type 2*/
812,154,28,/*autosomal recessive disorder*/
812,191,39,/*congenital contractural syndrome type 2*/
812,474,13,/*arthogryposis*/
813,184,17,/*genetic disorders*/
813,219,26,/*neurological abnormalities*/
813,247,47,/*radiosensitivity, cell cycle checkpoint defects*/
813,320,6,/*cancer*/
813,654,21,/*ataxia-telangiectasia*/
813,677,3,/*A-T*/
814,19,6,/*tumors*/
814,31,22,/*melanoma-breast cancer*/
815,274,36,/*neonatal alloimmune thrombocytopenia*/
815,1514,27,/*alloimmune thrombocytopenia*/
816,198,22,/*Pachyonychia congenita*/
816,222,2,/*PC*/
817,886,11,/*guinea-pigs*/
818,63,36,/*desmoplastic small round cell tumors*/
818,151,19,/*stromal desmoplasia*/
818,218,35,/*desmoplastic small round cell tumor*/
818,362,19,/*desmoplastic stroma*/
818,400,5,/*tumor*/
818,777,36,/*desmoplastic small round cell tumors*/
818,856,11,/*desmoplasia*/
818,877,6,/*tumors*/
818,1073,36,/*desmoplastic small round cell tumors*/
818,1122,36,/*desmoplastic small round cell tumors*/
818,1443,28,/*Tumor-associated desmoplasia*/
818,1556,36,/*Desmoplastic small round cell tumors*/
818,1793,28,/*Tumor-associated desmoplasia*/
818,1925,28,/*tumor-associated desmoplasia*/
818,2104,28,/*tumor-associated desmoplasia*/
818,2248,28,/*tumor-associated desmoplasia*/
818,2285,35,/*desmoplastic small round cell tumor*/
819,63,6,/*autism*/
819,129,6,/*autism*/
819,658,6,/*autism*/
819,707,6,/*autism*/
819,890,24,/*epigenetic abnormalities*/
819,1236,6,/*autism*/
819,1287,6,/*autism*/
819,1354,6,/*autism*/
821,25,27,/*buccal epithelial dysplasia*/
821,57,23,/*squamous cell carcinoma*/
821,121,9,/*carcinoma*/
821,184,20,/*epithelial dysplasia*/
821,362,27,/*buccal epithelial dysplasia*/
821,391,2,/*ED*/
821,399,23,/*squamous cell carcinoma*/
821,424,3,/*SCC*/
821,469,9,/*buccal ED*/
821,517,2,/*ED*/
821,972,9,/*buccal ED*/
821,987,3,/*SCC*/
821,1082,14,/*buccal lesions*/
821,1138,2,/*ED*/
821,1293,10,/*carcinomas*/
821,1461,10,/*carcinomas*/
821,1531,5,/*tumor*/
821,2080,30,/*cervical lymph node metastasis*/
821,2182,2,/*ED*/
821,2625,14,/*oral carcinoma*/
821,2669,27,/*malignant change of oral ED*/
822,33,8,/*migraine*/
822,302,35,/*familial hemiplegic migraine type 1*/
822,339,4,/*FHM1*/
823,40,13,/*breast cancer*/
823,182,13,/*breast cancer*/
823,312,6,/*tumour*/
823,491,13,/*breast cancer*/
823,687,13,/*breast cancer*/
823,746,33,/*steroid receptor positive tumours*/
823,992,13,/*breast cancer*/
823,1066,24,/*breast or ovarian cancer*/
823,1197,27,/*contralateral breast cancer*/
823,1636,13,/*breast cancer*/
823,1788,13,/*breast cancer*/
824,0,26,/*Nijmegen breakage syndrome*/
825,0,24,/*Wiskott-Aldrich syndrome*/
825,45,24,/*Wiskott-Aldrich syndrome*/
825,100,24,/*Wiskott-Aldrich syndrome*/
825,284,24,/*Wiskott-Aldrich syndrome*/
825,569,24,/*Wiskott-Aldrich syndrome*/
825,674,24,/*Wiskott-Aldrich syndrome*/
825,855,24,/*Wiskott-Aldrich syndrome*/
825,987,24,/*Wiskott-Aldrich syndrome*/
825,1079,24,/*Wiskott-Aldrich syndrome*/
825,1108,25,/*X-linked thrombocytopenia*/
825,1135,29,/*intermittent thrombocytopenia*/
825,1169,11,/*neutropenia*/
825,1182,24,/*Wiskott-Aldrich syndrome*/
825,1326,18,/*autoimmune disease*/
825,1518,24,/*Wiskott-Aldrich syndrome*/
825,1617,24,/*Wiskott-Aldrich syndrome*/
827,142,27,/*Family hypercholesterolemia*/
827,171,2,/*FH*/
827,180,16,/*genetic disorder*/
827,409,23,/*coronary artery disease*/
827,447,2,/*FH*/
827,834,2,/*FH*/
827,2130,20,/*hypercholesterolemia*/
828,173,17,/*Angelman syndrome*/
829,160,20,/*ataxia-telangiectsia*/
829,182,3,/*A-T*/
829,632,3,/*A-T*/
829,1089,3,/*A-T*/
829,1224,3,/*A-T*/
829,1318,3,/*A-T*/
830,105,17,/*enzyme deficiency*/
831,30,18,/*glomerulosclerosis*/
831,103,20,/*Denys-Drash syndrome*/
831,125,13,/*Renal failure*/
831,213,8,/*diabetes*/
831,262,13,/*renal failure*/
831,279,18,/*glomerulosclerosis*/
831,459,18,/*glomerulosclerosis*/
831,482,25,/*early-onset renal failure*/
831,509,20,/*Denys-Drash syndrome*/
831,531,3,/*DDS*/
831,664,11,/*proteinuria*/
831,680,18,/*glomerulosclerosis*/
831,717,3,/*DDS*/
831,1045,13,/*renal failure*/
831,1108,18,/*glomerulosclerosis*/
831,1505,18,/*glomerulosclerosis*/
831,1783,18,/*glomerulosclerosis*/
831,1945,13,/*renal failure*/
831,2261,18,/*glomerulosclerosis*/
832,233,21,/*given optical density*/
832,256,2,/*OD*/
833,98,39,/*Familial Hypercholesterolemia phenotype*/
833,286,48,/*autosomal dominant Familial Hypercholesterolemia*/
833,336,2,/*FH*/
833,429,2,/*FH*/
833,656,2,/*FH*/
833,791,2,/*FH*/
833,1305,2,/*FH*/
833,1454,2,/*FH*/
834,33,8,/*deafness*/
834,46,6,/*goiter*/
834,66,16,/*Pendred syndrome*/
834,131,16,/*Pendred syndrome*/
834,149,2,/*PS*/
834,181,18,/*syndromic deafness*/
834,236,32,/*autosomal-recessive hearing loss*/
834,299,36,/*bilateral sensorineural hearing loss*/
834,343,6,/*goiter*/
834,366,14,/*hypothyroidism*/
834,433,2,/*PS*/
834,440,8,/*deafness*/
834,468,28,/*enlarged vestibular aqueduct*/
834,505,6,/*goiter*/
834,573,2,/*PS*/
834,668,2,/*PS*/
834,840,12,/*hearing loss*/
834,932,23,/*nonprogressive deafness*/
834,1093,23,/*inner ear malformations*/
834,1292,7,/*goiters*/
834,1430,2,/*PS*/
835,0,69,/*Inherited deficiencies of the terminal components of human complement*/
835,120,23,/*complement deficiencies*/
835,161,21,/*Neisserial infections*/
835,275,22,/*Neisseria meningitidis*/
835,365,30,/*terminal complement deficiency*/
835,413,21,/*meningococcal disease*/
835,658,8,/*epidemic*/
835,692,32,/*terminal complement deficiencies*/
835,748,48,/*autoimmune diseases or non-Neisserial infections*/
835,840,23,/*complement deficiencies*/
835,1308,20,/*Neisserial infection*/
836,828,6,/*cancer*/
837,12,26,/*MSH3 in endometrial cancer*/
837,111,7,/*tumours*/
837,288,41,/*hereditary nonpolyposis colorectal cancer*/
837,332,5,/*HNPCC*/
837,650,22,/*endometrial carcinomas*/
837,874,21,/*endometrial carcinoma*/
837,906,31,/*endometrial carcinoma cell line*/
837,1628,7,/*tumours*/
839,94,3,/*DM1*/
839,102,20,/*myotonic dystrophy 1*/
839,124,3,/*DM1*/
839,427,3,/*DM1*/
839,487,3,/*DM1*/
839,959,3,/*DM1*/
839,1247,3,/*DM1*/
839,1412,3,/*DM1*/
839,1560,3,/*DM1*/
839,1623,3,/*DM1*/
839,1692,3,/*DM1*/
840,128,26,/*Hereditary hemochromatosis*/
840,176,29,/*hereditary metabolic disorder*/
840,250,16,/*genetic disorder*/
840,676,15,/*hemochromatosis*/
840,717,23,/*Liver disease/cirrhosis*/
840,742,17,/*diabetes mellitus*/
840,764,17,/*hyperpigmentation*/
840,820,28,/*Primer hepatocellular cancer*/
840,880,15,/*liver cirrhosis*/
841,561,16,/*bone homeostasis*/
841,914,10,/*bone tumor*/
841,936,10,/*osteolysis*/
841,948,14,/*immune disease*/
841,1094,25,/*excessive bone resorption*/
842,23,19,/*arginase deficiency*/
842,140,16,/*Hyperargininemia*/
842,174,23,/*neurometabolic disorder*/
842,208,42,/*deficiency of hepatic cytosolic arginase I*/
842,308,19,/*arginase deficiency*/
843,129,30,/*disorder ataxia telangiectasia*/
843,161,3,/*A-T*/
843,334,21,/*ataxia telangiectasia*/
844,87,16,/*Pendred-syndrome*/
844,118,16,/*Pendred-syndrome*/
844,141,27,/*autosomal recessive disease*/
844,206,26,/*sensorineural hearing loss*/
844,300,16,/*pendred-syndrome*/
844,800,12,/*hearing loss*/
844,817,8,/*deafness*/
844,878,12,/*hearing loss*/
844,895,16,/*thyroid disorder*/
844,1062,15,/*CI-implantation*/
845,0,22,/*Double-layered patella*/
845,26,29,/*multiple epiphyseal dysplasia*/
846,32,36,/*phenylalanine hydroxylase deficiency*/
846,177,15,/*Phenylketonuria*/
846,195,3,/*PKU*/
846,205,26,/*mild hyperphenylalaninemia*/
846,234,3,/*MHP*/
846,420,14,/*PAH deficiency*/
846,1465,14,/*PAH deficiency*/
846,1667,21,/*hyperphenylalaninemia*/
847,18,17,/*pancreatic cancer*/
847,95,20,/*colorectal carcinoma*/
847,165,17,/*pancreatic cancer*/
847,249,20,/*colorectal carcinoma*/
847,437,30,/*colorectal carcinoma cell line*/
847,2180,20,/*colorectal carcinoma*/
849,30,18,/*Huntington disease*/
849,162,20,/*Huntington's disease*/
849,184,2,/*HD*/
849,579,2,/*HD*/
849,901,2,/*HD*/
849,1056,2,/*HD*/
849,1366,2,/*HD*/
850,55,8,/*aniridia*/
850,121,8,/*aniridia*/
850,279,8,/*aniridia*/
851,0,16,/*Hemolytic crisis*/
851,60,82,/*glucose-6-phosphate dehydrogenase deficiency and onset of type 1 diabetes mellitus*/
851,144,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
851,215,11,/*enzymopathy*/
851,231,16,/*hemolytic anemia*/
851,379,16,/*hemolytic anemia*/
851,403,15,/*G6PD deficiency*/
851,436,24,/*type 1 diabetes mellitus*/
851,462,3,/*DM1*/
851,552,16,/*hemolytic anemia*/
851,599,3,/*DM1*/
851,681,16,/*hemolytic anemia*/
851,703,15,/*G6PD deficiency*/
851,1047,9,/*hemolysis*/
851,1098,2,/*DM*/
851,1128,15,/*G6PD deficiency*/
852,0,32,/*Familial non-syndromic cleft lip*/
852,160,37,/*non-syndromic cleft lip and/or palate*/
852,349,10,/*hypodontia*/
852,199,6,/*NSCL/P*/
852,980,20,/*cleft lip and palate*/
852,1002,3,/*CLP*/
852,1051,10,/*Hypodontia*/
852,1118,4,/*CL/P*/
852,1222,10,/*cleft area*/
852,1343,6,/*NSCL/P*/
852,1374,5,/*cleft*/
852,1394,22,/*Van der Woude syndrome*/
852,1418,3,/*VWS*/
852,1621,6,/*NSCL/P*/
853,36,34,/*breast carcinoma and other cancers*/
853,109,6,/*tumour*/
853,179,6,/*cancer*/
853,249,6,/*cancer*/
853,264,6,/*tumour*/
853,460,34,/*familial breast and ovarian cancer*/
853,541,35,/*sporadic breast and ovarian cancers*/
853,671,16,/*breast carcinoma*/
853,721,22,/*familial breast cancer*/
853,801,13,/*breast cancer*/
853,986,13,/*breast cancer*/
853,1010,7,/*tumours*/
853,1224,14,/*breast cancers*/
853,1294,6,/*tumour*/
853,1379,16,/*breast carcinoma*/
853,1442,17,/*pancreatic tumour*/
853,1517,17,/*pancreatic cancer*/
854,51,18,/*fragile X syndrome*/
854,176,18,/*fragile X syndrome*/
854,226,17,/*mental impairment*/
854,363,18,/*fragile X syndrome*/
854,448,20,/*neurogenetic disease*/
854,701,18,/*fragile X syndrome*/
854,764,20,/*neurological disease*/
854,969,18,/*fragile X syndrome*/
854,1129,18,/*fragile X syndrome*/
855,100,24,/*Wiskott-Aldrich syndrome*/
855,271,24,/*Wiskott-Aldrich syndrome*/
855,503,24,/*Wiskott-Aldrich syndrome*/
855,630,3,/*WAS*/
855,845,24,/*decreased cell viability*/
855,1463,3,/*WAS*/
855,1538,14,/*WASp-deficient*/
855,1740,3,/*WAS*/
856,0,12,/*Cytokeratins*/
856,17,24,/*carcinoembryonic antigen*/
856,81,25,/*colorectal adenocarcinoma*/
856,246,25,/*colorectal adenocarcinoma*/
856,727,25,/*colorectal adenocarcinoma*/
856,1444,24,/*neoplastic dissemination*/
856,1545,16,/*stage IV lesions*/
856,1577,27,/*stages I, II and III tumors*/
856,1676,15,/*stage I lesions*/
856,1720,16,/*stage II lesions*/
856,1765,17,/*stage III lesions*/
856,1815,16,/*stage IV lesions*/
856,1898,14,/*stage I tumors*/
856,1947,9,/*II tumors*/
856,1985,16,/*stage III tumors*/
856,2039,9,/*IV tumors*/
856,2388,25,/*colorectal adenocarcinoma*/
856,2475,5,/*tumor*/
856,2650,5,/*tumor*/
856,2697,17,/*colorectal cancer*/
857,61,17,/*Angelman syndrome*/
857,80,17,/*Angelman syndrome*/
857,412,19,/*developmental delay*/
857,433,8,/*seizures*/
857,443,43,/*virtual absence of speech, motor impairment*/
857,616,17,/*Angelman syndrome*/
858,74,27,/*nonketotic hyperglycinaemia*/
858,103,27,/*Nonketotic hyperglycinaemia*/
858,132,3,/*NKH*/
859,4,16,/*Wolfram syndrome*/
859,32,26,/*neurodegenerative disorder*/
859,112,16,/*Wolfram syndrome*/
859,137,19,/*congenital syndrome*/
859,196,17,/*diabetes mellitus*/
859,215,18,/*diabetes insipidus*/
859,235,29,/*optic atrophy, nerve deafness*/
859,350,12,/*mal epilepsy*/
859,425,18,/*progressive ataxia*/
859,472,18,/*status epilepticus*/
859,719,16,/*Wolfram syndrome*/
860,0,28,/*Pelizaeus-Merzbacher disease*/
861,0,28,/*Familial Mediterranean fever*/
861,114,28,/*Familial Mediterranean fever*/
861,144,3,/*FMF*/
861,155,27,/*autosomal recessive disease*/
861,612,3,/*FMF*/
861,1552,11,/*amyloidosis*/
861,1658,11,/*amyloidosis*/
861,1673,3,/*FMF*/
861,1876,11,/*amyloidosis*/
862,114,34,/*childhood adrenocortical carcinoma*/
862,254,20,/*Li-Fraumeni syndrome*/
862,276,3,/*LFS*/
862,539,3,/*LFS*/
862,623,34,/*childhood adrenocortical carcinoma*/
862,1090,5,/*tumor*/
862,1242,24,/*adrenocortical carcinoma*/
862,1436,12,/*cancer-prone*/
862,2084,3,/*LFS*/
863,0,29,/*Familial hypercholesterolemia*/
863,152,29,/*Familial hypercholesterolemia*/
863,2195,29,/*familial hypercholesterolemia*/
864,114,18,/*myotonic dystrophy*/
864,230,25,/*myotonic dystrophy type 1*/
864,257,3,/*DM1*/
864,276,3,/*DM1*/
864,464,3,/*DM1*/
864,634,8,/*myotonia*/
864,644,41,/*characteristic histological abnormalities*/
864,742,3,/*DM1*/
864,1076,3,/*DM1*/
864,1259,14,/*muscle wasting*/
865,41,18,/*Huntington disease*/
865,94,18,/*Huntington disease*/
865,115,2,/*HD*/
865,234,2,/*HD*/
865,432,2,/*HD*/
866,112,18,/*GM1-gangliosidosis*/
866,158,26,/*lysosomal storage disorder*/
866,197,32,/*deficiency of beta-galactosidase*/
866,346,24,/*elastic fiber deposition*/
866,1689,15,/*genetic lesions*/
867,46,17,/*colorectal cancer*/
867,84,17,/*colorectal cancer*/
867,280,24,/*neoplastic cell behavior*/
867,310,21,/*genetic abnormalities*/
867,462,17,/*colorectal cancer*/
867,558,17,/*colorectal cancer*/
867,653,6,/*tumors*/
867,690,21,/*III colorectal cancer*/
867,1049,17,/*colorectal cancer*/
867,1127,6,/*tumors*/
867,1238,6,/*tumors*/
867,1308,6,/*tumors*/
867,1741,17,/*colorectal cancer*/
868,96,15,/*Hemochromatosis*/
868,236,15,/*hemochromatosis*/
868,486,15,/*hemochromatosis*/
869,1,28,/*Hereditary colorectal cancer*/
869,93,17,/*colorectal cancer*/
869,112,3,/*CRC*/
869,192,42,/*hereditary non-polyposis colorectal cancer*/
869,236,5,/*HNPCC*/
869,264,19,/*polyposis syndromes*/
869,294,30,/*familial adenomatous polyposis*/
869,326,3,/*FAP*/
869,332,21,/*Peutz-Jegher syndrome*/
869,355,3,/*PJS*/
869,365,18,/*juvenile polyposis*/
869,385,2,/*JP*/
869,412,6,/*cancer*/
869,761,3,/*FAP*/
869,769,27,/*autosomal dominant disorder*/
869,859,16,/*colonic adenomas*/
869,877,3,/*CRC*/
869,1260,6,/*polyps*/
869,1272,33,/*autosomal recessive MYH polyposis*/
869,1332,21,/*category of polyposis*/
869,1372,3,/*FAP*/
869,1377,5,/*HNPCC*/
869,1500,6,/*polyps*/
869,1615,3,/*CRC*/
869,1683,6,/*cancer*/
869,1699,63,/*endometrial, ovarian, small bowel, and transitional cell cancer*/
869,1972,2,/*JP*/
871,42,6,/*favism*/
871,185,6,/*favism*/
871,248,51,/*glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
871,458,15,/*G6PD deficiency*/
872,19,5,/*tumor*/
872,79,11,/*lung cancer*/
872,242,11,/*lung cancer*/
872,285,5,/*tumor*/
872,317,13,/*breast cancer*/
872,400,5,/*tumor*/
872,432,62,/*malignant rhabdoid and childhood central nervous system tumors*/
872,539,11,/*lung cancer*/
872,675,7,/*cancers*/
872,1168,22,/*small-cell lung cancer*/
872,1358,11,/*lung cancer*/
873,69,10,/*piebaldism*/
874,13,40,/*Duchenne and Becker muscular dystrophies*/
874,192,40,/*Duchenne and Becker muscular dystrophies*/
874,234,7,/*DMD/BMD*/
874,879,7,/*DMD/BMD*/
874,1822,7,/*DMD/BMD*/
874,2032,7,/*DMD/BMD*/
875,121,28,/*Pelizaeus-Merzbacher disease*/
875,151,3,/*PMD*/
875,161,22,/*dysmyelinating disease*/
875,492,3,/*PMD*/
875,611,10,/*PMD-linked*/
875,1087,3,/*PMD*/
875,1232,3,/*PMD*/
876,49,17,/*Friedreich ataxia*/
876,92,17,/*Friedreich ataxia*/
876,114,57,/*autosomal recessive neurodegenerative and cardiac disease*/
876,261,17,/*Friedreich ataxia*/
876,434,16,/*loss-of-function*/
876,697,17,/*Friedreich ataxia*/
876,1325,17,/*Friedreich ataxia*/
876,1861,19,/*frataxin deficiency*/
876,1997,17,/*Friedreich ataxia*/
876,2035,25,/*neurodegenerative disease*/
877,86,39,/*adrenoleukodystrophy protein deficiency*/
877,127,29,/*X-linked adrenoleukodystrophy*/
877,158,5,/*X-ALD*/
877,415,5,/*X-ALD*/
877,545,5,/*X-ALD*/
877,886,5,/*X-ALD*/
877,1318,5,/*X-ALD*/
877,1568,5,/*X-ALD*/
878,23,18,/*myotonic dystrophy*/
878,44,18,/*Myotonic dystrophy*/
878,63,2,/*DM*/
878,104,18,/*muscular dystrophy*/
878,156,3,/*DM1*/
878,164,3,/*DM2*/
878,169,3,/*DM1*/
878,268,2,/*DM*/
878,448,3,/*DM2*/
878,464,3,/*DM1*/
878,472,3,/*DM2*/
878,625,2,/*DM*/
878,740,2,/*DM*/
879,20,17,/*Tay-Sachs disease*/
879,94,17,/*Tay-Sachs disease*/
879,113,3,/*TSD*/
879,124,56,/*inherited neurodegenerative ganglioside storage disorder*/
879,579,3,/*FCD*/
879,1125,3,/*FCD*/
879,1286,3,/*FCD*/
879,1375,3,/*FCD*/
879,1393,3,/*TSD*/
880,104,28,/*familial Mediterranean fever*/
880,137,11,/*amyloidosis*/
880,278,8,/*diarrhea*/
880,291,14,/*abdominal pain*/
880,476,5,/*fever*/
880,483,66,/*diarrhea, abdominal pain, myalgia and lower extremity parasthesias*/
880,663,12,/*hypoglycemia*/
880,762,16,/*renal impairment*/
881,85,21,/*ataxia-telangiectasia*/
882,42,28,/*Pelizaeus-Merzbacher disease*/
882,75,4,/*SPG2*/
882,329,33,/*X-linked dysmyelinating disorders*/
882,376,30,/*hypomyelinating leukodystrophy*/
882,408,28,/*Pelizaeus-Merzbacher disease*/
882,438,3,/*PMD*/
882,447,18,/*spastic paraplegia*/
882,467,4,/*SPG2*/
882,620,3,/*PMD*/
882,656,3,/*PMD*/
882,747,33,/*Pelizaeus-Merzbacher-like disease*/
882,782,4,/*PMLD*/
882,911,8,/*PMD/SPG2*/
882,970,4,/*PMLD*/
882,1453,4,/*PMLD*/
882,1639,4,/*PMLD*/
883,0,35,/*Differential glucocorticoid effects*/
883,146,17,/*dystrophic muscle*/
883,184,33,/*glucocorticoid methylprednisolone*/
883,319,15,/*Duchenne/Becker*/
883,490,19,/*neurologic diseases*/
883,521,25,/*Duchenne/Becker dystrophy*/
883,558,27,/*Duchenne muscular dystrophy*/
883,975,14,/*muscle disease*/
883,998,27,/*Duchenne muscular dystrophy*/
884,67,27,/*congenital afibrinogenaemia*/
884,96,27,/*Congenital afibrinogenaemia*/
884,134,40,/*autosomal recessive coagulation disorder*/
884,255,16,/*afibrinogenaemia*/
884,1403,27,/*congenital afibrinogenaemia*/
886,0,14,/*Tumor necrosis*/
886,25,28,/*familial Mediterranean fever*/
887,18,13,/*schizophrenia*/
887,179,13,/*schizophrenia*/
887,1634,13,/*schizophrenia*/
890,4,14,/*retinoblastoma*/
890,27,13,/*breast cancer*/
890,134,14,/*retinoblastoma*/
890,155,2,/*RB*/
890,187,13,/*breast cancer*/
890,272,2,/*RB*/
890,318,13,/*breast tumors*/
890,480,2,/*RB*/
890,581,6,/*tumors*/
890,641,2,/*RB*/
890,735,2,/*RB*/
890,782,13,/*breast tumors*/
890,956,2,/*RB*/
890,1112,5,/*tumor*/
891,42,10,/*hemophilia*/
891,227,12,/*hemophilia B*/
892,0,22,/*Restless legs syndrome*/
892,168,22,/*restless legs syndrome*/
892,194,28,/*common sensorimotor disorder*/
892,1079,22,/*restless legs syndrome*/
892,1285,22,/*restless legs syndrome*/
893,0,20,/*Cardiac dysrhythmias*/
893,21,14,/*cardiomyopathy*/
893,40,18,/*muscular dystrophy*/
893,76,33,/*Emery-Dreifuss muscular dystrophy*/
893,114,38,/*limb-girdle muscular dystrophy type 1B*/
893,154,33,/*Emery-Dreifuss muscular dystrophy*/
893,189,4,/*EDMD*/
893,199,38,/*limb-girdle muscular dystrophy type 1B*/
893,268,20,/*cardiac dysrhythmias*/
893,290,25,/*late-onset cardiomyopathy*/
893,336,17,/*skeletal myopathy*/
893,358,43,/*contractures of the neck, elbows and ankles*/
893,239,6,/*LGMD1B*/
893,456,23,/*X-linked recessive EDMD*/
893,500,24,/*autosomal dominant EDMD2*/
893,562,4,/*EDMD*/
893,568,16,/*EDMD2 and LGMD1B*/
893,644,38,/*contractures of both elbows and ankles*/
893,757,23,/*X-linked recessive EDMD*/
893,828,46,/*wasting and weakness of humeroperoneal muscles*/
893,918,38,/*contractures of both elbows and ankles*/
893,988,2,/*AV*/
893,1030,24,/*autosomal dominant EDMD2*/
893,1124,35,/*limb-girdle type muscular dystrophy*/
893,1174,18,/*atrial tachycardia*/
893,1240,25,/*autosomal dominant LGMD1B*/
893,1280,20,/*Cardiac dysrhythmias*/
893,1304,4,/*EDMD*/
893,1351,18,/*atrial tachycardia*/
893,1371,19,/*atrial fibrillation*/
893,1396,17,/*atrial standstill*/
893,1423,12,/*sudden death*/
893,1542,18,/*conduction defects*/
894,0,20,/*Huntington's disease*/
894,48,27,/*Huntington's Disease-like 2*/
894,89,20,/*Huntington's disease*/
894,111,2,/*HD*/
894,166,27,/*autosomal dominant disorder*/
894,256,21,/*psychiatric syndromes*/
894,77,4,/*HDL2*/
894,284,2,/*HD*/
894,454,7,/*HD-like*/
894,481,2,/*HD*/
894,627,2,/*HD*/
894,783,2,/*HD*/
894,857,2,/*HD*/
894,926,21,/*polyglutamine disease*/
894,1071,2,/*HD*/
894,1177,2,/*HD*/
894,1190,39,/*disorders of striatal neurodegeneration*/
895,30,17,/*Angelman syndrome*/
895,58,17,/*Angelman syndrome*/
895,78,2,/*AS*/
895,411,2,/*AS*/
895,1001,2,/*AS*/
895,1089,2,/*AS*/
896,0,22,/*Class-III malocclusion*/
896,76,22,/*class-III malocclusion*/
896,241,22,/*class-III malocclusion*/
896,377,12,/*malocclusion*/
897,112,16,/*genetic diseases*/
897,342,28,/*Mucopolysaccharidosis type I*/
897,665,20,/*multisystem disorder*/
897,701,15,/*IDUA deficiency*/
897,855,18,/*attenuated disease*/
897,918,17,/*progressive joint*/
897,940,15,/*cardiac disease*/
897,1569,4,/*CAZY*/
898,0,47,/*Genetic bases of human complement C7 deficiency*/
898,49,24,/*Complement C7 deficiency*/
898,122,20,/*bacterial infections*/
898,156,10,/*meningitis*/
898,177,22,/*Neisseria meningitidis*/
898,1161,37,/*deficiencies of complement components*/
899,0,52,/*Glaucoma with the oculocerebrorenal syndrome of Lowe*/
899,87,8,/*glaucoma*/
899,105,34,/*oculocerebrorenal syndrome of Lowe*/
899,141,4,/*OCRL*/
899,280,8,/*glaucoma*/
899,336,22,/*report of the syndrome*/
899,437,4,/*OCRL*/
899,474,8,/*glaucoma*/
899,484,15,/*corneal changes*/
899,513,8,/*glaucoma*/
899,523,25,/*gonioscopic abnormalities*/
899,581,8,/*glaucoma*/
899,631,8,/*glaucoma*/
899,644,22,/*defining abnormalities*/
899,752,8,/*glaucoma*/
899,843,8,/*glaucoma*/
899,943,8,/*Glaucoma*/
899,1586,23,/*synechial abnormalities*/
899,1730,17,/*normal optic disc*/
899,1765,22,/*variable abnormalities*/
899,1801,8,/*glaucoma*/
899,2006,27,/*X-linked infantile glaucoma*/
899,2074,4,/*OCRL*/
899,2123,24,/*filtration angle anomaly*/
899,2225,8,/*cataract*/
900,117,21,/*Prader-Willi syndrome*/
900,152,21,/*Prader-Willi syndrome*/
900,188,3,/*PWS*/
900,599,3,/*PWS*/
900,656,3,/*PWS*/
};
}
static void init6() {
a6 = new int[] {
900,719,3,/*PWS*/
900,1113,20,/*feeding difficulties*/
900,1135,12,/*hypogonadism*/
900,1149,13,/*short stature*/
900,1164,18,/*late-onset obesity*/
900,1184,21,/*learning difficulties*/
900,1207,24,/*abnormal social behavior*/
900,1236,24,/*marked tolerance to pain*/
900,1273,13,/*sticky saliva*/
900,1291,10,/*narcolepsy*/
900,1365,3,/*PWS*/
900,2031,3,/*PWS*/
901,57,15,/*hemochromatosis*/
901,789,15,/*choriocarcinoma*/
902,102,21,/*breast/ovarian cancer*/
902,1761,13,/*breast cancer*/
903,54,5,/*tumor*/
903,115,18,/*myotonic dystrophy*/
903,135,25,/*Type I myotonic dystrophy*/
903,162,3,/*DM1*/
903,654,5,/*tumor*/
903,1179,3,/*DM1*/
903,1367,18,/*insulin resistance*/
904,28,34,/*subtotal deficiencies of C6 and C7*/
904,111,15,/*C7 deficiencies*/
904,128,41,/*Combined subtotal deficiency of C6 and C7*/
904,471,9,/*C7 defect*/
904,983,13,/*C7 deficiency*/
904,1061,12,/*C6-deficient*/
904,1308,25,/*deficit of circulating C7*/
905,0,32,/*Autosomal recessive omodysplasia*/
905,101,32,/*Autosomal recessive omodysplasia*/
905,148,29,/*congenital skeletal dysplasia*/
905,199,10,/*micromelia*/
905,214,22,/*craniofacial anomalies*/
905,135,3,/*ARO*/
905,430,29,/*proximal radioulnar diastasis*/
905,465,37,/*anterolateral radial head dislocation*/
905,806,21,/*diastrophic dysplasia*/
906,220,42,/*ocular and otolaryngological abnormalities*/
906,301,28,/*spondyloepiphyseal dysplasia*/
906,331,3,/*SED*/
906,369,25,/*Stickler dysplasia type I*/
906,408,16,/*Kniest dysplasia*/
906,426,3,/*KND*/
906,396,5,/*STD-I*/
906,516,3,/*SED*/
906,685,3,/*KND*/
906,896,24,/*type II collagenopathies*/
906,1510,3,/*KND*/
907,30,22,/*ankylosing spondylitis*/
907,223,24,/*aberrant joint ankylosis*/
907,265,22,/*ankylosing spondylitis*/
907,289,2,/*AS*/
907,369,2,/*AS*/
907,525,2,/*AS*/
907,663,2,/*AS*/
907,754,2,/*AS*/
907,984,2,/*AS*/
907,1153,2,/*AS*/
907,1296,2,/*AS*/
907,1437,2,/*AS*/
907,1538,2,/*AS*/
907,1761,2,/*AS*/
908,49,29,/*X-linked adrenoleukodystrophy*/
908,92,29,/*X-linked adrenoleukodystrophy*/
908,123,5,/*X-ALD*/
908,149,20,/*peroxisomal disorder*/
908,199,73,/*demyelination of the central nervous system, adrenal cortex insufficiency*/
908,418,5,/*X-ALD*/
908,468,23,/*Childhood cerebral form*/
908,493,4,/*CCER*/
908,934,5,/*X-ALD*/
908,1004,3,/*ALD*/
908,1159,3,/*ALD*/
908,2228,5,/*X-ALD*/
908,2337,5,/*X-ALD*/
909,80,18,/*learning disorders*/
909,292,18,/*learning disorders*/
909,312,3,/*LDs*/
909,452,28,/*smooth-pursuit eye movements*/
909,482,4,/*SPEM*/
909,503,2,/*LD*/
909,1032,2,/*LD*/
909,1067,17,/*closed-loop gains*/
909,1129,28,/*acceleration of eye movement*/
909,1221,12,/*retinal slip*/
909,1284,2,/*LD*/
909,1463,24,/*supplementary eye fields*/
909,1529,33,/*voluntary control of eye movement*/
910,0,23,/*Alkaptonuric ochronosis*/
910,124,12,/*Alkaptonuria*/
910,147,42,/*autosomal recessive disorder of metabolism*/
910,341,21,/*homogentisic aciduria*/
910,414,10,/*ochronosis*/
910,430,27,/*arthropathy of large joints*/
910,494,28,/*cardiovascular abnormalities*/
910,524,36,/*renal, urethral and prostate calculi*/
910,592,10,/*ochronosis*/
910,719,58,/*pigmentation of the skin, sclera, and auricular cartilages*/
910,794,11,/*arthropathy*/
910,1165,23,/*alkaptonuric ochronosis*/
910,1519,12,/*alkaptonuria*/
910,1652,23,/*alkaptonuric ochronosis*/
911,155,17,/*myasthenia gravis*/
912,56,20,/*cognitive impairment*/
912,80,27,/*Duchenne muscular dystrophy*/
912,205,27,/*Duchenne muscular dystrophy*/
912,235,3,/*DMD*/
912,328,3,/*DMD*/
912,484,3,/*DMD*/
912,920,20,/*cognitive impairment*/
912,1048,20,/*cerebral dysfunction*/
912,1180,3,/*DMD*/
912,1238,20,/*cognitive impairment*/
912,1275,3,/*DMD*/
913,28,15,/*cystic fibrosis*/
913,180,15,/*cystic fibrosis*/
913,659,15,/*cystic fibrosis*/
913,676,2,/*CF*/
913,979,2,/*CF*/
913,1097,2,/*CF*/
913,1357,2,/*CF*/
914,103,28,/*rhabdoid tumor of the kidney*/
914,1248,5,/*tumor*/
914,1366,5,/*tumor*/
915,56,13,/*Wilson copper*/
915,85,14,/*Wilson disease*/
915,170,13,/*Wilson copper*/
916,92,21,/*prader-willi syndrome*/
916,184,27,/*neurodevelopmental disorder*/
916,212,21,/*Prader-Willi syndrome*/
916,235,3,/*PWS*/
916,298,35,/*abnormal respiratory rhythmogenesis*/
916,1024,16,/*dystrophic axons*/
916,1114,24,/*slow respiratory rhythms*/
916,1398,29,/*deficit in neuronal migration*/
916,1636,3,/*PWS*/
917,0,24,/*Congenital analbuminemia*/
918,171,6,/*cancer*/
918,343,26,/*lymphoid enhancer factor-1*/
918,371,5,/*LEF-1*/
918,596,15,/*colon carcinoma*/
918,717,5,/*tumor*/
918,942,6,/*cancer*/
918,1090,15,/*colon carcinoma*/
918,1406,15,/*colon carcinoma*/
919,57,15,/*prostate cancer*/
919,140,15,/*prostate cancer*/
919,201,15,/*prostate cancer*/
919,218,2,/*PC*/
919,713,2,/*PC*/
919,752,15,/*Prostate Cancer*/
920,57,13,/*choroideremia*/
920,223,13,/*choroideremia*/
920,238,3,/*CHM*/
920,395,3,/*CHM*/
920,651,3,/*CHM*/
920,746,3,/*CHM*/
920,923,13,/*choroideremia*/
921,47,33,/*colorectal and endometrial cancer*/
921,100,36,/*Hereditary nonpolyposis colon cancer*/
921,285,17,/*colorectal cancer*/
921,451,5,/*tumor*/
921,527,17,/*colorectal cancer*/
921,607,17,/*colorectal cancer*/
921,990,20,/*extracolonic cancers*/
921,1018,36,/*hereditary nonpolyposis colon cancer*/
921,1133,17,/*colorectal cancer*/
921,1238,18,/*endometrial cancer*/
921,1454,17,/*colorectal cancer*/
921,1476,18,/*endometrial cancer*/
921,1621,6,/*cancer*/
921,1695,35,/*American sporadic colorectal cancer*/
921,1734,14,/*uterine cancer*/
921,1936,17,/*colorectal cancer*/
921,1958,18,/*endometrial cancer*/
922,214,26,/*Nijmegen breakage syndrome*/
922,249,39,/*autosomal recessive hereditary disorder*/
922,1310,15,/*NBS1 deficiency*/
922,1506,15,/*NBS1 deficiency*/
922,1546,15,/*hypermutability*/
922,1627,6,/*cancer*/
923,27,24,/*Wiskott-Aldrich syndrome*/
923,58,24,/*Wiskott-Aldrich syndrome*/
923,84,3,/*WAS*/
923,95,33,/*X-linked primary immunodeficiency*/
923,174,3,/*WAS*/
923,577,3,/*WAS*/
923,714,41,/*actin cytoskeleton, immunological defects*/
923,794,3,/*WAS*/
923,993,3,/*WAS*/
924,0,29,/*Spinocerebellar ataxia type 2*/
924,169,30,/*polyglutamine (polyQ) diseases*/
924,1250,4,/*SCA2*/
924,1596,2,/*AO*/
924,1698,4,/*SCA2*/
924,2036,15,/*PC degeneration*/
924,2055,4,/*SCA6*/
924,2150,20,/*neuronal dysfunction*/
925,0,18,/*Cone-rod dystrophy*/
925,202,17,/*retinal dystrophy*/
925,1458,10,/*nyctalopia*/
925,1481,19,/*macular appearances*/
925,1568,15,/*macular atrophy*/
925,1790,19,/*macular dysfunction*/
925,1895,31,/*generalized retinal dysfunction*/
925,2273,17,/*macular dystrophy*/
926,26,5,/*tumor*/
926,102,21,/*advanced renal cancer*/
926,187,13,/*renal cancers*/
926,221,23,/*von Hippel-Lindau tumor*/
926,311,11,/*renal tumor*/
926,519,12,/*renal cancer*/
926,581,12,/*renal cancer*/
926,675,12,/*renal cancer*/
926,714,3,/*VHL*/
926,840,12,/*renal cancer*/
926,888,5,/*tumor*/
926,1189,12,/*renal cancer*/
926,1343,12,/*renal cancer*/
926,1481,5,/*tumor*/
927,130,18,/*Fragile X syndrome*/
927,184,18,/*Fragile X syndrome*/
927,204,58,/*Abnormalities in synaptic processes in the cerebral cortex*/
927,293,18,/*cognitive deficits*/
927,315,9,/*Fragile X*/
927,366,19,/*cerebellar deficits*/
927,514,38,/*classical delay eye-blink conditioning*/
927,812,9,/*Fragile X*/
927,848,19,/*cerebellar deficits*/
927,963,19,/*cerebellar deficits*/
927,1057,23,/*cerebellar dysfunctions*/
927,1099,23,/*motor learning deficits*/
927,1126,9,/*Fragile X*/
928,70,15,/*prostate cancer*/
928,214,15,/*prostate cancer*/
928,234,6,/*cancer*/
928,328,5,/*tumor*/
928,471,15,/*prostate cancer*/
928,544,15,/*prostate cancer*/
928,1010,5,/*tumor*/
928,1063,6,/*tumors*/
928,1288,5,/*tumor*/
929,22,66,/*hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiencies*/
929,237,20,/*Lesch-Nyhan syndrome*/
929,261,17,/*HPRT-related gout*/
930,87,21,/*Ataxia telangiectasia*/
930,110,3,/*A-T*/
930,121,27,/*autosomal recessive disease*/
930,220,21,/*ataxia telangiectasia*/
930,252,3,/*A-T*/
930,314,9,/*lymphomas*/
930,328,9,/*leukemias*/
930,430,23,/*lymphoblastic leukemias*/
930,1227,28,/*lymphoreticular malignancies*/
931,65,18,/*Zellweger syndrome*/
931,1971,18,/*Zellweger spectrum*/
932,68,19,/*Alzheimer's disease*/
932,233,19,/*Alzheimer's disease*/
932,254,2,/*AD*/
932,822,2,/*AD*/
932,935,2,/*AD*/
932,1097,2,/*AD*/
932,1371,2,/*AD*/
933,31,3,/*FAP*/
933,78,30,/*Familial adenomatous polyposis*/
933,110,3,/*FAP*/
933,417,8,/*adenomas*/
933,429,3,/*FAP*/
933,705,10,/*carcinomas*/
933,717,8,/*adenomas*/
933,1088,3,/*FAP*/
934,81,8,/*aniridia*/
934,213,23,/*aniridia (AN) disorders*/
934,480,13,/*glioblastomas*/
934,555,6,/*Sey/AN*/
935,117,3,/*MAP*/
935,86,29,/*MYH associated polyposis coli*/
935,211,9,/*polyposis*/
935,315,3,/*MAP*/
935,169,29,/*MYH associated polyposis coli*/
935,784,17,/*Colorectal cancer*/
935,951,3,/*MAP*/
935,993,22,/*gastro-duodenal polyps*/
935,1057,18,/*duodenal carcinoma*/
935,1077,13,/*Breast cancer*/
935,1258,3,/*MAP*/
935,1319,24,/*classical polyposis coli*/
935,1374,3,/*MAP*/
935,1391,17,/*colorectal cancer*/
935,1490,30,/*upper gastrointestinal lesions*/
935,1612,3,/*MAP*/
935,1735,13,/*breast cancer*/
936,33,17,/*colorectal cancer*/
936,136,26,/*stage II colorectal cancer*/
936,272,17,/*colorectal cancer*/
936,375,5,/*tumor*/
936,413,20,/*colorectal carcinoma*/
936,588,25,/*III colorectal carcinomas*/
936,707,5,/*tumor*/
936,730,5,/*tumor*/
936,889,31,/*stage III colorectal carcinomas*/
936,940,16,/*stage II disease*/
936,963,6,/*tumors*/
936,1060,19,/*DCC-negative tumors*/
936,1154,17,/*stage III disease*/
936,1329,27,/*stage III colorectal cancer*/
936,1371,21,/*colorectal carcinomas*/
936,1488,7,/*cancers*/
938,43,14,/*G6PD-deficient*/
938,95,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
938,166,22,/*hereditary enzymopathy*/
938,447,14,/*G6PD deficient*/
938,546,14,/*G6PD-deficient*/
938,782,14,/*G6PD-deficient*/
939,21,26,/*nonketotic hyperglycinemia*/
939,70,35,/*atypical nonketotic hyperglycinemia*/
939,107,3,/*NKH*/
939,440,18,/*Mental retardation*/
939,463,24,/*behavioral abnormalities*/
939,750,15,/*Hyperglycinemia*/
939,912,15,/*hyperglycinemia*/
940,79,27,/*autosomal dominant disorder*/
940,1220,9,/*catalysis*/
941,35,37,/*attenuated adenomatous polyposis coli*/
941,101,5,/*tumor*/
941,140,37,/*attenuated adenomatous polyposis coli*/
941,180,4,/*AAPC*/
941,202,30,/*familial adenomatous polyposis*/
941,235,3,/*FAP*/
941,289,16,/*colonic adenomas*/
941,327,17,/*colorectal cancer*/
941,437,4,/*AAPC*/
941,924,19,/*colorectal adenomas*/
941,1160,8,/*adenomas*/
941,1360,20,/*rectal polyp sparing*/
941,1399,14,/*desmoid tumors*/
941,1472,4,/*AAPC*/
941,1667,3,/*FAP*/
942,0,28,/*Familial hemiplegic migraine*/
942,43,24,/*recurrent encephalopathy*/
942,107,28,/*Familial hemiplegic migraine*/
942,137,3,/*FHM*/
942,148,27,/*autosomal dominant disorder*/
942,267,3,/*FHM*/
942,296,10,/*hemiplegia*/
942,353,3,/*FHM*/
942,418,4,/*coma*/
942,427,8,/*seizures*/
942,552,24,/*recurrent encephalopathy*/
942,581,3,/*FHM*/
942,661,14,/*encephalopathy*/
942,736,8,/*migraine*/
942,1030,3,/*FHM*/
942,1087,3,/*FHM*/
942,1103,24,/*recurrent encephalopathy*/
943,14,26,/*hereditary hemochromatosis*/
944,0,20,/*Pyoderma gangrenosum*/
944,37,12,/*hidradenitis*/
944,63,20,/*Pyoderma gangrenosum*/
944,85,2,/*PG*/
944,120,17,/*systemic diseases*/
944,162,12,/*hidradenitis*/
944,188,2,/*HS*/
944,302,2,/*PG*/
944,324,2,/*HS*/
944,364,2,/*HS*/
944,573,28,/*systemic lupus erythematosus*/
944,618,23,/*chronic iron-deficiency*/
945,0,22,/*Machado-Joseph disease*/
945,85,30,/*olivopontocerebellar atrophies*/
945,187,22,/*Machado-Joseph Disease*/
945,380,6,/*ataxia*/
945,388,9,/*nystagmus*/
945,399,10,/*dysarthria*/
945,411,21,/*facial fasciculations*/
945,540,10,/*spasticity*/
945,581,23,/*dystonic manifestations*/
945,637,14,/*distal atrophy*/
945,656,12,/*sensory loss*/
945,769,30,/*olivopontocerebellar atrophies*/
946,25,6,/*cancer*/
946,132,30,/*familial adenomatous polyposis*/
946,165,3,/*FAP*/
946,192,27,/*autosomal dominant disorder*/
946,321,17,/*colorectal cancer*/
946,341,3,/*CRC*/
946,349,3,/*APC*/
946,410,7,/*tumours*/
946,756,3,/*CRC*/
946,808,6,/*cancer*/
946,902,37,/*colorectal , breast and other cancers*/
947,105,16,/*Wilson's disease*/
947,245,16,/*Wilson's disease*/
947,263,2,/*WD*/
947,315,2,/*WD*/
947,495,2,/*WD*/
947,1083,2,/*WD*/
947,1340,2,/*WD*/
947,1371,2,/*WD*/
947,1479,2,/*WD*/
947,1589,2,/*WD*/
947,1737,2,/*WD*/
948,85,12,/*Prader-Willi*/
948,108,21,/*Prader-Willi syndrome*/
948,131,3,/*PWS*/
948,194,13,/*short stature*/
948,276,11,/*hyperphagia*/
948,292,7,/*obesity*/
948,301,38,/*Partial growth hormone (GH) deficiency*/
948,371,3,/*PWS*/
948,516,3,/*PWS*/
948,1258,3,/*PWS*/
948,1424,8,/*diabetes*/
948,1668,3,/*PWS*/
948,1843,3,/*PWS*/
949,71,28,/*familial Mediterranean fever*/
949,101,3,/*FMF*/
949,323,28,/*familial Mediterranean fever*/
949,370,25,/*immunologic abnormalities*/
949,450,19,/*Mediterranean fever*/
949,554,19,/*Mediterranean fever*/
949,663,19,/*Mediterranean fever*/
949,803,19,/*Mediterranean fever*/
949,1282,19,/*Mediterranean fever*/
949,1771,19,/*Mediterranean fever*/
949,1868,19,/*Mediterranean fever*/
950,131,13,/*breast cancer*/
950,149,14,/*ovarian cancer*/
950,203,16,/*sporadic cancers*/
950,361,21,/*breast (MCF-7) cancer*/
951,1078,2,/*WT*/
951,1570,5,/*tumor*/
952,46,14,/*retinoblastoma*/
952,169,14,/*retinoblastoma*/
952,297,14,/*retinoblastoma*/
952,318,2,/*Rb*/
952,396,2,/*Rb*/
952,888,2,/*Rb*/
953,35,5,/*tumor*/
953,87,6,/*cancer*/
953,212,15,/*prostate cancer*/
953,243,7,/*cancers*/
953,324,32,/*antiandrogen withdrawal syndrome*/
953,538,15,/*prostate cancer*/
953,677,15,/*prostate cancer*/
953,709,26,/*restricted prostate cancer*/
953,809,15,/*prostate cancer*/
953,1547,16,/*prostate cancers*/
954,0,39,/*Genome-wide linkage of febrile seizures*/
954,44,8,/*epilepsy*/
954,110,16,/*Febrile seizures*/
954,128,2,/*FS*/
954,158,16,/*seizure disorder*/
954,275,2,/*FS*/
954,315,17,/*afebrile seizures*/
954,334,47,/*Generalized epilepsy with febrile seizures plus*/
954,383,5,/*GEFS+*/
954,395,26,/*familial epilepsy syndrome*/
954,462,2,/*FS*/
954,466,25,/*atypical febrile seizures*/
954,493,2,/*FS*/
954,535,8,/*seizures*/
954,611,5,/*GEFS+*/
954,627,5,/*GEFS+*/
954,828,16,/*febrile seizures*/
954,849,8,/*epilepsy*/
954,1128,26,/*locus for febrile seizures*/
954,1455,21,/*idiopathic epilepsies*/
955,0,38,/*Unusual cerebrotendinous xanthomatosis*/
955,80,30,/*Cerebrotendinous xanthomatosis*/
955,112,3,/*CTX*/
955,123,41,/*autosomal recessive lipid storage disease*/
955,305,3,/*CTX*/
955,317,9,/*xanthomas*/
955,356,18,/*mental retardation*/
955,520,8,/*Cataract*/
955,533,6,/*ataxia*/
955,656,18,/*cerebellar atrophy*/
955,742,24,/*cerebellar hypoperfusion*/
955,810,41,/*excessive urinary bile alcohols excretion*/
955,1258,26,/*neurological deterioration*/
956,0,19,/*Disease concordance*/
956,115,26,/*inflammatory bowel disease*/
956,185,26,/*inflammatory bowel disease*/
956,219,15,/*Crohn's disease*/
956,236,2,/*CD*/
956,244,18,/*ulcerative colitis*/
956,264,2,/*UC*/
956,213,3,/*IBD*/
956,1060,2,/*CD*/
956,1283,2,/*CD*/
956,1357,2,/*UC*/
956,1496,2,/*CD*/
956,1524,2,/*UC*/
956,1658,2,/*CD*/
956,1798,2,/*CD*/
957,344,25,/*hemolytic uremic syndrome*/
957,371,3,/*HUS*/
957,408,18,/*glomerulonephritis*/
957,431,32,/*age-related macular degeneration*/
957,478,2,/*FH*/
957,554,2,/*FH*/
957,592,3,/*HUS*/
957,652,2,/*FH*/
957,776,3,/*HUS*/
957,1375,2,/*FH*/
957,1439,17,/*Type II disorders*/
957,1475,3,/*HUS*/
957,1937,2,/*FH*/
958,18,22,/*Machado-Joseph disease*/
958,95,24,/*Spinocerebellar ataxia 1*/
958,150,39,/*hereditary olivopontocerebellar atrophy*/
958,121,4,/*SCA1*/
958,296,4,/*SCA1*/
958,330,4,/*SCA1*/
958,339,22,/*Machado-Joseph disease*/
958,363,3,/*MJD*/
958,444,3,/*MJD*/
958,482,3,/*MJD*/
958,734,3,/*MJD*/
958,847,3,/*MJD*/
958,911,4,/*SCA1*/
960,4,21,/*ataxia-telangiectasia*/
960,152,21,/*ataxia-telangiectasia*/
960,693,21,/*ataxia-telangiectasia*/
961,157,24,/*Wiskott-Aldrich syndrome*/
961,299,24,/*Wiskott-Aldrich syndrome*/
961,325,3,/*WAS*/
961,639,3,/*WAS*/
961,1964,3,/*WAS*/
962,87,3,/*ALD*/
962,53,32,/*Admixture linkage disequilibrium*/
962,276,3,/*ALD*/
962,585,3,/*ALD*/
962,884,3,/*ALD*/
963,115,6,/*cancer*/
963,181,25,/*breast and ovarian cancer*/
963,600,3,/*CPD*/
963,570,28,/*cyclobutane pyrimidine dimer*/
963,804,13,/*breast cancer*/
963,873,3,/*CPD*/
963,1013,3,/*CPD*/
963,1090,3,/*CPD*/
964,271,30,/*cerebrotendinous xanthomatosis*/
964,304,3,/*CTX*/
965,4,15,/*hemochromatosis*/
965,185,26,/*hereditary hemochromatosis*/
965,2019,26,/*hereditary hemochromatosis*/
966,0,27,/*Neonatal epilepsy syndromes*/
966,32,47,/*generalized epilepsy with febrile seizures plus*/
966,81,4,/*GEFS*/
967,76,30,/*X-linked nonsyndromic deafness*/
967,205,17,/*X-linked deafness*/
967,572,17,/*X-linked deafness*/
967,710,12,/*hearing loss*/
967,1122,8,/*deafness*/
967,1163,8,/*Deafness*/
967,1349,24,/*dysplasia of the cochlea*/
967,1456,12,/*hearing loss*/
967,1566,22,/*vestibular dysfunction*/
967,1613,38,/*delayed developmental motor milestones*/
968,605,24,/*certain mental disorders*/
969,0,29,/*Mucopolysaccharidosis type IV*/
969,97,30,/*Mucopolysaccharidosis type IVA*/
969,155,18,/*Morquio A syndrome*/
969,129,7,/*MPS IVA*/
969,430,25,/*lysosomal storage disease*/
969,500,14,/*bone dysplasia*/
969,609,7,/*MPS IVA*/
969,678,7,/*MPS IVA*/
971,23,18,/*Huntington disease*/
971,93,2,/*HD*/
971,232,2,/*HD*/
971,317,2,/*HD*/
971,387,2,/*HD*/
971,456,2,/*HD*/
971,489,2,/*HD*/
971,619,2,/*HD*/
971,648,2,/*HD*/
971,878,2,/*HD*/
971,1176,2,/*HD*/
971,1292,2,/*HD*/
971,1486,2,/*HD*/
972,603,12,/*pepsinogen A*/
972,617,3,/*PGA*/
973,322,18,/*mental retardation*/
974,55,34,/*metachromatic leukodystrophy brain*/
974,148,17,/*brain dysfunction*/
974,238,21,/*neurological diseases*/
974,369,28,/*metachromatic leukodystrophy*/
974,399,3,/*MLD*/
974,735,3,/*MLD*/
974,1042,3,/*MLD*/
974,1318,3,/*MLD*/
974,1434,52,/*neurodegeneration and motor-learning/memory deficits*/
974,1841,3,/*MLD*/
975,108,26,/*Congenital afibrinogenemia*/
975,145,28,/*autosomal recessive disorder*/
975,310,25,/*inherited afibrinogenemia*/
975,828,15,/*afibrinogenemia*/
975,1126,15,/*afibrinogenemia*/
976,406,30,/*type 2A von Willebrand disease*/
977,27,24,/*muscle-eye-brain disease*/
977,332,54,/*muscle-eye-brain type of congenital muscular dystrophy*/
977,430,24,/*muscle-eye-brain disease*/
977,829,16,/*muscle-eye-brain*/
977,1363,16,/*muscle-eye-brain*/
977,1655,16,/*muscle-eye-brain*/
977,1860,16,/*muscle-eye-brain*/
977,2039,37,/*complex congenital muscular dystrophy*/
978,28,13,/*breast cancer*/
978,293,13,/*breast cancer*/
978,395,13,/*breast cancer*/
978,453,25,/*breast and ovarian cancer*/
978,576,13,/*breast cancer*/
978,718,13,/*breast cancer*/
978,876,13,/*breast cancer*/
978,969,13,/*breast cancer*/
978,1153,6,/*cancer*/
978,1279,22,/*familial breast cancer*/
978,1453,13,/*breast cancer*/
978,1694,12,/*breast tumor*/
978,1731,6,/*cancer*/
978,1767,6,/*cancer*/
978,1851,13,/*breast cancer*/
978,2048,13,/*breast cancer*/
978,2125,22,/*familial breast cancer*/
979,32,6,/*autism*/
979,147,25,/*Autism spectrum disorders*/
979,195,28,/*neurodevelopmental disorders*/
979,174,4,/*ASDs*/
979,495,6,/*autism*/
979,1693,6,/*autism*/
979,1973,17,/*autistic probands*/
979,2084,6,/*autism*/
980,67,14,/*Wilson disease*/
980,103,14,/*Wilson disease*/
980,277,14,/*Wilson disease*/
980,464,14,/*Wilson disease*/
980,494,33,/*intracellular copper accumulation*/
980,813,43,/*hepatocellular injury, nodular regeneration*/
980,1025,18,/*cholangiocarcinoma*/
981,0,30,/*Intronic breakpoint definition*/
981,61,7,/*DMD/BMD*/
981,626,7,/*DMD/BMD*/
981,1276,3,/*DMD*/
982,37,30,/*cerebrotendinous xanthomatosis*/
982,69,30,/*Cerebrotendinous xanthomatosis*/
982,101,3,/*CTX*/
982,116,28,/*autosomal recessive disorder*/
982,472,3,/*CTX*/
982,528,3,/*CTX*/
982,581,49,/*chronic inflammatory demyelinating polyneuropathy*/
982,632,4,/*CIDP*/
983,56,19,/*sudden infant death*/
983,141,28,/*sudden infant death syndrome*/
983,171,4,/*SIDS*/
983,755,10,/*arrhythmia*/
983,1001,20,/*respiratory acidosis*/
983,1258,27,/*acidosis-induced arrhythmia*/
984,22,32,/*atypical teratoid/rhabdoid tumor*/
984,56,15,/*Rhabdoid tumors*/
984,326,15,/*Rhabdoid tumors*/
984,543,6,/*tumors*/
984,578,6,/*tumors*/
986,42,32,/*hereditary breast/ovarian cancer*/
986,97,6,/*cancer*/
986,187,32,/*hereditary breast/ovarian cancer*/
986,319,32,/*hereditary breast/ovarian cancer*/
986,653,3,/*BIC*/
986,874,22,/*breast/ovarian cancers*/
987,24,14,/*hyperlipidemia*/
987,61,16,/*colorectal tumor*/
987,99,30,/*familial adenomatous polyposis*/
987,143,30,/*Familial adenomatous polyposis*/
987,175,3,/*FAP*/
987,286,18,/*colorectal cancers*/
987,322,17,/*colorectal polyps*/
987,456,14,/*hyperlipidemic*/
987,657,14,/*hyperlipidemia*/
987,676,16,/*colorectal tumor*/
987,708,3,/*FAP*/
987,870,17,/*colorectal polyps*/
987,892,6,/*cancer*/
987,917,3,/*FAP*/
987,1014,14,/*hyperlipidemia*/
987,1032,3,/*FAP*/
987,1101,3,/*FAP*/
987,1167,14,/*hyperlipidemia*/
987,1268,17,/*colorectal cancer*/
987,1318,17,/*colorectal cancer*/
987,1376,27,/*hyperlipidemic state occurs*/
987,1407,3,/*FAP*/
987,1501,11,/*colon tumor*/
987,1586,3,/*FAP*/
988,503,26,/*Nijmegen breakage syndrome*/
988,531,3,/*NBS*/
988,753,3,/*NBS*/
988,842,3,/*NBS*/
988,1172,3,/*NBS*/
988,1325,3,/*NBS*/
989,156,5,/*tumor*/
989,351,21,/*ataxia-telangiectasia*/
991,43,13,/*Wilms' tumors*/
991,203,12,/*Wilms' tumor*/
991,217,2,/*WT*/
991,500,5,/*tumor*/
991,606,6,/*tumors*/
991,680,6,/*tumors*/
991,761,5,/*tumor*/
991,918,12,/*Wilms' tumor*/
991,1053,2,/*WT*/
991,1060,27,/*genital tract malformations*/
992,104,23,/*Ehlers-Danlos syndromes*/
992,129,3,/*EDS*/
992,218,19,/*joint hypermobility*/
992,515,3,/*EDS*/
992,662,12,/*vascular EDS*/
992,730,12,/*vascular EDS*/
992,999,12,/*vascular EDS*/
992,1167,12,/*vascular EDS*/
992,1467,12,/*vascular EDS*/
992,1687,12,/*vascular EDS*/
992,1731,16,/*non-vascular EDS*/
992,1963,12,/*vascular EDS*/
993,4,22,/*movement abnormalities*/
993,265,76,/*autosomal dominant cerebellar ataxias type I spinocerebellar ataxias 1 and 2*/
993,380,29,/*SCA3 / Machado-Joseph disease*/
993,412,3,/*MJD*/
993,502,11,/*hypermetria*/
993,559,4,/*SCA2*/
993,843,4,/*SCA3*/
993,1134,4,/*SCA2*/
993,1171,4,/*SCA3*/
993,1275,4,/*SCA2*/
993,1286,4,/*SCA3*/
994,81,41,/*hereditary nonpolyposis colorectal cancer*/
994,161,5,/*HNPCC*/
994,416,5,/*tumor*/
994,1232,13,/*colon cancers*/
994,1335,12,/*colon cancer*/
995,22,38,/*autoimmune lymphoproliferative disease*/
995,137,40,/*Autoimmune lymphoproliferative disorders*/
995,189,39,/*autoimmune lymphoproliferative syndrome*/
995,230,4,/*ALPS*/
995,240,47,/*Dianzani autoimmune lymphoproliferative disease*/
995,289,4,/*DALD*/
995,666,19,/*antibody deficiency*/
995,748,32,/*common variable immunodeficiency*/
995,782,4,/*CVID*/
995,901,38,/*autoimmune lymphoproliferative disease*/
995,944,4,/*CVID*/
996,121,36,/*hereditary breast and/ovarian cancer*/
996,246,28,/*breast and/or ovarian cancer*/
996,533,25,/*breast and ovarian cancer*/
996,598,6,/*cancer*/
996,759,13,/*breast cancer*/
996,846,14,/*ovarian cancer*/
996,909,6,/*cancer*/
996,1566,13,/*breast cancer*/
996,1635,14,/*ovarian cancer*/
996,1705,13,/*breast cancer*/
997,44,23,/*Drosophila melanogaster*/
997,926,19,/*metabolic disorders*/
998,91,29,/*X-linked adrenoleukodystrophy*/
998,122,29,/*X-linked adrenoleukodystrophy*/
998,153,5,/*X-ALD*/
998,172,26,/*neurodegenerative disorder*/
998,371,5,/*X-ALD*/
998,416,5,/*X-ALD*/
998,1598,5,/*X-ALD*/
1000,566,7,/*DHAP-AT*/
1000,651,7,/*DHAP-AT*/
1000,811,15,/*DHAP-AT latency*/
1000,987,7,/*DHAP-AT*/
1001,0,25,/*Von Hippel-Lindau disease*/
1001,70,27,/*cerebellar hemangioblastoma*/
1001,136,17,/*hemangioblastomas*/
1001,158,22,/*benign vascular tumors*/
1001,234,31,/*von Hippel-Lindau (VHL) disease*/
1001,269,26,/*hereditary cancer syndrome*/
1001,343,21,/*CNS hemangioblastomas*/
1001,422,9,/*VHL tumor*/
1001,620,16,/*hemangioblastoma*/
1001,762,3,/*VHL*/
1001,905,5,/*tumor*/
1001,1110,11,/*VHL disease*/
1001,1123,34,/*five had sporadic hemangioblastoma*/
1001,1313,3,/*VHL*/
1001,1370,3,/*VHL*/
1001,1727,3,/*VHL*/
1001,1764,20,/*CNS hemangioblastoma*/
1002,105,15,/*renal carcinoma*/
1002,160,17,/*von Hippel-Lindau*/
1002,179,3,/*VHL*/
1002,222,15,/*renal carcinoma*/
1002,239,4,/*CCRC*/
1002,287,3,/*VHL*/
1002,549,4,/*CCRC*/
1002,709,3,/*VHL*/
1002,798,3,/*VHL*/
1002,953,3,/*VHL*/
1002,1127,4,/*CCRC*/
1002,1180,4,/*CCRC*/
1002,1465,13,/*tumorigenesis*/
1002,1513,4,/*CCRC*/
1005,115,15,/*maximal torus T*/
1005,662,26,/*Demazure operators defined*/
1006,20,37,/*hereditary and sporadic breast cancer*/
1006,128,13,/*breast cancer*/
1006,396,14,/*breast cancers*/
1006,459,7,/*cancers*/
1006,520,14,/*breast cancers*/
1006,542,14,/*breast cancers*/
1006,606,14,/*breast cancers*/
1006,658,18,/*hereditary disease*/
1006,1024,13,/*breast cancer*/
1006,1248,18,/*hereditary disease*/
1006,1407,17,/*Breast carcinomas*/
1006,1664,18,/*hereditary disease*/
1007,81,17,/*esophageal cancer*/
1007,258,13,/*tumorigenesis*/
1007,386,17,/*esophageal cancer*/
1007,522,10,/*carcinomas*/
1007,538,23,/*adenosquamous carcinoma*/
1007,566,18,/*one adenocarcinoma*/
1007,589,5,/*tumor*/
1007,624,18,/*esophageal cancers*/
1007,845,6,/*tumors*/
1007,1280,6,/*tumors*/
1007,1492,17,/*metastatic status*/
1007,1579,18,/*esophageal cancers*/
1007,1702,20,/*esophageal carcinoma*/
1008,260,10,/*dystrophic*/
1008,284,14,/*dystrophic mdx*/
1008,985,20,/*cross-sectional area*/
1008,1007,11,/*muscle mass*/
1008,1672,26,/*dystrophic skeletal muscle*/
1009,62,13,/*Fabry disease*/
1009,107,27,/*hypertrophic cardiomyopathy*/
1009,254,13,/*Fabry disease*/
1009,269,2,/*FD*/
1009,313,27,/*hypertrophic cardiomyopathy*/
1009,342,3,/*HCM*/
1009,707,2,/*FD*/
1009,1091,2,/*FD*/
1009,1144,19,/*cardiac hypertrophy*/
1009,1223,2,/*FD*/
1010,300,6,/*cancer*/
1010,686,5,/*tumor*/
1011,169,28,/*Pelizaeus-Merzbacher disease*/
1011,211,28,/*Pelizaeus-Merzbacher disease*/
1011,250,35,/*X-linked neurodegenerative disorder*/
1012,404,21,/*ataxia-telangiectasia*/
1013,273,19,/*arterial thrombosis*/
1014,88,12,/*Dutch cancer*/
1014,181,13,/*breast cancer*/
1014,389,13,/*breast cancer*/
1015,797,22,/*ischemic heart disease*/
1015,1183,2,/*CC*/
1015,1495,2,/*CC*/
1015,1905,16,/*coronary disease*/
1016,52,23,/*familial polyposis coli*/
1016,98,17,/*colorectal tumors*/
1016,196,34,/*hereditary familial polyposis coli*/
1016,232,3,/*FAP*/
1016,241,18,/*Gardner's syndrome*/
1016,261,2,/*GS*/
1016,294,3,/*APC*/
1016,380,6,/*tumors*/
1016,390,26,/*sporadic colorectal cancer*/
1016,523,3,/*APC*/
1016,531,2,/*GS*/
1016,645,20,/*colorectal neoplasia*/
1016,752,17,/*colorectal cancer*/
1016,791,15,/*colon carcinoma*/
1016,1322,5,/*tumor*/
1017,27,29,/*multiple epiphyseal dysplasia*/
1017,91,29,/*Multiple epiphyseal dysplasia*/
1017,122,3,/*MED*/
1017,171,19,/*skeletal dysplasias*/
1017,214,3,/*MED*/
1017,260,5,/*DTDST*/
1017,313,18,/*additional disease*/
1017,456,3,/*MED*/
1017,557,3,/*MED*/
1017,1440,3,/*MED*/
1017,1509,3,/*MED*/
1018,90,9,/*fragile-X*/
1018,259,9,/*fragile-X*/
1018,937,15,/*Hunter syndrome*/
1018,1200,9,/*fragile-X*/
1018,1712,9,/*fragile-X*/
1019,24,31,/*type IIB von Willebrand disease*/
1019,183,3,/*vWD*/
1019,159,22,/*von Willebrand Disease*/
1019,982,12,/*Type IIB vWD*/
1019,1342,17,/*authentic defects*/
1019,1376,12,/*Type IIB vWD*/
1019,1485,12,/*Type IIB vWD*/
1020,72,28,/*familial mediterranean fever*/
1020,102,3,/*FMF*/
1020,108,28,/*Familial Mediterranean fever*/
1020,138,3,/*FMF*/
1020,149,40,/*autosomal, recessively inherited disease*/
1020,208,15,/*recurrent fever*/
1020,228,9,/*serositis*/
1020,320,3,/*FMF*/
1020,581,3,/*FMF*/
1021,70,9,/*fragile X*/
1021,180,9,/*fragile X*/
1021,1180,18,/*fragile X syndrome*/
1022,0,24,/*Golabi-Ito-Hall syndrome*/
1022,151,27,/*X linked mental retardation*/
1022,201,27,/*postnatal growth deficiency*/
1022,261,20,/*atrial septal defect*/
1022,180,4,/*XLMR*/
1022,433,21,/*Extreme short stature*/
1022,459,12,/*microcephaly*/
1022,709,18,/*Porteous syndromes*/
1022,877,12,/*microcephaly*/
1022,891,13,/*short stature*/
1022,910,20,/*atrial septal defect*/
1024,19,28,/*metachromatic leukodystrophy*/
1026,24,66,/*X-linked liver glycogenosis due to phosphorylase kinase deficiency*/
1026,124,27,/*X-linked liver glycogenosis*/
1026,153,3,/*XLG*/
1026,163,12,/*glycogenosis*/
1026,690,3,/*XLG*/
1028,21,44,/*glucose-6-phosphate dehydrogenase deficiency*/
1028,110,15,/*G6PD deficiency*/
1030,34,9,/*fragile X*/
1030,180,18,/*fragile X syndrome*/
1032,96,30,/*familial adenomatous polyposis*/
1032,128,30,/*Familial adenomatous polyposis*/
1032,160,3,/*FAP*/
1032,171,43,/*autosomal dominant familial cancer syndrome*/
1032,251,5,/*tumor*/
1032,384,3,/*FAP*/
1032,423,19,/*colorectal adenomas*/
1032,463,3,/*FAP*/
1032,507,3,/*APC*/
1032,680,3,/*FAP*/
1032,977,3,/*APC*/
1033,40,6,/*cancer*/
1033,447,5,/*tumor*/
1033,668,5,/*tumor*/
1033,892,6,/*cancer*/
1033,947,18,/*TSG in oral cancer*/
1033,1079,6,/*cancer*/
1033,1316,11,/*oral cancer*/
1034,0,19,/*Lesch-Nyhan disease*/
1034,133,19,/*Lesch-Nyhan disease*/
1034,154,3,/*LND*/
1034,169,35,/*X-linked recessive genetic disorder*/
1034,217,74,/*deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme*/
1034,344,20,/*cognitive impairment*/
1034,366,9,/*hypotonia*/
1034,385,15,/*choreoathetosis*/
1034,402,14,/*hyperuricaemia*/
1034,456,27,/*involuntary self-mutilation*/
1034,508,3,/*LND*/
1034,562,25,/*dyskinetic cerebral palsy*/
1034,611,22,/*inguinal herniorrhaphy*/
1034,808,3,/*LND*/
1034,1331,26,/*neurological abnormalities*/
1035,33,24,/*chronic hemolytic anemia*/
1035,59,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
1035,136,16,/*hemolytic anemia*/
1035,196,17,/*chronic hemolysis*/
1035,286,40,/*chronic non-spherocytic hemolytic anemia*/
1035,328,5,/*CNSHA*/
1035,464,6,/*pallor*/
1035,475,8,/*jaundice*/
1035,507,16,/*hemolytic anemia*/
1035,529,15,/*G6PD deficiency*/
1035,795,17,/*chronic hemolysis*/
1037,26,17,/*bipolar disorders*/
1037,162,16,/*bipolar disorder*/
1037,557,14,/*mental illness*/
1037,766,18,/*bipolar I disorder*/
1037,816,19,/*affective disorders*/
1037,1196,16,/*bipolar disorder*/
1038,106,18,/*Visual dysfunction*/
1038,170,8,/*epilepsy*/
1038,194,19,/*visual disturbances*/
1038,321,8,/*seizures*/
1038,416,33,/*impaired in epileptic adolescents*/
1038,864,20,/*cryptogenic epilepsy*/
1038,1669,9,/*epileptic*/
1038,1979,9,/*epileptic*/
1038,1999,8,/*epilepsy*/
1038,2249,30,/*impairment in macular function*/
1038,2392,24,/*color perception defects*/
1039,82,24,/*Axenfeld-Rieger syndrome*/
1039,120,24,/*Axenfeld-Rieger syndrome*/
1039,146,3,/*ARS*/
1039,1657,3,/*ARS*/
};
}
static void init7() {
a7 = new int[] {
1039,1710,24,/*Axenfeld-Rieger syndrome*/
1040,35,16,/*Pendred syndrome*/
1040,53,16,/*Pendred syndrome*/
1040,76,28,/*autosomal recessive disorder*/
1040,138,8,/*deafness*/
1040,151,6,/*goiter*/
1040,394,3,/*PDS*/
1040,1209,16,/*Pendred syndrome*/
1042,1405,4,/*DRB5*/
1043,47,21,/*Prader-Willi syndrome*/
1043,85,12,/*Prader-Willi*/
1043,99,3,/*PWS*/
1043,108,18,/*Angelman syndromes*/
1043,128,2,/*AS*/
1043,264,3,/*PWS*/
1043,271,2,/*AS*/
1043,423,3,/*PWS*/
1043,431,2,/*AS*/
1043,535,2,/*AS*/
1043,571,17,/*mentally retarded*/
1043,696,2,/*AS*/
1043,851,3,/*PWS*/
1043,866,2,/*AS*/
1043,1062,2,/*AS*/
1043,1095,3,/*PWS*/
1043,1182,11,/*hyperphagia*/
1043,1210,7,/*obesity*/
1043,1226,2,/*AS*/
1043,1358,3,/*PWS*/
1043,1366,2,/*AS*/
1043,1391,2,/*AS*/
1043,1518,2,/*AS*/
1043,1581,2,/*AS*/
1044,30,44,/*autosomal dominant polycystic kidney disease*/
1044,149,44,/*autosomal dominant polycystic kidney disease*/
1044,195,5,/*ADPKD*/
1044,252,5,/*ADPKD*/
1044,1122,5,/*ADPKD*/
1044,1353,5,/*ADPKD*/
1044,1612,25,/*polycystic kidney disease*/
1045,95,28,/*metachromatic leukodystrophy*/
1045,614,27,/*strict anhydrous conditions*/
1045,1004,28,/*metachromatic leukodystrophy*/
1046,188,24,/*X-linked ocular albinism*/
1046,1292,3,/*XOA*/
1047,183,41,/*complete lack of eyes and nasal primordia*/
1047,345,19,/*congenital aniridia*/
1047,415,8,/*aniridia*/
1047,425,2,/*AN*/
1047,1005,8,/*aniridia*/
1048,103,28,/*breast and/or ovarian cancer*/
1048,167,21,/*breast/ovarian cancer*/
1048,277,21,/*breast/ovarian cancer*/
1048,466,21,/*breast/ovarian cancer*/
1048,750,24,/*hereditary breast cancer*/
1048,810,13,/*breast cancer*/
1049,496,5,/*ACADM*/
1050,1194,26,/*Nijmegen breakage syndrome*/
1050,1532,35,/*ataxia-telangiectasia-like disorder*/
1050,1689,26,/*nijmegen breakage syndrome*/
1050,1844,18,/*Checkpoint failure*/
1050,1867,23,/*chromosomal instability*/
1052,71,22,/*neuromuscular diseases*/
1052,262,23,/*neuromuscular disorders*/
1052,415,27,/*x-linked muscular dystrophy*/
1052,491,27,/*Duchenne muscular dystrophy*/
1052,520,3,/*DMD*/
1052,566,3,/*DMD*/
1052,720,25,/*Becker muscular dystrophy*/
1052,747,3,/*BMD*/
1052,829,3,/*DMD*/
1052,1012,18,/*muscular dystrophy*/
1052,1327,3,/*DMD*/
1052,1348,3,/*DMD*/
1052,1355,3,/*BMD*/
1052,1391,3,/*DMD*/
1053,191,6,/*cancer*/
1053,304,21,/*ataxia-telangiectasia*/
1054,162,29,/*inherited metabolic disorders*/
1055,0,25,/*Autoimmune hyperlipidemia*/
1055,166,13,/*xanthomatosis*/
1055,181,25,/*hyperbeta lipoproteinemia*/
1055,732,26,/*Peripheral atherosclerosis*/
1055,1819,7,/*myeloma*/
1055,1945,14,/*hyperlipidemia*/
1055,2019,23,/*atherosclerotic lesions*/
1055,2249,20,/*known hyperlipidemia*/
1056,58,15,/*phenylketonuria*/
1056,100,15,/*Phenylketonuria*/
1056,117,3,/*PKU*/
1056,141,37,/*inborn error of amino acid metabolism*/
1056,194,3,/*PKU*/
1056,431,3,/*PKU*/
1056,1055,3,/*PKU*/
1056,1107,3,/*PKU*/
1056,1224,3,/*PKU*/
1057,23,13,/*C6 deficiency*/
1057,72,53,/*Deficiency of the sixth component of human complement*/
1057,214,21,/*Meningococcal disease*/
1057,274,32,/*pedigrees of total C6 deficiency*/
1057,492,16,/*total deficiency*/
1058,196,2,/*SD*/
1058,206,38,/*autosomal recessive GM2 gangliosidosis*/
1058,178,16,/*Sandhoff disease*/
1058,689,3,/*FSD*/
1058,675,12,/*from SD mice*/
1058,1609,3,/*FSD*/
1059,120,22,/*ankylosing spondylitis*/
1059,233,22,/*ankylosing spondylitis*/
1059,257,2,/*AS*/
1059,304,2,/*AS*/
1059,532,2,/*AS*/
1059,635,2,/*AS*/
1059,879,2,/*AS*/
1059,1064,2,/*AS*/
1059,1138,2,/*AS*/
1059,1185,2,/*AS*/
1060,134,27,/*Maternal uniparental disomy*/
1060,258,28,/*postnatal growth retardation*/
1060,288,18,/*muscular hypotonia*/
1060,308,16,/*feeding problems*/
1060,326,11,/*motor delay*/
1060,339,20,/*small hands and feet*/
1060,384,15,/*truncal obesity*/
1060,457,21,/*Prader-Willi syndrome*/
1060,480,3,/*PWS*/
1060,1095,7,/*obesity*/
1060,1111,3,/*PWS*/
1060,1405,18,/*growth retardation*/
1060,1425,25,/*neonatal feeding problems*/
1060,1452,18,/*muscular hypotonia*/
1060,1472,11,/*motor delay*/
1060,1485,18,/*precocious puberty*/
1060,1508,15,/*truncal obesity*/
1060,1554,3,/*PWS*/
1060,1632,7,/*obesity*/
1061,9,32,/*inheritance of diabetes mellitus*/
1061,217,8,/*diabetes*/
1061,354,8,/*diabetic*/
1061,596,8,/*diabetes*/
1061,781,8,/*diabetic*/
1061,814,19,/*inheriting diabetes*/
1061,890,8,/*diabetes*/
1061,951,8,/*diabetic*/
1061,1210,8,/*diabetic*/
1061,1283,8,/*diabetes*/
1061,1415,8,/*diabetes*/
1061,1548,2,/*DM*/
1062,40,4,/*BFLS*/
1062,4,34,/*B  rjeson-Forssman-Lehman syndrome*/
1063,54,3,/*RDS*/
1063,124,20,/*retinitis pigmentosa*/
1063,180,3,/*RDS*/
1063,277,17,/*retinal dystrophy*/
1063,298,17,/*macular dystrophy*/
1063,346,17,/*retinal dystrophy*/
1063,638,20,/*retinitis pigmentosa*/
1063,709,21,/*fundus flavimaculatus*/
1063,785,20,/*retinitis pigmentosa*/
1063,898,35,/*adult vitelliform macular dystrophy*/
1063,978,20,/*retinitis pigmentosa*/
1063,1099,15,/*retinal disease*/
1063,1178,28,/*classic retinitis pigmentosa*/
1063,1430,20,/*retinitis pigmentosa*/
1064,42,18,/*retinal detachment*/
1064,122,18,/*retinal detachment*/
1064,142,2,/*RD*/
1064,300,2,/*RD*/
1064,379,26,/*photoreceptor degeneration*/
1064,517,2,/*RD*/
1064,613,2,/*RD*/
1064,1366,26,/*photoreceptor degeneration*/
1064,1642,5,/*tumor*/
1064,2952,2,/*RD*/
1064,3103,39,/*photoreceptor degeneration following RD*/
1065,33,34,/*DiGeorge/velocardiofacial syndrome*/
1065,214,17,/*DiGeorge syndrome*/
1065,233,3,/*DGS*/
1065,242,25,/*velocardiofacial syndrome*/
1065,269,4,/*VCFS*/
1065,538,20,/*congenital anomalies*/
1065,560,16,/*medical problems*/
1065,582,45,/*cognitive and neuropsychological difficulties*/
1065,703,8,/*DGS/VCFS*/
1066,72,21,/*meningococcal disease*/
1066,151,22,/*Neisseria meningitidis*/
1066,536,21,/*meningococcal disease*/
1066,559,2,/*MD*/
1066,1044,2,/*FH*/
1066,1457,2,/*MD*/
1067,108,15,/*phenylketonuria*/
1067,125,15,/*Phenylketonuria*/
1067,142,3,/*PKU*/
1067,165,38,/*autosomal recessive metabolic disorder*/
1067,216,60,/*deficiency of phenylalanine hydroxylase (PAH; EC 1.14.16.1).*/
1067,328,3,/*PKU*/
1067,589,3,/*PKU*/
1067,673,3,/*PKU*/
1067,905,3,/*PKU*/
1067,1576,3,/*PKU*/
1067,1652,3,/*PKU*/
1068,31,27,/*Duchenne muscular dystrophy*/
1068,83,27,/*Duchenne muscular dystrophy*/
1068,112,3,/*DMD*/
1068,335,19,/*developmental delay*/
1068,595,19,/*developmental delay*/
1068,669,3,/*DMD*/
1069,51,17,/*colorectal cancer*/
1069,78,41,/*Hereditary nonpolyposis colorectal cancer*/
1069,126,49,/*autosomal dominant cancer predisposition syndrome*/
1069,382,17,/*colorectal cancer*/
1069,515,12,/*colon cancer*/
1069,960,17,/*colorectal cancer*/
1070,446,30,/*type IV Ehlers-Danlos syndrome*/
1070,500,14,/*aortic rupture*/
1070,1069,30,/*type IV Ehlers-Danlos syndrome*/
1071,32,16,/*craniosynostosis*/
1071,77,17,/*Pfeiffer syndrome*/
1071,101,28,/*autosomal dominant condition*/
1071,160,16,/*craniosynostosis*/
1071,181,43,/*digital abnormalities of the hands and feet*/
1071,243,17,/*Pfeiffer syndrome*/
1071,563,17,/*Pfeiffer syndrome*/
1071,589,24,/*craniofacial involvement*/
1071,715,17,/*Pfeiffer syndrome*/
1071,738,27,/*absence of craniosynostosis*/
1071,891,26,/*craniosynostosis syndromes*/
1072,1,22,/*Aarskog-Scott syndrome*/
1073,104,42,/*hereditary non-polyposis colorectal cancer*/
1073,159,42,/*Hereditary non-polyposis colorectal cancer*/
1073,203,5,/*HNPCC*/
1073,247,28,/*hereditary colorectal cancer*/
1073,304,26,/*Microsatellite instability*/
1073,434,5,/*HNPCC*/
1073,332,3,/*MSI*/
1073,1089,5,/*HNPCC*/
1073,1310,5,/*tumor*/
1073,1715,21,/*extra-colonic cancers*/
1073,1742,14,/*gastric cancer*/
1073,1799,6,/*cancer*/
1073,1822,6,/*tumors*/
1073,2044,12,/*MSI-H tumors*/
1073,2070,10,/*MSS tumors*/
1073,2165,12,/*MSI-H tumors*/
1074,0,24,/*Complement C7 deficiency*/
1074,131,13,/*C7 deficiency*/
1075,38,21,/*generalized hypotonia*/
1075,77,45,/*deficiency of dihydropyrimidine dehydrogenase*/
1075,124,45,/*Deficiency of dihydropyrimidine dehydrogenase*/
1075,186,37,/*inborn error of pyrimidine metabolism*/
1075,608,24,/*insufficient weight gain*/
1075,770,17,/*deficiency of DPD*/
1075,1026,16,/*cerebral atrophy*/
1075,1094,14,/*DPD-deficiency*/
1075,1137,18,/*mental retardation*/
1075,1181,20,/*feeding difficulties*/
1075,1203,6,/*autism*/
1075,1215,10,/*hypertonia*/
1075,1309,24,/*slight motor retardation*/
1075,1338,21,/*generalized hypotonia*/
1075,1485,14,/*DPD deficiency*/
1075,1501,14,/*DPD deficiency*/
1075,1545,8,/*vomiting*/
1076,63,25,/*retinal hemangioblastomas*/
1076,105,25,/*von Hippel-Lindau disease*/
1076,166,24,/*retinal vascular lesions*/
1076,201,17,/*hemangioblastomas*/
1076,319,31,/*von Hippel-Lindau [VHL] disease*/
1076,382,13,/*retinal tumor*/
1076,418,5,/*tumor*/
1076,459,26,/*autosomal dominant disease*/
1076,498,23,/*defect of the VHL tumor*/
1076,543,3,/*VHL*/
1076,734,24,/*Retinal hemangioblastoma*/
1076,778,5,/*tumor*/
1076,796,11,/*VHL disease*/
1076,895,3,/*VHL*/
1076,907,48,/*VHL disease-associated retinal hemangioblastomas*/
1076,1138,15,/*retinal lesions*/
1076,1184,31,/*Large retinal hemangioblastomas*/
1076,1259,6,/*tumors*/
1076,1442,3,/*VHL*/
1076,1696,15,/*retinal lesions*/
1076,1722,31,/*Large retinal hemangioblastomas*/
1076,1792,3,/*VHL*/
1076,1909,3,/*VHL*/
1076,1933,3,/*VHL*/
1076,1996,5,/*tumor*/
1076,2136,17,/*hemangioblastomas*/
1076,2170,11,/*VHL disease*/
1076,2274,5,/*tumor*/
1076,2361,17,/*hemangioblastomas*/
1076,2415,31,/*large retinal hemangioblastomas*/
1076,2485,3,/*VHL*/
1076,2509,3,/*VHL*/
1076,2595,48,/*VHL disease-associated retinal hemangioblastomas*/
1076,2714,48,/*VHL disease-associated retinal hemangioblastomas*/
1077,193,22,/*aspartylglucosaminuria*/
1077,217,3,/*AGU*/
1078,61,18,/*myotonic dystrophy*/
1078,81,18,/*Myotonic dystrophy*/
1078,101,2,/*DM*/
1078,142,18,/*muscular dystrophy*/
1078,265,14,/*muscle wasting*/
1078,284,19,/*cardiac arrhythmias*/
1078,341,3,/*DM1*/
1078,349,3,/*DM2*/
1078,354,3,/*DM1*/
1078,474,3,/*DM2*/
1079,25,28,/*familial Mediterranean fever*/
1079,99,19,/*Alzheimer's disease*/
1079,233,19,/*Alzheimer's disease*/
1079,254,2,/*AD*/
1079,360,28,/*familial Mediterranean fever*/
1079,426,2,/*AD*/
1079,495,2,/*AD*/
1079,686,2,/*AD*/
1079,1004,2,/*AD*/
1079,1275,2,/*AD*/
1080,68,20,/*retinitis pigmentosa*/
1080,201,20,/*retinitis pigmentosa*/
1080,223,2,/*RP*/
1080,373,2,/*RP*/
1080,434,11,/*X-linked RP*/
1080,556,2,/*RP*/
1080,447,4,/*XLRP*/
1080,601,6,/*myopia*/
1080,1005,4,/*XLRP*/
1080,1135,2,/*RP*/
1080,1584,2,/*RP*/
1080,1616,6,/*myopia*/
1080,1903,6,/*myopia*/
1081,58,28,/*metachromatic leukodystrophy*/
1081,154,28,/*Metachromatic leukodystrophy*/
1081,184,3,/*MLD*/
1081,194,25,/*lysosomal storage disease*/
1081,508,3,/*MLD*/
1081,578,3,/*MLD*/
1081,638,3,/*PNS*/
1081,793,31,/*neuropathological abnormalities*/
1081,829,23,/*neuromotor disabilities*/
1081,895,32,/*pre-symptomatic stage of disease*/
1081,1097,31,/*neuropathological abnormalities*/
1081,1206,21,/*neuromotor disability*/
1081,1307,18,/*galactocerebroside*/
1082,266,12,/*Rous sarcoma*/
1083,91,28,/*Pelizaeus-Merzbacher disease*/
1083,250,28,/*Pelizaeus-Merzbacher disease*/
1083,280,3,/*PMD*/
1083,365,3,/*PMD*/
1083,1157,15,/*hypomyelination*/
1084,21,46,/*medium-chain acyl-CoA dehydrogenase deficiency*/
1084,297,15,/*MCAD deficiency*/
1084,399,20,/*acute encephalopathy*/
1084,633,15,/*MCAD deficiency*/
1084,736,17,/*proximal myopathy*/
1084,801,15,/*MCAD deficiency*/
1085,61,3,/*EUS*/
1085,66,31,/*Gastrointestinal stromal tumors*/
1085,99,5,/*GISTs*/
1085,720,27,/*non-GIST mesenchymal tumors*/
1086,57,15,/*retinal disease*/
1086,283,20,/*retinitis pigmentosa*/
1086,308,20,/*macular degeneration*/
1086,692,31,/*Rds-associated retinal diseases*/
1087,23,29,/*mucopolysaccharidosis type VI*/
1087,121,29,/*Mucopolysaccharidosis type VI*/
1087,160,23,/*Maroteaux-Lamy syndrome*/
1087,190,26,/*lysosomal storage disorder*/
1087,152,6,/*MPS VI*/
1087,352,6,/*MPS VI*/
1088,49,15,/*LCAT deficiency*/
1088,224,15,/*LCAT deficiency*/
1089,66,13,/*breast cancer*/
1089,81,22,/*Familial breast cancer*/
1089,131,13,/*breast cancer*/
1089,987,13,/*breast cancer*/
1090,57,3,/*DMD*/
1090,77,31,/*X-linked dilated cardiomyopathy*/
1090,110,31,/*X-linked dilated cardiomyopathy*/
1090,144,5,/*XLDCM*/
1090,179,16,/*dystrophinopathy*/
1090,294,17,/*skeletal myopathy*/
1090,349,27,/*Duchenne muscular dystrophy*/
1090,384,3,/*DMD*/
1090,502,3,/*DMD*/
1090,654,3,/*DMD*/
1090,667,5,/*XLDCM*/
1090,1091,3,/*DMD*/
1091,94,25,/*autism spectrum disorders*/
1091,249,25,/*autism spectrum disorders*/
1091,276,3,/*ASD*/
1091,282,35,/*Prader-Willi and Angelman syndromes*/
1091,418,3,/*ASD*/
1091,469,3,/*ASD*/
1091,609,3,/*ASD*/
1091,985,17,/*Angelman syndrome*/
1091,1183,3,/*ASD*/
1091,1333,3,/*ASD*/
1091,1499,19,/*developmental delay*/
1091,1523,3,/*ASD*/
1091,1621,3,/*ASD*/
1091,1737,3,/*ASD*/
1092,88,28,/*Familial Mediterranean fever*/
1092,153,3,/*FMF*/
1092,179,11,/*amyloidosis*/
1092,348,11,/*amyloidosis*/
1092,363,3,/*FMF*/
1092,469,11,/*amyloidosis*/
1092,525,3,/*FMF*/
1092,551,11,/*amyloidosis*/
1092,572,3,/*FMF*/
1092,719,3,/*FMF*/
1092,817,3,/*FMF*/
1092,835,11,/*amyloidosis*/
1092,889,11,/*amyloidosis*/
1092,1003,3,/*FMF*/
1092,1025,11,/*amyloidosis*/
1093,28,31,/*gastrointestinal stromal tumors*/
1093,61,5,/*GISTs*/
1093,635,6,/*tumors*/
1093,939,6,/*tumors*/
1093,1097,13,/*gastric GISTs*/
1093,1416,5,/*tumor*/
1093,1454,22,/*familial GIST syndrome*/
1093,1631,19,/*neurofibromatosis 1*/
1093,2028,2,/*US*/
1095,10,30,/*nephrogenic diabetes insipidus*/
1095,123,30,/*nephrogenic diabetes insipidus*/
1095,155,3,/*NDI*/
1095,324,10,/*polydipsia*/
1095,1270,30,/*nephrogenic diabetes insipidus*/
1096,0,26,/*Papillon-Lef  vre syndrome*/
1096,53,26,/*Papillon-Lef  vre syndrome*/
1096,81,3,/*PLS*/
1096,113,19,/*periodontal disease*/
1096,165,41,/*alveolar bone surrounding deciduous teeth*/
1096,211,39,/*palmoplantar hyperkeratosis of the skin*/
1096,489,3,/*PLS*/
1096,607,72,/*destruction of the alveolar bone around the residual deciduous dentition*/
1096,703,60,/*destruction of the alveolar bone around the permanent molars*/
1096,1136,3,/*PLS*/
1098,0,21,/*Peroxisomal disorders*/
1098,286,19,/*vestigial structure*/
1098,759,39,/*Zellweger cerebro-hepato-renal syndrome*/
1098,827,19,/*peroxisomal disease*/
1098,1090,21,/*peroxisomal disorders*/
1098,1164,21,/*peroxisomal disorders*/
1098,1377,21,/*peroxisomal disorders*/
1098,1457,21,/*peroxisomal disorders*/
1099,0,24,/*Wiskott-Aldrich syndrome*/
1099,282,24,/*Wiskott-Aldrich syndrome*/
1099,309,3,/*WAS*/
1099,951,3,/*WAS*/
1100,129,5,/*tumor*/
1100,183,30,/*familial adenomatous polyposis*/
1100,218,67,/*autosomal-dominant cancer predisposition syndrome of the colorectum*/
1101,40,23,/*retinoschisin-deficient*/
1101,180,31,/*X-linked juvenile retinoschisis*/
1101,213,2,/*RS*/
1101,313,2,/*RS*/
1101,423,23,/*retinoschisin-deficient*/
1101,1386,15,/*Rs1h-deficiency*/
1101,1793,23,/*retinoschisin-deficient*/
1102,409,24,/*epididymal sperms of rat*/
1103,0,35,/*Sporadic hyperphosphatasia syndrome*/
1103,46,11,/*periostitis*/
1103,269,22,/*widespread periostitis*/
1103,590,17,/*Hyperphosphatasia*/
1103,656,3,/*ALP*/
1103,670,19,/*hyperphosphatasemia*/
1103,736,3,/*ALP*/
1103,765,29,/*familial expansile osteolysis*/
1103,796,36,/*expansile skeletal hyperphosphatasia*/
1103,947,24,/*juvenile Paget's disease*/
1103,977,14,/*OPG deficiency*/
1103,1042,23,/*painful swollen fingers*/
1103,1101,24,/*unexplained pericarditis*/
1103,1130,24,/*restrictive lung disease*/
1103,1341,36,/*expansile skeletal hyperphosphatasia*/
1103,1382,30,/*PDB2, juvenile Paget's disease*/
1103,1417,23,/*Paget's disease of bone*/
1103,1442,3,/*PDB*/
1103,1485,38,/*osteocalcin and urinary hydroxyproline*/
1103,1571,22,/*symmetric hyperostosis*/
1103,1876,26,/*radiographic abnormalities*/
1103,1975,35,/*sporadic hyperphosphatasia syndrome*/
1103,2064,16,/*her pericarditis*/
1103,2082,24,/*restrictive lung disease*/
1103,2112,11,/*periostitis*/
1104,7,6,/*cancer*/
1104,78,19,/*hairy cell leukemia*/
1104,176,19,/*hairy cell leukemia*/
1104,316,7,/*cancers*/
1104,497,19,/*hairy cell leukemia*/
1104,548,6,/*cancer*/
1104,628,19,/*hairy cell leukemia*/
1104,907,7,/*cancers*/
1104,989,6,/*cancer*/
1104,1015,19,/*hairy cell leukemia*/
1104,1145,19,/*hairy cell leukemia*/
1104,1226,6,/*cancer*/
1104,1433,16,/*Hodgkin lymphoma*/
1104,1550,14,/*thyroid cancer*/
1104,1621,11,/*lung cancer*/
1104,1784,19,/*hairy cell leukemia*/
1104,1828,19,/*hairy cell leukemia*/
1104,1885,7,/*cancers*/
1104,1907,62,/*non-Hodgkin lymphomas, 2 Hodgkin lymphomas, and 7 solid tumors*/
1104,1983,15,/*thyroid cancers*/
1104,2043,12,/*solid tumors*/
1104,2342,19,/*hairy cell leukemia*/
1104,2387,16,/*Hodgkin lymphoma*/
1104,2405,40,/*non-Hodgkin lymphoma, and thyroid cancer*/
1104,2468,6,/*cancer*/
1104,2489,37,/*smoking-associated vascular mortality*/
1104,2582,19,/*hairy cell leukemia*/
1104,2681,19,/*hairy cell leukemia*/
1104,2790,19,/*hairy cell leukemia*/
1105,107,22,/*coronary heart disease*/
1105,208,22,/*coronary heart disease*/
1105,232,3,/*CHD*/
1105,633,3,/*CHD*/
1105,779,3,/*CHD*/
1105,924,3,/*CHD*/
1105,1032,3,/*CHD*/
1105,1526,3,/*CHD*/
1105,1614,3,/*CHD*/
1105,1724,3,/*CHD*/
1106,49,25,/*hemolytic uremic syndrome*/
1106,130,25,/*hemolytic uremic syndrome*/
1106,179,24,/*complement dysregulation*/
1106,576,26,/*deficiency-associated aHUS*/
1106,824,22,/*complete FH deficiency*/
1106,942,19,/*acute renal failure*/
1106,1059,34,/*micro-angiopathic hemolytic anemia*/
1106,1305,3,/*HUS*/
1106,1643,33,/*upper respiratory tract infection*/
1107,0,22,/*Van der woude syndrome*/
1107,64,22,/*Van Der Woude Syndrome*/
1107,114,21,/*pits in the lower lip*/
1107,140,26,/*bilateral cleft of the lip*/
1107,171,12,/*cleft palate*/
1108,86,14,/*von Willebrand*/
1109,105,12,/*hemophilia B*/
1109,162,10,/*Hemophilia*/
1109,181,48,/*X-linked recessively inherited bleeding disorder*/
1109,489,12,/*hemophilia B*/
1109,744,10,/*hemophilia*/
1109,826,12,/*hemophilia B*/
1109,906,12,/*hemophilia B*/
1110,29,28,/*familial Mediterranean fever*/
1110,63,4,/*MEFV*/
1110,94,28,/*Familial Mediterranean fever*/
1110,124,3,/*FMF*/
1110,281,3,/*FMF*/
1110,380,3,/*FMF*/
1110,514,3,/*FMF*/
1110,825,18,/*intermittent fever*/
1110,860,10,/*chest pain*/
1110,878,14,/*abdominal pain*/
1110,904,23,/*chest or abdominal pain*/
1110,1581,3,/*FMF*/
1110,1586,14,/*periodic fever*/
1110,1605,9,/*serositis*/
1111,133,4,/*AIMS*/
1111,497,27,/*Duchenne muscular dystrophy*/
1111,526,3,/*DMD*/
1111,534,25,/*Becker muscular dystrophy*/
1111,561,3,/*BMD*/
1111,699,3,/*DMD*/
1111,714,3,/*BMD*/
1111,1384,7,/*DMD/BMD*/
1112,10,13,/*breast cancer*/
1112,140,13,/*breast cancer*/
1112,189,13,/*breast cancer*/
1112,248,13,/*breast cancer*/
1112,330,13,/*breast cancer*/
1112,588,13,/*breast cancer*/
1112,767,15,/*familial cancer*/
1112,1042,13,/*breast cancer*/
1112,1246,13,/*breast cancer*/
1112,1349,14,/*breast cancers*/
1112,1464,14,/*breast cancers*/
1113,258,14,/*Xenopus laevis*/
1113,491,32,/*Pan troglodytes, Gorilla gorilla*/
1114,196,5,/*tumor*/
1114,325,6,/*tumors*/
1114,340,18,/*oligodendrogliomas*/
1116,22,14,/*von Willebrand*/
1116,80,14,/*von Willebrand*/
1117,47,14,/*ovarian cancer*/
1117,130,25,/*malignant ovarian tumours*/
1117,315,7,/*tumours*/
1117,349,2,/*AS*/
1117,334,13,/*abnormalities*/
1117,585,21,/*seropapillary tumours*/
1117,699,15,/*residual tumour*/
1117,805,2,/*AS*/
1117,813,2,/*AC*/
1117,947,6,/*tumour*/
1117,1051,7,/*tumours*/
1117,1274,2,/*AS*/
1117,1392,2,/*AS*/
1117,1410,15,/*residual tumour*/
1117,1659,17,/*ovarian carcinoma*/
1117,1719,6,/*tumour*/
1117,1805,25,/*malignant ovarian tumours*/
1119,0,28,/*Familial Mediterranean fever*/
1119,94,28,/*Familial Mediterranean fever*/
1119,124,3,/*FMF*/
1119,166,27,/*autosomal-recessive disease*/
1119,277,3,/*FMF*/
1119,458,3,/*FMF*/
1119,498,3,/*FMF*/
1119,1090,3,/*FMF*/
1119,1260,3,/*FMF*/
1119,1359,3,/*FMF*/
1119,1634,3,/*FMF*/
1119,1945,3,/*FMF*/
1120,55,17,/*Angelman syndrome*/
1120,101,17,/*Angelman syndrome*/
1121,48,27,/*hereditary haemochromatosis*/
1121,207,27,/*hereditary haemochromatosis*/
1121,236,2,/*HH*/
1121,324,2,/*HH*/
1121,716,2,/*HH*/
1122,85,25,/*breast and ovarian cancer*/
1122,165,36,/*breast and epithelial ovarian cancer*/
1123,21,46,/*X-linked congenital stationary night blindness*/
1123,143,46,/*X-linked congenital stationary night blindness*/
1123,314,13,/*X-linked CSNB*/
1124,113,27,/*globoid cell leukodystrophy*/
1124,142,27,/*Globoid cell leukodystrophy*/
1124,171,3,/*GLD*/
1124,191,14,/*Krabbe disease*/
1124,225,34,/*degenerative neurological disorder*/
1124,586,3,/*GLD*/
1124,1037,33,/*Following intracerebroventricular*/
1124,1828,27,/*lysosomal storage disorders*/
1125,0,12,/*Wilms' tumor*/
1125,97,12,/*Wilms' tumor*/
1125,249,12,/*Wilms' tumor*/
1125,265,23,/*pediatric kidney cancer*/
1125,313,21,/*Denys-Drash syndromes*/
1125,360,20,/*Denys-Drash syndrome*/
1125,389,21,/*pseudohermaphroditism*/
1125,818,24,/*M  llerian duct syndrome*/
1125,864,21,/*pseudohermaphroditism*/
1126,0,14,/*Colonic polyps*/
1126,44,14,/*Colonic polyps*/
1126,86,15,/*rectal bleeding*/
1126,375,17,/*intestinal cancer*/
1126,422,29,/*pediatric gastroenterologists*/
1126,487,17,/*colorectal cancer*/
1126,522,27,/*juvenile polyposis syndrome*/
1126,551,41,/*Attenuated familial adenamatous polyposis*/
1126,594,4,/*AFAP*/
1126,911,29,/*pediatric gastroenterologists*/
1126,1097,14,/*Colonic polyps*/
1126,1123,24,/*isolated juvenile polyps*/
1126,1149,27,/*juvenile polyposis syndrome*/
1126,1178,3,/*FAP*/
1126,1183,4,/*AFAP*/
1126,1192,24,/*MYH-associated polyposis*/
1127,258,36,/*DiGeorge/velo-cardio-facial syndrome*/
1127,908,15,/*palatal defects*/
1127,925,39,/*cognitive deficits, minor ear anomalies*/
1127,1078,16,/*immunodeficiency*/
1127,1100,12,/*hypocalcemia*/
1129,314,16,/*Bretschneider, T*/
1130,97,37,/*phosphoribosyl transferase deficiency*/
1130,136,19,/*Lesch-Nyhan disease*/
1130,277,15,/*HPRT deficiency*/
1130,301,25,/*neuropsychiatric symptoms*/
1130,1027,15,/*HPRT deficiency*/
1130,1102,15,/*HPRT deficiency*/
1130,1211,15,/*HPRT deficiency*/
1130,1317,15,/*HPRT deficiency*/
1130,1540,15,/*HPRT deficiency*/
1131,0,18,/*Uniparental disomy*/
1131,708,18,/*Uniparental disomy*/
1131,1181,16,/*genetic disorder*/
1131,1411,18,/*uniparental disomy*/
1132,51,22,/*Smith-Magenis syndrome*/
1132,75,3,/*SMS*/
1132,126,12,/*cleft palate*/
1132,142,3,/*SMS*/
1132,195,22,/*Smith-Magenis syndrome*/
1132,219,3,/*SMS*/
1132,280,17,/*psychomotor delay*/
1132,336,20,/*congenital anomalies*/
1132,443,36,/*haploinsufficiency of numerous genes*/
1132,655,3,/*SMS*/
1132,912,12,/*cleft palate*/
1132,980,3,/*SMS*/
1132,1066,12,/*cleft palate*/
1132,1082,3,/*SMS*/
1132,1391,21,/*isolated cleft palate*/
1133,724,18,/*Poor colour vision*/
1133,903,3,/*CCT*/
1134,33,22,/*Van der Woude syndrome*/
1134,197,22,/*Van der Woude syndrome*/
1134,416,22,/*Van der Woude syndrome*/
1134,570,22,/*Van der Woude syndrome*/
1134,746,8,/*lip pits*/
1134,759,16,/*cleft lip/palate*/
1134,940,15,/*isolated clefts*/
1134,957,17,/*isolated lip pits*/
1134,995,16,/*cleft lip/palate*/
1134,1017,8,/*lip pits*/
1134,1331,22,/*Van der Woude syndrome*/
1134,1570,22,/*Van der Woude syndrome*/
1134,1616,22,/*Van der Woude syndrome*/
1135,112,31,/*dermatofibrosarcoma protuberans*/
1135,145,31,/*Dermatofibrosarcoma protuberans*/
1135,178,4,/*DFSP*/
1135,787,4,/*DFSP*/
1136,79,22,/*Classical galactosemia*/
1136,108,28,/*autosomal recessive disorder*/
1136,1302,12,/*galactosemia*/
1137,73,26,/*Cornelia-de Lange syndrome*/
1137,225,26,/*Cornelia-de Lange syndrome*/
1137,253,4,/*CdLS*/
1137,278,18,/*growth retardation*/
1137,327,16,/*facial anomalies*/
1137,348,28,/*mild extremity malformations*/
1137,1391,20,/*congenital disorders*/
1138,626,38,/*obesity and/or coronary artery disease*/
1139,48,43,/*hereditary breast and breast-ovarian cancer*/
1139,268,32,/*Hereditary Breast/Ovarian cancer*/
1139,361,21,/*Breast/Ovarian cancer*/
1139,400,25,/*breast and/ovarian cancer*/
1139,903,21,/*breast/ovarian cancer*/
1139,1203,32,/*Hereditary Breast/Ovarian cancer*/
1139,1239,6,/*Kerala*/
1140,49,17,/*Angelman syndrome*/
1140,145,17,/*Angelman syndrome*/
1140,164,2,/*AS*/
1140,173,27,/*neurodevelopmental disorder*/
1140,218,18,/*mental retardation*/
1140,238,13,/*absent speech*/
1140,253,6,/*ataxia*/
1140,353,2,/*AS*/
1140,1084,2,/*AS*/
1140,1811,39,/*Angelman syndrome-Prader-Willi syndrome*/
1140,1852,6,/*AS-PWS*/
1141,68,26,/*glycerol kinase deficiency*/
1141,96,32,/*congenital suprarenal hypoplasia*/
1141,133,29,/*Duchenne's muscular dystrophy*/
1141,179,39,/*Complex glycerol kinase (GK) deficiency*/
1141,296,29,/*congenital adrenal hypoplasia*/
1141,327,3,/*AHC*/
1141,343,29,/*Duchenne's muscular dystrophy*/
1141,374,3,/*DMD*/
1141,654,18,/*metabolic acidosis*/
1141,674,13,/*hypoglycaemia*/
1141,689,13,/*hyponatraemia*/
1141,707,16,/*hyperpotassaemia*/
1141,834,18,/*mental retardation*/
1141,857,29,/*progressive muscular weakness*/
1141,1027,21,/*fasting hypoglycaemia*/
1141,1050,27,/*hydroelectrolytic disorders*/
1141,1082,12,/*ketoacidosis*/
1141,1190,27,/*pseudohypertriglyceridaemia*/
1141,1450,19,/*DMD, the GK deficit*/
1141,1474,3,/*AHC*/
1141,1724,21,/*suprarenal hypoplasia*/
1143,84,5,/*tumor*/
1143,303,5,/*tumor*/
1143,595,25,/*breast and ovarian cancer*/
1143,641,14,/*poor prognosis*/
1143,737,6,/*cancer*/
1144,78,10,/*hemophilia*/
1144,93,3,/*VWD*/
1144,867,3,/*VWD*/
1144,1593,13,/*recessive VWD*/
1145,318,14,/*nail dystrophy*/
1145,335,15,/*patchy alopecia*/
1145,357,20,/*dental abnormalities*/
1146,110,3,/*MED*/
1146,337,29,/*multiple epiphyseal dysplasia*/
1146,368,3,/*MED*/
1146,912,3,/*MED*/
1146,1131,14,/*chondrosarcoma*/
1146,1364,3,/*MED*/
1146,1714,3,/*CTD*/
1146,1847,3,/*CTD*/
1147,99,19,/*isovaleric acidemia*/
1147,120,19,/*Isovaleric acidemia*/
1147,141,3,/*IVA*/
1147,152,58,/*autosomal recessive inborn error of the leucine metabolism*/
1147,231,42,/*deficiency of isovaleryl-CoA dehydrogenase*/
1147,424,14,/*IVD deficiency*/
1147,572,3,/*IVD*/
1147,602,3,/*IVA*/
1147,1428,3,/*IVA*/
1148,55,10,/*alcoholism*/
1148,99,19,/*Unipolar depression*/
1148,632,10,/*alcoholism*/
1149,102,28,/*familial Mediterranean fever*/
1149,184,28,/*familial Mediterranean fever*/
1149,214,3,/*FMF*/
1149,710,3,/*FMF*/
1149,860,21,/*colchicine resistance*/
1149,1549,3,/*FMF*/
1150,223,27,/*X-linked mental retardation*/
1150,319,55,/*syndromic and non-syndromic forms of mental retardation*/
1150,252,4,/*XLMR*/
1150,751,19,/*Fragile XA syndrome*/
1150,934,3,/*ARX*/
1150,1210,19,/*Fragile XA syndrome*/
1150,1529,24,/*infantile spasm syndrome*/
1150,1555,19,/*Partington syndrome*/
1150,1579,41,/*non-syndromic X-linked mental retardation*/
1150,1737,18,/*mental retardation*/
1151,77,42,/*familial and sporadic renal cell carcinoma*/
1151,159,31,/*familial forms of kidney cancer*/
1151,243,29,/*sporadic renal cell carcinoma*/
1151,274,3,/*RCC*/
1151,340,3,/*VHL*/
1151,345,24,/*familial cancer syndrome*/
1151,376,3,/*VHL*/
1151,423,3,/*VHL*/
1151,321,17,/*von Hippel Lindau*/
1151,501,12,/*familial RCC*/
1151,545,3,/*RCC*/
1151,641,3,/*RCC*/
1151,648,11,/*VHL disease*/
1151,767,3,/*VHL*/
1151,841,11,/*VHL disease*/
1151,1166,3,/*RCC*/
1151,1189,15,/*retinal angioma*/
1151,1209,28,/*cerebellar haemangioblastoma*/
1151,1242,11,/*VHL disease*/
1151,1471,3,/*RCC*/
1151,1609,3,/*RCC*/
1151,1621,11,/*VHL disease*/
1151,1804,25,/*familial and sporadic RCC*/
1152,118,25,/*Autosomal dominant cancer*/
1152,176,7,/*cancers*/
1152,192,13,/*breast cancer*/
1152,210,17,/*colorectal cancer*/
1152,344,18,/*adult-onset cancer*/
1152,527,16,/*childhood cancer*/
1152,627,26,/*autosomal recessive cancer*/
1152,687,15,/*Fanconi anaemia*/
1152,707,21,/*ataxia-telangiectasia*/
1152,777,13,/*adult cancers*/
1152,945,6,/*cancer*/
1153,15,12,/*Wilms tumour*/
1153,45,8,/*aniridia*/
1153,200,12,/*Wilms tumour*/
1153,294,6,/*tumour*/
1153,475,8,/*aniridia*/
1153,517,8,/*aniridia*/
1153,618,8,/*aniridia*/
1153,788,8,/*aniridia*/
1153,866,12,/*Wilms tumour*/
1153,956,12,/*Wilms tumour*/
1153,1159,12,/*Wilms tumour*/
1153,1366,12,/*Wilms tumour*/
1153,1396,8,/*aniridia*/
1153,1486,12,/*Wilms tumour*/
1154,147,22,/*Machado-Joseph disease*/
1154,182,29,/*spinocerebellar ataxia type 3*/
1154,213,8,/*MJD/SCA3*/
1154,228,50,/*hereditary and neurodegenerative movement disorder*/
1154,348,13,/*Neuronal loss*/
1154,365,8,/*MJD/SCA3*/
1154,735,13,/*neuroblastoma*/
1154,961,3,/*MJD*/
1155,0,21,/*Ataxia-telangiectasia*/
1155,111,21,/*Ataxia-telangiectasia*/
1155,134,3,/*A-T*/
1155,145,28,/*autosomal recessive disorder*/
1155,203,17,/*neurodegeneration*/
1155,222,16,/*immunodeficiency*/
1155,258,6,/*cancer*/
1155,266,19,/*genomic instability*/
1155,326,3,/*A-T*/
1155,507,3,/*A-T*/
1155,623,3,/*A-T*/
1155,682,3,/*A-T*/
1155,1035,3,/*A-T*/
1155,1124,3,/*A-T*/
1155,1200,3,/*A-T*/
1157,146,26,/*Hereditary Hemochromatosis*/
1157,174,2,/*HH*/
1157,183,15,/*genetic disease*/
1157,215,13,/*iron overload*/
1157,351,36,/*disorders particularly liver disease*/
1157,779,2,/*HH*/
1158,98,13,/*breast cancer*/
1158,260,17,/*metastatic tumors*/
1158,448,5,/*tumor*/
1158,516,13,/*breast cancer*/
1158,568,17,/*breast carcinomas*/
1158,765,7,/*cancers*/
1158,845,13,/*breast cancer*/
1158,930,13,/*breast cancer*/
1159,0,20,/*Fabry kidney disease*/
1159,22,13,/*Fabry disease*/
1159,37,2,/*FD*/
1159,73,25,/*lysosomal storage disease*/
1159,100,3,/*LSD*/
1159,218,27,/*X-linked recessive disorder*/
1159,398,2,/*FD*/
1159,453,2,/*FD*/
1159,462,17,/*X-linked disorder*/
1159,631,16,/*neuropathic pain*/
1159,667,14,/*angiokeratomas*/
1159,687,28,/*asymptomatic corneal lesions*/
1159,862,47,/*cardiac, renal or cerebrovascular complications*/
1159,1049,13,/*renal disease*/
1159,1092,21,/*microscopic hematuria*/
1159,1131,11,/*proteinuria*/
1159,1164,15,/*nephrotic range*/
1159,1185,9,/*lipiduria*/
1159,1196,23,/*End-stage renal disease*/
1159,1247,8,/*dialysis*/
1160,61,18,/*myotonic dystrophy*/
1160,215,18,/*myotonic dystrophy*/
1160,261,23,/*neuromuscular disorders*/
1161,105,25,/*Fragile X (FRAX) syndrome*/
1161,163,18,/*mental retardation*/
1161,227,28,/*fragile X mental retardation*/
1161,540,9,/*fragile X*/
1161,623,18,/*mental retardation*/
1161,743,4,/*FRAX*/
1161,1227,27,/*delay eyeblink conditioning*/
1162,97,28,/*chronic lymphocytic leukemia*/
1162,127,28,/*Chronic lymphocytic leukemia*/
1162,157,3,/*CLL*/
1162,172,36,/*B-cell lymphoproliferative disorders*/
1162,1370,25,/*chromosomal abnormalities*/
1162,1495,3,/*CLL*/
1163,15,44,/*glucose-6-phosphate dehydrogenase deficiency*/
1163,76,24,/*congenital heart disease*/
1164,0,58,/*Hereditary deficiency of the fifth component of complement*/
1164,156,58,/*hereditary deficiency of the fifth component of complement*/
1164,283,28,/*systemic lupus erythematosus*/
1164,437,15,/*immunodiffusion*/
1164,1003,13,/*C5 deficiency*/
1164,1076,12,/*C5-deficient*/
1164,1091,3,/*C5D*/
1164,1283,3,/*C5D*/
1164,1455,3,/*C5D*/
1164,1665,18,/*glomerulonephritis*/
1164,1686,10,/*vasculitis*/
1164,1703,9,/*arthritis*/
1164,1811,20,/*bacterial infections*/
1164,1960,3,/*C5D*/
1164,2045,25,/*neutrophilic leukocytosis*/
1164,2078,18,/*pyogenic infection*/
1165,73,26,/*refractory prostate cancer*/
1165,214,44,/*advanced hormone-refractory prostate cancers*/
1165,280,15,/*prostate cancer*/
1165,299,38,/*androgen-sensitive, metastatic disease*/
1165,390,17,/*androgen ablation*/
1165,409,15,/*Prostate cancer*/
1165,1101,4,/*HRPC*/
1165,1421,6,/*AR-GGN*/
1165,1497,4,/*HRPC*/
1166,123,30,/*metachromatic leukodystrophies*/
1166,231,28,/*metachromatic leukodystrophy*/
1166,530,3,/*MLD*/
1166,535,35,/*sphingolipid activator B deficiency*/
1167,76,17,/*isolated aniridia*/
1167,169,8,/*aniridia*/
1167,198,25,/*inherited eye abnormality*/
1167,241,39,/*partial or complete absence of the iris*/
1167,862,25,/*chromosomal abnormalities*/
1167,904,20,/*developmental delays*/
1167,929,6,/*cancer*/
1167,1104,8,/*aniridia*/
1168,0,53,/*Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency*/
1169,57,46,/*autosomal recessive non-syndromic hearing loss*/
1170,120,25,/*breast and ovarian cancer*/
1170,425,25,/*breast and ovarian cancer*/
1170,744,14,/*ovarian cancer*/
1170,964,7,/*cancers*/
1170,994,12,/*BRCA1 defect*/
1170,1055,6,/*cancer*/
1170,1112,6,/*cancer*/
1170,1343,13,/*breast cancer*/
1170,1389,6,/*cancer*/
1170,1552,26,/*breast and ovarian cancers*/
1171,54,14,/*Fas deficiency*/
1171,384,39,/*autoimmune lymphoproliferative syndrome*/
1171,425,4,/*ALPS*/
1171,458,19,/*lymphoproliferation*/
1171,482,12,/*autoimmunity*/
1171,543,4,/*ALPS*/
1171,1188,4,/*ALPS*/
1171,1379,4,/*ALPS*/
1172,445,17,/*Tay Sachs disease*/
1172,464,15,/*Canavan disease*/
1172,481,21,/*familial dysautonomia*/
1172,504,16,/*mucolipidosis IV*/
};
}
static void init8() {
a8 = new int[] {
1172,551,21,/*Fanconi anemia type C*/
1172,574,14,/*Bloom syndrome*/
1172,594,15,/*Gaucher disease*/
1172,1167,17,/*Tay Sachs disease*/
1172,1186,15,/*Canavan disease*/
1172,1203,21,/*familial dysautonomia*/
1172,1226,16,/*mucolipidosis IV*/
1172,1273,21,/*Fanconi anemia type C*/
1172,1296,14,/*Bloom syndrome*/
1172,1312,15,/*Gaucher disease*/
1172,1333,24,/*glycogen storage disease*/
1174,68,30,/*Ehlers-Danlos syndrome type IV*/
1174,100,22,/*Ehlers-Danlos syndrome*/
1174,124,3,/*EDS*/
1174,366,6,/*EDS IV*/
1174,506,6,/*EDS IV*/
1174,615,11,/*type IV EDS*/
1174,746,24,/*carotidcavernous fistula*/
1174,1439,6,/*EDS IV*/
1175,87,24,/*complement C9 deficiency*/
1175,113,53,/*Deficiency of the ninth component of human complement*/
1175,193,21,/*complement deficiency*/
1175,291,13,/*C9 deficiency*/
1175,322,12,/*C9-deficient*/
1175,366,24,/*meningococcal meningitis*/
1175,523,12,/*C9-deficient*/
1175,890,13,/*C9 deficiency*/
1176,13,15,/*hemochromatosis*/
1176,45,15,/*hemochromatosis*/
1176,71,15,/*serious illness*/
1176,457,13,/*iron overload*/
1176,528,20,/*absence of cirrhosis*/
1176,691,15,/*hemochromatosis*/
1176,804,15,/*hemochromatosis*/
1176,916,15,/*hemochromatosis*/
1176,939,17,/*hepatic cirrhosis*/
1176,1011,15,/*chronic disease*/
1177,47,21,/*ataxia-telangiectasia*/
1177,166,3,/*A-T*/
1177,284,17,/*recessive disease*/
1177,302,21,/*ataxia-telangiectasia*/
1177,326,3,/*A-T*/
1177,408,3,/*A-T*/
1177,563,3,/*A-T*/
1178,57,27,/*Duchenne muscular dystrophy*/
1178,86,3,/*DMD*/
1178,358,3,/*DMD*/
1178,371,14,/*genetic lesion*/
1178,426,3,/*DMD*/
1178,1234,3,/*DMD*/
1180,1310,27,/*cardiac and muscle symptoms*/
1180,1375,16,/*VLCAD deficiency*/
1180,1501,16,/*VLCAD deficiency*/
1181,43,25,/*hereditary retinoblastoma*/
1181,136,25,/*hereditary retinoblastoma*/
1181,1374,5,/*tumor*/
1181,1408,16,/*nonocular tumors*/
1183,876,39,/*Abnormality of color perception depends*/
1184,1181,3,/*GCL*/
1184,1160,19,/*ganglion cell layer*/
1184,2379,16,/*embryonic stages*/
1185,43,25,/*alveolar rhabdomyosarcoma*/
1185,88,25,/*alveolar rhabdomyosarcoma*/
1185,147,6,/*tumors*/
1185,222,5,/*tumor*/
1185,367,25,/*alveolar rhabdomyosarcoma*/
1185,497,25,/*alveolar rhabdomyosarcoma*/
1186,0,18,/*Fragile ecosystems*/
1188,19,39,/*autosomal dominant retinitis pigmentosa*/
1188,178,39,/*autosomal dominant retinitis pigmentosa*/
1188,219,4,/*ADRP*/
1188,1744,4,/*ADRP*/
1189,301,2,/*AD*/
1190,0,24,/*Wiskott-Aldrich syndrome*/
1190,139,4,/*WASP*/
1190,162,24,/*Wiskott-Aldrich syndrome*/
1190,261,3,/*WAS*/
1190,289,25,/*X-linked thrombocytopenia*/
1190,960,3,/*WAS*/
1191,0,16,/*Pendred syndrome*/
1191,37,25,/*congenital hypothyroidism*/
1191,146,16,/*Pendred syndrome*/
1191,169,28,/*autosomal recessive disorder*/
1191,215,26,/*sensorineural hearing loss*/
1191,246,25,/*thyroid dyshormonogenesis*/
1191,359,14,/*Hypothyroidism*/
1191,377,16,/*Pendred syndrome*/
1191,536,16,/*Pendred syndrome*/
1191,596,25,/*congenital hypothyroidism*/
1191,623,2,/*CH*/
1191,764,2,/*CH*/
1191,861,16,/*Pendred syndrome*/
1191,931,25,/*thyroid dyshormonogenesis*/
1191,977,26,/*sensorineural hearing loss*/
1191,1043,16,/*Pendred syndrome*/
1191,1136,12,/*Hearing loss*/
1191,1204,2,/*CH*/
1191,1261,16,/*Pendred syndrome*/
1191,1676,16,/*Pendred syndrome*/
1191,1707,2,/*CH*/
1192,0,13,/*Danon disease*/
1192,30,22,/*dilated cardiomyopathy*/
1192,78,31,/*X-linked dilated cardiomyopathy*/
1192,111,4,/*XLCM*/
1192,182,3,/*DMD*/
1192,327,3,/*DMD*/
1192,479,13,/*Danon disease*/
1192,550,27,/*hypertrophic cardiomyopathy*/
1192,603,17,/*skeletal myopathy*/
1192,700,22,/*pigmentary retinopathy*/
1192,899,13,/*Danon disease*/
1192,1010,28,/*retinal pigmentary dystrophy*/
1192,1106,17,/*vacuolar myopathy*/
1192,1172,13,/*Danon disease*/
1193,110,11,/*Parkinson's*/
1193,131,19,/*Lesch Nyhan disease*/
1193,152,3,/*LND*/
1193,255,13,/*mesencephalon*/
1193,406,2,/*PD*/
1193,584,23,/*metabolism deficiencies*/
1193,739,3,/*LND*/
1193,774,39,/*neurodegenerative neurological disorder*/
1193,1018,3,/*LND*/
1193,1061,15,/*HPRT deficiency*/
1193,1209,12,/*CNS disorder*/
1193,1288,23,/*neurotransmitter defect*/
1194,27,13,/*WAGR syndrome*/
1194,54,4,/*WAGR*/
1194,113,11,/*Wilms tumor*/
1194,126,8,/*aniridia*/
1194,136,27,/*genitourinary abnormalities*/
1194,169,18,/*mental retardation*/
1194,203,13,/*WAGR syndrome*/
1194,281,22,/*WT1 haploinsufficiency*/
1194,345,11,/*Wilms tumor*/
1194,395,8,/*aniridia*/
1194,471,13,/*WAGR syndrome*/
1194,505,21,/*genital abnormalities*/
1194,535,14,/*cryptorchidism*/
1194,553,11,/*hypospadias*/
1194,581,19,/*ambiguous genitalia*/
1194,669,13,/*WAGR syndrome*/
1194,786,13,/*WAGR syndrome*/
1194,1261,16,/*Frasier syndrome*/
1194,1279,2,/*FS*/
1194,1287,20,/*Denys-Drash syndrome*/
1194,1309,3,/*DDS*/
1194,1429,2,/*FS*/
1194,1449,3,/*DDS*/
1194,1486,13,/*WAGR syndrome*/
1195,1409,5,/*tumor*/
1196,176,18,/*Huntington disease*/
1196,197,2,/*HD*/
1196,289,5,/*CED-3*/
1196,437,2,/*HD*/
1196,720,2,/*HD*/
1197,165,15,/*legal blindness*/
1197,270,3,/*AMD*/
1197,454,3,/*AMD*/
1197,656,40,/*photodynamic therapy for neovascular AMD*/
1197,698,3,/*PDT*/
1197,1146,3,/*AMD*/
1197,1293,3,/*PDT*/
1197,1327,21,/*legal blindness group*/
1197,1497,20,/*diabetic retinopathy*/
1197,1623,12,/*Advanced AMD*/
1197,1844,3,/*AMD*/
1198,51,34,/*isolated unilateral retinoblastoma*/
1198,109,34,/*isolated unilateral retinoblastoma*/
1198,146,5,/*tumor*/
1198,281,14,/*retinoblastoma*/
1198,424,34,/*isolated unilateral retinoblastoma*/
1198,508,5,/*tumor*/
1198,539,6,/*tumors*/
1198,755,6,/*tumors*/
1198,915,6,/*tumors*/
1198,953,6,/*tumors*/
1198,1027,6,/*tumors*/
1198,1126,6,/*tumors*/
1198,1828,17,/*multifocal tumors*/
1198,1876,24,/*bilateral retinoblastoma*/
1198,1988,14,/*retinoblastoma*/
1199,21,3,/*VHL*/
1199,224,11,/*dysmorphism*/
1199,278,5,/*tumor*/
1199,357,5,/*tumor*/
1199,415,6,/*cancer*/
1199,438,22,/*cancer-free dysmorphic*/
1199,583,3,/*VHL*/
1199,623,30,/*familial Adenomatous polyposis*/
1199,672,26,/*von-Hippel-Lindau syndrome*/
1199,1123,3,/*VHL*/
1199,1207,3,/*APC*/
1199,1248,3,/*VHL*/
1199,1329,3,/*VHL*/
1199,1459,5,/*tumor*/
1199,1497,6,/*cancer*/
1199,1574,5,/*tumor*/
1200,32,24,/*centrosome abnormalities*/
1200,60,11,/*oral cancer*/
1200,83,13,/*solid tumours*/
1200,98,29,/*oral squamous cell carcinomas*/
1200,154,23,/*chromosomal instability*/
1200,195,10,/*aneuploidy*/
1200,129,4,/*OSCC*/
1200,179,3,/*CIN*/
1200,1046,25,/*Centrosomal abnormalities*/
1200,1112,26,/*oral epithelial dysplasias*/
1200,1143,10,/*carcinomas*/
1200,1360,10,/*carcinomas*/
1200,1677,18,/*centrosome defects*/
1200,1791,24,/*centrosome abnormalities*/
1200,1819,15,/*oral dysplasias*/
1202,45,14,/*retinoblastoma*/
1202,105,5,/*tumor*/
1202,282,14,/*retinoblastoma*/
1202,355,17,/*unilateral tumors*/
1202,806,6,/*tumors*/
1203,523,20,/*hypercholesterolemic*/
1203,1788,20,/*hypercholesterolemic*/
1204,0,15,/*Acute hepatitis*/
1204,34,28,/*familial Mediterranean fever*/
1204,64,28,/*Familial Mediterranean fever*/
1204,94,3,/*FMF*/
1204,104,19,/*hereditary syndrome*/
1204,163,5,/*fever*/
1204,173,9,/*serositis*/
1204,236,3,/*FMF*/
1204,248,15,/*gren's syndrome*/
1204,401,9,/*hepatitis*/
1204,417,19,/*liver cell necrosis*/
1204,506,19,/*interface hepatitis*/
1204,529,16,/*bile duct injury*/
1204,619,20,/*hepatic inflammation*/
1205,0,22,/*Ankylosing spondylitis*/
1206,56,3,/*VHL*/
1206,82,20,/*Renal Cell Carcinoma*/
1206,213,17,/*von Hippel-Lindau*/
1206,232,3,/*VHL*/
1206,270,20,/*renal cell carcinoma*/
1206,292,3,/*RCC*/
1206,479,3,/*RCC*/
1206,501,3,/*RCC*/
1206,740,6,/*tumour*/
1206,827,7,/*tumours*/
1206,893,3,/*RCC*/
1206,1137,3,/*RCC*/
1206,1147,3,/*VHL*/
1206,1460,3,/*TCE*/
1206,1666,3,/*VHL*/
1208,25,24,/*Wiskott-Aldrich syndrome*/
1208,207,24,/*Wiskott-Aldrich syndrome*/
1208,1031,24,/*Wiskott-Aldrich syndrome*/
1210,46,20,/*Huntington's disease*/
1210,154,20,/*Huntington's disease*/
1210,176,2,/*HD*/
1210,378,22,/*degenerative disorders*/
1210,415,2,/*HD*/
1210,473,2,/*HD*/
1210,659,2,/*HD*/
1210,846,2,/*TC*/
1210,947,2,/*HD*/
1210,1126,7,/*illness*/
1210,1249,18,/*psychotic features*/
1210,1350,2,/*HD*/
1210,1496,2,/*HD*/
1210,1669,2,/*HD*/
1211,70,15,/*atherosclerosis*/
1211,1237,31,/*smaller atherosclerotic lesions*/
1211,1306,15,/*atherosclerosis*/
1212,28,11,/*D-deficient*/
1212,453,4,/*VDDR*/
1213,97,25,/*congenital hypothyroidism*/
1213,278,16,/*DUOX2 deficiency*/
1213,304,25,/*congenital hypothyroidism*/
1213,331,2,/*CH*/
1213,579,2,/*CH*/
1213,639,2,/*CH*/
1213,740,36,/*partial iodine organification defect*/
1213,1428,2,/*CH*/
1213,1528,17,/*DUOXA2 deficiency*/
1213,1591,2,/*CH*/
1213,1741,2,/*CH*/
1213,1748,22,/*dyshormonogenic goiter*/
1213,1937,2,/*CH*/
1214,14,17,/*Tay-Sachs disease*/
1215,32,21,/*ataxia-telangiectasia*/
1215,126,8,/*leukemia*/
1215,136,8,/*lymphoma*/
1215,150,13,/*breast cancer*/
1215,220,21,/*ataxia-telangiectasia*/
1215,244,3,/*A-T*/
1215,460,23,/*cerebellar degeneration*/
1215,527,3,/*A-T*/
1215,623,13,/*breast cancer*/
1215,747,3,/*A-T*/
1215,787,23,/*cerebellar degeneration*/
1215,986,3,/*A-T*/
1215,1032,8,/*leukemia*/
1215,1043,8,/*lymphoma*/
1215,1092,16,/*Hodgkin lymphoma*/
1215,1286,3,/*A-T*/
1216,89,20,/*Lesch-Nyhan syndrome*/
1216,190,62,/*deficiencies of hypoxanthine-guanine phosphoribosyltransferase*/
1217,60,13,/*breast cancer*/
1217,160,13,/*breast cancer*/
1217,304,13,/*breast cancer*/
1217,393,13,/*breast cancer*/
1217,422,5,/*tumor*/
1217,451,13,/*breast cancer*/
1217,536,13,/*breast cancer*/
1217,688,13,/*breast cancer*/
1217,876,13,/*breast cancer*/
1217,1085,13,/*breast cancer*/
1217,1233,13,/*breast cancer*/
1218,171,27,/*neurodegenerative disorders*/
1219,0,45,/*Normophosphatemic familial tumoral calcinosis*/
1219,132,45,/*Normophosphatemic familial tumoral calcinosis*/
1219,191,28,/*autosomal recessive disorder*/
1219,334,15,/*skin infections*/
1219,179,4,/*NFTC*/
1219,1255,4,/*NFTC*/
1219,1519,5,/*tumor*/
1220,0,30,/*Inherited colorectal polyposis*/
1220,35,6,/*cancer*/
1220,162,16,/*colorectal tumor*/
1220,192,39,/*familial adenomatous polyposis syndrome*/
1220,481,3,/*APC*/
1220,609,18,/*adenomatous polyps*/
1220,637,17,/*colorectal cancer*/
1220,924,20,/*colorectal neoplasia*/
1220,1052,8,/*adenomas*/
1220,1065,18,/*colorectal cancers*/
1220,1200,27,/*increased adenoma formation*/
1220,1289,17,/*colorectal cancer*/
1220,1543,17,/*colorectal cancer*/
1221,78,6,/*cancer*/
1221,147,6,/*cancer*/
1221,509,16,/*Burkitt lymphoma*/
1221,584,17,/*colorectal cancer*/
1221,701,29,/*impaired spontaneous lymphoma*/
1221,783,21,/*ataxia telangiectasia*/
1221,1206,9,/*MEF death*/
1221,1595,6,/*cancer*/
1221,1650,16,/*cancer syndromes*/
1221,1668,16,/*Burkitt lymphoma*/
1221,1689,21,/*ataxia telangiectasia*/
1221,1795,6,/*cancer*/
1222,31,14,/*retinoblastoma*/
1222,149,14,/*retinoblastoma*/
1222,213,13,/*tumorigenesis*/
1222,671,14,/*retinoblastoma*/
1224,91,22,/*coronary heart disease*/
1224,338,22,/*coronary heart disease*/
1224,362,3,/*CHD*/
1224,436,3,/*CHD*/
1224,567,3,/*CHD*/
1224,716,3,/*CHD*/
1225,311,13,/*breast cancer*/
1225,564,13,/*breast cancer*/
1226,75,17,/*eye abnormalities*/
1226,94,8,/*Aniridia*/
1226,136,36,/*semidominant developmental disorders*/
1226,261,15,/*iris hypoplasia*/
1226,328,27,/*exhibit brain abnormalities*/
1226,974,21,/*developmental defects*/
1227,0,30,/*Cerebrotendinous xanthomatosis*/
1227,148,30,/*cerebrotendinous xanthomatosis*/
1227,180,3,/*CTX*/
1227,260,20,/*psychiatric symptoms*/
1227,285,10,/*osteopenia*/
1227,553,9,/*cataracts*/
1227,564,22,/*ischemic heart disease*/
1227,588,25,/*premature atherosclerosis*/
1227,615,20,/*mental deterioration*/
1227,640,12,/*osteoporosis*/
1227,680,3,/*CTX*/
1228,76,9,/*fragile X*/
1228,97,18,/*Fragile X syndrome*/
1228,122,17,/*X-linked disorder*/
1228,212,72,/*impaired cognitive functions to seizures, anxiety, sensory abnormalities*/
1228,290,13,/*hyperactivity*/
1228,494,9,/*fragile X*/
1228,524,13,/*hyperactivity*/
1228,539,8,/*seizures*/
1228,553,27,/*abnormal sensory processing*/
1228,728,2,/*WT*/
1228,745,2,/*WT*/
1228,618,9,/*wild-type*/
1228,978,39,/*seizures or abnormal sensory processing*/
1228,1282,13,/*hyperactivity*/
1229,24,3,/*PKU*/
1229,131,15,/*Phenylketonuria*/
1229,148,3,/*PKU*/
1229,159,46,/*autosomal recessive inborn error of metabolism*/
1229,384,3,/*PKU*/
1229,421,3,/*PKU*/
1229,719,3,/*PKU*/
1229,797,3,/*PKU*/
1229,995,3,/*PKU*/
1229,1065,3,/*PKU*/
1229,1290,3,/*PKU*/
1230,37,6,/*autism*/
1231,19,14,/*retinoblastoma*/
1231,55,14,/*retinoblastoma*/
1231,71,2,/*RB*/
1231,393,2,/*RB*/
1231,520,2,/*RB*/
1232,34,5,/*tumor*/
1232,125,13,/*breast cancer*/
1232,186,13,/*breast cancer*/
1232,460,13,/*breast cancer*/
1232,631,14,/*hydrocortisone*/
1232,710,17,/*growth conditions*/
1232,729,14,/*Hydrocortisone*/
1232,1520,13,/*tumorigenesis*/
1232,1610,22,/*cortisol's involvement*/
1232,1636,13,/*breast cancer*/
1233,32,21,/*Prader-Willi syndrome*/
1233,115,21,/*Prader-Willi Syndrome*/
1233,138,3,/*PWS*/
1233,258,3,/*PWS*/
1233,332,3,/*PWS*/
1233,826,3,/*PWS*/
1233,941,3,/*PWS*/
1233,1037,3,/*PWS*/
1233,1046,5,/*obese*/
1233,1397,3,/*PWS*/
1233,1441,55,/*Obesity-related cardiovascular and respiratory diseases*/
1233,1630,21,/*Respiratory infection*/
1233,1656,15,/*cardiac illness*/
1233,1898,3,/*PWS*/
1235,417,15,/*embryonic death*/
1235,556,24,/*absence of the allantois*/
1235,623,30,/*abnormality of the neural tube*/
1235,860,4,/*TWis*/
1235,898,9,/*TWis/TWis*/
1235,945,3,/*T/T*/
1236,24,38,/*Duchenne and Becker muscular dystrophy*/
1236,67,18,/*myotonic dystrophy*/
1237,55,31,/*colonic and extracolonic tumors*/
1237,90,3,/*FAP*/
1237,180,26,/*adenomatous polyposis coli*/
1237,231,17,/*colorectal tumors*/
1237,276,30,/*familial adenomatous polyposis*/
1237,308,3,/*FAP*/
1237,325,34,/*colorectal and extracolonic tumors*/
1237,393,17,/*colorectal tumors*/
1237,416,3,/*FAP*/
1237,518,19,/*extracolonic tumors*/
1237,548,36,/*duodenal, gastric and desmoid tumors*/
1237,208,3,/*APC*/
1237,593,6,/*tumors*/
1237,904,17,/*colorectal tumors*/
1237,940,3,/*FAP*/
1237,1231,19,/*FAP duodenal tumors*/
1237,1268,14,/*gastric tumors*/
1237,1324,14,/*desmoid tumors*/
1237,1477,24,/*colorectal tumorigenesis*/
1237,1558,3,/*FAP*/
1237,1593,13,/*tumorigenesis*/
1237,1633,34,/*colorectal and extracolonic tumors*/
1238,0,28,/*X-linked and FSH dystrophies*/
1238,101,38,/*facioscapulohumeral muscular dystrophy*/
1238,170,27,/*Duchenne muscular dystrophy*/
1238,199,3,/*DMD*/
1239,79,6,/*cancer*/
1240,230,26,/*benign parathyroid tumours*/
1240,1128,15,/*various tumours*/
1240,1149,22,/*abnormalities in 11q13*/
1241,54,25,/*myotonic dystrophy type 1*/
1241,81,18,/*Muscular dystrophy*/
1241,112,19,/*multisystem disease*/
1242,0,51,/*Autosomal recessive GTP cyclohydrolase I deficiency*/
1242,60,21,/*hyperphenylalaninemia*/
1242,193,64,/*autosomal recessive (AR) GTP cyclohydrolase I (GTPCH) deficiency*/
1242,299,21,/*hyperphenylalaninemia*/
1242,351,22,/*progressive spasticity*/
1242,375,8,/*dystonia*/
1242,388,19,/*oculogyric episodes*/
1242,548,3,/*CSF*/
1242,1015,18,/*GTPCH I deficiency*/
1242,1054,21,/*hyperphenylalaninemia*/
1242,1145,16,/*GTPCH deficiency*/
1242,1201,33,/*unexplained neurological symptoms*/
1242,1239,32,/*extrapyramidal movement disorder*/
1243,44,18,/*Zellweger syndrome*/
1243,176,29,/*autosomal recessive disorders*/
1243,296,42,/*cerebro-hepato-renal syndrome of Zellweger*/
1243,391,18,/*Zellweger syndrome*/
1243,462,9,/*dystrophy*/
1243,473,15,/*axial hypotonia*/
1243,490,16,/*facial dysmorphy*/
1243,508,21,/*posterior embryotoxon*/
1243,535,12,/*hepatomegaly*/
1243,605,19,/*hyperbilirubinaemia*/
1243,626,33,/*hypoketotic dicarboxylic aciduria*/
1243,864,17,/*bile duct paucity*/
1243,883,11,/*cholestasis*/
1243,896,20,/*arterial hyperplasia*/
1243,1697,16,/*PEX14-deficiency*/
1243,1730,18,/*Zellweger syndrome*/
1243,1782,15,/*PEX14-deficient*/
1244,53,17,/*pancreatic cancer*/
1244,254,12,/*solid tumors*/
1244,285,17,/*pancreatic cancer*/
1244,429,5,/*tumor*/
1244,560,17,/*pancreatic tumors*/
1244,638,17,/*pancreatic tumors*/
1244,681,6,/*tumors*/
1244,802,17,/*pancreatic tumors*/
1244,878,17,/*pancreatic cancer*/
1244,920,7,/*cancers*/
1246,31,18,/*Huntington disease*/
1246,77,18,/*Huntington disease*/
1246,97,2,/*HD*/
1246,357,2,/*HD*/
1246,704,2,/*HD*/
1246,898,2,/*HD*/
1247,62,22,/*ankylosing spondylitis*/
1247,368,19,/*autoimmune diseases*/
1247,619,22,/*ankylosing spondylitis*/
1247,643,2,/*AS*/
1247,769,2,/*AS*/
1247,1216,2,/*AS*/
1247,1448,2,/*AS*/
1247,1548,2,/*AS*/
1247,1644,2,/*AS*/
1247,1723,2,/*AS*/
1247,1775,9,/*arthrosis*/
1247,1930,2,/*AS*/
1247,1995,2,/*AS*/
1248,45,16,/*Bartter syndrome*/
1248,67,22,/*sensorineural deafness*/
1248,103,16,/*Bartter syndrome*/
1248,121,2,/*BS*/
1248,130,16,/*genetic disorder*/
1248,162,32,/*hypokalaemic metabolic alkalosis*/
1248,196,2,/*BS*/
1248,204,22,/*sensorineural deafness*/
1248,408,10,/*type IV BS*/
1248,228,3,/*SND*/
1248,523,21,/*chronic renal failure*/
1248,608,2,/*BS*/
1248,616,3,/*SND*/
1248,801,3,/*SND*/
1248,974,2,/*BS*/
1248,992,3,/*SND*/
1248,1111,6,/*CLCNKB*/
1248,1244,6,/*CLCNKB*/
1248,1831,31,/*Mendelian inheritance disorders*/
1249,50,15,/*HPRT deficiency*/
1249,67,20,/*Lesch-Nyhan syndrome*/
1249,94,45,/*X-linked recessive inborn error of metabolism*/
1249,455,20,/*Lesch-Nyhan syndrome*/
1249,697,4,/*gout*/
1249,710,15,/*HPRT deficiency*/
1249,836,15,/*HPRT deficiency*/
1249,873,20,/*Lesch-Nyhan syndrome*/
1249,1023,20,/*Lesch-Nyhan syndrome*/
1250,66,17,/*Alzheimer disease*/
1250,85,17,/*Alzheimer disease*/
1250,104,2,/*AD*/
1250,203,2,/*AD*/
1250,477,3,/*A/T*/
1250,568,2,/*AD*/
1250,643,2,/*AD*/
1250,805,2,/*AD*/
1250,899,2,/*AD*/
1250,1091,2,/*AD*/
1250,1409,2,/*AD*/
1251,358,20,/*Denys-Drash syndrome*/
1251,381,3,/*DDS*/
1251,400,19,/*mesangial sclerosis*/
1251,422,3,/*DMS*/
1251,444,21,/*pseudohermaphroditism*/
1251,475,11,/*Wilms tumor*/
1251,489,2,/*WT*/
1251,514,3,/*DDS*/
1251,703,3,/*DMS*/
1251,709,4,/*IDMS*/
1251,726,3,/*DDS*/
1251,743,24,/*urogenital abnormalities*/
1251,777,2,/*WT*/
1251,861,4,/*IDMS*/
1251,982,4,/*IDMS*/
1251,1025,3,/*DDS*/
1251,1088,4,/*IDMS*/
1251,1460,3,/*DMS*/
1251,1492,3,/*DMS*/
1252,23,39,/*ataxia-telangiectasia protein-deficient*/
1252,105,21,/*ataxia-telangiectasia*/
1252,354,8,/*thymomas*/
1252,644,21,/*ataxia-telangiectasia*/
1253,59,22,/*ankylosing spondylitis*/
1253,221,22,/*ankylosing spondylitis*/
1253,245,2,/*AS*/
1253,571,2,/*AS*/
1253,654,2,/*AS*/
1253,790,22,/*ankylosing spondylitis*/
1253,859,2,/*AS*/
1253,1332,2,/*AS*/
1254,165,28,/*mucopolysaccharidosis type I*/
1254,214,23,/*Hurler/Scheie syndromes*/
1254,473,20,/*Huntington's disease*/
1254,495,2,/*HD*/
1254,1014,2,/*HD*/
1255,139,23,/*non-dystrophic myotonia*/
1255,412,27,/*presence of tongue myotonia*/
1255,500,12,/*Lid myotonia*/
1255,514,22,/*absence of hypertrophy*/
1255,753,13,/*grip myotonia*/
1255,768,19,/*percussion myotonia*/
1255,1170,24,/*non-dystrophic myotonias*/
1256,0,18,/*Huntington disease*/
1256,78,25,/*Huntington disease-like 2*/
1256,121,49,/*autosomal dominant disorder of the nervous system*/
1256,206,18,/*Huntington disease*/
1256,226,2,/*HD*/
1256,105,4,/*HDL2*/
1256,667,2,/*HD*/
1256,695,2,/*HD*/
1256,711,35,/*dentatorubralpallidoluysian atrophy*/
1256,751,25,/*spinocerebellar ataxia 17*/
1256,816,2,/*HD*/
1256,838,13,/*HDL disorders*/
1256,1463,7,/*HD-like*/
1257,67,15,/*Gaucher disease*/
1257,195,15,/*Gaucher disease*/
1257,559,11,/*CNS disease*/
1257,863,8,/*seizures*/
1257,929,26,/*neuronal degeneration loss*/
1257,1010,17,/*CNS abnormalities*/
1257,1098,21,/*neuronal degeneration*/
1257,1267,30,/*persistent neurological damage*/
1257,1334,17,/*CNS deterioration*/
1257,1353,24,/*histologic abnormalities*/
1257,1383,16,/*glucosylceramide*/
1258,24,28,/*mucopolysaccharidosis type I*/
1258,57,18,/*Huntington disease*/
1259,71,23,/*Langer-Giedion syndrome*/
1259,100,23,/*Langer-Giedion syndrome*/
1259,125,3,/*LGS*/
1259,157,24,/*craniofacial dysmorphism*/
1259,186,22,/*skeletal abnormalities*/
1259,225,14,/*genetic defect*/
1259,438,3,/*LGS*/
1260,45,63,/*autosomal recessive congenital hereditary endothelial dystrophy*/
1260,218,63,/*autosomal recessive congenital hereditary endothelial dystrophy*/
1260,283,4,/*CHED*/
1260,471,4,/*CHED*/
1260,1314,4,/*CHED*/
1261,35,18,/*myotonic dystrophy*/
1261,319,18,/*myotonic dystrophy*/
1262,0,33,/*Complement deficiency and disease*/
1262,35,21,/*Complement deficiency*/
1262,103,19,/*pyogenic infections*/
1262,127,22,/*immune complex disease*/
1262,350,34,/*hereditary complement deficiencies*/
1263,0,30,/*Complement factor H deficiency*/
1263,55,18,/*glomerulonephritis*/
1263,79,20,/*isolated C3 deposits*/
1263,153,15,/*uremic syndrome*/
1263,185,36,/*complement factor H (CFH) deficiency*/
1263,244,18,/*glomerulonephritis*/
1263,268,20,/*isolated C3 deposits*/
1263,361,15,/*uremic syndrome*/
1263,471,23,/*end-stage renal failure*/
1263,847,14,/*glomerulopathy*/
1263,994,18,/*glomerulonephritis*/
1263,1122,16,/*hemolytic anemia*/
1263,1224,26,/*thrombotic microangiopathy*/
1263,1489,32,/*wide spectrum of kidney diseases*/
1263,1527,18,/*glomerulonephritis*/
1263,1551,20,/*isolated C3 deposits*/
1263,1576,26,/*thrombotic microangiopathy*/
1263,1718,22,/*CFH haploinsufficiency*/
1264,49,15,/*Gaucher disease*/
1264,66,15,/*Gaucher disease*/
1264,379,15,/*Gaucher disease*/
1264,525,15,/*Gaucher disease*/
1264,836,17,/*Tay-Sachs disease*/
1264,1219,17,/*Tay-Sachs disease*/
1264,1321,15,/*Gaucher disease*/
1265,25,18,/*myotonic dystrophy*/
1265,45,2,/*DM*/
1265,49,18,/*myotonic dystrophy*/
1265,145,18,/*muscular dystrophy*/
1265,331,3,/*DM1*/
1265,336,2,/*DM*/
1265,480,2,/*DM*/
1265,1177,3,/*DM1*/
1265,1295,3,/*DM1*/
1266,55,21,/*breast/ovarian cancer*/
1266,127,23,/*breast / ovarian cancer*/
1266,250,13,/*breast cancer*/
1266,284,21,/*breast-ovarian cancer*/
1266,852,23,/*breast / ovarian cancer*/
1267,72,17,/*colorectal cancer*/
1267,98,3,/*APC*/
1267,274,17,/*colorectal cancer*/
1267,293,3,/*CRC*/
1267,445,3,/*CRC*/
1267,698,3,/*CRC*/
1267,986,3,/*HRT*/
1267,1835,25,/*colorectal carcinogenesis*/
1268,29,17,/*colorectal cancer*/
1268,115,17,/*Colorectal cancer*/
1268,169,24,/*cancer-related mortality*/
1268,421,42,/*Hereditary Non-Polyposis Colorectal Cancer*/
1268,465,5,/*HNPCC*/
1268,475,30,/*Familial Adenomatous Polyposis*/
1268,507,3,/*FAP*/
1268,545,17,/*colorectal cancer*/
1268,705,17,/*colorectal cancer*/
1268,972,17,/*colorectal cancer*/
1269,17,21,/*ataxia telangiectasia*/
1269,40,21,/*Ataxia telangiectasia*/
1269,63,2,/*AT*/
1269,77,47,/*neurodegenerative, autosomal recessive disorder*/
1269,142,22,/*chromosome instability*/
1269,166,16,/*radiosensitivity*/
1269,184,16,/*immunodeficiency*/
1269,226,6,/*cancer*/
1269,274,2,/*AT*/
1269,317,6,/*cancer*/
1269,340,13,/*breast cancer*/
1269,660,2,/*AT*/
1270,0,21,/*Ataxia-telangiectasia*/
1270,216,13,/*breast cancer*/
1270,311,21,/*ataxia-telangiectasia*/
1270,335,3,/*A-T*/
1270,1270,3,/*A-T*/
1271,0,15,/*Afibrinogenemia*/
1271,128,26,/*Congenital afibrinogenemia*/
1271,337,10,/*thrombosis*/
1271,375,17,/*dysfibrinogenemia*/
1271,418,25,/*thrombotic manifestations*/
1271,452,26,/*congenital afibrinogenemia*/
1271,1336,15,/*afibrinogenemia*/
1271,1432,10,/*thrombosis*/
1271,1453,15,/*atherosclerosis*/
1271,1482,17,/*Buerger's disease*/
1271,1538,15,/*afibrinogenemia*/
1271,1592,30,/*arterial and venous thrombosis*/
1272,185,27,/*inherited metabolic disease*/
1272,742,103,/*CPT II (carnitine palmitoyltransferase II) or VLCAD (very long-chain acyl-CoA dehydrogenase) deficiency*/
1273,128,3,/*DMD*/
1273,137,33,/*Becker (BMD) muscular dystrophies*/
1273,872,3,/*DMD*/
1273,906,3,/*BMD*/
1273,1179,3,/*DMD*/
1273,1187,3,/*BMD*/
1273,1276,3,/*DMD*/
1273,1283,3,/*BMD*/
1274,0,6,/*Cancer*/
1274,23,18,/*esophageal atresia*/
1274,92,18,/*Esophageal atresia*/
1274,112,2,/*EA*/
1274,131,23,/*gastroesophageal reflux*/
1274,179,21,/*intestinal metaplasia*/
1274,234,31,/*adenocarcinoma of the esophagus*/
1274,315,17,/*esophageal cancer*/
1274,363,2,/*EA*/
1274,422,17,/*esophageal cancer*/
1274,590,6,/*cancer*/
1274,700,6,/*cancer*/
1274,788,6,/*cancer*/
1274,829,6,/*cancer*/
1274,936,6,/*cancer*/
1274,1283,6,/*cancer*/
1274,1356,8,/*lymphoma*/
1274,1391,8,/*leukemia*/
1274,1447,17,/*esophageal cancer*/
1274,1527,17,/*esophageal cancer*/
1274,1747,17,/*esophageal cancer*/
1274,1818,2,/*EA*/
1275,0,29,/*Contiguous deletion syndromes*/
1275,274,29,/*contiguous deletion syndromes*/
1275,305,43,/*are an important component of the syndromes*/
1276,0,22,/*Ankylosing spondylitis*/
1276,247,22,/*ankylosing spondylitis*/
1276,271,2,/*AS*/
1276,473,2,/*AS*/
1276,543,2,/*AS*/
1276,624,2,/*AS*/
1276,739,2,/*AS*/
1276,857,2,/*AS*/
1276,975,2,/*AS*/
1276,1091,2,/*AS*/
1276,1138,2,/*AS*/
1276,1464,2,/*AS*/
1276,1494,2,/*AS*/
1276,1541,2,/*AS*/
1276,1749,2,/*AS*/
1277,25,21,/*ileoanal pouch polyps*/
1277,65,17,/*colorectal polyps*/
1277,96,21,/*Ileoanal pouch polyps*/
1277,190,30,/*familial adenomatous polyposis*/
1277,222,3,/*FAP*/
1277,231,12,/*FAP adenomas*/
1277,391,6,/*tumour*/
1277,623,14,/*colonic polyps*/
1277,726,21,/*ileoanal pouch polyps*/
1277,770,5,/*polyp*/
1277,854,14,/*pouch adenomas*/
1277,1132,12,/*pouch polyps*/
1277,1262,6,/*polyps*/
1277,1339,29,/*upper gastrointestinal polyps*/
1277,1387,19,/*colorectal adenomas*/
1277,1496,12,/*pouch polyps*/
1277,1545,18,/*large bowel polyps*/
1278,123,35,/*paroxysmal nocturnal hemoglobinuria*/
1278,172,35,/*Paroxysmal nocturnal hemoglobinuria*/
1278,209,3,/*PNH*/
1278,559,3,/*PNH*/
1278,620,21,/*genetic abnormalities*/
1278,805,3,/*PNH*/
1278,1136,3,/*PNH*/
1278,1712,3,/*PNH*/
1279,0,15,/*Episodic ataxia*/
1280,71,8,/*leukemia*/
1280,173,8,/*leukemia*/
1280,323,2,/*AL*/
1280,307,14,/*acute leukemia*/
1280,821,2,/*AL*/
1280,857,2,/*AL*/
1280,917,2,/*AL*/
1280,1120,2,/*AL*/
1280,1194,8,/*leukemia*/
1281,38,30,/*familial adenomatous polyposis*/
1281,90,5,/*tumor*/
1281,393,30,/*familial adenomatous polyposis*/
1282,71,21,/*Prader-Willi syndrome*/
1282,102,21,/*Prader-Willi syndrome*/
1282,125,3,/*PWS*/
1282,135,16,/*genomic disorder*/
1282,452,3,/*PWS*/
1282,612,3,/*PWS*/
1282,705,27,/*recurrence for the syndrome*/
1282,767,3,/*PWS*/
1282,1149,3,/*PWS*/
1282,1471,3,/*PWS*/
1282,1688,3,/*PWS*/
1283,26,19,/*colorectal adenomas*/
1283,303,19,/*colorectal adenomas*/
1283,342,30,/*familial adenomatous polyposis*/
1283,374,3,/*FAP*/
1283,452,18,/*ulcerative colitis*/
1283,480,9,/*dysplasia*/
1283,808,19,/*colorectal adenomas*/
1283,867,3,/*FAP*/
1284,187,13,/*iron overload*/
1284,225,23,/*primary hemochromatosis*/
1284,1200,8,/*fibrosis*/
1284,1213,38,/*cirrhosis, (2) porphyria cutanea tarda*/
1284,1261,24,/*hepatocellular carcinoma*/
1284,1499,13,/*iron overload*/
1285,16,23,/*cognitive abnormalities*/
1285,89,21,/*Prader-Willi syndrome*/
1285,204,22,/*psychiatric conditions*/
1285,235,13,/*schizophrenia*/
1285,253,6,/*autism*/
1285,357,21,/*Prader-Willi syndrome*/
1285,380,3,/*PWS*/
1285,388,27,/*neurodevelopmental disorder*/
1285,440,28,/*failure to thrive in infancy*/
1285,501,21,/*learning disabilities*/
1285,557,3,/*PWS*/
1285,637,30,/*neuropsychiatric abnormalities*/
1285,716,19,/*frontal dysfunction*/
1285,919,3,/*PWS*/
1285,1643,3,/*PWS*/
1285,1702,21,/*frontal abnormalities*/
1286,135,40,/*breast and ovarian cancer-specific tumor*/
1286,911,18,/*structural defects*/
1287,65,29,/*X-linked adrenoleukodystrophy*/
1287,96,29,/*X-linked adrenoleukodystrophy*/
1287,127,5,/*X-ALD*/
1287,216,20,/*adrenoleukodystrophy*/
1287,253,5,/*X-ALD*/
1287,467,5,/*X-ALD*/
1287,536,12,/*A deficiency*/
1287,911,5,/*X-ALD*/
1287,1149,5,/*X-ALD*/
1287,1313,5,/*X-ALD*/
1288,81,13,/*ameloblastoma*/
1288,99,21,/*odontogenic carcinoma*/
1288,316,7,/*cancers*/
1288,517,18,/*odontogenic tumors*/
1288,546,13,/*ameloblastoma*/
1288,564,21,/*odontogenic carcinoma*/
1288,587,2,/*OC*/
1288,707,14,/*ameloblastomas*/
1288,732,3,/*OCs*/
1288,848,13,/*ameloblastoma*/
1288,895,2,/*OC*/
1288,994,2,/*OC*/
1288,1030,13,/*ameloblastoma*/
1288,1077,2,/*OC*/
1288,1090,3,/*APC*/
1288,1278,29,/*epithelial odontogenic tumors*/
1289,17,15,/*genetic disease*/
1290,35,14,/*Sotos syndrome*/
1290,51,30,/*Haploinsufficiency of the NSD1*/
1290,145,14,/*Sotos syndrome*/
1290,161,3,/*SoS*/
1291,1,17,/*Colonic polyposis*/
1291,23,20,/*cancers of the colon*/
1291,128,21,/*colorectal carcinomas*/
1291,162,28,/*inherited familial syndromes*/
1291,342,7,/*cancers*/
1291,589,30,/*familial adenomatous polyposis*/
1291,677,21,/*colorectal neoplasias*/
1291,756,22,/*colonic carcinogenesis*/
1292,0,20,/*Multilayered patella*/
1292,55,20,/*pseudoachondroplasia*/
1292,80,39,/*recessive multiple epiphyseal dysplasia*/
1292,188,39,/*recessive multiple epiphyseal dysplasia*/
1292,229,4,/*rMED*/
1292,314,3,/*MED*/
1292,414,20,/*pseudoachondroplasia*/
1292,549,4,/*rMED*/
1292,697,19,/*skeletal dysplasias*/
1292,726,20,/*pseudoachondroplasia*/
1292,830,20,/*pseudoachondroplasia*/
1292,956,31,/*abnormal patellar ossifications*/
1292,1068,58,/*pseudoachondroplasia-MED bone dysplasia group of disorders*/
1293,24,22,/*von Willebrand disease*/
1293,59,10,/*hemostasis*/
1293,74,10,/*thrombosis*/
1293,86,40,/*von Willebrand factor ( vWf ) deficiency*/
1293,141,22,/*von Willebrand disease*/
1293,518,10,/*hemostasis*/
1293,571,20,/*spontaneous bleeding*/
1293,774,20,/*Defective thrombosis*/
1295,97,13,/*Fabry disease*/
1295,214,13,/*Fabry disease*/
1295,233,53,/*X-linked inborn error of glycosphingolipid metabolism*/
1295,638,5,/*Fabry*/
1295,1393,15,/*intronic lesion*/
1295,1634,13,/*Fabry disease*/
1295,1856,13,/*Fabry disease*/
1296,0,25,/*Myotonic dystrophy type 1*/
1296,42,17,/*myasthenia gravis*/
1296,64,7,/*thymoma*/
1296,73,25,/*Myotonic dystrophy type 1*/
1296,100,3,/*DM1*/
1296,111,41,/*autosomal-dominant multisystemic disorder*/
1296,188,30,/*benign and malignant neoplasms*/
1296,234,7,/*thymoma*/
1296,246,17,/*myasthenia gravis*/
1296,284,3,/*DM1*/
1296,417,3,/*DM1*/
1296,450,6,/*ptosis*/
1296,523,7,/*thymoma*/
1296,576,17,/*ocular myasthenia*/
1296,641,3,/*DM1*/
1296,712,19,/*myotonic discharges*/
1296,786,3,/*DM1*/
1296,914,3,/*DM1*/
1296,979,5,/*tumor*/
1296,1084,7,/*thymoma*/
1296,1096,17,/*myasthenia gravis*/
1297,130,18,/*GM1-gangliosidosis*/
1297,209,18,/*GM1-gangliosidosis*/
1297,473,4,/*AIMS*/
1297,611,18,/*GM1-gangliosidosis*/
1297,1755,18,/*GM1-gangliosidosis*/
1298,0,13,/*Analbuminemia*/
1298,95,13,/*Analbuminemia*/
1298,119,28,/*autosomal recessive disorder*/
1298,259,24,/*hereditary analbuminemia*/
1298,1148,13,/*analbuminemia*/
1298,1412,13,/*analbuminemia*/
1299,79,20,/*renal cell carcinoma*/
1299,229,20,/*renal cell carcinoma*/
1299,453,20,/*renal cell carcinoma*/
1299,810,20,/*renal cell carcinoma*/
1299,926,5,/*tumor*/
1299,994,20,/*renal cell carcinoma*/
1299,1221,3,/*RCC*/
1300,128,18,/*Fragile X syndrome*/
1300,148,3,/*FXS*/
1300,175,28,/*inherited mental retardation*/
1300,361,3,/*FXS*/
1300,561,3,/*FXS*/
1301,60,18,/*Huntington disease*/
1301,148,18,/*Huntington disease*/
1301,168,2,/*HD*/
1301,243,18,/*poor mental health*/
1301,322,2,/*HD*/
1301,435,2,/*HD*/
1301,459,13,/*mental health*/
1301,565,2,/*HD*/
1301,851,2,/*HD*/
1301,939,2,/*HD*/
1301,1380,2,/*HD*/
1302,135,27,/*Duchenne muscular dystrophy*/
1302,164,3,/*DMD*/
};
}
static void init9() {
a9 = new int[] {
1302,196,16,/*genetic disorder*/
1302,384,14,/*muscle wasting*/
1302,431,15,/*cardiac failure*/
1302,492,3,/*DMD*/
1302,641,3,/*DMD*/
1302,1457,18,/*muscular dystrophy*/
1302,1567,3,/*DMD*/
1304,4,39,/*autoimmune lymphoproliferative syndrome*/
1304,105,39,/*autoimmune lymphoproliferative syndrome*/
1304,146,4,/*ALPS*/
1304,250,23,/*multilineage cytopenias*/
1304,300,8,/*lymphoma*/
1304,386,4,/*ALPS*/
1304,716,4,/*ALPS*/
1304,739,19,/*autoimmune diseases*/
1304,995,4,/*ALPS*/
1304,1067,29,/*sporadic autoimmune disorders*/
1305,134,19,/*recessive disorders*/
1305,349,21,/*ataxia telangiectasia*/
1305,372,2,/*AT*/
1305,435,21,/*ataxia telangiectasia*/
1305,549,2,/*AT*/
1305,605,2,/*AT*/
1305,722,2,/*AT*/
1305,746,2,/*AT*/
1305,777,18,/*recessive disorder*/
1305,838,2,/*AT*/
1305,1135,2,/*AT*/
1305,1341,13,/*breast cancer*/
1305,1407,15,/*atherosclerosis*/
1305,1502,13,/*breast cancer*/
1305,1520,13,/*heart disease*/
1305,1537,2,/*AT*/
1306,54,26,/*Papillon-Lef  vre syndrome*/
1306,124,26,/*Papilion-Lef  vre syndrome*/
1306,152,3,/*PLS*/
1306,167,28,/*autosomal recessive disorder*/
1306,210,22,/*palmoplantar keratosis*/
1306,234,2,/*PK*/
1306,327,3,/*PLS*/
1306,551,24,/*aggressive periodontitis*/
1306,607,46,/*hyperkeratosis of the palms of hands and soles*/
1306,860,3,/*PLS*/
1306,916,13,/*periodontitis*/
1306,1104,26,/*Papillon-Lef  vre syndrome*/
1307,25,28,/*fragile X mental retardation*/
1307,63,18,/*Fragile X syndrome*/
1307,115,28,/*inherited mental retardation*/
1307,181,28,/*fragile X mental retardation*/
1307,584,18,/*mental retardation*/
1307,700,22,/*neurological disorders*/
1307,822,18,/*fragile X syndrome*/
1307,916,18,/*mental retardation*/
1308,94,20,/*non-Hodgkin lymphoma*/
1308,119,20,/*basal cell carcinoma*/
1308,141,25,/*Cartilage-hair hypoplasia*/
1308,168,3,/*CHH*/
1308,179,36,/*autosomal recessive chondrodysplasia*/
1308,221,13,/*short stature*/
1308,512,6,/*cancer*/
1308,522,3,/*CHH*/
1308,565,3,/*CHH*/
1308,670,7,/*cancers*/
1308,716,6,/*cancer*/
1308,948,6,/*cancer*/
1308,977,3,/*CHH*/
1308,1129,62,/*squamous cell carcinoma (3), leukemia (1) and Hodgkin lymphoma*/
1308,1201,5,/*tumor*/
1308,1257,7,/*cancers*/
1308,1439,3,/*CHH*/
1308,1516,20,/*basal cell carcinoma*/
1309,44,15,/*genetic disease*/
1309,134,6,/*cancer*/
1309,145,17,/*inherited disease*/
1310,39,14,/*von Willebrand*/
1310,122,24,/*von Willebrand's disease*/
1310,234,14,/*von Willebrand*/
1310,718,24,/*von Willebrand's disease*/
1310,744,3,/*vWD*/
1310,1322,12,/*type III vWD*/
1311,82,39,/*autosomal dominant retinitis pigmentosa*/
1311,163,20,/*retinitis pigmentosa*/
1311,185,2,/*RP*/
1311,498,2,/*RP*/
1311,1302,26,/*Leber congenital amaurosis*/
1311,1531,20,/*retinal degeneration*/
1312,21,22,/*von Willebrand disease*/
1312,78,31,/*mucocutaneous bleeding disorder*/
1312,111,22,/*von Willebrand disease*/
1312,135,3,/*VWD*/
1312,457,3,/*VWD*/
1312,643,3,/*VWD*/
1312,695,3,/*VWD*/
1312,756,23,/*intracellular retention*/
1312,1181,3,/*VWD*/
1312,1233,3,/*VWD*/
1313,53,32,/*adenomatous polyposis coli tumor*/
1313,140,38,/*adenomatous polyposis coli (APC) tumor*/
1313,412,5,/*tumor*/
1313,1198,3,/*APC*/
1313,1206,4,/*DDEF*/
1314,51,26,/*pancreatic adenocarcinomas*/
1314,96,13,/*breast cancer*/
1314,162,26,/*familial pancreatic cancer*/
1314,405,14,/*breast cancers*/
1314,705,17,/*pancreatic cancer*/
1314,931,26,/*sporadic pancreatic cancer*/
1314,1031,7,/*cancers*/
1315,61,16,/*rhabdomyosarcoma*/
1315,138,6,/*tumors*/
1315,201,19,/*insulin-like growth*/
1315,278,16,/*rhabdomyosarcoma*/
1315,296,3,/*RMS*/
1315,422,3,/*RMS*/
1315,625,13,/*embryonal RMS*/
1315,640,4,/*ERMS*/
1315,661,3,/*RMS*/
1315,666,4,/*ARMS*/
1315,687,6,/*tumors*/
1315,854,4,/*ERMS*/
1315,863,4,/*ARMS*/
1315,944,4,/*ARMS*/
1315,1021,6,/*tumors*/
1315,1112,6,/*tumors*/
1315,1132,3,/*RMS*/
1315,1284,4,/*ERMS*/
1315,1443,4,/*ERMS*/
1315,1628,6,/*tumors*/
1315,1687,3,/*RMS*/
1316,140,7,/*obesity*/
1316,152,32,/*nonalcoholic fatty liver disease*/
1316,328,7,/*obesity*/
1316,337,18,/*insulin resistance*/
1316,361,32,/*nonalcoholic fatty liver disease*/
1316,819,18,/*insulin resistance*/
1316,839,17,/*hepatic steatosis*/
1316,862,35,/*focal pericellular hepatic fibrosis*/
1316,1221,2,/*HF*/
1316,1460,3,/*FAS*/
1316,1514,2,/*HF*/
1316,1600,2,/*HF*/
1316,1717,7,/*obesity*/
1316,1729,15,/*steatohepatitis*/
1316,1822,2,/*HF*/
1316,1975,2,/*HF*/
1316,2062,40,/*obesity/nonalcoholic fatty liver disease*/
1317,31,19,/*Lesch-Nyhan disease*/
1319,643,3,/*MHC*/
1319,687,3,/*MHC*/
1319,851,3,/*MHC*/
1319,2241,5,/*NS/NS*/
1320,153,26,/*breast and ovarian cancers*/
1321,0,18,/*Myotonic disorders*/
1321,161,8,/*myotonia*/
1321,171,18,/*Myotonic disorders*/
1321,202,20,/*myotonic dystrophies*/
1321,227,23,/*nondystrophic myotonias*/
1321,375,23,/*nondystrophic myotonias*/
1321,423,20,/*myotonic dystrophies*/
1321,565,8,/*myotonia*/
1321,581,20,/*myotonic dystrophies*/
1321,603,25,/*Myotonic dystrophy Type 1*/
1321,749,25,/*Myotonic dystrophy Type 2*/
1321,968,20,/*myotonic dystrophies*/
1321,1290,20,/*myotonic dystrophies*/
1321,1463,20,/*myotonic dystrophies*/
1321,1517,18,/*myotonic disorders*/
1322,51,47,/*pediatric undifferentiated soft tissue sarcomas*/
1322,100,24,/*Malignant rhabdoid tumor*/
1322,220,24,/*malignant rhabdoid tumor*/
1322,415,24,/*malignant rhabdoid tumor*/
1322,544,8,/*sarcomas*/
1322,801,5,/*tumor*/
1322,870,6,/*tumors*/
1322,952,6,/*tumors*/
1322,1226,6,/*tumors*/
1322,1240,21,/*genetic abnormalities*/
1322,1526,11,/*neck tumors*/
1322,1543,16,/*extremity tumors*/
1322,1569,16,/*paraspinal tumor*/
1322,1851,8,/*sarcomas*/
1322,1983,8,/*sarcomas*/
1322,2043,32,/*classic malignant rhabdoid tumor*/
1323,112,14,/*Wilson disease*/
1323,132,16,/*genetic disorder*/
1323,244,14,/*Wilson disease*/
1323,471,22,/*lipid storage disorder*/
1323,668,3,/*NPC*/
1323,846,3,/*NPC*/
1324,59,22,/*von Willebrand disease*/
1324,181,18,/*hemostatic process*/
1324,493,31,/*type III von Willebrand disease*/
1324,526,3,/*vWD*/
1324,646,20,/*factor VIII activity*/
1324,1647,3,/*vWD*/
1325,40,16,/*Wilson's disease*/
1325,58,16,/*Wilson's disease*/
1325,427,25,/*psychiatric abnormalities*/
1325,735,16,/*Wilson's disease*/
1325,1071,16,/*Wilson's disease*/
1326,33,14,/*ovarian cancer*/
1326,136,14,/*ovarian cancer*/
1326,520,44,/*basic and specific laboratory investigations*/
1326,640,6,/*cancer*/
1326,939,14,/*Abdominal pain*/
1326,1013,20,/*abdominal distension*/
1326,1099,23,/*postmenopausal bleeding*/
1326,1171,20,/*stage III-IV disease*/
1326,1207,38,/*papillary serous cystic adenocarcinoma*/
1326,1344,12,/*dysgerminoma*/
1326,1367,27,/*adult granulose cell tumour*/
1326,1437,26,/*ovarian carcinoma symptoms*/
1327,103,9,/*Morquio A*/
1327,137,25,/*Mucopolysaccharidosis IVA*/
1327,164,9,/*Morquio A*/
1327,190,57,/*deficiency of N-acetylgalactosamine-6-sulphate-sulphatase*/
1327,352,12,/*A deficiency*/
1327,786,7,/*MPS IVA*/
1327,902,17,/*enzyme deficiency*/
1327,923,25,/*mucopolysaccharidosis IVA*/
1328,0,31,/*Spinocerebellar ataxias types 1*/
1328,332,23,/*spinocerebellar ataxias*/
1328,415,6,/*ataxia*/
1328,611,4,/*SCA2*/
1328,684,4,/*SCA3*/
1328,839,3,/*SCA*/
1328,1088,4,/*SCA2*/
1328,1110,4,/*SCA3*/
1328,1142,4,/*SCAs*/
1328,1664,4,/*SCA2*/
1329,668,25,/*brainstem-related tumours*/
1329,698,16,/*vascular lesions*/
1329,1184,17,/*permanent paresis*/
1329,1369,23,/*Permanent motor deficit*/
1329,1442,3,/*MEP*/
1330,44,15,/*phenylketonuria*/
1331,70,18,/*myotonic dystrophy*/
1331,100,18,/*myotonic dystrophy*/
1331,696,27,/*Duchenne muscular dystrophy*/
1331,1030,18,/*myotonic dystrophy*/
1331,1118,25,/*myotonic dystrophy type 1*/
1331,1565,18,/*myotonic dystrophy*/
1332,206,18,/*inherited disorder*/
1332,350,14,/*Wilson disease*/
1332,367,2,/*WD*/
1332,674,19,/*Bedlington terriers*/
1332,739,25,/*progressive liver disease*/
1332,791,2,/*WD*/
1332,1169,2,/*WD*/
1333,118,6,/*myopia*/
1333,651,19,/*refractive disorder*/
1333,1933,10,/*eye growth*/
1335,0,18,/*Myotonic dystrophy*/
1335,114,18,/*Myotonic dystrophy*/
1335,135,2,/*DM*/
1335,161,17,/*muscular disorder*/
1336,57,18,/*myotonic dystrophy*/
1336,144,18,/*myotonic dystrophy*/
1336,165,2,/*DM*/
1336,311,2,/*DM*/
1336,376,2,/*DM*/
1336,531,2,/*DM*/
1336,729,2,/*DM*/
1336,931,2,/*DM*/
1336,1274,2,/*DM*/
1336,1281,18,/*Friedreichs ataxia*/
1337,107,22,/*craniofacial disorders*/
1337,183,22,/*Class III malocclusion*/
1337,228,20,/*craniofacial problem*/
1337,1023,22,/*mandibular prognathism*/
1337,1125,22,/*mandibular prognathism*/
1337,1152,20,/*maxillary deficiency*/
1338,82,36,/*hereditary deficiencies of protein S*/
1338,147,36,/*Hereditary deficiencies of protein S*/
1338,252,15,/*thromboembolism*/
1338,350,21,/*thrombophilic defects*/
1338,572,23,/*antithrombin deficiency*/
1338,651,15,/*thromboembolism*/
1338,776,2,/*XI*/
1338,784,20,/*hyperhomocysteinemia*/
1338,1004,20,/*protein S deficiency*/
1338,1053,12,/*C deficiency*/
1338,1088,23,/*antithrombin deficiency*/
1338,1485,13,/*non-deficient*/
1338,1686,23,/*antithrombin deficiency*/
1338,1846,21,/*thrombophilic defects*/
1339,68,33,/*Emery-Dreifuss muscular dystrophy*/
1339,173,33,/*Emery-Dreifuss muscular dystrophy*/
1339,209,4,/*EDMD*/
1339,1164,15,/*cardiac defects*/
1339,1183,4,/*EDMD*/
1339,1478,4,/*EDMD*/
1339,1712,4,/*EDMD*/
1339,1769,22,/*skeletal muscle nuclei*/
1340,117,21,/*Prader-Willi syndrome*/
1340,140,21,/*Prader-Willi syndrome*/
1340,163,3,/*PWS*/
1340,173,24,/*neurobehavioral disorder*/
1340,288,7,/*obesity*/
1340,431,3,/*PWS*/
1340,839,3,/*PWS*/
1340,1221,3,/*PWS*/
1340,1574,3,/*PWS*/
1340,1608,47,/*infantile hypotonia, early-onset morbid obesity*/
1340,1661,12,/*hypogonadism*/
1340,1810,3,/*PWS*/
1341,153,52,/*X-linked disorder of phosphatidylinositol metabolism*/
1341,223,20,/*congenital cataracts*/
1341,245,52,/*renal proximal tubulopathy and neurological deficits*/
1341,583,13,/*Lowe syndrome*/
1341,645,13,/*Lowe syndrome*/
1341,804,16,/*ocrl1 deficiency*/
1342,116,28,/*chronic respiratory symptoms*/
1342,263,28,/*chronic respiratory symptoms*/
1342,316,25,/*chronic cough and dyspnea*/
1342,857,2,/*SZ*/
1342,1601,9,/*emphysema*/
1342,1749,2,/*MS*/
1343,10,9,/*nystagmus*/
1343,24,17,/*late onset ataxia*/
1343,242,29,/*spinocerebellar ataxia type 6*/
1343,280,29,/*familial haemiplegic migraine*/
1343,311,3,/*FHM*/
1343,320,22,/*episodic ataxia type 2*/
1343,273,4,/*SCA6*/
1343,344,3,/*EA2*/
1343,479,9,/*nystagmus*/
1343,646,29,/*isolated congenital nystagmus*/
1343,834,12,/*nystagmology*/
1343,1156,9,/*nystagmus*/
1343,1181,17,/*late onset ataxia*/
1343,1498,18,/*isolated nystagmus*/
1343,1623,29,/*isolated congenital nystagmus*/
1344,74,18,/*glomerulonephritis*/
1344,94,40,/*Membranoproliferative glomerulonephritis*/
1344,147,33,/*chronic progressive renal disease*/
1344,136,4,/*MPGN*/
1344,308,34,/*composition of glomerular deposits*/
1344,406,3,/*DDD*/
1344,620,2,/*AP*/
1344,588,30,/*alternative complement pathway*/
1344,383,21,/*dense deposit disease*/
1344,768,2,/*AP*/
1344,835,18,/*glomerulonephritis*/
1344,938,15,/*nephrotic range*/
1344,997,24,/*end-stage kidney disease*/
1345,25,16,/*VLCAD deficiency*/
1345,92,57,/*Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency*/
1345,156,46,/*autosomal recessive inborn error of metabolism*/
1345,392,16,/*VLCAD deficiency*/
1345,551,16,/*VLCAD deficiency*/
1345,604,24,/*hypoketotic hypoglycemia*/
1345,836,14,/*rhabdomyolysis*/
1345,855,13,/*myoglobinuria*/
1345,901,15,/*chronic myalgia*/
1345,918,15,/*muscle weakness*/
1346,252,29,/*familial hypercholesterolemia*/
1346,283,2,/*FH*/
1346,536,18,/*Epstein-Barr virus*/
1346,556,3,/*EBV*/
1348,27,25,/*mucopolysaccharidosis IVA*/
1348,173,25,/*Mucopolysaccharidosis IVA*/
1348,201,7,/*MPS IVA*/
1348,217,46,/*autosomal recessive lysosomal storage disorder*/
1348,481,7,/*MPS IVA*/
1348,599,7,/*MPS IVA*/
1348,1925,7,/*MPS IVA*/
1349,27,20,/*rheumatoid arthritis*/
1349,69,28,/*Familiar Mediterranean Fever*/
1349,99,3,/*FMF*/
1349,282,20,/*rheumatoid arthritis*/
1349,436,3,/*FMF*/
1349,481,2,/*RA*/
1349,578,2,/*RA*/
1349,769,2,/*RA*/
1349,835,2,/*RA*/
1349,892,2,/*RA*/
1349,921,11,/*amyloidosis*/
1349,1026,2,/*RA*/
1349,1179,11,/*amyloidosis*/
1350,44,28,/*Southeast Asian ovalocytosis*/
1350,74,28,/*Southeast Asian ovalocytosis*/
1350,104,3,/*SAO*/
1350,115,23,/*erythrocyte abnormality*/
1350,179,16,/*cerebral malaria*/
1350,369,3,/*SAO*/
1350,466,3,/*SAO*/
1350,906,3,/*SAO*/
1350,1046,3,/*SAO*/
1351,102,28,/*Pelizaeus-Merzbacher disease*/
1351,285,28,/*Pelizaeus-Merzbacher disease*/
1351,316,3,/*PMD*/
1351,474,27,/*X-linked spastic paraplegia*/
1351,504,3,/*SPG*/
1351,578,3,/*PMD*/
1351,660,9,/*nystagmus*/
1351,706,18,/*mental retardation*/
1351,772,21,/*personality disorders*/
1352,79,26,/*impaired glucose tolerance*/
1352,109,5,/*obese*/
1352,148,26,/*impaired glucose tolerance*/
1352,185,15,/*Type 2 diabetes*/
1352,176,3,/*IGT*/
1352,425,28,/*impaired glucose homeostasis*/
1352,567,26,/*IGT and metabolic syndrome*/
1352,1052,18,/*Metabolic syndrome*/
1352,1185,18,/*Metabolic syndrome*/
1352,1390,18,/*metabolic syndrome*/
1352,1660,8,/*diabetes*/
1353,0,28,/*Familial Mediterranean fever*/
1353,105,28,/*Familial Mediterranean fever*/
1353,140,28,/*autosomal recessive disorder*/
1353,207,14,/*abdominal pain*/
1353,223,9,/*synovitis*/
1353,237,9,/*pleuritis*/
1353,926,3,/*FMF*/
1354,227,27,/*multiple sporadic melanomas*/
1354,1611,8,/*melanoma*/
1355,73,14,/*retinoblastoma*/
1355,208,14,/*retinoblastoma*/
1356,48,15,/*Gaucher disease*/
1356,82,6,/*cancer*/
1356,186,22,/*Type 1 Gaucher Disease*/
1356,210,2,/*GD*/
1356,439,2,/*GD*/
1356,477,21,/*cross-sectional study*/
1356,539,6,/*cancer*/
1356,628,6,/*cancer*/
1356,893,16,/*skeletal disease*/
1356,1094,7,/*myeloma*/
1356,1215,24,/*hematologic malignancies*/
1356,1281,6,/*cancer*/
1356,1411,31,/*relative sparing of the viscera*/
1356,1470,16,/*multiple myeloma*/
1356,1519,7,/*cancers*/
1356,1546,10,/*gammopathy*/
1356,1636,2,/*GD*/
1356,1660,2,/*GD*/
1356,1708,7,/*cancers*/
1356,1726,16,/*multiple myeloma*/
1357,143,25,/*breast and ovarian cancer*/
1357,608,25,/*breast and ovarian cancer*/
1358,0,11,/*Wilms tumor*/
1358,36,39,/*X-linked nephrogenic diabetes insipidus*/
1358,103,39,/*X-linked nephrogenic diabetes insipidus*/
1358,144,3,/*NDI*/
1358,163,11,/*Wilms tumor*/
1358,176,2,/*WT*/
1358,181,30,/*Nephrogenic diabetes insipidus*/
1358,310,11,/*Wilms tumor*/
1358,470,17,/*failure to thrive*/
1358,489,8,/*polyuria*/
1358,499,13,/*hypernatremia*/
1358,517,14,/*abdominal mass*/
1358,690,5,/*tumor*/
1358,984,5,/*tumor*/
1358,1188,2,/*WT*/
1358,1340,11,/*Wilms tumor*/
1359,64,27,/*Duchenne muscular dystrophy*/
1359,270,37,/*Duchenne or Becker muscular dystrophy*/
1361,119,18,/*Huntington disease*/
1361,174,18,/*Huntington disease*/
1361,195,2,/*HD*/
1361,242,2,/*HD*/
1361,325,2,/*HD*/
1361,396,2,/*HD*/
1361,653,2,/*HD*/
1361,896,2,/*HD*/
1361,954,2,/*HD*/
1361,1179,2,/*HD*/
1362,34,14,/*ovarian cancer*/
1362,132,25,/*epithelial ovarian cancer*/
1362,341,14,/*ovarian cancer*/
1362,404,36,/*fallopian tube and peritoneal cancer*/
1362,462,7,/*cancers*/
1362,642,28,/*breast and/or ovarian cancer*/
1362,714,14,/*ovarian cancer*/
1362,1010,14,/*ovarian cancer*/
1362,1169,13,/*breast cancer*/
1362,1320,15,/*ovarian cancers*/
1362,1726,37,/*Ovarian Cancer Association Consortium*/
1362,1765,4,/*OCAC*/
1363,0,21,/*Ataxia-telangiectasia*/
1363,100,28,/*autosomal recessive disorder*/
1363,129,21,/*ataxia-telangiectasia*/
1363,153,3,/*A-T*/
1363,178,23,/*cerebellar degeneration*/
1363,204,16,/*immunodeficiency*/
1363,225,6,/*cancer*/
1363,249,3,/*A-T*/
1363,326,3,/*A-T*/
1363,576,3,/*A-T*/
1363,1116,3,/*A-T*/
1364,32,20,/*retinal degeneration*/
1364,383,20,/*retinitis pigmentosa*/
1364,405,2,/*RP*/
1364,476,20,/*retinal degeneration*/
1364,1166,20,/*retinal degeneration*/
1364,1275,3,/*ONL*/
1364,1254,19,/*outer nuclear layer*/
1364,1359,20,/*retinal degeneration*/
1364,1463,20,/*retinal degeneration*/
1365,61,21,/*Prader-Willi syndrome*/
1365,84,21,/*Prader-Willi syndrome*/
1365,107,3,/*PWS*/
1365,135,20,/*multisystem disorder*/
1365,193,18,/*neonatal hypotonia*/
1365,216,37,/*failure to thrive, mental retardation*/
1365,255,12,/*hypogonadism*/
1365,269,20,/*short hands and feet*/
1365,310,7,/*obesity*/
1365,371,3,/*PWS*/
1365,514,3,/*PWS*/
1365,547,3,/*PWS*/
1365,975,3,/*PWS*/
1365,1200,3,/*PWS*/
1365,1256,3,/*PWS*/
1366,73,14,/*ovarian cancer*/
1366,189,14,/*ovarian cancer*/
1366,313,28,/*Seattle-based Ovarian Cancer*/
1366,377,5,/*OCEDS*/
1366,430,14,/*ovarian cancer*/
1366,474,6,/*cancer*/
1366,594,27,/*abdominal pain, pelvic pain*/
1366,672,18,/*abdominal bloating*/
1366,1337,27,/*abdominal pain, pelvic pain*/
1367,71,13,/*Choroideremia*/
1367,86,3,/*CHM*/
1367,96,26,/*chorioretinal degeneration*/
1367,275,18,/*eventual blindness*/
1367,299,3,/*CHM*/
1367,459,3,/*CHM*/
1367,667,3,/*CHM*/
1367,1413,3,/*CHM*/
1368,12,15,/*hyperglycinemia*/
1368,101,15,/*hyperglycinemia*/
1368,318,15,/*hyperglycinemia*/
1368,1134,15,/*hyperglycinemia*/
1369,35,30,/*familial adenomatous polyposis*/
1369,121,30,/*Familial adenomatous polyposis*/
1369,153,3,/*FAP*/
1369,164,38,/*autosomal dominantly inherited disease*/
1369,290,19,/*colorectal adenomas*/
1369,354,15,/*adenocarcinomas*/
1369,756,3,/*FAP*/
1369,1574,3,/*FAP*/
1370,104,3,/*HIV*/
1370,346,3,/*HIV*/
1370,959,2,/*AD*/
1370,970,2,/*AC*/
1370,1252,2,/*AD*/
1371,91,25,/*Myotonic dystrophy type 1*/
1371,118,3,/*DM1*/
1371,128,16,/*genetic disorder*/
1372,116,19,/*Lesch-Nyhan disease*/
1372,137,19,/*Lesch-Nyhan disease*/
1372,158,3,/*LND*/
1372,166,16,/*genetic disorder*/
1372,209,23,/*psychiatric disturbance*/
1372,237,24,/*self-injurious behaviour*/
1372,292,67,/*deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT)*/
1372,263,3,/*SIB*/
1372,391,39,/*deficiency and neurological involvement*/
1372,479,25,/*basal ganglia dysfunction*/
1372,533,33,/*excess serotonin striatal content*/
1372,694,3,/*LND*/
1373,0,18,/*Myotonia congenita*/
1373,103,30,/*recessive generalized myotonia*/
1373,182,16,/*diffuse myotonia*/
1373,232,8,/*weakness*/
1373,593,8,/*myotonia*/
1374,36,5,/*tumor*/
1374,99,12,/*glioblastoma*/
1374,128,7,/*cancers*/
1374,471,5,/*tumor*/
1374,638,12,/*glioblastoma*/
1374,671,36,/*deadly primary neoplasm of the brain*/
1374,763,15,/*intragenic loss*/
1374,1013,6,/*tumors*/
1374,1076,38,/*head and neck squamous cell carcinomas*/
1374,1129,12,/*lung cancers*/
1374,1224,10,/*GBM tumors*/
1374,1290,6,/*glioma*/
1374,1360,5,/*tumor*/
1374,1604,5,/*tumor*/
1374,1701,7,/*cancers*/
1375,0,26,/*Papillon-Lef  vre syndrome*/
1375,31,18,/*malignant melanoma*/
1376,53,56,/*autosomal recessive von Willebrand disease type Normandy*/
1376,122,12,/*hemophilia A*/
1376,279,22,/*von Willebrand disease*/
1376,303,3,/*VWD*/
1376,328,10,/*hemophilia*/
1376,721,10,/*hemophilia*/
1376,845,12,/*desmopressin*/
1377,20,8,/*melanoma*/
1377,64,17,/*Familial melanoma*/
1377,177,8,/*melanoma*/
1377,187,19,/*Hereditary melanoma*/
1377,263,8,/*melanoma*/
1377,366,8,/*melanoma*/
1377,569,18,/*cutaneous melanoma*/
1377,1078,19,/*hereditary melanoma*/
1377,1418,17,/*familial melanoma*/
1378,24,13,/*breast cancer*/
1378,158,13,/*breast cancer*/
1378,278,13,/*breast cancer*/
1378,385,32,/*Ovarian, endometrial and cancers*/
1378,438,13,/*SBLA syndrome*/
1378,464,21,/*benign breast disease*/
1378,521,22,/*familial breast cancer*/
1378,634,13,/*breast cancer*/
1379,0,25,/*Papillon-Lefevre syndrome*/
1379,73,25,/*Papillon-Lefevre syndrome*/
1379,100,3,/*PLS*/
1379,167,28,/*autosomal recessive disorder*/
1379,236,14,/*hyperkeratosis*/
1379,279,25,/*devastating periodontitis*/
1380,75,14,/*Wilson disease*/
1380,91,14,/*Wilson disease*/
1380,107,3,/*WND*/
1380,118,29,/*autosomal recessive condition*/
1380,353,36,/*liver, neurological and renal damage*/
1380,393,3,/*WND*/
1381,59,32,/*hereditary gingival fibromatosis*/
1381,203,63,/*autosomal dominant early-onset hereditary gingival fibromatosis*/
1382,308,18,/*colorectal tumours*/
1382,407,6,/*tumour*/
1382,817,3,/*UPS*/
1382,1300,3,/*APC*/
1382,1433,3,/*APC*/
1382,1983,6,/*cancer*/
1382,2022,6,/*tumour*/
1382,2046,10,/*metastasis*/
1383,16,21,/*renal cell carcinomas*/
1383,54,25,/*von Hippel-Lindau disease*/
1383,161,21,/*renal cell carcinomas*/
1383,184,3,/*RCC*/
1383,213,25,/*von Hippel-Lindau disease*/
1383,240,3,/*VHL*/
1383,312,3,/*VHL*/
1383,380,6,/*tumors*/
1383,572,6,/*tumors*/
1383,604,6,/*tumors*/
1383,777,3,/*VHL*/
1385,123,17,/*gastric carcinoma*/
1385,158,19,/*murine fibrosarcoma*/
1385,289,32,/*metastatic spread to lymph nodes*/
1385,443,17,/*gastric carcinoma*/
1385,518,17,/*gastric carcinoma*/
1385,574,4,/*KKLS*/
1385,612,17,/*gastric carcinoma*/
1385,731,17,/*gastric carcinoma*/
1385,981,21,/*lymph node metastasis*/
1385,1075,9,/*carcinoma*/
1385,1093,25,/*intestinal-type carcinoma*/
1385,1143,5,/*tumor*/
1385,1177,7,/*PDGF-Rb*/
1385,1375,6,/*tumors*/
1385,1383,6,/*cancer*/
1385,1421,7,/*PDGF-Rb*/
1385,1430,7,/*PDGF-Rb*/
1385,1752,20,/*lymphatic metastasis*/
1385,1849,17,/*gastric carcinoma*/
1386,38,29,/*X-linked adrenoleukodystrophy*/
1386,69,22,/*X-adrenoleukodystrophy*/
1386,93,5,/*X-ALD*/
1386,116,19,/*peroxisomal disease*/
1386,585,12,/*cerebral ALD*/
1386,627,9,/*adulthood*/
1386,638,21,/*adrenomyeloneuropathy*/
1386,661,3,/*AMN*/
1386,667,17,/*Addison's disease*/
1386,702,21,/*gonadal insufficiency*/
1386,775,15,/*myeloneuropathy*/
1386,806,3,/*AMN*/
1386,1082,21,/*course of the disease*/
1386,1151,3,/*AMN*/
1386,1163,22,/*cerebral demyelination*/
1386,1539,22,/*cerebral demyelination*/
1386,1861,5,/*tumor*/
1387,87,20,/*myotonic dystrophy 2*/
1387,118,20,/*Myotonic dystrophy 2*/
1387,140,3,/*DM2*/
1387,988,3,/*DM2*/
1387,1126,3,/*DM2*/
1387,1225,3,/*DM2*/
1388,64,30,/*familial adenomatous polyposis*/
1388,107,30,/*Familial adenomatous polyposis*/
1388,139,3,/*FAP*/
1388,185,17,/*colorectal tumour*/
1388,232,3,/*FAP*/
1388,409,3,/*FAP*/
1388,437,3,/*FAP*/
1388,522,3,/*FAP*/
1388,697,22,/*ileorectal anastomosis*/
1388,820,20,/*ileoanal anastomosis*/
1388,857,35,/*Duodenal and jejunal-ileal adenomas*/
1388,1042,3,/*APC*/
1388,1092,9,/*polyposis*/
1388,1179,6,/*cancer*/
1388,1450,3,/*APC*/
1388,1522,3,/*FAP*/
1388,1717,3,/*FAP*/
1389,86,26,/*sensorineural hearing loss*/
1389,114,16,/*Pendred syndrome*/
1389,137,28,/*autosomal recessive disorder*/
1389,183,33,/*congenital sensorineural deafness*/
1389,218,42,/*goitre and defective iodide organification*/
1389,286,12,/*hearing loss*/
1389,338,6,/*goitre*/
1389,349,19,/*thyroid dysfunction*/
1389,794,29,/*bilateral Mondini's dysplasia*/
1389,828,6,/*goitre*/
1390,32,10,/*thrombosis*/
1390,47,10,/*hemostasis*/
1390,374,3,/*VWD*/
1390,387,17,/*venous thrombosis*/
1390,603,10,/*thrombosis*/
1390,739,19,/*ADAMTS13 deficiency*/
1390,844,10,/*thrombosis*/
1391,13,25,/*familial thrombocythemias*/
1392,216,26,/*sensorineural hearing loss*/
1392,244,4,/*SNHL*/
1392,381,4,/*SNHL*/
1392,387,28,/*Enlarged vestibular aqueduct*/
1392,417,3,/*EVA*/
1392,472,4,/*SNHL*/
1392,609,23,/*inner-ear abnormalities*/
1392,671,4,/*SNHL*/
1392,1005,3,/*EVA*/
1392,1065,4,/*SNHL*/
1392,1186,3,/*EVA*/
1392,1306,3,/*EVA*/
1392,1333,4,/*SNHL*/
1392,1381,4,/*SNHL*/
1392,1390,3,/*EVA*/
1393,191,24,/*bilateral retinoblastoma*/
1393,934,14,/*retinoblastoma*/
1393,1000,14,/*retinoblastoma*/
1394,74,26,/*Hereditary Hemochromatosis*/
1394,102,2,/*HH*/
1394,112,22,/*iron overload syndrome*/
1394,282,9,/*cirrhosis*/
1394,293,8,/*diabetes*/
1394,303,15,/*cardiac failure*/
1394,320,23,/*endocrine complications*/
1394,348,9,/*arthritis*/
1394,380,2,/*HH*/
1394,715,2,/*HH*/
1395,31,14,/*retinoblastoma*/
1396,46,17,/*anhaptoglobinemia*/
1396,154,17,/*anhaptoglobinemia*/
1396,465,17,/*anhaptoglobinemia*/
1396,691,19,/*hypohaptoglobinemia*/
1396,1829,17,/*anhaptoglobinemia*/
1396,1956,19,/*hypohaptoglobinemia*/
1397,69,12,/*alkaptonuria*/
1397,1555,12,/*alkaptonuria*/
1397,1575,3,/*AKU*/
1397,1718,12,/*alkaptonuria*/
1398,4,5,/*tumor*/
1398,171,26,/*breast and ovarian cancers*/
1398,250,23,/*fertile and lack tumors*/
1399,53,17,/*metabolic defects*/
1399,72,3,/*PMD*/
1399,77,28,/*Pelizaeus-Merzbacher disease*/
1399,110,36,/*CNS (central nervous system) disease*/
1399,194,18,/*neural dysfunction*/
1400,25,29,/*congenital myotonic dystrophy*/
1400,115,18,/*myotonic dystrophy*/
1400,136,2,/*DM*/
1400,174,17,/*mentally retarded*/
1400,216,17,/*muscular weakness*/
1400,343,2,/*DM*/
1400,388,2,/*DM*/
1400,482,2,/*DM*/
1400,579,2,/*DM*/
1400,630,2,/*DM*/
1400,768,2,/*DM*/
1400,971,2,/*DM*/
1400,1018,13,/*congenital DM*/
1400,1080,2,/*DM*/
1401,58,29,/*spinocerebellar ataxia type 3*/
1401,89,29,/*Spinocerebellar ataxia type 3*/
1401,120,4,/*SCA3*/
1401,699,15,/*reduced anxiety*/
1401,716,13,/*hyperactivity*/
1401,1205,22,/*sufficiently long time*/
1402,96,15,/*Gaucher disease*/
1402,363,15,/*Gaucher disease*/
1402,427,15,/*Gaucher disease*/
1402,644,15,/*Gaucher disease*/
1402,813,14,/*type I disease*/
1402,932,15,/*type II disease*/
1402,1281,15,/*Gaucher disease*/
1402,1437,29,/*neuronopathic Gaucher disease*/
1402,1548,15,/*Gaucher disease*/
1402,1619,23,/*type I disease of the 8*/
1403,95,6,/*tumors*/
1403,191,82,/*neuroendocrine neoplasm of the parathyroid glands, the pancreatic islet parenchyma*/
1403,424,35,/*MEN1-associated parathyroid lesions*/
1403,550,19,/*hyperparathyroidism*/
1403,880,27,/*sporadic pituitary adenomas*/
1404,59,40,/*Duchenne and Becker muscular dystrophies*/
1404,189,27,/*Duchenne muscular dystrophy*/
1404,218,3,/*DMD*/
1404,226,25,/*Becker muscular dystrophy*/
1404,253,3,/*BMD*/
1404,322,7,/*DMD/BMD*/
1404,662,3,/*DMD*/
1405,61,24,/*Glanzmann thrombasthenia*/
1405,99,24,/*Glanzmann thrombasthenia*/
1405,125,2,/*GT*/
1405,135,54,/*autosomal recessive inherited platelet function defect*/
1405,553,2,/*GT*/
1405,672,2,/*GT*/
1405,1141,2,/*GT*/
1405,1256,2,/*GT*/
1405,1602,2,/*GT*/
1406,93,20,/*Li-Fraumeni syndrome*/
1406,158,20,/*Li-Fraumeni syndrome*/
1406,228,6,/*tumour*/
1406,538,16,/*sporadic tumours*/
1406,717,7,/*tumours*/
1406,774,14,/*leiomyosarcoma*/
1407,68,18,/*Huntington disease*/
1407,118,18,/*Huntington disease*/
1407,138,2,/*HD*/
1407,261,2,/*HD*/
1407,430,2,/*HD*/
1407,1384,2,/*AO*/
1407,1520,2,/*HD*/
1407,1662,2,/*HD*/
1408,23,27,/*scalp and bilateral kidneys*/
1408,349,15,/*B cell lymphoma*/
1408,366,4,/*DLBL*/
1408,667,17,/*pulmonary lesions*/
1408,1776,23,/*deranged renal function*/
1408,1871,37,/*scalp and bilateral renal involvement*/
1408,1930,19,/*lymphoma literature*/
1408,2015,32,/*part of widespread dissemination*/
1409,56,22,/*Van der Woude syndrome*/
1409,80,22,/*Van der Woude syndrome*/
1409,104,3,/*VWS*/
1409,173,31,/*clefts of the lip and/or palate*/
1409,209,14,/*lower lip pits*/
1409,341,16,/*cleft lip/palate*/
1409,459,3,/*VWS*/
1409,545,29,/*nonsyndromic cleft lip/palate*/
1409,576,5,/*NSCLP*/
1409,632,3,/*VWS*/
1409,745,3,/*VWS*/
1409,961,3,/*VWS*/
1409,1080,3,/*VWS*/
1409,1235,21,/*isolated cleft palate*/
1409,1261,19,/*bilateral cleft lip*/
1409,1318,3,/*VWS*/
1409,1426,3,/*VWS*/
1410,34,15,/*afibrinogenemia*/
1410,104,25,/*Inherited afibrinogenemia*/
1410,140,36,/*autosomal recessive bleeding disease*/
1410,285,25,/*inherited afibrinogenemia*/
1410,1171,25,/*inherited afibrinogenemia*/
1411,80,25,/*vivo platelet consumption*/
1411,170,16,/*thrombocytopenia*/
1411,197,24,/*Wiskott-Aldrich syndrome*/
1411,223,3,/*WAS*/
1411,476,5,/*CMFDA*/
1411,439,35,/*5-chloromethylfluorescein diacetate*/
1411,898,16,/*thrombocytopenia*/
1411,1336,16,/*thrombocytopenia*/
1411,1550,15,/*WASP deficiency*/
1412,366,21,/*secondary infertility*/
1412,1249,10,/*aneuploidy*/
1413,120,21,/*ataxia telangiectasia*/
1413,656,3,/*A-T*/
1413,846,3,/*A-T*/
1413,945,3,/*A-T*/
1413,1249,3,/*A-T*/
1415,237,15,/*phenylketonuria*/
1415,257,21,/*hyperphenylalaninemia*/
1415,1175,15,/*phenylketonuria*/
1415,1527,36,/*phenylalanine hydroxylase deficiency*/
1416,0,20,/*Retinal degeneration*/
1416,154,31,/*hereditary retinal degeneration*/
1416,238,20,/*retinitis pigmentosa*/
1417,18,21,/*Prader-Willi syndrome*/
1417,287,21,/*Prader-Willi syndrome*/
1417,311,3,/*PWS*/
1417,380,3,/*PWS*/
1417,555,3,/*PWS*/
1417,768,3,/*PWS*/
1418,0,10,/*Hemophilia*/
1418,336,12,/*hemophilia B*/
1418,966,10,/*hemophilia*/
1418,1257,12,/*hemophilia B*/
1419,49,37,/*glucose-6-phosphate (G6PD) deficiency*/
1419,88,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
1419,618,15,/*G6PD deficiency*/
1419,727,15,/*G6PD deficiency*/
1419,888,10,/*G6PD-MutDB*/
1419,977,32,/*non-spherocytic hemolytic anemia*/
1419,1011,5,/*CNSHA*/
1419,1169,15,/*G6PD deficiency*/
1420,95,15,/*Petunia hybrida*/
1421,4,5,/*tumor*/
1421,152,5,/*tumor*/
1421,259,18,/*pancreatic cancers*/
1421,693,19,/*gastrulation defect*/
1421,833,19,/*gastrulation defect*/
1422,95,3,/*FAP*/
1422,103,4,/*AFAP*/
1422,149,8,/*adenomas*/
1422,179,30,/*familial adenomatous polyposis*/
1422,211,3,/*FAP*/
1422,217,41,/*attenuated familial adenomatous polyposis*/
1422,260,4,/*AFAP*/
1422,442,3,/*FAP*/
1422,543,3,/*FAP*/
1422,548,3,/*FAP*/
1422,571,19,/*colorectal adenomas*/
1422,618,17,/*colorectal cancer*/
1422,643,8,/*adenomas*/
1422,696,2,/*FH*/
1422,793,3,/*FAP*/
1422,798,4,/*AFAP*/
1422,888,3,/*FAP*/
1422,924,4,/*AFAP*/
1422,1118,8,/*adenomas*/
1422,1471,3,/*FAP*/
1422,1479,4,/*AFAP*/
1422,1526,19,/*colorectal adenomas*/
1422,1631,8,/*adenomas*/
1422,1765,8,/*FAP-like*/
1423,53,19,/*congenital aniridia*/
1423,77,8,/*cataract*/
1423,158,19,/*congenital aniridia*/
1423,182,8,/*cataract*/
1423,1027,19,/*congenital aniridia*/
1423,1051,8,/*cataract*/
1424,510,4,/*HRAS*/
1425,111,14,/*Wilson disease*/
1425,284,14,/*Wilson disease*/
1425,769,14,/*Wilson disease*/
1426,88,19,/*leukocyte neoplasia*/
1427,33,19,/*psychiatric illness*/
1427,144,28,/*metachromatic leukodystrophy*/
1427,174,3,/*MLD*/
1428,29,37,/*benign familial infantile convulsions*/
1428,134,37,/*benign familial infantile convulsions*/
1428,173,4,/*BFIC*/
1428,242,26,/*epilepsy-associated repeat*/
1428,305,18,/*various epilepsies*/
1428,270,3,/*EAR*/
1428,378,4,/*BFIC*/
1428,415,4,/*BFIC*/
1428,683,4,/*BFIC*/
1428,868,4,/*BFIC*/
1428,943,35,/*benign familial neonatal convulsion*/
1428,983,8,/*epilepsy*/
1428,1053,4,/*BFIC*/
1428,1114,4,/*BFIC*/
1428,1207,4,/*BFIC*/
1429,53,17,/*deficiency anemia*/
1429,91,15,/*iron deficiency*/
1429,237,15,/*iron deficiency*/
1429,549,17,/*deficiency anemia*/
1429,610,17,/*deficiency anemia*/
1429,1495,15,/*iron deficiency*/
1430,37,28,/*metachromatic leukodystrophy*/
1430,97,28,/*Metachromatic leukodystrophy*/
1430,127,3,/*MLD*/
1430,138,28,/*autosomal recessive disorder*/
1430,252,3,/*MLD*/
1430,435,3,/*MLD*/
1430,559,3,/*MLD*/
1430,1544,3,/*MLD*/
1431,16,7,/*dysuria*/
1431,42,17,/*Addison's disease*/
1431,76,29,/*X-linked adrenoleukodystrophy*/
1431,112,27,/*X-linked recessive disorder*/
1431,219,21,/*adrenal insufficiency*/
1431,290,17,/*Addison's disease*/
1431,509,21,/*adrenal insufficiency*/
1431,535,36,/*progressive neurological dysfunction*/
1431,605,29,/*X-linked adrenoleukodystrophy*/
1431,655,21,/*adrenomyeloneuropathy*/
1432,53,16,/*beta-thalassemia*/
1432,96,16,/*beta-Thalassemia*/
1432,118,18,/*hereditary disease*/
1432,499,16,/*beta-thalassemia*/
1432,1247,11,/*thalassemia*/
1432,1597,16,/*beta-thalassemia*/
1434,135,16,/*thrombocytopenia*/
1434,209,35,/*quantitative platelet abnormalities*/
1434,593,36,/*prolonged bleeding times ante partum*/
1434,703,29,/*type I von Willebrand disease*/
1434,783,25,/*Neonatal thrombocytopenia*/
1434,861,16,/*thrombocytopenia*/
};
}
static void init10() {
a10 = new int[] {
1434,954,25,/*isolated thrombocytopenia*/
1434,1145,23,/*prolonged bleeding time*/
1434,1189,22,/*von Willebrand disease*/
1434,1217,29,/*qualitative platelet disorder*/
1435,103,28,/*congenital eye malformations*/
1435,175,8,/*aniridia*/
1435,186,30,/*congenital absence of the iris*/
1435,223,37,/*rare dominant malformation of the eye*/
1435,297,8,/*aniridia*/
1435,756,8,/*aniridia*/
1435,991,8,/*aniridia*/
1435,1142,20,/*congenital nystagmus*/
1435,1230,8,/*aniridia*/
1436,56,22,/*anaplastic astrocytoma*/
1436,102,5,/*tumor*/
1436,577,11,/*astrocytoma*/
1436,608,12,/*glioblastoma*/
1436,1106,20,/*cellular instability*/
1437,119,31,/*dermatofibrosarcoma protuberans*/
1438,105,21,/*breast/ovarian cancer*/
1438,214,21,/*breast/ovarian cancer*/
1439,113,21,/*Congenital deficiency*/
1439,248,21,/*neurogenetic disorder*/
1439,283,20,/*Lesch-Nyhan syndrome*/
1440,19,7,/*obesity*/
1440,28,21,/*adrenal insufficiency*/
1440,54,21,/*red hair pigmentation*/
1440,407,15,/*ACTH deficiency*/
1440,718,7,/*obesity*/
1440,838,7,/*obesity*/
1440,1019,7,/*obesity*/
1440,1060,15,/*ACTH deficiency*/
1440,1611,7,/*obesity*/
1440,1621,21,/*adrenal insufficiency*/
1440,1647,21,/*red hair pigmentation*/
1441,57,18,/*epithelial cancers*/
1441,149,10,/*leukaemias*/
1441,164,8,/*sarcomas*/
1441,216,10,/*carcinomas*/
1441,436,18,/*epithelial cancers*/
1441,464,27,/*prostate and lung carcinoma*/
1441,498,16,/*prostate cancers*/
1441,673,35,/*breast and other epithelial cancers*/
1441,738,7,/*tumours*/
1441,1165,10,/*carcinomas*/
1441,1356,7,/*cancers*/
1442,11,23,/*goitrous hypothyroidism*/
1442,36,8,/*deafness*/
1442,107,23,/*pseudo-Pendred syndrome*/
1442,132,16,/*Pendred syndrome*/
1442,150,3,/*PDS*/
1442,161,28,/*autosomal recessive disorder*/
1442,207,19,/*congenital deafness*/
1442,228,6,/*goiter*/
1442,281,23,/*inner ear malformations*/
1442,368,3,/*PDS*/
1442,505,3,/*PDS*/
1442,580,3,/*PDS*/
1442,600,23,/*inner ear malformations*/
1442,645,3,/*PDS*/
1442,820,6,/*goiter*/
1442,835,14,/*hypothyroidism*/
1442,893,22,/*sensorineural deafness*/
1442,929,21,/*inner ear abnormality*/
1442,975,3,/*PDS*/
1442,1073,34,/*congenital goitrous hypothyroidism*/
1442,1112,8,/*deafness*/
1443,55,43,/*metachronous gastrointestinal stromal tumor*/
1443,103,31,/*dermatofibrosarcoma protuberans*/
1443,234,20,/*intra-abdominal mass*/
1443,299,38,/*lumbar dermatofibrosarcoma protuberans*/
1443,619,30,/*gastrointestinal stromal tumor*/
1443,651,4,/*GIST*/
1443,748,4,/*DFSP*/
1443,849,4,/*DFSP*/
1443,918,4,/*DFSP*/
1443,942,6,/*tumors*/
1443,1318,6,/*tumors*/
1444,22,26,/*hereditary hemochromatosis*/
1444,50,26,/*Hereditary hemochromatosis*/
1444,78,2,/*HH*/
1444,86,21,/*iron overload disease*/
1444,193,2,/*HH*/
1444,378,15,/*hemochromatosis*/
1444,579,2,/*HH*/
1444,780,2,/*HH*/
1444,968,2,/*HH*/
1444,1026,31,/*cutaneous-type hypersensitivity*/
1444,1162,2,/*HH*/
1444,1392,6,/*cancer*/
1445,65,54,/*autosomal dominant central areolar choroidal dystrophy*/
1445,155,54,/*autosomal dominant central areolar choroidal dystrophy*/
1445,211,4,/*CACD*/
1445,1100,23,/*autosomal dominant CACD*/
1445,1231,19,/*visual disturbances*/
1445,1438,32,/*geographic atrophy of the macula*/
1445,1581,21,/*chorioretinal atrophy*/
1445,2116,4,/*CACD*/
1446,17,33,/*Shwachman-Bodian-Diamond syndrome*/
1448,284,6,/*cancer*/
1449,1,35,/*Xanthomas of the Achilles tendon as*/
1449,61,15,/*sitolsterolemia*/
1449,554,15,/*sitosterolaemia*/
1449,583,27,/*autosomal recessive disease*/
1449,619,55,/*intestinal hyperabsorption of a range of plant steroids*/
1449,982,15,/*sitosterolaemia*/
1450,56,15,/*cystic fibrosis*/
1450,179,15,/*cystic fibrosis*/
1450,196,2,/*CF*/
1450,276,2,/*CF*/
1450,592,2,/*CF*/
1451,115,26,/*sensorineural hearing loss*/
1451,143,54,/*Non-syndromic low-frequency sensorineural hearing loss*/
1451,199,6,/*LFSNHL*/
1451,229,12,/*hearing loss*/
1451,400,6,/*LFSNHL*/
1451,462,34,/*postlingual and progressive LFSNHL*/
1451,916,6,/*LFSNHL*/
1451,1542,6,/*LFSNHL*/
1452,1346,15,/*phenylketonuria*/
1453,128,20,/*Huntington's disease*/
1453,166,20,/*Huntington's disease*/
1453,188,2,/*HD*/
1453,209,26,/*neurodegenerative disorder*/
1453,559,2,/*HD*/
1453,921,2,/*HD*/
1453,1267,2,/*HD*/
1453,1375,2,/*HD*/
1453,1807,2,/*HD*/
1454,26,15,/*POMC-deficiency*/
1454,88,23,/*multifactorial disorder*/
1454,278,12,/*disquietness*/
1454,295,7,/*obesity*/
1454,445,7,/*obesity*/
1454,505,7,/*obesity*/
1454,540,12,/*hypoglycemia*/
1454,899,19,/*overgrowth syndrome*/
1454,930,12,/*hypoglycemia*/
1454,947,15,/*hypocortisolism*/
1454,993,15,/*POMC deficiency*/
1454,1061,12,/*Hypoglycemia*/
1454,1149,37,/*relative mineralocorticoid deficiency*/
1454,1196,23,/*urinary tract infection*/
1454,1224,15,/*POMC deficiency*/
1454,1241,37,/*relative mineralocorticoid deficiency*/
1455,283,6,/*cancer*/
1456,31,25,/*Velocardiofacial syndrome*/
1456,245,25,/*velocardiofacial syndrome*/
1456,272,4,/*VCFS*/
1456,392,4,/*VCFS*/
1456,877,18,/*mental retardation*/
1456,897,24,/*congenital heart defects*/
1456,923,3,/*CHD*/
1456,932,13,/*schizophrenia*/
1456,1739,3,/*CHD*/
1457,81,22,/*dopa-response dystonia*/
1457,183,24,/*dopa-responsive dystonia*/
1457,209,3,/*DRD*/
1457,787,3,/*DRD*/
1457,873,19,/*multifocal dystonia*/
1457,1000,12,/*bradykinesia*/
1457,1046,19,/*Parkinson's disease*/
1457,1163,3,/*DRD*/
1457,1336,3,/*DRD*/
1458,42,9,/*Tay-Sachs*/
1458,62,17,/*Tay-Sachs disease*/
1458,81,3,/*TSD*/
1458,189,40,/*beta-hexosaminidase A (Hex A) deficiency*/
1458,281,23,/*molecular abnormalities*/
1458,511,3,/*TSD*/
1458,1017,3,/*TSD*/
1458,1300,17,/*Tay-Sachs-causing*/
1459,98,17,/*colorectal cancer*/
1459,349,26,/*familial colorectal cancer*/
1459,496,17,/*colorectal cancer*/
1459,652,9,/*neoplasia*/
1459,797,17,/*colorectal cancer*/
1459,969,15,/*familial cancer*/
1459,1072,20,/*Colorectal neoplasia*/
1459,1223,20,/*noncolonic neoplasia*/
1459,1346,7,/*cancers*/
1459,1421,17,/*colorectal cancer*/
1460,33,12,/*sudden death*/
1460,64,49,/*very-long-chain acyl-CoA dehydrogenase deficiency*/
1460,115,62,/*Very-long-chain acyl-coenzyme A (CoA) dehydrogenase deficiency*/
1460,179,6,/*VLCADD*/
1460,193,52,/*autosomal recessive disorder of fatty acid oxidation*/
1460,264,6,/*VLCADD*/
1460,466,6,/*VLCADD*/
1460,932,18,/*fatal hypoglycemia*/
1460,987,6,/*VLCADD*/
1461,0,13,/*Breast cancer*/
1461,17,15,/*Cowden syndrome*/
1461,53,24,/*familial cancer syndrome*/
1461,79,15,/*Cowden syndrome*/
1461,100,39,/*familial cancer predisposition syndrome*/
1461,178,40,/*breast, thyroid, and endometrial cancers*/
1461,329,6,/*tumors*/
1461,340,7,/*cancers*/
1461,405,15,/*Cowden syndrome*/
1462,25,24,/*Wiskott-Aldrich syndrome*/
1462,80,24,/*Wiskott-Aldrich Syndrome*/
1462,106,3,/*WAS*/
1462,116,25,/*triad of immunodeficiency*/
1462,143,6,/*eczema*/
1462,155,16,/*thrombocytopenia*/
1462,574,3,/*WAS*/
1463,102,14,/*Wilson disease*/
1463,118,14,/*Wilson disease*/
1463,134,2,/*WD*/
1463,144,28,/*autosomal recessive disorder*/
1463,378,2,/*WD*/
1463,567,2,/*WD*/
1463,1116,2,/*WD*/
1463,1259,2,/*WD*/
1464,54,26,/*Cornelia de Lange syndrome*/
1464,109,26,/*Cornelia de Lange syndrome*/
1464,162,27,/*multiple congenital anomaly*/
1464,227,12,/*growth delay*/
1464,241,18,/*mental retardation*/
1464,261,12,/*limb defects*/
1464,275,19,/*behavioral problems*/
1464,307,19,/*hearing impairments*/
1464,332,41,/*gastrointestinal or cardiac abnormalities*/
1464,137,4,/*CdLS*/
1464,506,4,/*CdLS*/
1464,635,4,/*CdLS*/
1464,729,21,/*genital abnormalities*/
1464,756,22,/*bilateral hearing loss*/
1464,855,13,/*short stature*/
1464,874,18,/*mental retardation*/
1464,1493,13,/*CdLS in Korea*/
1465,1075,18,/*intrinsic disorder*/
1466,195,3,/*FLC*/
1466,177,16,/*ferritin L chain*/
1466,403,3,/*FHC*/
1466,450,3,/*FLC*/
1466,533,3,/*FLC*/
1467,0,3,/*VHL*/
1467,69,23,/*Drosophila melanogaster*/
1467,494,3,/*VHL*/
1467,513,25,/*von Hippel-Lindau disease*/
1467,971,3,/*NMD*/
1467,1097,23,/*Drosophila melanogaster*/
1467,1188,3,/*VHL*/
1468,0,12,/*Alkaptonuria*/
1468,29,39,/*degenerative collagenous palmar plaques*/
1469,161,15,/*hemochromatosis*/
1469,281,19,/*Alzheimer's disease*/
1469,302,2,/*AD*/
1469,413,26,/*neurodegenerative diseases*/
1469,451,2,/*AD*/
1469,458,19,/*Parkinson's disease*/
1469,682,24,/*putamen, globus pallidus*/
1469,708,8,/*thalamus*/
1469,1507,26,/*neurodegenerative diseases*/
1469,1726,38,/*age-related neurodegenerative diseases*/
1470,33,18,/*GM1 gangliosidosis*/
1470,91,18,/*GM1 gangliosidosis*/
1470,125,37,/*progressive psychomotor deterioration*/
1470,167,10,/*dysostosis*/
1470,373,17,/*Morquio B disease*/
1470,392,3,/*MBD*/
1470,415,10,/*dysostosis*/
1470,621,18,/*GM1 gangliosidosis*/
1470,652,3,/*MBD*/
1470,694,18,/*GM1 gangliosidosis*/
1470,766,15,/*genetic lesions*/
1470,1121,18,/*GM1 gangliosidosis*/
1471,48,26,/*adenomatous polyposis coli*/
1471,76,26,/*Adenomatous polyposis coli*/
1471,104,3,/*APC*/
1471,493,18,/*colorectal cancers*/
1471,570,21,/*cancer cell migration*/
1471,1448,7,/*cancers*/
1473,35,14,/*Norrie disease*/
1473,250,5,/*MAO-B*/
1473,1061,14,/*Norrie disease*/
1473,1160,44,/*Marked plasma amine metabolite abnormalities*/
1474,80,3,/*FAP*/
1474,129,8,/*APC loss*/
1474,310,30,/*familial adenomatous polyposis*/
1474,342,3,/*FAP*/
1474,347,7,/*tumours*/
1474,380,3,/*FAP*/
1474,632,12,/*FAP adenomas*/
1474,659,17,/*adenoma-carcinoma*/
1474,729,8,/*adenomas*/
1474,856,8,/*adenomas*/
1474,1038,8,/*adenomas*/
1474,1146,4,/*KRAS*/
1474,1443,15,/*APC-FAP tumours*/
1474,1608,15,/*APC-FAP tumours*/
1474,1663,3,/*APC*/
1474,1670,14,/*tumourigenesis*/
1475,87,15,/*prostate cancer*/
1475,202,5,/*tumor*/
1475,295,7,/*cancers*/
1475,385,12,/*glioblastoma*/
1475,445,15,/*prostate cancer*/
1475,492,13,/*breast cancer*/
1475,565,13,/*glioblastomas*/
1475,800,5,/*tumor*/
1475,876,5,/*tumor*/
1476,74,32,/*Progressive muscular dystrophies*/
1476,111,16,/*genetic diseases*/
1476,164,27,/*Duchenne muscular dystrophy*/
1476,193,3,/*DMD*/
1476,241,38,/*Fukuyama congenital muscular dystrophy*/
1476,281,4,/*FCMD*/
1476,700,23,/*neuromuscular disorders*/
1476,837,3,/*DMD*/
1476,845,4,/*FCMD*/
1476,904,3,/*DMD*/
1476,1033,3,/*DMD*/
1476,1160,3,/*DMD*/
1476,1285,4,/*FCMD*/
1476,1406,20,/*muscular dystrophies*/
1477,58,18,/*longevity syndrome*/
1477,185,22,/*coronary heart disease*/
1477,209,3,/*CHD*/
1477,383,18,/*longevity syndrome*/
1477,403,2,/*LS*/
1477,640,2,/*LS*/
1477,767,3,/*CHD*/
1477,796,2,/*LS*/
1477,1052,2,/*LS*/
1477,1387,2,/*LS*/
1478,38,13,/*breast cancer*/
1479,69,13,/*WHIM syndrome*/
1479,162,13,/*WHIM syndrome*/
1479,177,5,/*warts*/
1479,184,21,/*hypogammaglobulinemia*/
1479,207,34,/*immunodeficiency and myelokathexis*/
1479,1024,13,/*WHIM syndrome*/
1480,24,17,/*eye abnormalities*/
1481,0,12,/*Galactosemia*/
1482,0,29,/*Type 1 von Willebrand disease*/
1482,45,14,/*von Willebrand*/
1482,159,29,/*type 1 von Willebrand disease*/
1482,190,3,/*VWD*/
1482,347,3,/*VWD*/
1482,406,3,/*VWD*/
1482,1713,10,/*type 1 VWD*/
1483,95,15,/*pycnodysostosis*/
1483,249,49,/*osteosclerotic skeletal dysplasia pycnodysostosis*/
1483,444,15,/*pycnodysostosis*/
1483,1133,35,/*autosomal recessive pycnodysostosis*/
1484,60,22,/*Machado-Joseph disease*/
1484,116,22,/*Machado-Joseph disease*/
1484,142,29,/*spinocerebellar ataxia type 3*/
1484,173,8,/*MJD/SCA3*/
1484,195,27,/*autosomal dominant disorder*/
1484,434,3,/*MJD*/
1484,597,3,/*MJD*/
1484,671,3,/*MJD*/
1484,730,3,/*MJD*/
1484,851,3,/*MJD*/
1484,955,3,/*MJD*/
1486,0,11,/*Fructosuria*/
1487,0,22,/*Ankylosing spondylitis*/
1489,16,34,/*arylalkylamine-N-acetyltransferase*/
1489,1448,2,/*WT*/
1490,37,36,/*familial exudative vitreoretinopathy*/
1490,78,14,/*Norrie disease*/
1490,153,3,/*NDP*/
1490,595,36,/*familial exudative vitreoretinopathy*/
1490,633,4,/*FEVR*/
1490,726,14,/*Norrie disease*/
1490,745,4,/*FEVR*/
1490,756,4,/*FEVR*/
1490,765,14,/*Norrie disease*/
1490,948,9,/*blindness*/
1490,1032,3,/*NDP*/
1491,40,13,/*breast cancer*/
1491,71,13,/*Breast cancer*/
1491,361,6,/*cancer*/
1491,702,13,/*breast cancer*/
1491,809,46,/*breast cancer transformation and proliferation*/
1491,919,13,/*breast cancer*/
1491,1022,13,/*breast cancer*/
1491,1089,13,/*breast cancer*/
1492,35,19,/*Lesch-Nyhan disease*/
1492,80,19,/*Lesch-Nyhan disease*/
1494,261,22,/*Machado-Joseph disease*/
1494,285,3,/*MJD*/
1494,440,22,/*spinocerebellar ataxia*/
1494,463,3,/*SCA*/
1494,602,3,/*MJD*/
1494,689,3,/*MJD*/
1494,990,3,/*MJD*/
1494,1043,3,/*MJD*/
1495,51,5,/*NIDDM*/
1495,850,39,/*non-insulin-dependent diabetes mellitus*/
1495,891,5,/*NIDDM*/
1496,23,27,/*congenital mirror movements*/
1496,488,20,/*colorectal carcinoma*/
1497,73,18,/*Huntington disease*/
1497,93,2,/*HD*/
1497,110,2,/*HD*/
1497,259,18,/*Huntington disease*/
1497,280,2,/*HD*/
1497,387,2,/*HD*/
1497,1295,2,/*HD*/
1497,1435,2,/*HD*/
1497,1780,2,/*HD*/
1497,1887,2,/*HD*/
1498,17,14,/*Wilson disease*/
1498,126,14,/*Wilson disease*/
1498,241,14,/*Wilson disease*/
1498,461,14,/*Wilson disease*/
1498,719,9,/*hemolysis*/
1498,1080,13,/*liver disease*/
1498,1196,14,/*encephalopathy*/
1499,57,32,/*acampomelic campomelic dysplasia*/
1499,108,20,/*Campomelic dysplasia*/
1499,147,28,/*severe malformation syndrome*/
1499,423,18,/*muscular hypotonia*/
1499,443,24,/*craniofacial dysmorphism*/
1499,469,12,/*cleft palate*/
1499,483,46,/*brachydactyly, malformations of thoracic spine*/
1499,535,18,/*gonadal dysgenesis*/
1499,719,10,/*campomelia*/
1499,1441,32,/*acampomelic campomelic dysplasia*/
1500,649,12,/*alkaptonuria*/
1500,739,12,/*alkaptonuria*/
1501,93,13,/*Fabry disease*/
1501,108,13,/*Fabry disease*/
1501,128,35,/*X-linked lysosomal storage disorder*/
1501,171,35,/*deficiency of alpha-Galactosidase A*/
1501,454,13,/*Fabry disease*/
1501,663,14,/*Fabry symptoms*/
1501,918,20,/*white matter lesions*/
1501,1670,13,/*Fabry disease*/
1501,1742,36,/*cerebrovascular white matter lesions*/
1501,1805,23,/*ventricular hypertrophy*/
1502,69,13,/*breast cancer*/
1502,196,13,/*breast cancer*/
1502,507,13,/*breast cancer*/
1502,714,13,/*breast cancer*/
1502,786,13,/*breast cancer*/
1502,808,14,/*ovarian cancer*/
1502,916,25,/*breast and ovarian cancer*/
1502,1024,13,/*breast cancer*/
1502,1056,14,/*ovarian cancer*/
1502,1089,25,/*breast and ovarian cancer*/
1502,1289,23,/*bilateral breast cancer*/
1502,1330,14,/*breast cancers*/
1502,1475,14,/*ovarian cancer*/
1502,1534,13,/*breast cancer*/
1503,19,25,/*fulminant hepatic failure*/
1503,107,16,/*Wilson's disease*/
1503,167,16,/*Wilson's disease*/
1503,185,2,/*WD*/
1503,292,3,/*FHF*/
1503,265,25,/*fulminant hepatic failure*/
1503,420,3,/*FHF*/
1503,444,2,/*WD*/
1503,523,2,/*WD*/
1503,1389,3,/*FHF*/
1504,39,24,/*Wiskott-Aldrich syndrome*/
1504,126,24,/*Wiskott-Aldrich syndrome*/
1504,152,3,/*WAS*/
1504,163,17,/*X-linked disorder*/
1504,239,16,/*immunodeficiency*/
1504,257,6,/*eczema*/
1504,290,16,/*thrombocytopenia*/
1504,420,3,/*WAS*/
1504,688,3,/*WAS*/
1504,696,25,/*X-linked thrombocytopenia*/
1505,48,8,/*melanoma*/
1505,74,8,/*melanoma*/
1506,272,17,/*Cat-eye syndromes*/
1506,291,3,/*CES*/
1506,452,24,/*congenital malformations*/
1506,480,20,/*cognitive impairment*/
1507,33,22,/*Machado-Joseph disease*/
1507,103,22,/*Machado-Joseph disease*/
1507,127,3,/*MJD*/
1507,138,44,/*autosomal dominant neurodegenerative disease*/
1507,325,17,/*autonomic failure*/
1507,380,14,/*Onuf's nucleus*/
1507,396,2,/*ON*/
1507,703,3,/*MJD*/
1507,823,3,/*MJD*/
1507,927,3,/*MJD*/
1507,1144,13,/*neuronal loss*/
1507,1218,13,/*neuronal loss*/
1507,1332,3,/*MJD*/
1507,1605,13,/*neuronal loss*/
1507,1737,3,/*MJD*/
1508,386,22,/*coronary heart disease*/
1509,117,14,/*retinoblastoma*/
1511,12,35,/*Charcot-Marie-Tooth disease type 1D*/
1512,212,11,/*proteinuria*/
1512,419,17,/*von Hippel-Lindau*/
1512,522,8,/*HIFalpha*/
1512,438,3,/*VHL*/
1512,581,3,/*VHL*/
1512,799,3,/*VHL*/
1513,0,20,/*Periodic acid-schiff*/
1513,128,33,/*Hereditary diffuse gastric cancer*/
1513,163,4,/*HDGC*/
1513,173,49,/*autosomal dominant cancer susceptibility syndrome*/
1513,409,6,/*cancer*/
1513,533,15,/*gastric cancers*/
1514,13,15,/*Fabry's disease*/
1514,197,15,/*Fabry's disease*/
1514,876,20,/*Lesch-Nyhan syndrome*/
1514,1229,15,/*Fabry's disease*/
1515,53,13,/*C4 deficiency*/
1515,158,49,/*deficiency of the seventh component of complement*/
1515,356,19,/*autoimmune diseases*/
1515,513,13,/*C7 deficiency*/
1515,759,24,/*meningococcal infections*/
1515,1025,10,/*infectious*/
1515,1040,18,/*autoimmune disease*/
1516,61,8,/*trachoma*/
1516,136,8,/*trachoma*/
1516,178,9,/*blindness*/
1516,292,21,/*Chlamydia trachomatis*/
1516,479,8,/*trachoma*/
1516,756,8,/*trachoma*/
1516,978,8,/*trachoma*/
1516,1386,8,/*trachoma*/
1516,1503,8,/*trachoma*/
1517,91,19,/*atrial fibrillation*/
1517,143,19,/*Atrial fibrillation*/
1517,164,2,/*AF*/
1517,187,18,/*cardiac arrhythmia*/
1517,387,2,/*AF*/
1517,502,2,/*AF*/
1517,643,2,/*AF*/
1517,779,7,/*lone AF*/
1517,1725,2,/*AF*/
1518,25,23,/*cleidocranial dysplasia*/
1518,59,23,/*Cleidocranial dysplasia*/
1518,84,3,/*CCD*/
1518,95,36,/*autosomal dominant inherited disease*/
1518,199,3,/*CCD*/
1518,642,3,/*CCD*/
1518,735,3,/*CCD*/
1519,46,19,/*congenital cataract*/
1519,70,11,/*microcornea*/
1519,139,19,/*congenital cataract*/
1519,163,11,/*microcornea*/
1519,909,8,/*cataract*/
1519,922,11,/*microcornea*/
1520,214,20,/*diacylphosphocholine*/
1522,66,29,/*X-linked adrenoleukodystrophy*/
1522,97,29,/*X-linked adrenoleukodystrophy*/
1522,128,3,/*ALD*/
1522,151,26,/*neurodegenerative disorder*/
1522,399,5,/*X-ALD*/
1523,68,16,/*Hodgkin lymphoma*/
1523,157,11,/*cytokinesis*/
1523,230,16,/*Hodgkin lymphoma*/
1523,480,30,/*deficiency impairs cytokinesis*/
1523,688,16,/*Hodgkin lymphoma*/
1523,837,16,/*Hodgkin lymphoma*/
1523,912,16,/*Hodgkin lymphoma*/
1525,24,14,/*von Willebrand*/
1525,143,20,/*nonsurgical bleeding*/
1525,230,4,/*LVAD*/
1525,410,32,/*postimplant nonsurgical bleeding*/
1525,198,30,/*left ventricular assist device*/
1525,509,17,/*deficiency in vWF*/
1525,582,10,/*hemostasis*/
1525,594,41,/*High molecular weight multimer deficiency*/
1525,1488,9,/*HMWM loss*/
1525,1768,4,/*LVAD*/
1526,102,21,/*adenomatous polyposis*/
1526,187,32,/*colorectal adenomatous polyposis*/
1526,1134,9,/*polyposis*/
1527,77,15,/*phenylketonuria*/
1528,84,29,/*X-linked adrenoleukodystrophy*/
1528,160,29,/*X-linked adrenoleukodystrophy*/
1528,191,5,/*X-ALD*/
1528,409,6,/*X- ALD*/
1528,1272,4,/*CALD*/
1528,1331,4,/*CALD*/
1528,1499,4,/*CALD*/
1528,1638,5,/*X-ALD*/
1529,46,44,/*Familial Neurohypophysial Diabetes Insipidus*/
1529,101,44,/*Familial neurohypophysial diabetes insipidus*/
1529,147,4,/*FNDI*/
1529,157,27,/*autosomal dominant disorder*/
1529,372,4,/*FNDI*/
1529,405,8,/*polyuria*/
1529,894,4,/*FNDI*/
1530,19,13,/*C7 deficiency*/
1530,82,13,/*C7 deficiency*/
1530,651,12,/*C7-deficient*/
1531,23,29,/*X-linked adrenoleukodystrophy*/
1531,54,29,/*X-linked adrenoleukodystrophy*/
1531,85,5,/*X-ALD*/
1531,111,20,/*peroxisomal disorder*/
1531,250,5,/*X-ALD*/
1531,799,5,/*X-ALD*/
1532,23,20,/*adrenoleukodystrophy*/
1532,163,20,/*adrenoleukodystrophy*/
1532,186,3,/*ALD*/
1532,246,3,/*ALD*/
1532,524,3,/*ALD*/
1532,722,18,/*Alzheimers disease*/
1532,743,2,/*AD*/
1532,800,53,/*abnormalities in the bilateral cerebellar hemispheres*/
1532,1225,3,/*ALD*/
1532,1443,3,/*ALD*/
1532,1578,16,/*insidious lesion*/
1532,1720,21,/*neuronal degeneration*/
1532,1745,3,/*ALD*/
1534,43,39,/*autism-pervasive developmental disorder*/
1534,87,17,/*Tourette syndrome*/
1534,141,6,/*autism*/
1534,151,32,/*pervasive developmental disorder*/
1534,185,3,/*PDD*/
1534,194,17,/*Tourette syndrome*/
1534,213,2,/*TS*/
1534,289,3,/*PDD*/
1534,325,2,/*TS*/
1534,342,9,/*PDD----TS*/
1534,440,2,/*TS*/
1534,455,6,/*autism*/
1534,693,2,/*TS*/
1534,793,3,/*PDD*/
1534,801,2,/*TS*/
1534,855,14,/*genetic defect*/
1534,873,2,/*TS*/
1534,1104,3,/*PDD*/
1534,1233,3,/*PDD*/
1534,1284,3,/*PDD*/
1534,1386,9,/*PDD----TS*/
1534,1413,23,/*serotonin abnormalities*/
1535,42,8,/*melanoma*/
1535,187,8,/*melanoma*/
1535,229,8,/*melanoma*/
1535,492,14,/*seven melanoma*/
1535,716,8,/*melanoma*/
1535,853,8,/*melanoma*/
1535,881,7,/*cancers*/
1536,46,7,/*malaria*/
1536,254,7,/*malaria*/
1536,694,7,/*malaria*/
1536,802,30,/*hemoglobin-inherited disorders*/
1536,834,11,/*thalassemia*/
1536,907,12,/*ovalocytosis*/
1536,959,15,/*G6PD deficiency*/
1536,979,13,/*PK deficiency*/
1536,1064,5,/*tumor*/
1538,114,13,/*breast cancer*/
1538,277,26,/*non-small cell lung cancer*/
1538,316,14,/*ovarian cancer*/
1538,357,14,/*ovarian cancer*/
1538,386,36,/*hereditary breast and ovarian cancer*/
1538,621,13,/*breast cancer*/
1538,849,13,/*breast cancer*/
1538,987,14,/*breast cancers*/
1538,1110,13,/*breast cancer*/
1538,1306,13,/*breast cancer*/
1538,1379,13,/*breast cancer*/
1538,1555,13,/*breast cancer*/
1538,1633,13,/*breast cancer*/
1539,0,14,/*Retinoblastoma*/
1539,16,14,/*Retinoblastoma*/
1539,32,2,/*Rb*/
1539,41,15,/*malignant tumor*/
1539,275,5,/*tumor*/
1539,424,16,/*nonhereditary Rb*/
1539,519,11,/*familial Rb*/
1539,600,2,/*Rb*/
1539,633,2,/*Rb*/
1539,698,11,/*familial Rb*/
1539,727,2,/*Rb*/
1539,795,6,/*tumors*/
1539,993,5,/*tumor*/
1539,1181,25,/*hereditary retinoblastoma*/
1539,1438,5,/*tumor*/
1541,441,13,/*breast cancer*/
1541,584,6,/*cancer*/
1541,734,13,/*breast cancer*/
1541,995,6,/*cancer*/
1542,80,25,/*myotonic dystrophy type 1*/
1542,113,18,/*Myotonic dystrophy*/
1542,302,3,/*DM1*/
1542,352,3,/*DM1*/
1543,198,27,/*Duchenne muscular dystrophy*/
1544,18,20,/*colorectal neoplasms*/
1544,342,19,/*colorectal neoplasm*/
1544,466,21,/*lymphnodes metastasis*/
1544,888,17,/*colorectal cancer*/
1544,1221,6,/*tumors*/
1544,1345,17,/*colorectal cancer*/
1545,56,20,/*renal cell carcinoma*/
1545,161,17,/*von Hippel-Lindau*/
1545,222,20,/*renal cell carcinoma*/
1545,758,20,/*renal cell carcinoma*/
1545,930,3,/*VHL*/
1545,1193,7,/*cancers*/
1545,1374,6,/*cancer*/
1547,61,18,/*myotonic dystrophy*/
1547,81,18,/*Myotonic dystrophy*/
1547,102,2,/*DM*/
1547,172,2,/*DM*/
1547,195,2,/*DM*/
1547,684,2,/*DM*/
1547,871,2,/*DM*/
1549,67,29,/*X-linked adrenoleukodystrophy*/
1549,110,29,/*X-linked adrenoleukodystrophy*/
1549,141,5,/*X-ALD*/
1549,153,33,/*neurodegenerative genetic disease*/
1549,243,21,/*adrenal insufficiency*/
1549,269,20,/*elevated VLCFA level*/
1549,515,5,/*X-ALD*/
1549,566,14,/*X-ALD-stricken*/
1549,1218,3,/*ALD*/
1549,1612,5,/*X-ALD*/
1549,1714,14,/*X-ALD-stricken*/
1550,66,17,/*colorectal cancer*/
1551,56,17,/*Angelman syndrome*/
1551,77,21,/*Prader-Willi syndrome*/
1551,175,17,/*Angelman syndrome*/
1551,194,2,/*AS*/
1551,201,21,/*Prader-Willi syndrome*/
1551,224,3,/*PWS*/
1551,297,2,/*AS*/
1551,321,3,/*PWS*/
1551,500,2,/*AS*/
1551,514,3,/*PWS*/
1551,627,3,/*PWS*/
1551,716,2,/*AS*/
1551,1061,3,/*PWS*/
1552,0,43,/*Autosomal dominant occult macular dystrophy*/
1552,128,17,/*macular dystrophy*/
1552,147,3,/*OMD*/
1552,254,3,/*OMD*/
1552,467,3,/*OMD*/
1552,751,22,/*autosomal dominant OMD*/
1552,812,3,/*OMD*/
1552,1008,3,/*OMD*/
1552,1788,3,/*OMD*/
1553,24,20,/*pyoderma gangrenosum*/
1553,46,2,/*PG*/
1553,66,17,/*aortitis syndrome*/
1553,85,3,/*AOS*/
1553,137,3,/*AOS*/
1553,223,3,/*AOS*/
1553,292,2,/*PG*/
1553,299,3,/*AOS*/
1553,452,10,/*vasculitis*/
1553,513,12,/*skin lesions*/
1553,563,3,/*AOS*/
1553,573,3,/*AOS*/
1553,719,3,/*AOS*/
1554,0,22,/*Type 1 Gaucher disease*/
1554,109,15,/*Gaucher disease*/
1554,126,2,/*GD*/
1554,134,45,/*autosomal recessive lysosomal storage disease*/
1554,563,2,/*GD*/
1554,591,15,/*Gaucher disease*/
1554,766,2,/*GD*/
1554,1252,21,/*GD medical complaints*/
1554,1292,6,/*anemia*/
1554,1306,16,/*thrombocytopenia*/
1554,1480,28,/*Erlenmeyer flask deformities*/
1554,1632,10,/*osteopenia*/
1554,1646,12,/*osteoporosis*/
1555,4,23,/*von Hippel-Lindau tumor*/
1555,123,31,/*von Hippel-Lindau ( VHL ) tumor*/
1555,217,19,/*VHL cancer syndrome*/
1555,260,66,/*sporadic renal cell carcinomas ( RCC ) and brain hemangioblastomas*/
1555,432,3,/*VHL*/
1555,580,6,/*cancer*/
1555,704,3,/*VHL*/
1555,737,23,/*VHL-negative RCC cancer*/
1555,1026,3,/*VHL*/
1555,1120,3,/*VHL*/
1555,1151,15,/*cellular defect*/
1555,1222,5,/*tumor*/
1555,1293,3,/*VHL*/
1555,1311,3,/*VHL*/
1555,1328,5,/*tumor*/
1556,0,26,/*Adenomatous polyposis coli*/
1556,102,5,/*tumor*/
1556,182,18,/*colorectal cancers*/
1556,354,12,/*solid tumors*/
1556,386,7,/*hypoxia*/
1556,522,3,/*APC*/
1556,530,7,/*hypoxia*/
1556,590,7,/*Hypoxia*/
1556,1022,7,/*hypoxia*/
1556,1057,3,/*APC*/
1556,1114,18,/*hypoxic conditions*/
1557,107,18,/*endometrial cancer*/
1557,174,27,/*familial Endometrial Cancer*/
1557,260,37,/*Hereditary Non-Polyposis Colon Cancer*/
1557,361,32,/*hereditary breast/ovarian cancer*/
1557,442,2,/*EC*/
1557,712,2,/*EC*/
1557,958,17,/*clear cell cancer*/
1557,1253,10,/*type II EC*/
1557,1547,2,/*EC*/
1557,1700,2,/*EC*/
1558,473,21,/*GPI anchor deficiency*/
1558,496,35,/*paroxysmal nocturnal hemoglobinuria*/
1559,253,30,/*peroxisome-deficient disorders*/
1559,631,30,/*peroxisome-deficient disorders*/
1559,670,18,/*Zellweger syndrome*/
1559,693,29,/*neonatal adrenoleukodystrophy*/
1559,724,3,/*ALD*/
1559,1404,22,/*metabolic disturbances*/
1559,1454,49,/*steroidogenesis in peroxisome-deficient disorders*/
1560,315,17,/*Von Hippel-Lindau*/
1560,334,3,/*VHL*/
1560,418,6,/*tumors*/
1560,537,18,/*epithelial cancers*/
1560,921,20,/*renal cell carcinoma*/
1560,968,5,/*tumor*/
1560,1051,17,/*embryo compaction*/
1560,1227,5,/*tumor*/
1560,1270,16,/*motility defects*/
1561,0,51,/*Pattern dystrophy of the retinal pigment epithelium*/
1562,100,27,/*psycho-intellectual outcome*/
1562,145,3,/*PKU*/
1562,170,14,/*PAH deficiency*/
1562,1350,38,/*phenylketonuric/hyperphenylalaninaemic*/
1562,1541,14,/*PAH deficiency*/
1563,71,31,/*familial lobular breast cancers*/
1563,163,33,/*hereditary diffuse gastric cancer*/
1563,198,21,/*lobular breast cancer*/
1563,335,21,/*lobular breast cancer*/
1563,394,22,/*diffuse gastric cancer*/
1563,497,21,/*lobular breast cancer*/
1563,592,13,/*breast cancer*/
1563,727,13,/*breast cancer*/
1563,853,13,/*breast cancer*/
1563,1358,30,/*familial lobular breast cancer*/
1565,77,14,/*Wilson disease*/
1565,104,14,/*Wilson disease*/
1565,286,14,/*Wilson disease*/
1568,114,56,/*hypoxanthine phosphoribosyltransferase (HPRT) deficiency*/
1568,198,41,/*gross sex-linked neurological dysfunction*/
1568,241,23,/*gout and urinary stones*/
1568,270,50,/*Lesch-Nyhan or 'complete HPRT-deficiency' syndrome*/
1568,436,20,/*deficiency' syndrome*/
1568,487,27,/*neurological manifestations*/
1568,1181,38,/*testicular, splenic and kidney tissues*/
1569,47,19,/*congenital aniridia*/
1569,173,38,/*autosomal dominant congenital aniridia*/
1569,267,8,/*aniridia*/
1569,291,34,/*unrelated senile cataract controls*/
1569,1000,19,/*congenital aniridia*/
1569,1735,8,/*aniridia*/
1570,155,25,/*X-linked thrombocytopenia*/
1570,796,25,/*X-linked thrombocytopenia*/
1571,60,30,/*cerebrotendinous xanthomatosis*/
1571,164,30,/*cerebrotendinous xanthomatosis*/
1571,196,3,/*CTX*/
1571,251,3,/*CTX*/
1571,265,18,/*inherited disorder*/
1571,313,23,/*neurological impairment*/
1571,447,22,/*neurological disorders*/
1571,566,3,/*CTX*/
1571,659,3,/*CTX*/
1571,764,19,/*Clinical disability*/
1571,1064,3,/*CTX*/
1571,1551,3,/*CTX*/
1571,1677,19,/*white matter volume*/
1571,1724,3,/*CTX*/
1571,1904,3,/*CTX*/
1572,39,19,/*Lesch-Nyhan disease*/
1572,77,19,/*Lesch-Nyhan disease*/
1572,102,21,/*neurogenetic disorder*/
1572,417,65,/*hypoxanthine-guanine phosphoribosyltransferase (HGprt) deficiency*/
1572,1623,22,/*neurogenetic disorders*/
1573,0,33,/*Hypochloremic metabolic alkalosis*/
1573,38,25,/*failure to thrive: answer*/
1574,0,18,/*Tuberous sclerosis*/
1574,42,39,/*fibromatosis of the facial soft tissues*/
1574,83,18,/*Tuberous Sclerosis*/
1574,103,2,/*TS*/
1574,179,17,/*mental deficiency*/
1574,198,8,/*epilepsy*/
1574,211,13,/*angiofibromas*/
1574,247,19,/*periungual fibromas*/
1574,329,26,/*hypopigmented skin lesions*/
1574,377,30,/*Paraventricular calcifications*/
1574,409,18,/*skeletal disorders*/
1574,440,18,/*ophthalmic tumours*/
1574,567,16,/*mandibular cysts*/
1574,589,13,/*oral fibromas*/
1576,1487,20,/*Huntington's disease*/
1576,1517,23,/*spinocerebellar ataxias*/
1576,1548,22,/*polyglutamine diseases*/
1576,1572,17,/*Friedreich ataxia*/
1576,1591,18,/*fragile X syndrome*/
1576,1611,41,/*myoclonic epilepsy, polyalanine disorders*/
1576,1658,18,/*myotonic dystrophy*/
1576,1845,34,/*various polygenic complex diseases*/
1577,19,14,/*Best's disease*/
1577,175,14,/*Best's disease*/
1577,452,14,/*Best's disease*/
1578,0,39,/*Autoimmune lymphoproliferative syndrome*/
1578,43,23,/*multifactorial disorder*/
1579,244,8,/*ischemia*/
1579,256,6,/*cancer*/
1579,339,38,/*angiodysplasia, vascular malformations*/
1579,396,25,/*gastrointestinal bleeding*/
1579,423,14,/*Angiodysplasia*/
1579,461,22,/*von Willebrand disease*/
1579,485,3,/*VWD*/
1579,507,17,/*bleeding disorder*/
1579,533,3,/*VWD*/
1579,562,28,/*deficiency in von Willebrand*/
1579,607,44,/*glycoprotein essential for normal hemostasis*/
1579,1129,3,/*VWD*/
1579,1423,10,/*hemostasis*/
1579,1520,3,/*VWD*/
1579,1569,17,/*vascular diseases*/
1581,12,25,/*epithelial ovarian cancer*/
1581,150,30,/*BRCA-associated ovarian cancer*/
1581,182,2,/*OC*/
1581,337,3,/*DFS*/
1581,314,21,/*disease-free survival*/
1581,460,2,/*OC*/
1581,603,3,/*DFS*/
1581,611,2,/*OS*/
1581,921,2,/*OS*/
1581,1009,3,/*DFS*/
1581,1371,5,/*tumor*/
1582,0,24,/*Familial pycnodysostosis*/
1582,105,15,/*Pycnodysostosis*/
1582,125,38,/*autosomal recessive skeletal dysplasia*/
1582,185,13,/*short stature*/
1582,200,14,/*osteosclerosis*/
1582,287,20,/*hypoplastic clavicle*/
1582,313,16,/*dental anomalies*/
1582,491,15,/*pycnodysostosis*/
1582,627,15,/*pycnodysostosis*/
1582,1008,15,/*pycnodysostosis*/
1583,71,43,/*glucose 6-phosphate dehydrogenase-deficient*/
1584,0,13,/*Lowe syndrome*/
1584,51,13,/*Lowe Syndrome*/
1584,69,27,/*Oculocerebrorenal Dystrophy*/
1584,98,4,/*OCRL*/
1584,169,9,/*cataracts*/
1584,183,8,/*glaucoma*/
1584,193,37,/*delay in neuropsychomotor development*/
1584,232,18,/*cognitive deficits*/
1584,256,22,/*renal Fanconi syndrome*/
1584,319,4,/*OCRL*/
1584,337,11,/*Tubulopathy*/
1584,453,4,/*OCRL*/
1584,613,9,/*cataracts*/
1584,627,9,/*nystagmus*/
1584,738,8,/*polyuria*/
1584,748,10,/*polydipsia*/
1584,764,23,/*intestinal constipation*/
1584,789,18,/*metabolic acidosis*/
1584,809,12,/*phosphaturia*/
1584,839,11,/*proteinuria*/
1584,852,14,/*hypercalciuria*/
1584,868,15,/*hyperuricosuria*/
1584,885,16,/*Nephrocalcinosis*/
1584,925,15,/*renal lithiasis*/
1584,1028,9,/*rachitism*/
1584,1463,22,/*metabolic disturbances*/
1585,21,25,/*mucopolysaccharidosis VII*/
1585,129,25,/*mucopolysaccharidosis VII*/
1585,383,25,/*mucopolysaccharidosis VII*/
1585,410,12,/*Sly syndrome*/
1585,504,25,/*mucopolysaccharidosis VII*/
1585,575,20,/*skeletal deformities*/
1585,601,15,/*premature death*/
1585,989,25,/*mucopolysaccharidosis VII*/
1585,1417,37,/*mucopolysaccharidosis storage disease*/
1586,51,12,/*hearing loss*/
1587,0,20,/*Adrenoleukodystrophy*/
1587,22,29,/*X-linked adrenoleukodystrophy*/
1587,53,3,/*ALD*/
1587,436,26,/*attention deficit disorder*/
1587,466,13,/*hyperactivity*/
1587,520,70,/*impairment of cognition, behavior, vision, hearing, and motor function*/
1587,637,16,/*total disability*/
1587,692,21,/*adrenomyeloneuropathy*/
1587,763,23,/*progressive paraparesis*/
1587,788,22,/*sphincter disturbances*/
1587,812,18,/*sexual dysfunction*/
1587,843,32,/*impaired adrenocortical function*/
1587,979,36,/*primary adrenocortical insufficiency*/
1587,1106,22,/*neurologic abnormality*/
1587,1224,21,/*adrenomyeloneuropathy*/
1587,1382,3,/*ALD*/
1588,25,8,/*Aniridia*/
1588,35,23,/*urogenital malformation*/
1588,63,18,/*mental retardation*/
1590,27,15,/*atherosclerosis*/
1590,47,9,/*xanthomas*/
1590,67,4,/*WHHL*/
1590,239,27,/*established atherosclerosis*/
};
}
static void init11() {
a11 = new int[] {
1590,271,9,/*xanthomas*/
1590,962,22,/*aortic atherosclerosis*/
1590,1217,27,/*xanthomas in digital joints*/
1590,1333,15,/*atherosclerosis*/
1590,1353,9,/*xanthomas*/
1591,17,11,/*amyloidosis*/
1591,83,28,/*familial Mediterranean fever*/
1591,140,28,/*familial Mediterranean fever*/
1591,170,3,/*FMF*/
1591,187,23,/*end-stage renal failure*/
1591,360,3,/*FMF*/
1591,473,3,/*FMF*/
1591,619,3,/*FMF*/
1591,677,3,/*FMF*/
1591,698,11,/*amyloidosis*/
1591,770,3,/*FMF*/
1591,836,3,/*FMF*/
1591,857,11,/*amyloidosis*/
1591,968,3,/*FMF*/
1591,1133,3,/*FMF*/
1591,1185,3,/*FMF*/
1591,1201,3,/*FMF*/
1591,1213,11,/*amyloidosis*/
1591,1337,3,/*FMF*/
1591,1395,11,/*amyloidosis*/
1591,1410,3,/*FMF*/
1591,1448,3,/*FMF*/
1592,0,20,/*Lesch-Nyhan syndrome*/
1592,255,20,/*Lesch-Nyhan syndrome*/
1592,277,3,/*LNS*/
1592,285,11,/*Lesch-Nyhan*/
1592,307,3,/*LNV*/
1593,16,51,/*autosomal recessive nonsyndromic hearing impairment*/
1593,119,51,/*autosomal recessive nonsyndromic hearing impairment*/
1593,172,6,/*ARNSHI*/
1593,362,6,/*ARNSHI*/
1594,0,17,/*Angelman syndrome*/
1594,68,17,/*Angelman syndrome*/
1594,87,2,/*AS*/
1594,96,27,/*neurodevelopmental disorder*/
1594,221,2,/*AS*/
1594,309,2,/*AS*/
1594,385,2,/*AS*/
1594,1198,13,/*macrocephalic*/
1594,1285,14,/*attention span*/
1594,1627,2,/*AS*/
1594,1715,2,/*AS*/
1594,1719,7,/*Obesity*/
1596,37,20,/*muscular dystrophies*/
1597,28,27,/*hereditary haemochromatosis*/
1598,35,22,/*lipoprotein deficiency*/
1600,44,25,/*breast and ovarian cancer*/
1600,140,13,/*breast cancer*/
1600,158,14,/*ovarian cancer*/
1600,382,13,/*breast cancer*/
1600,434,13,/*breast cancer*/
1600,772,25,/*breast and ovarian cancer*/
1600,1290,24,/*breast or ovarian cancer*/
1600,1418,13,/*breast cancer*/
1600,1586,13,/*breast cancer*/
1602,9,17,/*foveal hypoplasia*/
1602,178,26,/*isolated foveal hypoplasia*/
1602,276,3,/*OCT*/
1602,246,28,/*optical coherence tomography*/
1602,339,25,/*chromosomal abnormalities*/
1602,418,4,/*OCA2*/
1602,452,15,/*ocular albinism*/
1602,510,8,/*aniridia*/
1602,638,17,/*foveal hypoplasia*/
1602,823,26,/*isolated foveal hypoplasia*/
1602,1005,26,/*isolated foveal hypoplasia*/
1603,188,34,/*familial breast and ovarian cancer*/
1603,940,23,/*breast / ovarian cancer*/
1604,0,20,/*Lesch-Nyhan syndrome*/
1605,166,5,/*tumor*/
1605,208,12,/*colon cancer*/
1605,824,3,/*CHO*/
1605,1100,3,/*APC*/
1605,1115,3,/*APC*/
1606,151,13,/*tumorigenesis*/
1606,410,18,/*multipolar mitosis*/
1606,579,15,/*bipolar mitosis*/
1607,20,30,/*familial adenomatous polyposis*/
1607,434,7,/*cancers*/
1607,979,42,/*colorectal cancer predisposition syndromes*/
1607,1023,30,/*Familial Adenomatous Polyposis*/
1607,1055,3,/*FAP*/
1608,86,15,/*Canavan disease*/
1608,103,15,/*Canavan disease*/
1608,186,28,/*deficiency of aspartoacylase*/
1608,256,15,/*Canavan disease*/
1608,590,15,/*Canavan disease*/
1608,1281,15,/*Canavan disease*/
1608,1841,15,/*Canavan disease*/
1609,97,12,/*galactosemia*/
1609,122,22,/*Classical galactosemia*/
1609,150,16,/*genetic disorder*/
1609,479,12,/*galactosemia*/
1609,642,12,/*galactosemia*/
1609,770,12,/*galactosemia*/
1609,1027,12,/*galactosemia*/
1610,155,23,/*breast / ovarian cancer*/
1612,0,42,/*Corticosteroid treatment of kidney disease*/
1612,61,56,/*familial lecithin-cholesterol acyltransferase deficiency*/
1612,119,63,/*Familial lecithin-cholesterol acyltransferase (LCAT) deficiency*/
1612,184,3,/*FLD*/
1612,295,18,/*haemolytic anaemia*/
1612,318,17,/*corneal opacities*/
1612,405,13,/*renal failure*/
1612,448,13,/*renal disease*/
1612,525,13,/*renal disease*/
1612,560,3,/*FLD*/
1612,614,11,/*proteinuria*/
1612,630,12,/*ankle oedema*/
1612,684,3,/*FLD*/
1612,736,30,/*serpiginous fibrillar deposits*/
1612,1300,3,/*FLD*/
1612,1371,12,/*dyslipidemia*/
1612,1407,20,/*glomerular disorders*/
1612,1431,14,/*LCAT-deficient*/
1613,43,25,/*Chanarin-Dorfman syndrome*/
1613,103,25,/*Chanarin-Dorfman syndrome*/
1613,130,3,/*CDS*/
1613,145,38,/*autosomal recessive metabolic disorder*/
1613,194,21,/*congenital ichthyosis*/
1613,456,3,/*CDS*/
1613,558,3,/*CDS*/
1615,183,10,/*hemostasis*/
1615,221,10,/*thrombosis*/
1615,1143,22,/*von Willebrand disease*/
1616,179,3,/*VWD*/
1616,190,37,/*autosomal recessive bleeding disorder*/
1616,155,22,/*von Willebrand disease*/
1616,397,3,/*VWD*/
1616,542,3,/*VWD*/
1616,649,3,/*VWD*/
1616,1577,3,/*VWD*/
1617,76,14,/*Wilson disease*/
1617,92,14,/*Wilson disease*/
1617,108,2,/*WD*/
1617,234,52,/*hepatic copper accumulation and lethal liver failure*/
1617,446,2,/*WD*/
1617,1643,2,/*WD*/
1618,1521,18,/*myotonic dystrophy*/
1618,1544,18,/*Huntington disease*/
1619,45,15,/*Gaucher disease*/
1619,108,15,/*Gaucher disease*/
1619,125,2,/*GD*/
1619,135,28,/*autosomal recessive disorder*/
1619,223,2,/*GD*/
1619,315,26,/*neurological abnormalities*/
1619,432,21,/*neurological symptoms*/
1619,463,19,/*Parkinson's disease*/
1619,484,2,/*PD*/
1619,499,2,/*GD*/
1619,455,2,/*NS*/
1619,719,15,/*Gaucher Disease*/
1619,745,26,/*Neurological abnormalities*/
1619,913,19,/*Pearson coefficient*/
1619,1072,2,/*PD*/
1619,1147,2,/*PD*/
1619,1176,2,/*NS*/
1619,1279,2,/*PD*/
1619,1399,2,/*PD*/
1619,1557,15,/*PD in type 1 GD*/
1619,1598,2,/*PD*/
1619,1756,9,/*type 1 GD*/
1620,64,14,/*von Willebrand*/
1620,110,29,/*type 1 von Willebrand disease*/
1620,471,29,/*type 1 von Willebrand disease*/
1620,534,14,/*von Willebrand*/
1620,750,14,/*von Willebrand*/
1620,1272,14,/*von Willebrand*/
1620,1330,14,/*von Willebrand*/
1620,1372,14,/*von Willebrand*/
1620,1630,22,/*von Willebrand disease*/
1620,1749,22,/*von Willebrand disease*/
1621,10,8,/*aniridia*/
1621,24,25,/*unilateral Peters anomaly*/
1621,51,8,/*Aniridia*/
1621,66,49,/*autosomal-dominant, panocular, congenital anomaly*/
1621,208,14,/*Peters anomaly*/
1621,312,8,/*aniridia*/
1621,385,29,/*lenticular-corneal attachment*/
1621,439,8,/*aniridia*/
1621,452,14,/*Peters anomaly*/
1622,51,17,/*dystrophinopathic*/
1622,101,38,/*Duchenne and Becker muscular dystrophy*/
1622,141,3,/*DMD*/
1622,149,3,/*BMD*/
1622,277,3,/*DMD*/
1622,490,18,/*dystrophinopathies*/
1622,681,3,/*DMD*/
1622,725,7,/*DMD/BMD*/
1622,758,17,/*dystrophinopathic*/
1622,790,3,/*DMD*/
1622,802,3,/*BMD*/
1622,827,47,/*cardiac, respiratory, and cognitive involvement*/
1622,1140,3,/*DMD*/
1622,1331,3,/*BMD*/
1622,1389,18,/*cardiac impairment*/
1622,1413,3,/*BMD*/
1622,1460,3,/*BMD*/
1622,1529,28,/*muscle dystrophin deficiency*/
1622,1793,3,/*DMD*/
1623,11,20,/*retinitis pigmentosa*/
1623,108,20,/*retinitis pigmentosa*/
1623,146,33,/*retinal angiomatous proliferation*/
1623,181,3,/*RAP*/
1623,232,20,/*retinitis pigmentosa*/
1623,282,23,/*intraretinal hemorrhage*/
1623,323,13,/*retinal edema*/
1623,417,28,/*retino-choroidal anastomosis*/
1623,519,3,/*RAP*/
1623,526,32,/*age-related macular degeneration*/
1623,560,3,/*AMD*/
1623,714,20,/*retinitis pigmentosa*/
1623,752,3,/*RAP*/
1623,798,20,/*retinitis pigmentosa*/
1623,836,28,/*choroidal neovascularization*/
1623,913,3,/*RAP*/
1623,931,20,/*retinitis pigmentosa*/
1624,34,15,/*Muenke syndrome*/
1624,105,26,/*syndromal craniosynostosis*/
1624,405,15,/*Muenke syndrome*/
1624,480,26,/*craniosynostosis syndromes*/
1624,658,15,/*Muenke syndrome*/
1624,798,31,/*hypoplasia of the frontal sinus*/
1624,831,81,/*ptosis of the upper eyelids, dysplastic elbow joints with restricted elbow motion*/
1624,959,11,/*polydactyly*/
1624,979,52,/*ankylosis of the elbow, fusion of cervical vertebrae*/
1624,1037,8,/*epilepsy*/
1624,1058,19,/*Upper eyelid ptosis*/
1624,1113,24,/*Saethre-Chotzen syndrome*/
1624,1191,15,/*Muenke syndrome*/
1624,1227,24,/*Saethre-Chotzen syndrome*/
1625,52,22,/*dilated cardiomyopathy*/
1626,723,32,/*liver, the kidney, the brown fat*/
1626,1892,40,/*embryonic and extra-embryonic structures*/
1627,78,14,/*gastric cancer*/
1627,106,33,/*Hereditary diffuse gastric cancer*/
1627,141,4,/*HDGC*/
1627,153,34,/*autosomal dominant cancer syndrome*/
1627,216,4,/*HDGC*/
1627,804,6,/*cancer*/
1627,1796,4,/*HDGC*/
1628,0,20,/*Denys-Drash syndrome*/
1628,113,20,/*Denys-Drash syndrome*/
1628,152,9,/*nephrosis*/
1628,163,17,/*dysgenetic gonads*/
1628,205,11,/*Wilms tumor*/
1628,353,21,/*pseudohermaphroditism*/
1628,376,18,/*nephrotic syndrome*/
1628,414,13,/*renal failure*/
1628,744,20,/*Denys-Drash syndrome*/
1629,88,26,/*adenomatous polyposis coli*/
1629,116,3,/*Apc*/
1629,248,17,/*colorectal cancer*/
1629,267,3,/*CRC*/
1629,355,3,/*CRC*/
1629,438,3,/*CRC*/
1629,522,3,/*CRC*/
1629,678,3,/*CRC*/
1629,784,3,/*APC*/
1629,1091,3,/*CIS*/
1629,1067,22,/*common insertion sites*/
1629,1503,3,/*CRC*/
1629,1627,6,/*cancer*/
1629,1725,14,/*deadly disease*/
1630,0,28,/*Lesch-Nyhan variant syndrome*/
1630,220,20,/*Lesch-Nyhan syndrome*/
1630,242,3,/*LNS*/
1630,260,3,/*LNV*/
1630,694,16,/*genetic diseases*/
1631,96,12,/*alkaptonuria*/
1631,208,12,/*alkaptonuria*/
1631,297,12,/*alkaptonuria*/
1631,960,12,/*alkaptonuria*/
1631,1053,12,/*alkaptonuria*/
1632,25,25,/*von Hippel-Lindau disease*/
1632,51,20,/*renal cell carcinoma*/
1632,99,9,/*VHL tumor*/
1632,131,31,/*von Hippel-Lindau (VHL) disease*/
1632,175,3,/*VHL*/
1632,225,20,/*renal cell carcinoma*/
1632,316,3,/*VHL*/
1632,380,3,/*VHL*/
1632,573,3,/*VHL*/
1632,661,6,/*cancer*/
1632,669,6,/*GISTIC*/
1632,689,3,/*VHL*/
1632,865,6,/*tumors*/
1632,915,3,/*VHL*/
1632,982,3,/*VHL*/
1632,1025,9,/*loss/gain*/
1632,1092,5,/*tumor*/
1632,1183,3,/*VHL*/
1632,1268,6,/*cancer*/
1632,1366,3,/*VHL*/
1632,1600,3,/*VHL*/
1633,0,13,/*LAMM syndrome*/
1633,19,20,/*middle ear dysplasia*/
1633,234,20,/*labyrinthine aplasia*/
1633,283,4,/*LAMM*/
1633,589,29,/*absence of otodental syndrome*/
1633,758,13,/*LAMM Syndrome*/
1634,72,8,/*aniridia*/
1634,196,16,/*classic aniridia*/
1634,809,8,/*aniridia*/
1634,833,9,/*nystagmus*/
1634,1416,8,/*aniridia*/
1635,40,16,/*gait abnormality*/
1635,60,20,/*dystrophin-deficient*/
1635,131,18,/*gait abnormalities*/
1635,153,4,/*GRMD*/
1635,159,35,/*Golden retriever muscular dystrophy*/
1635,397,4,/*GRMD*/
1635,556,20,/*dystrophin-deficient*/
1635,713,3,/*PCA*/
1635,683,28,/*principal component analysis*/
1635,1184,4,/*GRMD*/
1635,1246,12,/*gait quality*/
1635,1368,14,/*gait disorders*/
1635,1473,4,/*GRMD*/
1636,0,27,/*Myoclonus-dystonia syndrome*/
1636,29,27,/*Myoclonus dystonia syndrome*/
1636,170,9,/*myoclonus*/
1636,58,3,/*MDS*/
1636,241,3,/*MDS*/
1636,263,28,/*inherited myoclonus-dystonia*/
1636,846,16,/*primary dystonia*/
1636,908,40,/*irregular and arrhythmic jerky movements*/
1636,965,8,/*dystonia*/
1636,975,16,/*Usually dystonia*/
1636,1109,18,/*myoclonic dystonia*/
1636,1166,24,/*Dopa-responsive dystonia*/
1636,1283,8,/*dystonia*/
1636,1296,9,/*myoclonus*/
1637,117,28,/*fragile X mental retardation*/
1637,260,18,/*fragile X syndrome*/
1638,93,50,/*glucose-6-phosphate dehydrogenase (G6PD)-deficient*/
1638,292,15,/*G6PD deficiency*/
1638,346,14,/*G6PD-deficient*/
1638,645,15,/*G6PD deficiency*/
1638,1866,15,/*G6PD deficiency*/
1639,125,16,/*Craniosynostosis*/
1639,376,29,/*isolated bicoronal synostosis*/
1640,26,24,/*hereditary breast cancer*/
1640,88,26,/*breast and ovarian cancers*/
1640,503,14,/*breast cancers*/
1640,559,23,/*sporadic breast cancers*/
1640,612,6,/*tumors*/
1640,823,6,/*tumors*/
1641,29,14,/*ovarian cancer*/
1641,230,19,/*gynecologic cancers*/
1641,416,14,/*ovarian cancer*/
1641,581,14,/*ovarian cancer*/
1642,281,25,/*breast and ovarian cancer*/
1642,666,14,/*ovarian cancer*/
1642,1471,26,/*breast and ovarian cancers*/
1644,964,15,/*embryonic liver*/
1645,152,35,/*Familial Adenomatous Polyposis coli*/
1645,189,3,/*FAP*/
1645,340,26,/*adenomatous polyposis coli*/
1645,809,3,/*APC*/
1645,993,5,/*tumor*/
1645,1328,10,/*Rb-1 tumor*/
1645,1362,14,/*retinoblastoma*/
1647,35,15,/*Kabuki syndrome*/
1647,52,15,/*Kabuki syndrome*/
1647,69,2,/*KS*/
1647,129,38,/*anomalies/mental retardation syndromes*/
1647,284,19,/*developmental delay*/
1647,305,13,/*short stature*/
1647,347,26,/*urogenital tract anomalies*/
1647,479,15,/*Kabuki syndrome*/
1647,900,13,/*short stature*/
1647,918,15,/*renal anomalies*/
1647,1415,15,/*Kabuki syndrome*/
1648,1,41,/*X-linked progressive muscular dystrophies*/
1649,44,6,/*cancer*/
1649,512,7,/*cancers*/
1649,524,6,/*cancer*/
1649,994,13,/*breast cancer*/
1649,1036,17,/*ACHN renal cancer*/
1649,1065,22,/*OVCAR-3 ovarian cancer*/
1650,108,31,/*Von Hippel-Lindau (VHL) disease*/
1650,177,3,/*VHL*/
1650,226,6,/*tumors*/
1650,251,3,/*VHL*/
1650,503,3,/*VHL*/
1650,534,22,/*vascular abnormalities*/
1650,579,3,/*VHL*/
1650,615,16,/*vascular lesions*/
1650,893,3,/*VHL*/
1650,1077,15,/*EAF2-deficiency*/
1650,1149,14,/*VHL deficiency*/
1650,1204,24,/*hepatic vascular lesions*/
1650,1263,16,/*vascular lesions*/
1650,1451,38,/*proliferative hepatic vascular lesions*/
1650,1508,3,/*VHL*/
1650,1617,19,/*microvessel density*/
1650,1684,25,/*intraepithelial neoplasia*/
1650,1753,3,/*VHL*/
1650,1868,5,/*tumor*/
1652,32,13,/*tumorigenesis*/
1652,291,5,/*tumor*/
1652,340,5,/*tumor*/
1652,398,5,/*tumor*/
1652,648,5,/*tumor*/
1652,856,6,/*tumors*/
1652,872,8,/*lymphoma*/
1652,969,10,/*carcinomas*/
1652,1076,5,/*tumor*/
1653,46,18,/*colorectal cancers*/
1653,164,18,/*colorectal cancers*/
1653,386,18,/*pancreatic cancers*/
1653,484,18,/*colorectal cancers*/
1653,917,7,/*cancers*/
1653,1033,18,/*colorectal cancers*/
1653,1114,18,/*colorectal cancers*/
1654,60,24,/*dopa-responsive dystonia*/
1655,74,22,/*Classical galactosemia*/
1655,103,46,/*autosomal recessive inborn error of metabolism*/
1655,427,22,/*classical galactosemia*/
1656,93,26,/*hematological malignancies*/
1657,22,9,/*Neisseria*/
1657,201,11,/*gonorrhoeae*/
1657,938,2,/*LF*/
1658,0,43,/*Normocholesterolemic dysbetalipoproteinemia*/
1658,49,13,/*xanthomatosis*/
1658,102,20,/*palmar xanthomatosis*/
1658,197,9,/*xanthomas*/
1658,413,29,/*Type III hyperlipoproteinemia*/
1658,631,20,/*hypercholesterolemic*/
1658,802,22,/*dysbetalipoproteinemia*/
1658,947,13,/*xanthomatosis*/
1658,969,20,/*hypercholesterolemia*/
1659,26,25,/*colorectal carcinogenesis*/
1660,0,36,/*Familial forms of diabetes insipidus*/
1660,158,18,/*diabetes insipidus*/
1660,198,18,/*Diabetes insipidus*/
1660,222,17,/*clinical syndrome*/
1660,317,8,/*polyuria*/
1660,392,18,/*diabetes insipidus*/
1660,551,15,/*neurohypophysis*/
1660,581,18,/*diabetes insipidus*/
1660,623,35,/*neurohypophyseal diabetes insipidus*/
1660,924,39,/*renal or nephrogenic diabetes insipidus*/
1660,1008,18,/*diabetes insipidus*/
1660,1202,18,/*diabetes insipidus*/
1662,21,22,/*Aarskog-Scott syndrome*/
1662,80,22,/*Aarskog-Scott syndrome*/
1662,113,27,/*X-linked recessive disorder*/
1662,183,21,/*genital abnormalities*/
1662,219,22,/*Aarskog-Scott syndrome*/
1663,109,23,/*Familial Ovarian Cancer*/
1663,276,30,/*breast and / or ovarian cancer*/
1663,741,23,/*breast / ovarian cancer*/
1663,855,30,/*breast and / or ovarian cancer*/
1664,325,6,/*cancer*/
1664,448,3,/*VUS*/
1664,512,3,/*VUS*/
1664,611,3,/*VUS*/
1664,1506,3,/*VUS*/
1665,28,36,/*hereditary breast and ovarian cancer*/
1665,1109,21,/*breast-ovarian cancer*/
1665,1165,26,/*predominant ovarian cancer*/
1665,1282,21,/*breast-ovarian cancer*/
1665,1409,6,/*tumors*/
1665,1424,5,/*tumor*/
1665,1513,22,/*skin , and lung cancer*/
1665,1540,18,/*malignant melanoma*/
1665,1564,17,/*oligodendroglioma*/
1665,1590,14,/*carcinosarcoma*/
1665,1682,14,/*ovarian cancer*/
1665,1862,24,/*hereditary breast cancer*/
1665,1919,15,/*ovarian cancers*/
1666,8,18,/*myotonic dystrophy*/
1667,30,29,/*von Willebrand disease type 3*/
1668,63,25,/*male renal cell carcinoma*/
1668,125,6,/*cancer*/
1668,241,25,/*breast and ovarian cancer*/
1668,310,7,/*cancers*/
1668,329,13,/*breast cancer*/
1668,420,20,/*renal cell carcinoma*/
1668,631,20,/*renal cell carcinoma*/
1669,98,17,/*Familial Melanoma*/
1669,208,8,/*melanoma*/
1669,967,17,/*familial melanoma*/
1670,110,14,/*Wilson disease*/
1670,192,16,/*Wilson's disease*/
1670,210,2,/*WD*/
1670,272,2,/*WD*/
1670,349,2,/*WD*/
1670,1014,2,/*WD*/
1670,1247,27,/*neurological manifestations*/
1670,1278,2,/*WD*/
1670,1352,2,/*WD*/
1670,1449,2,/*WD*/
1670,1535,27,/*neurological manifestations*/
1670,1566,2,/*WD*/
1672,37,27,/*Duchenne Muscular Dystrophy*/
1672,66,27,/*Duchenne Muscular Dystrophy*/
1672,95,3,/*DMD*/
1672,106,27,/*X-linked recessive disorder*/
1672,161,14,/*muscle wasting*/
1672,180,8,/*weakness*/
1672,237,3,/*DMD*/
1672,403,22,/*postural abnormalities*/
1672,578,3,/*DMD*/
1672,667,3,/*DMD*/
1672,805,3,/*DMD*/
1673,0,29,/*X-linked adrenoleukodystrophy*/
1673,53,28,/*idiopathic Addison's disease*/
1673,112,29,/*X-Linked adrenoleukodystrophy*/
1673,144,3,/*ALD*/
1673,187,67,/*demyelination of the central nervous system , adrenal insufficiency*/
1673,333,3,/*ALD*/
1673,480,3,/*ALD*/
1673,554,21,/*Adrenomyeloneuropathy*/
1673,578,3,/*AMN*/
1673,658,21,/*Adrenal insufficiency*/
1673,682,16,/*Addisons disease*/
1673,731,3,/*AMN*/
1673,738,12,/*cerebral ALD*/
1673,798,3,/*ALD*/
1673,839,3,/*ALD*/
1673,861,16,/*Addisons disease*/
1673,1093,39,/*idiopathic adrenocortical insufficiency*/
1673,1400,12,/*cerebral ALD*/
1673,1423,21,/*adrenomyeloneuropathy*/
1673,1450,20,/*cerebral involvement*/
1673,1497,3,/*AMN*/
1673,1540,3,/*ALD*/
1673,1567,27,/*idiopathic Addisons disease*/
1674,43,20,/*abetalipoproteinemia*/
1674,195,30,/*recessive abetalipoproteinemia*/
1674,455,20,/*abetalipoproteinemia*/
1674,1803,20,/*abetalipoproteinemia*/
1675,1,15,/*LCAT deficiency*/
1675,66,43,/*autosomal recessive condition of deficiency*/
1675,240,29,/*complete enzymatic deficiency*/
1675,337,3,/*FLD*/
1675,379,12,/*dyslipidemia*/
1675,393,17,/*corneal opacities*/
1675,412,6,/*anemia*/
1675,423,23,/*progressive nephropathy*/
1675,503,3,/*FED*/
1675,513,12,/*dyslipidemia*/
1675,530,34,/*progressive corneal opacities only*/
1675,583,3,/*FLD*/
1675,653,23,/*end-stage renal disease*/
1675,769,17,/*corneal opacities*/
1675,800,6,/*anemia*/
1675,839,21,/*chronic renal failure*/
1675,874,23,/*proteinuric nephropathy*/
1675,974,16,/*toward sclerosis*/
1675,1359,24,/*hypoalphalipoproteinemia*/
1675,1656,23,/*coronary artery disease*/
1675,1754,15,/*LCAT deficiency*/
1675,2246,24,/*hypoalphalipoproteinemia*/
1676,99,19,/*Parkinson's disease*/
1676,182,19,/*Parkinson's disease*/
1676,203,2,/*PD*/
1676,560,2,/*PD*/
1676,1804,2,/*PD*/
1677,49,30,/*hypokalemic periodic paralysis*/
1677,129,30,/*Hypokalemic periodic paralysis*/
1677,161,6,/*HypoPP*/
1677,175,27,/*autosomal dominant disorder*/
1677,240,15,/*muscle weakness*/
1677,620,6,/*HypoPP*/
1678,53,25,/*breast and ovarian cancer*/
1678,138,13,/*breast cancer*/
1678,203,22,/*Canadian breast cancer*/
1678,230,23,/*breast / ovarian cancer*/
1678,361,6,/*cancer*/
1678,821,14,/*ovarian cancer*/
1678,983,13,/*breast cancer*/
1678,1047,13,/*breast cancer*/
1678,1467,22,/*Canadian breast cancer*/
1678,1494,23,/*breast / ovarian cancer*/
1679,1,16,/*Hemolytic anemia*/
1679,54,16,/*Lawsonia inermis*/
1679,103,15,/*G6PD deficiency*/
1679,128,16,/*Lawsonia inermis*/
1679,398,14,/*G6PD-deficient*/
1679,520,16,/*hemolytic anemia*/
1679,657,15,/*G6PD-deficiency*/
1680,75,24,/*Wiskott-Aldrich syndrome*/
1680,117,16,/*thrombocytopenia*/
1680,838,16,/*thrombocytopenia*/
1680,856,6,/*eczema*/
1680,965,24,/*Wiskott-Aldrich syndrome*/
1680,991,3,/*WAS*/
1680,1192,3,/*WAS*/
1680,1717,18,/*X-linked disorders*/
1681,27,33,/*classical and Duarte galactosemia*/
1681,124,22,/*Classical galactosemia*/
1681,560,19,/*Duarte galactosemia*/
1681,633,22,/*classical galactosemia*/
1681,830,12,/*galactosemia*/
1681,946,12,/*galactosemia*/
1681,1161,12,/*galactosemia*/
1681,1233,12,/*galactosemia*/
1683,111,17,/*colorectal cancer*/
1683,130,3,/*CRC*/
1683,233,3,/*APC*/
1683,1711,17,/*visible neoplasia*/
1683,1903,3,/*CRC*/
1684,83,13,/*breast cancer*/
1685,11,30,/*cerebrotendinous xanthomatosis*/
1685,139,8,/*seizures*/
1685,244,18,/*mental retardation*/
1685,517,39,/*bilateral swellings of Achilles tendons*/
1685,584,25,/*poor intellectual ability*/
1685,611,13,/*hyperreflexia*/
1685,659,17,/*cerebellar ataxia*/
1685,1023,16,/*multiple lesions*/
1685,1193,8,/*seizures*/
1685,1270,25,/*irreversible brain damage*/
1685,1346,3,/*CTX*/
1685,1381,8,/*seizures*/
1685,1406,3,/*CTX*/
1685,1431,20,/*symptomatic epilepsy*/
1686,0,25,/*von Hippel-Lindau disease*/
1686,71,6,/*tumors*/
1686,132,25,/*von Hippel-Lindau disease*/
1686,260,6,/*tumors*/
1686,279,25,/*audiovestibular morbidity*/
1686,429,5,/*tumor*/
1686,540,3,/*VHL*/
1686,778,25,/*von Hippel-Lindau disease*/
1686,864,6,/*tumors*/
1686,928,6,/*tumors*/
1686,959,24,/*audiovestibular symptoms*/
1686,1148,6,/*tumors*/
1686,1228,5,/*tumor*/
1686,1357,5,/*tumor*/
1686,1548,25,/*Audiometric abnormalities*/
1686,1591,25,/*von Hippel-Lindau disease*/
1686,1678,6,/*tumors*/
1686,1701,36,/*microscopic endolymphatic sac tumors*/
1686,1786,5,/*tumor*/
1686,1869,5,/*tumor*/
1687,101,14,/*Wilson disease*/
1687,117,14,/*Wilson disease*/
1687,133,2,/*WD*/
1687,167,2,/*WD*/
1687,236,2,/*WD*/
1687,268,20,/*neurological disease*/
1687,939,19,/*deficiency of ATP7B*/
1687,1878,2,/*WD*/
1688,1,16,/*Wolfram syndrome*/
1689,262,6,/*AO-GLD*/
1689,1519,6,/*AO-GLD*/
1689,1727,6,/*IF-GLD*/
1689,1834,3,/*GLD*/
1690,28,17,/*von Hippel-Lindau*/
1690,47,3,/*VHL*/
1690,69,29,/*von Hippel-Lindau (VHL) tumor*/
1690,288,3,/*VHL*/
1690,397,5,/*tumor*/
1690,580,5,/*tumor*/
1690,726,9,/*ARF tumor*/
1690,778,3,/*VHL*/
1690,821,3,/*VHL*/
1690,834,3,/*ARF*/
1691,849,3,/*DFO*/
1691,713,15,/*desferrioxamine*/
1692,32,46,/*cryptic splicing in 17a-hydroxylase deficiency*/
1692,134,27,/*autosomal recessive disease*/
1692,170,30,/*congenital adrenal hyperplasia*/
1692,221,12,/*hypertension*/
1692,239,11,/*hypokalemia*/
1693,0,26,/*Pyruvate kinase deficiency*/
1693,28,31,/*Pyruvate kinase (PK) deficiency*/
1693,189,13,/*PK deficiency*/
1693,222,42,/*hereditary nonspherocytic hemolytic anemia*/
1693,310,34,/*Embden-Meyerhof glycolytic pathway*/
1693,843,13,/*PK deficiency*/
1694,205,13,/*Lowe syndrome*/
1694,246,20,/*congenital cataracts*/
1694,268,17,/*central hypotonia*/
1694,291,34,/*renal proximal tubular dysfunction*/
1694,440,11,/*endocytosis*/
1694,491,13,/*Lowe syndrome*/
1694,1004,34,/*renal proximal tubular dysfunction*/
1694,1042,13,/*Lowe syndrome*/
1695,0,24,/*Fanconi- Bickel Syndrome*/
1695,57,24,/*Fanconi -Bickel Syndrome*/
1695,83,3,/*FBS*/
1695,177,13,/*enzyme defect*/
1695,365,21,/*galactose intolerance*/
1695,388,34,/*proximal renal tubular dysfunction*/
1695,424,12,/*hepatomegaly*/
1696,18,12,/*hemophilia B*/
1696,287,17,/*X-linked diseases*/
1696,313,10,/*hemophilia*/
1696,631,12,/*hemophiliacs*/
1696,1936,10,/*hemophilia*/
1696,2411,10,/*hemophilia*/
1697,272,6,/*cancer*/
1697,457,6,/*cancer*/
1697,1811,6,/*cancer*/
1697,1939,6,/*cancer*/
1698,440,5,/*HADHB*/
1698,644,14,/*neuromyopathic*/
1698,815,14,/*MTP deficiency*/
1698,1187,14,/*rhabdomyolysis*/
1698,1383,14,/*MTP deficiency*/
1698,1700,14,/*MTP deficiency*/
1698,1846,14,/*neuromyopathic*/
1698,1982,14,/*MTP deficiency*/
1698,2084,14,/*rhabdomyolysis*/
1699,162,14,/*Wilson disease*/
1699,405,14,/*Wilson disease*/
1699,760,18,/*hepatosplenomegaly*/
1699,806,6,/*anemia*/
1699,817,16,/*thrombocytopenia*/
1699,1162,14,/*Wilson disease*/
1699,1264,14,/*Wilson disease*/
1700,23,27,/*X-linked muscular dystrophy*/
1701,40,21,/*Prader-Willi syndrome*/
1701,87,21,/*Prader-Willi syndrome*/
1701,110,3,/*PWS*/
1701,135,13,/*short stature*/
1701,150,18,/*muscular hypotonia*/
1701,170,21,/*cognitive dysfunction*/
1701,235,7,/*obesity*/
1701,258,3,/*PWS*/
1701,286,25,/*growth hormone deficiency*/
1701,313,3,/*GHD*/
1701,380,3,/*PWS*/
1701,495,18,/*glucose metabolism*/
1701,573,3,/*PWS*/
1701,612,3,/*PWS*/
1701,782,3,/*GHD*/
1701,791,45,/*impaired glucose tolerance and seven diabetes*/
1701,1530,8,/*diabetes*/
1701,1732,3,/*PWS*/
1702,127,3,/*HCP*/
1702,139,26,/*autosomal dominant disease*/
1702,185,40,/*deficiency of coproporphyrinogen oxidase*/
1702,325,3,/*HCP*/
1703,58,22,/*sporadic breast cancer*/
1703,112,13,/*breast cancer*/
1703,319,14,/*breast cancers*/
1703,389,5,/*tumor*/
1703,428,22,/*sporadic breast cancer*/
1703,653,14,/*breast cancers*/
1703,723,13,/*breast cancer*/
1703,1045,6,/*tumors*/
1703,1096,23,/*sporadic breast cancers*/
1704,256,16,/*embryonic growth*/
1704,355,28,/*neurodevelopmental disorders*/
1704,712,28,/*neurodevelopmental disorders*/
1705,55,36,/*hereditary breast and ovarian cancer*/
1705,217,26,/*breast and ovarian cancers*/
1705,720,6,/*Cancer*/
1705,1334,6,/*cancer*/
1706,89,35,/*autosomal recessive Alport syndrome*/
1706,126,35,/*Autosomal recessive Alport syndrome*/
1706,189,18,/*glomerulonephritis*/
1706,723,35,/*autosomal recessive Alport syndrome*/
1707,41,33,/*aneurysms-osteoarthritis syndrome*/
1707,88,33,/*Aneurysms-osteoarthritis syndrome*/
1707,123,3,/*AOS*/
1707,137,62,/*autosomal dominant syndromic form of thoracic aortic aneurysms*/
1707,249,18,/*arterial aneurysms*/
1707,272,10,/*tortuosity*/
1707,316,51,/*cutaneous anomalies, and early-onset osteoarthritis*/
1707,369,3,/*AOS*/
1707,691,3,/*AOS*/
1707,1031,3,/*AOS*/
1707,1204,19,/*joint abnormalities*/
1707,1235,14,/*osteoarthritis*/
1707,1254,25,/*osteochondritis dissecans*/
1707,1343,28,/*Cardiovascular abnormalities*/
1707,1425,23,/*mainly aortic aneurysms*/
1707,1565,21,/*intracranial arteries*/
1707,1629,19,/*joint abnormalities*/
1707,1673,17,/*aortic dissection*/
1707,1713,26,/*craniofacial abnormalities*/
1707,1750,13,/*hypertelorism*/
1707,1768,14,/*abnormal uvula*/
1708,44,13,/*Lowe syndrome*/
1708,118,13,/*Lowe syndrome*/
1709,53,14,/*paediatric FMF*/
1709,196,3,/*FMF*/
1709,339,3,/*FMF*/
1709,356,14,/*paediatric FMF*/
1709,484,3,/*FMF*/
1709,748,3,/*FMF*/
1709,768,3,/*FMF*/
1710,14,15,/*prostate cancer*/
1710,184,15,/*Prostate Cancer*/
1710,218,24,/*Multiple prostate cancer*/
1710,244,3,/*PCa*/
1710,324,4,/*GWAS*/
1710,291,31,/*genome-wide association studies*/
1710,652,26,/*hereditary prostate cancer*/
1710,680,3,/*HPC*/
1710,917,15,/*Prostate Cancer*/
1710,1478,3,/*HPC*/
1710,1688,3,/*HPC*/
1712,8,28,/*chronic lymphocytic leukemia*/
1714,20,20,/*hypertriglyceridemia*/
1714,59,16,/*hepatic fibrosis*/
1714,179,31,/*hereditary hypertriglyceridemia*/
1714,275,23,/*monogenic dyslipidemias*/
1714,466,20,/*hypertriglyceridemia*/
1714,515,16,/*hepatic fibrosis*/
1714,986,20,/*hypertriglyceridemia*/
1714,1604,24,/*hepatocellular carcinoma*/
1715,17,16,/*Wolfram syndrome*/
1715,105,21,/*mitochondrial disease*/
1715,140,22,/*Mitochondrial diseases*/
1715,659,19,/*Mendelian disorders*/
1715,882,22,/*mitochondrial disorder*/
1715,933,17,/*diabetes mellitus*/
1715,960,13,/*brain atrophy*/
1715,975,41,/*autonomic neuropathy, optic nerve atrophy*/
1715,1031,17,/*amnestic syndrome*/
1715,1347,16,/*Wolfram syndrome*/
1715,1527,17,/*genetic disorders*/
1715,1586,19,/*thiamine deficiency*/
1715,1624,16,/*Wolfram syndrome*/
1715,1765,16,/*Wolfram syndrome*/
1716,10,25,/*ambiguous hemochromatosis*/
1716,457,15,/*Hemochromatosis*/
1716,855,9,/*arthritis*/
1716,866,8,/*diabetes*/
1716,876,13,/*heart failure*/
1716,1130,25,/*ambiguous hemochromatosis*/
1717,27,24,/*Wiskott-Aldrich syndrome*/
1717,53,24,/*Wiskott-Aldrich syndrome*/
1717,1139,27,/*Wiskott-Aldrich lymphocytes*/
1718,51,21,/*Prader-Willi syndrome*/
1718,133,21,/*Prader-Willi syndrome*/
1718,156,3,/*PWS*/
1718,335,3,/*PWS*/
1718,433,3,/*PWS*/
1718,514,3,/*PWS*/
1718,753,19,/*white matter volume*/
1718,774,3,/*WMV*/
1718,872,3,/*PWS*/
1719,53,28,/*metachromatic leukodystrophy*/
1719,145,28,/*metachromatic leukodystrophy*/
1719,176,3,/*MLD*/
1719,232,3,/*MLD*/
1719,327,3,/*MLD*/
1719,768,3,/*MLD*/
1720,41,23,/*atelosteogenesis type 2*/
1720,69,21,/*diastrophic dysplasia*/
1720,200,17,/*chondrodysplasias*/
1720,269,21,/*diastrophic dysplasia*/
1720,293,3,/*DTD*/
1720,301,23,/*atelosteogenesis type 2*/
1720,327,3,/*AO2*/
1720,339,23,/*achondrogenesis type 1B*/
1720,418,23,/*DTDST chondrodysplasias*/
1720,565,3,/*DTD*/
1720,612,9,/*AO2 / DTD*/
1720,886,3,/*DTD*/
1720,894,9,/*AO2 / DTD*/
1720,1701,3,/*AO2*/
1720,1708,3,/*DTD*/
1721,0,23,/*Amelogenesis imperfecta*/
1722,0,31,/*X-linked juvenile retinoschisis*/
1722,97,31,/*X-linked juvenile retinoschisis*/
1722,130,4,/*XLRS*/
1722,1476,4,/*XLRS*/
1722,1784,4,/*XLRS*/
1723,53,29,/*X-linked adrenoleukodystrophy*/
1723,84,29,/*X-linked adrenoleukodystrophy*/
1723,115,5,/*X-ALD*/
1723,183,21,/*adrenomyeloneuropathy*/
1723,206,3,/*AMN*/
1723,214,22,/*childhood cerebral ALD*/
1723,238,5,/*CCALD*/
1723,246,5,/*X-ALD*/
1723,536,5,/*X-ALD*/
1723,616,5,/*CCALD*/
1723,815,3,/*AMN*/
1723,840,5,/*CCALD*/
1723,945,3,/*AMN*/
1723,1248,5,/*X-ALD*/
1723,1457,5,/*X-ALD*/
1724,208,39,/*autosomal dominant retinitis pigmentosa*/
1724,249,4,/*ADRP*/
1725,0,15,/*Gaucher disease*/
1725,70,15,/*Gaucher disease*/
1725,133,26,/*lysosomal storage disorder*/
1725,173,43,/*deficiency in the enzyme glucocerebrosidase*/
1725,290,18,/*hepatosplenomegaly*/
1725,338,25,/*orthopaedic complications*/
1725,396,15,/*Gaucher disease*/
1725,953,15,/*Gaucher disease*/
1725,1000,6,/*cancer*/
1725,1011,19,/*Parkinson's Disease*/
1725,1099,15,/*Gaucher disease*/
1725,1123,17,/*synucleinopathies*/
1725,1153,27,/*neurodegenerative disorders*/
1727,151,8,/*melanoma*/
1727,996,17,/*familial melanoma*/
1728,17,18,/*myotonic dystrophy*/
1728,72,20,/*progressive myopathy*/
1728,94,18,/*Myotonic dystrophy*/
1728,115,2,/*DM*/
1728,126,27,/*autosomal dominant disorder*/
1728,301,2,/*DM*/
1728,335,14,/*Dmpk deficient*/
1728,420,17,/*skeletal myopathy*/
1728,482,2,/*DM*/
1728,559,25,/*degeneration and fibrosis*/
1728,882,2,/*DM*/
1729,57,28,/*familial Mediterranean fever*/
1729,162,3,/*FMF*/
1729,309,11,/*amyloidosis*/
1729,389,3,/*FMF*/
1729,444,11,/*amyloidosis*/
1729,532,11,/*amyloidosis*/
1729,905,11,/*amyloidosis*/
1730,260,29,/*juvenile retinitis pigmentosa*/
1730,1020,13,/*Tub-deficient*/
1730,1596,12,/*hearing loss*/
1730,1645,20,/*retinal degeneration*/
1731,149,24,/*Wiskott-Aldrich syndrome*/
1731,785,11,/*endocytosis*/
1731,1093,17,/*early endocytosis*/
1733,66,25,/*myotonic dystrophy type 1*/
1733,359,25,/*myotonic dystrophy type 1*/
1733,386,3,/*DM1*/
1733,438,3,/*DM1*/
1733,777,3,/*DM1*/
1735,77,21,/*ataxia-telangiectasia*/
1735,164,21,/*ataxia-telangiectasia*/
1735,188,3,/*A-T*/
1736,18,25,/*von Hippel-Lindau disease*/
1736,134,3,/*VHL*/
1736,162,31,/*Von Hippel-Lindau (VHL) disease*/
1736,200,43,/*autosomal dominant familial cancer syndrome*/
1736,276,9,/*VHL tumor*/
1736,326,16,/*hemangioblastoma*/
1736,381,20,/*renal cell carcinoma*/
1736,429,15,/*pancreatic cyst*/
1736,449,5,/*tumor*/
1736,456,23,/*endolymphatic-sac tumor*/
1736,485,54,/*papillary cystadenoma in epididymis and broad ligament*/
1736,659,3,/*VHL*/
1736,714,11,/*VHL disease*/
1736,1184,11,/*VHL disease*/
1736,1298,11,/*VHL disease*/
1736,1324,3,/*VHL*/
1736,1419,3,/*VHL*/
1736,1444,11,/*VHL disease*/
1737,38,18,/*Huntington disease*/
1737,89,25,/*Huntington disease-like 2*/
1737,151,45,/*autosomal dominant neurodegenerative disorder*/
1737,230,18,/*Huntington disease*/
1737,250,2,/*HD*/
1737,116,4,/*HDL2*/
1737,435,27,/*polyleucine and polyalanine*/
1737,1025,2,/*HD*/
1737,1498,23,/*abnormal motor function*/
1737,1592,4,/*HDL2*/
1738,324,2,/*TD*/
1738,297,25,/*"transmission distortion"*/
1738,493,2,/*TD*/
1738,651,3,/*FHS*/
1738,627,22,/*Framingham Heart Study*/
1738,839,3,/*FHS*/
1738,1395,2,/*TD*/
1738,1480,3,/*FHS*/
1739,24,49,/*very long-chain acyl-coA dehydrogenase deficiency*/
1739,293,17,/*energy deficiency*/
1739,1151,10,/*euglycemia*/
1739,1524,12,/*hypoglycemia*/
1739,1653,16,/*VLCAD deficiency*/
1740,31,16,/*cat eye syndrome*/
1740,92,22,/*preauricular anomalies*/
1740,145,16,/*Cat eye syndrome*/
1740,163,3,/*CES*/
1740,552,15,/*ocular coloboma*/
1740,609,30,/*congenital heart malformations*/
1740,941,3,/*CES*/
1740,977,12,/*anal atresia*/
1740,994,25,/*preauricular tags or pits*/
1740,1242,22,/*preauricular anomalies*/
1740,1282,3,/*CES*/
1741,175,18,/*muscular dystrophy*/
1741,226,25,/*Becker muscular dystrophy*/
1741,253,3,/*BMD*/
1741,527,31,/*BMD, glycerol kinase deficiency*/
1741,564,18,/*adrenal hypoplasia*/
1741,647,19,/*developmental delay*/
1742,72,11,/*Lesch-Nyhan*/
1742,94,19,/*Lesch-Nyhan disease*/
};
}
static void init12() {
a12 = new int[] {
1742,115,3,/*LND*/
1742,142,72,/*deficiency of the hypoxanthine-guanine phosphoribosyltransferase enzyme.*/
1742,339,15,/*physiopathology*/
1742,935,3,/*LND*/
1742,1137,11,/*Lesch-Nyhan*/
1742,1265,11,/*Lesch-Nyhan*/
1742,1516,24,/*behavioural disturbances*/
1743,12,18,/*pigmentary changes*/
1743,67,19,/*Lesch-Nyhan disease*/
1744,370,5,/*tumor*/
1744,428,3,/*NGS*/
1744,502,28,/*breast and/or ovarian cancer*/
1744,890,3,/*NGS*/
1744,1149,6,/*cancer*/
1745,60,21,/*Coffin-Siris syndrome*/
1745,179,21,/*Coffin-Siris syndrome*/
1745,202,3,/*CSS*/
1745,215,35,/*autosomal dominant anomaly syndrome*/
1745,420,3,/*CSS*/
1746,47,25,/*non-syndromic oral clefts*/
1746,141,25,/*Non-syndromic oral clefts*/
1746,203,22,/*Van der Woude Syndrome*/
1746,227,3,/*VWS*/
1746,242,30,/*exception of the lower lip pit*/
1746,293,3,/*VWS*/
1746,341,25,/*non-syndromic oral clefts*/
1746,406,3,/*VWS*/
1746,471,25,/*non-syndromic oral clefts*/
1746,544,14,/*cleft lip only*/
1746,560,3,/*CLO*/
1746,620,3,/*CLO*/
1746,1279,25,/*non-syndromic oral clefts*/
1746,1342,3,/*VWS*/
1747,87,20,/*classic galactosemia*/
1747,121,50,/*Galactose-1-phosphate uridyltransferase deficiency*/
1747,214,20,/*classic galactosemia*/
1747,472,12,/*galactosemia*/
1747,541,15,/*phenylketonuria*/
1747,656,12,/*galactosemia*/
1747,1145,12,/*galactosemia*/
1747,1312,3,/*PKU*/
1747,1343,12,/*galactosemia*/
1748,432,8,/*aniridia*/
1748,443,14,/*Peters anomaly*/
1748,460,28,/*autosomal dominant keratitis*/
1748,495,25,/*familial foveal dysplasia*/
1748,603,8,/*aniridia*/
1748,629,26,/*genetic haploinsufficiency*/
1748,770,8,/*Aniridia*/
1748,1543,8,/*aniridia*/
1749,65,30,/*familial adenomatous polyposis*/
1749,117,30,/*Familial adenomatous polyposis*/
1749,149,3,/*FAP*/
1750,77,18,/*myotonic dystrophy*/
1750,127,18,/*myotonic dystrophy*/
1750,148,2,/*DM*/
1750,217,2,/*DM*/
1750,296,2,/*DM*/
1750,972,2,/*DM*/
1750,1063,18,/*myotonic dystrophy*/
1751,65,18,/*myotonic dystrophy*/
1751,271,2,/*DM*/
1751,330,18,/*myotonic dystrophy*/
1751,351,2,/*DM*/
1751,664,2,/*DM*/
1751,898,2,/*DM*/
1751,1187,2,/*DM*/
1752,171,35,/*insulin-dependent diabetes mellitus*/
1752,344,8,/*diabetes*/
1753,61,25,/*hyperalphalipoproteinemia*/
1753,120,25,/*hyperalphalipoproteinemia*/
1753,147,4,/*HALP*/
1753,444,4,/*HALP*/
1753,1063,4,/*HALP*/
1753,1207,4,/*HALP*/
1753,1355,4,/*HALP*/
1753,1563,4,/*HALP*/
1754,83,33,/*hereditary diffuse gastric cancer*/
1754,269,33,/*Hereditary Diffuse Gastric Cancer*/
1754,304,4,/*HDGC*/
1754,456,16,/*loss-of-function*/
1754,901,4,/*HDGC*/
1754,1450,42,/*premature proteasome-dependent degradation*/
1754,1689,17,/*cancer-associated*/
1755,132,25,/*breast and ovarian cancer*/
1756,0,28,/*Pelizaeus-Merzbacher disease*/
1756,138,28,/*Pelizaeus-Merzbacher disease*/
1756,168,3,/*PMD*/
1756,195,23,/*X-linked leukodystrophy*/
1756,241,19,/*developmental delay*/
1756,277,10,/*spasticity*/
1756,292,9,/*nystagmus*/
1756,303,3,/*PMD*/
1756,519,19,/*developmental delay*/
1756,543,10,/*spasticity*/
1756,944,3,/*PMD*/
1756,1211,3,/*PMD*/
1757,9,5,/*tumor*/
1757,61,5,/*tumor*/
1757,410,5,/*tumor*/
1758,29,21,/*Prader-Willi syndrome*/
1759,0,27,/*Abnormal myotonic dystrophy*/
1759,68,8,/*myopathy*/
1759,86,18,/*Myotonic dystrophy*/
1759,107,2,/*DM*/
1759,632,27,/*hypertrophic cardiomyopathy*/
1759,736,2,/*DM*/
1759,793,8,/*myotonia*/
1759,804,8,/*cataract*/
1759,817,16,/*male-infertility*/
1760,135,25,/*Sj  gren Larsson Syndrome*/
1760,162,3,/*SLS*/
1760,418,9,/*ichtyosis*/
1760,429,18,/*mental retardation*/
1760,453,10,/*spasticity*/
1760,781,3,/*SLS*/
1760,958,3,/*SLS*/
1760,994,16,/*hypersensitivity*/
1760,1171,3,/*SLS*/
1761,25,15,/*Fraser syndrome*/
1761,54,15,/*Fraser syndrome*/
1761,71,2,/*FS*/
1761,80,41,/*autosomal recessive malformation syndrome*/
1761,156,10,/*syndactyly*/
1761,171,18,/*urogenital defects*/
1761,191,2,/*FS*/
1761,308,2,/*FS*/
1761,631,15,/*FS-like defects*/
1761,705,2,/*FS*/
1761,818,22,/*parental consanguinity*/
1761,1280,2,/*FS*/
1762,0,18,/*Myotonia congenita*/
1762,104,18,/*Myotonia congenita*/
1762,199,26,/*impaired muscle relaxation*/
1762,260,15,/*muscle weakness*/
1763,69,13,/*breast cancer*/
1764,85,24,/*colorectal tumorigenesis*/
1764,199,21,/*colorectal carcinomas*/
1764,308,10,/*carcinomas*/
1764,465,16,/*malignant tumors*/
1764,516,16,/*benign neoplasms*/
1764,575,17,/*colorectal tumors*/
1764,621,5,/*tumor*/
1764,894,8,/*adenomas*/
1764,939,8,/*adenomas*/
1764,980,30,/*familial adenomatous polyposis*/
1764,1019,10,/*carcinomas*/
1764,1044,8,/*adenomas*/
1764,1103,6,/*tumors*/
1764,1165,6,/*tumors*/
1764,1180,6,/*tumors*/
1764,1287,6,/*tumors*/
1764,1364,5,/*tumor*/
1764,1409,6,/*tumors*/
1767,0,27,/*Dysspondyloenchondromatosis*/
1767,72,27,/*Dysspondyloenchondromatosis*/
1767,116,18,/*skeletal dysplasia*/
1767,188,30,/*spondylometaphyseal dysplasias*/
1767,101,3,/*DSC*/
1767,386,24,/*enchondroma-like lesions*/
1767,518,14,/*kyphoscoliosis*/
1767,638,32,/*spondyloepimetaphyseal dysplasia*/
1767,701,25,/*type II collagen disorder*/
1767,672,4,/*SEMD*/
1767,904,3,/*DSC*/
1767,1089,25,/*type II collagen disorder*/
1768,39,4,/*PMS2*/
1768,72,4,/*PMS2*/
1768,97,14,/*Lynch syndrome*/
1768,113,2,/*LS*/
1768,149,28,/*hereditary colorectal cancer*/
1768,778,4,/*PMS2*/
1768,1369,4,/*PMS2*/
1769,0,24,/*Schwartz-Jampel syndrome*/
1769,70,24,/*Schwartz-Jampel syndrome*/
1769,96,3,/*SJS*/
1769,111,38,/*autosomal recessive skeletal dysplasia*/
1769,166,8,/*myotonia*/
1769,210,13,/*short stature*/
1769,225,16,/*blepharophimosis*/
1769,247,18,/*skeletal anomalies*/
1769,299,22,/*muscular abnormalities*/
1769,392,12,/*micrognathia*/
1769,406,11,/*microstomia*/
1769,443,12,/*cleft palate*/
1769,468,21,/*mandibular hypoplasia*/
1769,503,17,/*dentigerous cysts*/
1769,526,14,/*impacted teeth*/
1769,589,3,/*SJS*/
1769,629,22,/*malignant hyperthermia*/
1769,734,3,/*SJS*/
1769,866,37,/*hypodontia of the permanent dentition*/
1769,1037,18,/*general anesthesia*/
1770,111,22,/*Juvenile Paget disease*/
1770,135,3,/*JPD*/
1770,163,22,/*inherited bone disease*/
1770,236,3,/*JPD*/
1770,331,16,/*bone deformities*/
1770,364,13,/*short stature*/
1771,325,7,/*malaria*/
1771,664,7,/*malaria*/
1771,718,15,/*G6PD deficiency*/
1771,768,18,/*malaria infections*/
1771,1037,24,/*antimalarial drug design*/
1771,1195,18,/*malaria infections*/
1772,22,28,/*recessive myotonia congenita*/
1772,183,28,/*recessive myotonia congenita*/
1772,694,24,/*infantile onset myotonia*/
1773,350,28,/*Shprintzen-Goldberg syndrome*/
1773,1091,28,/*Shprintzen-Goldberg syndrome*/
1774,74,56,/*familial lecithin:cholesterol acyltransferase deficiency*/
1774,135,23,/*hypobetalipoproteinemia*/
1774,302,24,/*familial LCAT deficiency*/
1774,330,18,/*metabolic disorder*/
1774,366,24,/*hypoalphalipoproteinemia*/
1774,543,32,/*familial hypobetalipoproteinemia*/
1774,745,23,/*hypobetalipoproteinemia*/
1774,798,24,/*hypoalphalipoproteinemia*/
1774,834,22,/*chronic kidney disease*/
1774,1280,32,/*familial hypobetalipoproteinemia*/
1774,1737,24,/*hypoalphalipoproteinemia*/
1774,1766,20,/*impairment of plasma*/
1774,2004,32,/*familial hypobetalipoproteinemia*/
1775,156,21,/*hamartomatous lesions*/
1775,225,20,/*various malignancies*/
1775,280,45,/*benign and malignant gastrointestinal lesions*/
1775,459,32,/*type of gastrointestinal lesions*/
1775,549,24,/*gastrointestinal lesions*/
1775,757,30,/*Benign gastrointestinal polyps*/
1775,889,10,/*hamartomas*/
1775,948,30,/*lower gastrointestinal lesions*/
1775,998,15,/*colonic lesions*/
1775,1031,24,/*gastrointestinal lesions*/
1775,1108,30,/*benign gastrointestinal polyps*/
1775,1192,20,/*colorectal carcinoma*/
1775,1289,20,/*colorectal carcinoma*/
1775,1381,30,/*upper gastrointestinal cancers*/
1775,1439,31,/*Benign gastrointestinal lesions*/
1775,1562,17,/*colorectal cancer*/
1776,39,18,/*juvenile polyposis*/
1776,83,33,/*Bannayan-Riley-Ruvalcaba syndrome*/
1776,162,12,/*macrocephaly*/
1776,176,17,/*benign hamartomas*/
1776,195,7,/*lipomas*/
1776,204,12,/*haemangiomas*/
1776,218,17,/*pigmented maculae*/
1776,237,19,/*developmental delay*/
1776,261,18,/*mental retardation*/
1776,331,12,/*macrocephaly*/
1776,345,13,/*hypertelorism*/
1776,376,20,/*intestinal polyposis*/
1776,645,18,/*juvenile polyposis*/
1778,210,19,/*skeletal dysplasias*/
1778,512,18,/*skeletal dysplasia*/
1778,654,6,/*PLSD-T*/
1778,598,54,/*platyspondylic lethal skeletal dysplasia Torrance type*/
1778,985,6,/*PLSD-T*/
1779,86,21,/*ataxia telangiectasia*/
1779,255,9,/*lymphomas*/
1779,556,19,/*embryonic lethality*/
1780,38,17,/*colorectal cancer*/
1780,157,17,/*colorectal cancer*/
1780,187,6,/*cancer*/
1780,296,5,/*tumor*/
1780,345,17,/*recurrent disease*/
1780,603,17,/*colorectal cancer*/
1780,674,5,/*tumor*/
1780,772,5,/*tumor*/
1780,835,17,/*colorectal cancer*/
1781,85,19,/*prostate malignancy*/
1781,197,26,/*hereditary prostate cancer*/
1781,281,15,/*prostate cancer*/
1781,423,15,/*prostate cancer*/
1781,1129,15,/*prostate cancer*/
1781,1219,6,/*SPANXL*/
1781,1621,19,/*prostate malignancy*/
1782,0,29,/*X-linked adrenoleukodystrophy*/
1782,44,17,/*Addison's disease*/
1782,125,30,/*deficit/hyperactivity disorder*/
1782,165,20,/*cognitive impairment*/
1782,222,8,/*anorexia*/
1782,711,40,/*adolescent X-linked adrenoleukodystrophy*/
1782,753,5,/*X-ALD*/
1782,1103,33,/*progressive neurological deficits*/
1783,1,24,/*Erythrocytic enzymopathy*/
1783,217,27,/*erythrocyte G6PD deficiency*/
1783,347,16,/*hemolytic anemia*/
1783,418,30,/*deficiency of erythrocyte G6PD*/
1783,629,30,/*deficiency of erythrocyte G6PD*/
1783,713,43,/*hereditary nonspherecytary hemolytic anemia*/
1783,777,16,/*hemolytic anemia*/
1783,975,30,/*deficiency of erythrocyte G6PD*/
1783,1059,43,/*hereditary nonspherecytary hemolytic anemia*/
1783,1123,16,/*hemolytic anemia*/
1784,0,31,/*Dermatofibrosarcoma protuberans*/
1784,87,31,/*Dermatofibrosarcoma protuberans*/
1784,120,4,/*DFSP*/
1784,131,22,/*fibrohistiocytic tumor*/
1784,602,4,/*DFSP*/
1784,1205,6,/*tumors*/
1784,1340,6,/*tumors*/
1785,488,17,/*Alzheimer disease*/
1786,71,9,/*Tay-Sachs*/
1786,134,46,/*autosomal recessive lysosomal storage diseases*/
1786,491,17,/*Tay-Sachs disease*/
1786,608,17,/*Tay-Sachs disease*/
1786,1559,18,/*GM2 gangliosidoses*/
1787,29,30,/*familial adenomatous polyposis*/
1787,117,24,/*Birt-Hogg-Dub   syndrome*/
1787,153,12,/*colon cancer*/
1787,143,4,/*BHDS*/
1787,329,15,/*colon carcinoma*/
1787,349,30,/*familial adenomatous polyposis*/
1787,381,3,/*FAP*/
1787,448,4,/*BHDS*/
1787,585,26,/*adenomatous polyposis coli*/
1787,613,3,/*APC*/
1787,729,15,/*colon carcinoma*/
1788,94,12,/*Wilms tumour*/
1788,143,12,/*Wilms tumour*/
1788,215,24,/*WT1-associated syndromes*/
1788,244,20,/*overgrowth syndromes*/
1788,365,12,/*Wilms tumour*/
1788,547,12,/*Wilms tumour*/
1788,867,12,/*Wilms tumour*/
1788,1042,13,/*WAGR syndrome*/
1788,1057,11,/*Wilms tumor*/
1788,1070,8,/*aniridia*/
1788,1080,27,/*genitourinary malformations*/
1788,1112,18,/*mental retardation*/
1788,1141,20,/*Denys-Drash syndrome*/
1788,1172,23,/*genitourinary anomalies*/
1788,1317,20,/*congenital anomalies*/
1788,1396,27,/*Beckwith-Wiedemann syndrome*/
1788,1425,3,/*BWS*/
1788,1457,3,/*BWS*/
1788,1488,3,/*BWS*/
1788,1495,15,/*hemihypertrophy*/
1788,1580,12,/*Wilms tumour*/
1788,1754,12,/*Wilms tumour*/
1789,88,25,/*breast and ovarian cancer*/
1789,245,25,/*breast and ovarian cancer*/
1789,272,3,/*BOC*/
1789,337,3,/*BOC*/
1789,484,24,/*Hereditary Breast Cancer*/
1789,654,3,/*BOC*/
1789,723,13,/*breast cancer*/
1789,805,3,/*BOC*/
1789,1273,3,/*BOC*/
1789,1584,3,/*BOC*/
1789,1751,3,/*BOC*/
1790,80,13,/*Lowe syndrome*/
1790,99,34,/*oculocerebrorenal syndrome of Lowe*/
1790,135,4,/*OCRL*/
1790,147,17,/*X-linked disorder*/
1790,420,13,/*OCRL syndrome*/
1790,461,20,/*congenital cataracts*/
1790,506,18,/*cognitive deficits*/
1790,530,25,/*renal tubular dysfunction*/
1790,564,16,/*Fanconi syndrome*/
1790,604,32,/*low molecular weight proteinuria*/
1790,638,16,/*nephrocalcinosis*/
1790,656,15,/*nephrolithiasis*/
1790,686,18,/*growth retardation*/
1790,719,25,/*progressive renal failure*/
1791,85,31,/*dermatofibrosarcoma protuberans*/
1791,338,31,/*dermatofibrosarcoma protuberans*/
1791,371,4,/*DFSP*/
1791,865,4,/*DFSP*/
1791,1086,4,/*DFSP*/
1791,1345,4,/*DFSP*/
1792,219,27,/*globoid cell leukodystrophy*/
1792,248,3,/*GLD*/
1792,481,14,/*GALC-deficient*/
1792,644,15,/*GALC deficiency*/
1792,1195,3,/*GLD*/
1792,1375,36,/*pediatric neurodegenerative disorder*/
1793,85,25,/*breast and ovarian cancer*/
1793,196,13,/*breast cancer*/
1793,584,6,/*cancer*/
1793,759,6,/*cancer*/
1793,935,13,/*breast cancer*/
1793,1620,24,/*breast or ovarian cancer*/
1793,1777,31,/*ambiguous functional deficiency*/
1793,1873,25,/*breast and ovarian cancer*/
1794,117,34,/*atypical hemolytic uremic syndrome*/
1794,204,20,/*rheumatoid arthritis*/
1794,226,2,/*RA*/
1794,231,28,/*systemic lupus erythematosus*/
1794,270,34,/*atypical hemolytic uremic syndrome*/
1794,261,3,/*SLE*/
1794,306,4,/*aHUS*/
1794,521,2,/*FH*/
1794,746,2,/*FH*/
1794,813,2,/*RA*/
1794,905,10,/*thrombosis*/
1794,1003,4,/*aHUS*/
1794,1727,2,/*FI*/
1794,1897,2,/*FH*/
1795,1,17,/*Diabetes mellitus*/
1795,20,13,/*optic atrophy*/
1795,38,22,/*inner ear hearing loss*/
1795,62,16,/*Wolfram syndrome*/
1796,16,13,/*hyperkyphosis*/
1796,351,6,/*anemia*/
1797,12,17,/*Friedreich ataxia*/
1797,118,17,/*Friedreich ataxia*/
1797,493,17,/*Friedreich ataxia*/
1797,633,18,/*Muscular Dystrophy*/
1797,759,17,/*Friedreich ataxia*/
1797,886,17,/*Friedreich ataxia*/
1797,1018,17,/*Friedreich ataxia*/
1798,58,28,/*chronic lymphocytic leukemia*/
1798,100,28,/*chronic lymphocytic leukemia*/
1798,130,3,/*CLL*/
1798,156,21,/*ataxia telangiectasia*/
1798,1301,3,/*CLL*/
1798,1506,3,/*CLL*/
1800,31,25,/*inherited blood disorders*/
1800,105,25,/*inherited blood disorders*/
1800,251,17,/*childhood anaemia*/
1800,431,7,/*malaria*/
1800,1073,15,/*G6PD deficiency*/
1800,1151,7,/*malaria*/
1800,1216,15,/*G6PD deficiency*/
1800,1271,7,/*malaria*/
1800,1361,20,/*malaria parasitaemia*/
1800,1425,15,/*iron deficiency*/
1800,1548,7,/*anaemia*/
1800,1847,7,/*anaemia*/
1801,77,25,/*breast and ovarian cancer*/
1801,590,36,/*hypersensitive to ionizing radiation*/
1802,0,28,/*Familial Mediterranean fever*/
1802,376,28,/*familial Mediterranean fever*/
1802,425,28,/*familial Mediterranean fever*/
1802,602,28,/*Familial Mediterranean fever*/
1803,19,28,/*alveolar capillary dysplasia*/
1803,133,28,/*Alveolar capillary dysplasia*/
1803,167,31,/*misalignment of pulmonary veins*/
1803,219,27,/*developmental lung disorder*/
1803,571,7,/*ACD/MPV*/
1803,711,7,/*ACD/MPV*/
1804,63,25,/*pediatric rhabdoid tumors*/
1804,102,15,/*Rhabdoid tumors*/
1804,131,32,/*atypical teratoid/rhabdoid tumor*/
1804,209,22,/*poor prognosis lesions*/
1804,463,6,/*tumors*/
1804,761,4,/*NRAS*/
1804,925,28,/*progression of adult cancers*/
1804,1017,16,/*pediatric tumors*/
1805,0,16,/*Combating cancer*/
1805,52,28,/*idiopathic immune deficiency*/
1805,167,25,/*cartilage-hair hypoplasia*/
1806,70,29,/*advanced renal cell carcinoma*/
1807,0,24,/*Wiskott-Aldrich syndrome*/
1807,70,33,/*juvenile myelomonocytic leukaemia*/
1807,117,24,/*Wiskott-Aldrich syndrome*/
1807,143,3,/*WAS*/
1807,158,25,/*X-linked immunodeficiency*/
1807,209,3,/*WAS*/
1807,248,3,/*WAS*/
1807,274,22,/*micro-thrombocytopenia*/
1807,355,3,/*WAS*/
1807,389,12,/*leukocytosis*/
1807,403,11,/*monocytosis*/
1807,486,28,/*dysplasia in the bone marrow*/
1807,564,33,/*juvenile myelomonocytic leukaemia*/
1807,599,4,/*JMML*/
1807,684,12,/*Splenomegaly*/
1807,757,4,/*JMML*/
1807,853,4,/*JMML*/
1807,981,3,/*WAS*/
1807,1356,3,/*WAS*/
1807,1398,3,/*WAS*/
1807,1501,4,/*JMML*/
1808,220,39,/*measurement of horizontal eye movements*/
1809,36,15,/*prostate cancer*/
1809,99,15,/*Prostate Cancer*/
1809,133,15,/*Prostate cancer*/
1809,373,15,/*prostate cancer*/
1809,574,15,/*prostate cancer*/
1809,676,15,/*prostate cancer*/
1809,747,15,/*Prostate Cancer*/
1809,828,15,/*prostate cancer*/
1809,973,15,/*prostate cancer*/
1809,1432,7,/*cancers*/
1809,1580,15,/*prostate cancer*/
1809,1674,15,/*prostate cancer*/
1810,61,37,/*cognitive and behavioral improvements*/
1810,122,18,/*fragile x syndrome*/
1810,142,18,/*Fragile X syndrome*/
1810,162,3,/*FXS*/
1810,205,23,/*intellectual disability*/
1810,452,3,/*FXS*/
1810,610,3,/*FXS*/
1810,655,3,/*FXS*/
1813,159,27,/*Duchenne muscular dystrophy*/
1813,188,3,/*DMD*/
1813,257,15,/*muscle symptoms*/
1813,277,14,/*cardiomyopathy*/
1813,502,3,/*DMD*/
1813,738,15,/*DMD-manifesting*/
1813,1195,3,/*DMD*/
1814,1514,11,/*PKU disease*/
1815,17,44,/*hepatoblastoma-familial polyposis connection*/
1815,102,14,/*hepatoblastoma*/
1815,118,2,/*HB*/
1815,147,24,/*congenital abnormalities*/
1815,233,30,/*familial adenomatous polyposis*/
1815,265,3,/*FAP*/
1815,442,32,/*HB-familial polyposis connection*/
1815,497,3,/*FAP*/
1815,722,3,/*FAP*/
1815,750,2,/*HB*/
1815,791,3,/*FAP*/
1815,810,2,/*HB*/
1815,896,20,/*colorectal carcinoma*/
1815,1224,3,/*FAP*/
1815,1291,3,/*FAP*/
1815,1429,3,/*FAP*/
1815,1436,2,/*HB*/
1815,1529,3,/*FAP*/
1815,1581,3,/*FAP*/
1816,0,17,/*Angelman syndrome*/
1816,136,17,/*Angelman syndrome*/
1816,159,27,/*neurodevelopmental disorder*/
1816,204,18,/*mental retardation*/
1816,231,15,/*speech disorder*/
1816,248,18,/*facial dysmorphism*/
1816,292,6,/*ataxia*/
1816,300,8,/*seizures*/
1816,746,22,/*Angelman-like syndrome*/
1816,1107,17,/*Angelman syndrome*/
1816,1246,17,/*Angelman syndrome*/
1816,1384,17,/*Angelman syndrome*/
1816,1458,21,/*Prader-Willi syndrome*/
1816,1485,17,/*Angelman syndrome*/
1816,1653,4,/*OCA2*/
1816,1675,26,/*oculocutaneous albinism II*/
1816,1778,22,/*Warburg Micro syndrome*/
1817,76,14,/*osteoarthritis*/
1817,186,7,/*obesity*/
1817,248,14,/*osteoarthritis*/
1817,264,2,/*OA*/
1817,669,2,/*OA*/
1817,1142,7,/*obesity*/
1817,1295,2,/*OA*/
1817,1336,3,/*WTD*/
1817,1389,3,/*WTD*/
1817,1408,2,/*OA*/
1817,1755,3,/*WTD*/
1817,1854,18,/*metabolic syndrome*/
1818,47,13,/*breast cancer*/
1818,107,13,/*breast cancer*/
1818,311,10,/*carcinomas*/
1818,406,13,/*breast cancer*/
1818,460,13,/*breast cancer*/
1818,795,13,/*breast cancer*/
1818,888,13,/*breast cancer*/
1818,942,13,/*breast cancer*/
1818,1644,13,/*breast cancer*/
1819,62,17,/*colorectal cancer*/
1819,178,25,/*breast and ovarian cancer*/
1819,318,14,/*ovarian cancer*/
1819,341,13,/*breast cancer*/
1819,373,14,/*ovarian cancer*/
1819,404,7,/*cancers*/
1819,497,6,/*cancer*/
1819,605,15,/*prostate cancer*/
1819,638,17,/*colorectal cancer*/
1819,793,17,/*colorectal cancer*/
1819,901,29,/*prostate or colorectal cancer*/
1820,18,16,/*ductal carcinoma*/
1820,84,24,/*Ductal carcinoma in situ*/
1820,218,13,/*breast cancer*/
1820,110,4,/*DCIS*/
1820,314,4,/*DCIS*/
1820,579,4,/*DCIS*/
1820,758,4,/*DCIS*/
1820,1057,4,/*DCIS*/
1820,1401,13,/*breast cancer*/
1821,36,25,/*hereditary ovarian cancer*/
1821,211,14,/*ovarian cancer*/
1821,264,14,/*ovarian cancer*/
1821,366,14,/*ovarian cancer*/
1821,419,25,/*hereditary ovarian cancer*/
1821,937,14,/*ovarian cancer*/
1821,1269,14,/*ovarian cancer*/
1821,1570,14,/*ovarian cancer*/
1822,28,21,/*abetalipoproteinaemia*/
1822,54,33,/*familial hypobetalipoproteinaemia*/
1822,112,21,/*abetalipoproteinaemia*/
1822,188,33,/*familial hypobetalipoproteinaemia*/
1822,300,21,/*abetalipoproteinaemia*/
1822,365,21,/*abetalipoproteinaemia*/
1822,391,33,/*familial hypobetalipoproteinaemia*/
1823,345,15,/*atopic diseases*/
1823,612,9,/*urticaria*/
1823,639,15,/*atopic diseases*/
1823,807,9,/*urticaria*/
1823,968,17,/*atopic dermatitis*/
1823,1393,9,/*hay fever*/
1823,1588,17,/*atopic dermatitis*/
1823,1640,9,/*hay fever*/
1824,292,16,/*Pendred syndrome*/
1824,343,12,/*hearing loss*/
1824,361,29,/*enlarged vestibular aqueducts*/
1824,415,14,/*hypothyroidism*/
1824,434,6,/*goiter*/
1824,549,4,/*DOCA*/
1824,592,18,/*mineralocorticoids*/
1824,1220,17,/*mineralocorticoid*/
1825,0,17,/*Cardiac anomalies*/
1825,21,24,/*Axenfeld-Rieger syndrome*/
1825,77,24,/*Axenfeld-Rieger syndrome*/
1825,103,3,/*ARS*/
1825,114,28,/*autosomal dominant condition*/
1825,175,30,/*anterior segment abnormalities*/
1825,241,16,/*dental anomalies*/
1825,463,3,/*ARS*/
1825,635,8,/*glaucoma*/
1825,688,13,/*heart failure*/
1825,882,8,/*glaucoma*/
1825,910,24,/*congenital hip dysplasia*/
1825,970,20,/*atrial septal defect*/
1825,1134,3,/*ARS*/
1825,1374,24,/*congenital heart disease*/
1825,1570,13,/*atrial septum*/
1825,1662,3,/*ASD*/
1825,1667,13,/*Hip dysplasia*/
1826,100,24,/*Brooke-Spiegler syndrome*/
1826,273,24,/*Brooke-Spiegler syndrome*/
1826,299,3,/*BSS*/
1826,326,27,/*autosomal dominant disorder*/
1826,386,36,/*multiple adnexal cutaneous neoplasms*/
1826,433,11,/*spiradenoma*/
1826,446,10,/*cylindroma*/
1826,458,19,/*spiradenocylindroma*/
1826,483,17,/*trichoepithelioma*/
1826,556,3,/*MFT*/
1826,599,3,/*BSS*/
1826,634,18,/*trichoepitheliomas*/
1826,518,36,/*multiple familial trichoepitheliomas*/
1826,708,4,/*CYLD*/
1826,870,5,/*tumor*/
1826,941,4,/*CYLD*/
1826,1021,4,/*CYLD*/
1826,1077,3,/*BSS*/
1826,1229,3,/*BSS*/
1826,1561,6,/*tumors*/
1826,1601,4,/*CYLD*/
1826,1624,12,/*spiradenomas*/
1826,1641,20,/*spiradenocylindromas*/
1826,1666,11,/*cylindromas*/
1826,1682,18,/*trichoepitheliomas*/
1826,1719,5,/*tumor*/
1826,1792,6,/*tumors*/
1826,2003,4,/*CYLD*/
1826,2040,5,/*tumor*/
1826,2083,6,/*tumors*/
1826,2385,4,/*CYLD*/
1826,2657,4,/*CYLD*/
1827,69,8,/*aniridia*/
1827,120,14,/*Peters anomaly*/
1827,142,20,/*congenital cataracts*/
1827,170,28,/*autosomal dominant keratitis*/
1827,210,26,/*isolated foveal hypoplasia*/
1827,299,8,/*aniridia*/
1828,29,26,/*acute lymphocytic leukemia*/
1828,111,26,/*acute lymphocytic leukemia*/
1828,139,3,/*ALL*/
1828,163,16,/*childhood cancer*/
1828,207,3,/*ALL*/
1828,348,8,/*leukemia*/
1828,455,8,/*sarcomas*/
1828,482,39,/*Li Fraumeni syndrome-associated cancers*/
1828,537,17,/*familial leukemia*/
1829,0,16,/*Gardner syndrome*/
1830,25,24,/*neonatal hemochromatosis*/
1830,109,24,/*Neonatal hemochromatosis*/
1830,135,2,/*NH*/
1830,422,8,/*neonates*/
1830,552,2,/*NH*/
1830,576,13,/*liver failure*/
1831,84,17,/*colorectal cancer*/
1831,209,15,/*prostate cancer*/
1831,289,15,/*Prostate Cancer*/
1831,552,15,/*prostate cancer*/
1831,611,13,/*breast cancer*/
1831,633,17,/*colorectal cancer*/
1831,652,3,/*CRC*/
1831,953,15,/*prostate cancer*/
1831,1034,26,/*hereditary prostate cancer*/
1831,1303,25,/*increased prostate cancer*/
1831,1357,27,/*benign prostate hyperplasia*/
1831,1386,3,/*BPH*/
1831,1480,3,/*CRC*/
1831,1584,13,/*breast cancer*/
1831,1648,6,/*cancer*/
1831,1750,15,/*prostate cancer*/
1831,1891,15,/*prostate cancer*/
1832,24,18,/*congenital defects*/
1832,60,21,/*Prader-Willi syndrome*/
1832,148,18,/*congenital defects*/
1832,193,21,/*Prader-Willi syndrome*/
1832,216,3,/*PWS*/
1832,420,3,/*PWS*/
1832,705,18,/*congenital defects*/
1832,783,18,/*congenital defects*/
1832,922,20,/*Congenital Anomalies*/
1832,1026,18,/*congenital defects*/
1832,1140,18,/*congenital defects*/
1832,1164,13,/*heart defects*/
1832,1179,26,/*renoureteral malformations*/
1832,1207,19,/*vertebral anomalies*/
1832,1228,13,/*hip dysplasia*/
1832,1257,19,/*agenesis/hypoplasia*/
1832,1315,18,/*congenital defects*/
1832,1387,3,/*PWS*/
1832,1427,24,/*congenital heart defects*/
1832,1498,3,/*PWS*/
1832,1653,18,/*congenital defects*/
1832,1689,3,/*PWS*/
1832,1757,3,/*PWS*/
1832,1806,18,/*congenital defects*/
1832,1939,3,/*PWS*/
1833,150,33,/*Bannayan-Riley-Ruvalcaba syndrome*/
1833,187,15,/*Cowden syndrome*/
1834,64,9,/*Apoptosis*/
1834,129,17,/*Colorectal cancer*/
1834,148,3,/*CRC*/
1834,305,49,/*benign (adenoma) and invasive (carcinoma) disease*/
1834,418,35,/*familial adenomatous polyposis coli*/
1834,455,3,/*FAP*/
1834,489,19,/*CRCs, the APC tumor*/
1834,743,3,/*APC*/
1834,912,5,/*tumor*/
1834,977,3,/*CRC*/
1835,63,6,/*autism*/
1835,71,6,/*Autism*/
1835,83,18,/*pervasive disorder*/
1835,166,18,/*social dysfunction*/
1835,412,6,/*autism*/
1835,475,18,/*social dysfunction*/
1835,589,17,/*autistic symptoms*/
1835,882,18,/*Fragile X syndrome*/
1835,904,27,/*neurodevelopmental syndrome*/
1835,946,17,/*autistic symptoms*/
1835,1398,6,/*autism*/
1836,55,34,/*hereditary breast and colon cancer*/
1836,453,28,/*breast and colorectal cancer*/
1836,549,27,/*contralateral breast cancer*/
1836,642,29,/*breast and colorectal cancers*/
1836,788,6,/*cancer*/
1836,977,48,/*hereditary breast and colorectal cancer syndrome*/
1836,1330,28,/*breast and colorectal cancer*/
1836,1555,17,/*colorectal cancer*/
1838,0,3,/*SWS*/
1838,55,20,/*retinal degeneration*/
1838,163,11,/*retinopathy*/
1838,187,15,/*night blindness*/
1838,204,19,/*cystoid maculopathy*/
1838,1084,23,/*photopic intensity axis*/
1838,1207,3,/*SWS*/
1838,1324,3,/*SWS*/
1839,71,18,/*myotonic disorders*/
1839,91,8,/*Myotonia*/
1839,215,8,/*myotonia*/
1839,249,40,/*deficiencies of skeletal muscle chloride*/
1839,569,8,/*myotonia*/
1840,99,6,/*tumour*/
1840,177,6,/*tumour*/
1840,305,7,/*tumours*/
1840,318,6,/*tumour*/
1840,363,3,/*VHL*/
1840,336,25,/*von Hippel-Lindau protein*/
1840,623,3,/*VHL*/
1840,755,3,/*VHL*/
1840,837,3,/*VHL*/
1840,929,3,/*VHL*/
1840,1289,3,/*VHL*/
1840,1340,3,/*VHL*/
1841,46,13,/*Lowe syndrome*/
1841,73,13,/*Lowe syndrome*/
1841,97,37,/*X-linked recessive hereditary disease*/
1841,271,20,/*congenital cataracts*/
1841,293,23,/*psychomotor retardation*/
1841,322,20,/*proximal tubulopathy*/
1841,419,13,/*Lowe syndrome*/
1841,462,50,/*abnormalities of eyes, nervous system, and kidneys*/
1841,1025,13,/*Lowe syndrome*/
1842,224,25,/*atrial natriuretic factor*/
1843,54,19,/*developmental delay*/
1843,78,27,/*sudden loss of muscle tonus*/
1843,426,14,/*Norrie disease*/
1843,482,13,/*short stature*/
1843,497,9,/*hypotonia*/
1843,515,20,/*developmental delays*/
1843,549,26,/*sudden loss of muscle tone*/
1843,612,17,/*autistic features*/
1844,0,10,/*Piebaldism*/
1844,16,8,/*deafness*/
1844,122,10,/*piebaldism*/
1844,146,33,/*congenital sensorineural deafness*/
1844,420,3,/*KIT*/
1844,436,8,/*deafness*/
1844,469,10,/*piebaldism*/
1844,507,22,/*sensorineural deafness*/
1844,591,10,/*piebaldism*/
1844,682,10,/*piebaldism*/
1844,718,20,/*Waardenburg syndrome*/
1845,49,17,/*Angelman Syndrome*/
1845,68,17,/*Angelman Syndrome*/
1845,87,2,/*AS*/
1845,96,27,/*neurodevelopmental disorder*/
1845,148,19,/*developmental delay*/
1845,169,17,/*speech impairment*/
1845,264,2,/*AS*/
1845,362,18,/*uniparental disomy*/
1845,600,2,/*AS*/
1845,906,2,/*AS*/
1845,966,19,/*developmental delay*/
1845,997,2,/*AS*/
1845,1123,19,/*developmental delay*/
1846,114,15,/*genetic disease*/
1847,46,27,/*intracranial retinoblastoma*/
1847,138,27,/*intracranial retinoblastoma*/
1847,199,26,/*pineal and retinal tumours*/
1847,353,30,/*retinal and the pineal tumours*/
1847,760,14,/*retinoblastoma*/
1848,55,20,/*inherited deficiency*/
1848,113,17,/*inflammatory pain*/
1848,332,17,/*inflammatory pain*/
1848,477,10,/*lower pain*/
1848,520,18,/*pain sensitisation*/
1848,811,24,/*DOPA-responsive dystonia*/
1848,837,3,/*DRD*/
1848,899,17,/*inflammatory pain*/
1848,1019,21,/*hyperphenylalaninemia*/
1848,1078,3,/*DRD*/
1848,1583,16,/*motor impairment*/
1848,1603,22,/*dystonia-like symptoms*/
1848,1734,26,/*pain-like hypersensitivity*/
1848,1937,16,/*hypersensitivity*/
1848,2047,28,/*inflammatory pain conditions*/
1848,2152,51,/*congenital deficiency of GCH1 in painful conditions*/
1849,40,21,/*renal cell carcinomas*/
1849,79,25,/*von Hippel Lindau disease*/
1849,160,20,/*Renal cell carcinoma*/
1849,182,3,/*RCC*/
1849,204,31,/*von Hippel Lindau (VHL) disease*/
1849,296,6,/*tumors*/
1849,729,11,/*VHL disease*/
1849,948,3,/*RCC*/
1849,969,11,/*VHL disease*/
1850,175,20,/*Lesch-Nyhan syndrome*/
1850,197,3,/*LNS*/
1850,205,11,/*Lesch-Nyhan*/
1850,408,12,/*LNS affected*/
1851,31,29,/*X-linked adrenoleukodystrophy*/
1853,0,35,/*Neonatal nonketotic hyperglycinemia*/
1853,108,26,/*Nonketotic hyperglycinemia*/
1853,136,3,/*NKH*/
1853,147,54,/*autosomal recessive inborn error of glycine metabolism*/
1853,335,8,/*seizures*/
1853,771,21,/*neurologic impairment*/
1853,794,20,/*intractable seizures*/
1854,38,20,/*Li-Fraumeni syndrome*/
1854,135,13,/*tumorigenesis*/
1854,198,20,/*Li-Fraumeni syndrome*/
1854,556,20,/*Li-Fraumeni syndrome*/
1855,0,36,/*Selective sound sensitivity syndrome*/
1855,38,10,/*misophonia*/
1855,68,17,/*Tourette syndrome*/
1856,20,15,/*retinoblastomas*/
1856,119,14,/*Retinoblastoma*/
1856,141,24,/*childhood retinal cancer*/
1856,265,14,/*retinoblastoma*/
1856,353,22,/*retinoblastoma tumours*/
1856,451,22,/*retinoblastoma tumours*/
1856,543,7,/*tumours*/
1856,741,8,/*FINDINGS*/
1856,815,33,/*unilateral retinoblastoma tumours*/
1856,872,7,/*tumours*/
1856,1178,14,/*retinoblastoma*/
1856,1211,7,/*tumours*/
1856,1348,14,/*retinoblastoma*/
1856,1379,14,/*MYCN(A) tumour*/
1856,1687,14,/*retinoblastoma*/
1856,1769,14,/*retinoblastoma*/
1856,1859,15,/*retinoblastomas*/
1856,2001,14,/*retinoblastoma*/
1856,2193,14,/*Retinoblastoma*/
1857,236,24,/*Wiskott-Aldrich syndrome*/
1858,56,28,/*alveolar capillary dysplasia*/
1858,90,26,/*misaligned pulmonary veins*/
1858,158,28,/*Alveolar capillary dysplasia*/
1858,192,31,/*misalignment of pulmonary veins*/
1858,525,7,/*ACD/MPV*/
1861,83,28,/*Metachromatic leukodystrophy*/
1861,118,46,/*autosomal recessive neurodegenerative disorder*/
1861,293,28,/*metachromatic leukodystrophy*/
1861,323,3,/*MLD*/
1861,658,3,/*MLD*/
1861,792,3,/*MLD*/
1862,131,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
1862,223,16,/*hemolytic anemia*/
1862,304,15,/*acute hemolysis*/
1862,337,15,/*G6PD deficiency*/
1862,394,34,/*particular peripheral nerve blocks*/
1862,467,15,/*G6PD deficiency*/
1862,582,48,/*ultrasound-guided axillary brachial plexus block*/
1862,649,25,/*geriatric G6PD deficiency*/
1862,741,15,/*G6PD deficiency*/
1862,884,48,/*ultrasound-guided axillary brachial plexus block*/
1862,1059,9,/*hemolysis*/
1862,1082,48,/*Ultrasound-guided axillary brachial plexus block*/
1862,1204,15,/*G6PD deficiency*/
1862,1221,22,/*Peripheral nerve block*/
1863,109,37,/*attenuated adenomatous polyposis coli*/
1863,148,30,/*Familial adenomatous polyposis*/
1863,181,3,/*FAP*/
1863,221,17,/*colorectal cancer*/
1863,284,18,/*adenomatous polyps*/
1863,444,3,/*FAP*/
1863,476,3,/*APC*/
1863,559,37,/*attenuated adenomatous polyposis coli*/
1863,599,4,/*AAPC*/
1863,1114,3,/*APC*/
1863,1241,4,/*AAPC*/
1864,193,19,/*Friedreich's Ataxia*/
1864,214,4,/*FRDA*/
1864,223,25,/*neurodegenerative disease*/
1864,631,26,/*neurodegenerative diseases*/
1864,962,4,/*FRDA*/
1864,1044,4,/*FRDA*/
1865,87,26,/*Hereditary hemochromatosis*/
1865,115,2,/*HH*/
1865,304,2,/*HH*/
1865,653,2,/*HH*/
1865,811,2,/*HH*/
1866,673,15,/*hemochromatosis*/
1866,721,26,/*hereditary hemochromatosis*/
1866,891,31,/*glucose and blood from diabetes*/
1866,927,15,/*hemochromatosis*/
1867,24,20,/*Lesch-Nyhan syndrome*/
1867,182,11,/*Lesch-Nyhan*/
1867,349,11,/*Lesch-Nyhan*/
1867,894,11,/*Lesch-Nyhan*/
1869,0,20,/*Adrenoleukodystrophy*/
1869,84,20,/*Adrenoleukodystrophy*/
1869,106,3,/*ALD*/
1869,116,19,/*sex-linked disorder*/
1869,301,14,/*hypoadrenalism*/
1869,317,12,/*hypogonadism*/
1869,334,69,/*central and peripheral nervous system impairment due to demyelination*/
1869,440,12,/*hearing loss*/
1869,658,3,/*ALD*/
1870,38,35,/*familial amyloidotic polyneuropathy*/
1871,30,7,/*Obesity*/
1871,377,7,/*obesity*/
1871,661,7,/*obesity*/
1871,682,23,/*metabolic abnormalities*/
1871,786,30,/*hereditary symptomatic obesity*/
1872,0,24,/*Chediak-Higashi syndrome*/
1872,95,24,/*Chediak-Higashi syndrome*/
1872,121,3,/*CHS*/
1872,132,27,/*autosomal recessive disease*/
1872,214,3,/*CHS*/
1872,272,3,/*CHS*/
1872,430,3,/*CHS*/
1872,550,3,/*CHS*/
1872,670,17,/*enzyme deficiency*/
1872,691,3,/*CHS*/
1872,1312,3,/*CHS*/
1872,1555,3,/*CHS*/
1872,1770,3,/*CHS*/
1873,857,16,/*poor-metabolizer*/
1874,96,44,/*POMC deficiency and type 1 diabetes mellitus*/
1874,566,11,/*homeostasis*/
1874,633,46,/*complete proopiomelanocortin (POMC) deficiency*/
1874,699,40,/*coincidental concomitant type 1 diabetes*/
1874,819,19,/*glucose homeostasis*/
1874,929,38,/*adrenocorticotropic hormone deficiency*/
1874,1311,19,/*insulin sensitivity*/
1875,265,15,/*atherosclerosis*/
1875,302,38,/*relevance for type 2 diabetes mellitus*/
1876,47,15,/*prostate cancer*/
1876,64,27,/*Sporadic prostate carcinoma*/
1876,231,6,/*cancer*/
1876,380,24,/*sporadic prostate cancer*/
1876,530,5,/*tumor*/
1876,675,15,/*prostate cancer*/
1876,719,15,/*prostate tumors*/
1876,1081,6,/*tumors*/
1876,1158,24,/*sporadic prostate cancer*/
1877,19,14,/*von Willebrand*/
1877,109,13,/*hemophilia  A*/
1878,19,26,/*acid ceramidase deficiency*/
1878,68,14,/*Farber disease*/
};
}
static void init13() {
a13 = new int[] {
1878,142,14,/*Farber disease*/
1878,172,27,/*Farber's lipogranulomatosis*/
1878,643,14,/*Farber disease*/
1878,1740,14,/*Farber disease*/
1878,2060,19,/*devastating disease*/
1880,118,13,/*heart failure*/
1880,133,12,/*hepatomegaly*/
1880,150,27,/*hypoglycemic encephalopathy*/
1880,244,20,/*carnitine deficiency*/
1881,10,35,/*paroxysmal nocturnal hemoglobinuria*/
1881,144,35,/*paroxysmal nocturnal hemoglobinuria*/
1881,181,3,/*PNH*/
1881,586,34,/*attachment of the preassembled GPI*/
1881,723,31,/*GPI-anchored protein deficiency*/
1882,31,15,/*prostate cancer*/
1882,76,15,/*prostate cancer*/
1882,96,13,/*breast cancer*/
1882,175,23,/*inherited breast cancer*/
1882,380,15,/*prostate cancer*/
1882,520,15,/*prostate cancer*/
1882,619,15,/*prostate cancer*/
1882,972,15,/*prostate cancer*/
1882,1057,15,/*prostate cancer*/
1882,1143,15,/*prostate cancer*/
1882,1184,15,/*prostate cancer*/
1884,16,13,/*breast cancer*/
1884,101,13,/*breast cancer*/
1884,191,13,/*breast cancer*/
1884,246,15,/*cancer syndrome*/
1884,823,13,/*breast cancer*/
1884,1415,13,/*breast cancer*/
1884,1465,19,/*early-onset disease*/
1884,1567,5,/*tumor*/
1885,274,6,/*cancer*/
1885,1011,6,/*cancer*/
1885,1172,6,/*cancer*/
1886,6,15,/*MLH1 deficiency*/
1886,66,17,/*neurofibromatosis*/
1886,166,41,/*hereditary nonpolyposis colorectal cancer*/
1886,354,41,/*hereditary nonpolyposis colorectal cancer*/
1886,417,24,/*hematological malignancy*/
1886,746,17,/*repair deficiency*/
1886,812,8,/*leukemia*/
1886,830,8,/*lymphoma*/
1887,103,16,/*Brugada syndrome*/
1887,239,11,/*arrhythmias*/
1887,261,16,/*long QT syndrome*/
1887,291,16,/*Brugada syndrome*/
1887,309,3,/*BrS*/
1887,1272,4,/*LQT3*/
1888,51,42,/*pediatric disorder of early language delay*/
1888,98,38,/*cerebral white matter hyperintensities*/
1888,223,20,/*small-vessel disease*/
1888,1279,3,/*WMH*/
1891,26,15,/*Hyperlipidaemia*/
1891,46,22,/*cardiovascular disease*/
1893,183,29,/*spinocerebellar ataxia type-1*/
1893,684,13,/*tumorigenesis*/
1893,747,17,/*neurodegeneration*/
1893,801,3,/*CIC*/
1894,13,16,/*hemolytic anemia*/
1894,33,14,/*G6PD- subjects*/
1894,538,18,/*G6PD- erythrocytes*/
1894,860,15,/*G6PD deficiency*/
1894,991,14,/*G6PD- subjects*/
1895,60,28,/*familial mediterranean fever*/
1895,235,28,/*familial Mediterranean fever*/
1895,265,3,/*FMF*/
1895,356,3,/*FMF*/
1895,416,3,/*FMF*/
1895,910,2,/*TR*/
1895,1513,3,/*FMF*/
1895,1641,3,/*FMF*/
1895,1799,12,/*longer delay*/
1896,12,17,/*Tay-Sachs disease*/
1896,99,17,/*Tay-Sachs disease*/
1896,118,3,/*TSD*/
1896,745,3,/*TSD*/
1896,962,3,/*TSD*/
1897,1359,13,/*import defect*/
1898,101,15,/*Gaucher disease*/
1898,179,15,/*Gaucher disease*/
1898,196,2,/*GD*/
1898,326,2,/*GD*/
1898,456,2,/*GD*/
1898,1430,2,/*GD*/
1900,36,17,/*Friedreich ataxia*/
1900,149,17,/*Friedreich ataxia*/
1900,168,4,/*FRDA*/
1900,439,4,/*FRDA*/
1900,558,4,/*FRDA*/
1900,705,4,/*FRDA*/
1900,859,4,/*FRDA*/
1900,1135,4,/*FRDA*/
1900,1421,20,/*exercise intolerance*/
1900,1513,4,/*FRDA*/
1900,1650,4,/*FRDA*/
1901,0,17,/*Friedreich ataxia*/
1901,88,17,/*Friedreich ataxia*/
1901,107,4,/*FRDA*/
1901,134,16,/*inherited ataxia*/
1901,192,4,/*FRDA*/
1901,229,20,/*cognitive impairment*/
1901,522,4,/*FRDA*/
1901,963,20,/*Cognitive impairment*/
1901,1444,4,/*FRDA*/
1902,73,10,/*piebaldism*/
1902,182,10,/*piebaldism*/
1902,692,4,/*HGMD*/
1902,661,29,/*human gene mutation data base*/
1903,58,23,/*Langer-Giedion syndrome*/
1903,83,26,/*Cornelia de Lange syndrome*/
1903,114,8,/*epilepsy*/
1903,159,44,/*laxity of skin and joints, sparse scalp hair*/
1903,205,18,/*facial dysmorphism*/
1903,225,8,/*epilepsy*/
1903,255,9,/*scoliosis*/
1903,266,23,/*gastroesophageal reflux*/
1903,291,22,/*cardiovascular defects*/
1903,448,22,/*Ehlers-Danlos syndrome*/
1903,531,62,/*trichorhinophalangeal syndrome type II/Langer-Giedion syndrome*/
1903,598,28,/*Cornelia de Lange syndrome-4*/
1904,574,22,/*Machado-Joseph Disease*/
1905,72,17,/*cerebellar ataxia*/
1905,95,10,/*neuropathy*/
1905,238,17,/*recessive ataxias*/
1905,266,20,/*ataxia-telangectasia*/
1905,288,3,/*A-T*/
1905,537,18,/*cerebellar atrophy*/
1905,557,30,/*sensorimotor axonal neuropathy*/
1905,593,26,/*elevated alpha-fetoprotein*/
1905,735,17,/*cerebellar ataxia*/
1905,754,17,/*axonal neuropathy*/
1905,1234,3,/*A-T*/
1905,1229,3,/*ATM*/
1905,1493,4,/*SETX*/
1905,1529,11,/*gait ataxia*/
1905,1545,17,/*facial dyskinesia*/
1905,1789,4,/*AOA2*/
1905,2117,29,/*absence of oculomotor apraxia*/
1905,2199,17,/*cerebellar ataxia*/
1905,2218,23,/*sensorimotor neuropathy*/
1906,10,16,/*Chotzen syndrome*/
1906,117,16,/*Chotzen syndrome*/
1906,149,38,/*autosomal dominant congenital disorder*/
1906,205,16,/*craniosynostosis*/
1906,226,21,/*acrocephalosyndactyly*/
1906,481,21,/*craniofacial features*/
1906,525,16,/*Chotzen syndrome*/
1906,553,16,/*craniosynostosis*/
1906,571,12,/*low-set ears*/
1906,621,18,/*high-arched palate*/
1906,755,16,/*Chotzen syndrome*/
1906,1336,16,/*Chotzen syndrome*/
1908,1111,24,/*congenital heart defects*/
1908,1137,22,/*cardiovascular disease*/
1909,22,27,/*fetal peters' plus syndrome*/
1909,66,21,/*Peters' plus syndrome*/
1909,126,43,/*autosomal recessive ocular genetic syndrome*/
1909,294,15,/*growth-retarded*/
1909,353,21,/*Peters' plus syndrome*/
1910,128,6,/*cancer*/
1910,214,6,/*cancer*/
1910,367,6,/*cancer*/
1910,441,6,/*cancer*/
1910,1114,3,/*ROI*/
1910,1351,13,/*breast cancer*/
1910,1520,13,/*breast cancer*/
1910,1897,6,/*cancer*/
1910,2055,6,/*cancer*/
1910,2248,6,/*cancer*/
1911,42,13,/*Breast Cancer*/
1911,78,13,/*Breast cancer*/
1911,93,2,/*BC*/
1911,116,6,/*cancer*/
1911,255,2,/*BC*/
1911,809,23,/*bilateral breast cancer*/
1911,1661,13,/*breast cancer*/
1913,118,27,/*Globoid cell leukodystrophy*/
1913,147,3,/*GLD*/
1913,157,20,/*neurological disease*/
1913,188,55,/*deficiency of the lysosomal enzyme galactosylceramidase*/
1913,530,3,/*GLD*/
1913,554,13,/*motor defects*/
1913,569,18,/*cognitive deficits*/
1913,589,8,/*seizures*/
1913,752,3,/*GLD*/
1914,40,25,/*Myotonic Dystrophy type 1*/
1915,56,41,/*mucosa of sporadic diffuse gastric cancer*/
1915,182,62,/*potential precursor lesions of sporadic diffuse gastric cancer*/
1915,246,3,/*DGC*/
1915,522,2,/*PS*/
1915,506,14,/*pyrosequencing*/
1915,668,3,/*DGC*/
1915,930,3,/*DGC*/
1915,1117,5,/*tumor*/
1916,254,23,/*chromosomal instability*/
1916,279,3,/*CIN*/
1916,333,5,/*tumor*/
1916,397,13,/*colon cancers*/
1916,540,3,/*CIN*/
1917,39,25,/*fanconi anemia gene ERCC4*/
1917,76,30,/*familial breast/ovarian cancer*/
1917,219,14,/*Fanconi anemia*/
1917,235,2,/*FA*/
1917,298,25,/*breast and ovarian cancer*/
1917,482,34,/*familial breast and ovarian cancer*/
1917,721,6,/*cancer*/
1917,1110,17,/*cross-link repair*/
1918,102,11,/*FG syndrome*/
1918,115,14,/*Lujan syndrome*/
1918,135,13,/*Ohdo syndrome*/
1918,434,23,/*intellectual disability*/
1918,459,2,/*ID*/
1918,903,10,/*malar area*/
1918,1011,20,/*friendly personality*/
1918,1033,20,/*Cognitive impairment*/
1918,1276,2,/*ID*/
1918,1317,20,/*cognitive impairment*/
1918,1586,11,/*dysmorphism*/
1919,0,15,/*C3 deficiencies*/
1920,43,28,/*familial Mediterranean fever*/
1920,235,28,/*familial Mediterranean fever*/
1920,266,3,/*FMF*/
1920,508,3,/*FMF*/
1920,1286,3,/*FMF*/
1921,20,15,/*uremic syndrome*/
1922,42,15,/*phenylketonuria*/
1922,243,15,/*phenylketonuria*/
1922,260,3,/*PKU*/
1922,1463,3,/*PKU*/
1922,1593,3,/*PKU*/
1922,1606,25,/*neurocognitive impairment*/
1922,1852,3,/*PKU*/
1923,95,35,/*insulin-dependent diabetes mellitus*/
1923,249,35,/*insulin-dependent diabetes mellitus*/
1923,662,4,/*IDDM*/
1924,0,30,/*Inherited arrhythmia syndromes*/
1925,18,22,/*ankylosing spondylitis*/
1925,199,22,/*ankylosing spondylitis*/
1925,224,2,/*AS*/
1925,251,2,/*AS*/
1925,819,2,/*AS*/
1925,1542,2,/*AS*/
1925,1725,2,/*AS*/
1926,195,3,/*HCP*/
1926,206,36,/*autosomal dominant-inherited disease*/
1926,282,51,/*deficiency of the enzyme coproporphyrinogen oxidase*/
1926,168,25,/*Hereditary coproporphyria*/
1926,413,36,/*autosomal recessive harderoporphyria*/
1926,1144,3,/*HCP*/
1926,1614,3,/*HCP*/
1926,1897,11,/*HCP disease*/
1927,468,24,/*asymmetric limb weakness*/
1928,111,21,/*Prader-Willi syndrome*/
1928,134,21,/*Prader-Willi syndrome*/
1928,157,3,/*PWS*/
1928,167,16,/*genetic disorder*/
1928,307,18,/*neonatal hypotonia*/
1928,327,13,/*short stature*/
1928,342,20,/*cognitive impairment*/
1928,364,12,/*hypogonadism*/
1928,378,11,/*hyperphagia*/
1928,391,14,/*morbid obesity*/
1928,411,8,/*diabetes*/
1928,529,3,/*PWS*/
1928,690,3,/*PWS*/
1928,970,3,/*PWS*/
1928,1181,3,/*PWS*/
1929,12,7,/*obesity*/
1929,96,7,/*Obesity*/
1929,469,7,/*obesity*/
1929,478,11,/*hyperphagia*/
1929,491,23,/*intellectual deficiency*/
1929,1446,7,/*obesity*/
1929,1468,23,/*intellectual deficiency*/
1930,42,14,/*ovarian cancer*/
1930,148,17,/*ovarian carcinoma*/
1930,430,17,/*ovarian carcinoma*/
1930,595,17,/*ovarian carcinoma*/
1930,721,5,/*tumor*/
1930,883,29,/*insulin-like growth factor-II*/
1930,1048,17,/*ovarian carcinoma*/
1930,1257,17,/*ovarian carcinoma*/
1931,20,24,/*hereditary breast cancer*/
1931,95,24,/*hereditary breast cancer*/
1931,121,3,/*HBC*/
1931,486,6,/*cancer*/
1931,529,6,/*cancer*/
1931,598,7,/*cancers*/
1931,1034,3,/*HBC*/
1932,30,25,/*epithelial ovarian cancer*/
1932,57,3,/*EOC*/
1932,116,25,/*Epithelial ovarian cancer*/
1932,143,3,/*EOC*/
1932,1248,3,/*EOC*/
1932,1377,21,/*nonhereditary disease*/
1932,1450,6,/*cancer*/
1933,0,15,/*Cowden syndrome*/
1933,39,14,/*tumor syndrome*/
1933,74,17,/*genetic syndromes*/
1934,73,24,/*hereditary breast cancer*/
1934,324,13,/*breast cancer*/
1934,511,24,/*breast or ovarian cancer*/
1934,707,13,/*breast cancer*/
1934,989,6,/*cancer*/
1934,1406,6,/*cancer*/
1934,1697,24,/*hereditary breast cancer*/
1936,69,21,/*Prader-Willi syndrome*/
1936,331,21,/*Prader-Willi syndrome*/
1936,355,3,/*PWS*/
1936,397,3,/*PWS*/
1936,684,3,/*PWS*/
1936,754,3,/*PWS*/
1937,17,37,/*glucosephosphate isomerase deficiency*/
1937,84,37,/*glucosephosphate isomerase deficiency*/
1938,472,40,/*hereditary spinocerebellar ataxia type 1*/
1939,73,15,/*uremic syndrome*/
1939,122,26,/*thrombotic microangiopathy*/
1939,166,16,/*hemolytic anemia*/
1939,184,16,/*thrombocytopenia*/
1939,206,19,/*acute renal failure*/
1939,444,13,/*FH deficiency*/
1939,563,3,/*HUS*/
1940,56,11,/*argininemia*/
1940,70,11,/*Argininemia*/
1940,93,39,/*autosomal recessive, metabolic disorder*/
1940,146,36,/*hereditary deficiency of hepatocytes*/
1940,306,18,/*ornithine and urea*/
1940,433,11,/*argininemia*/
1940,519,11,/*argininemia*/
1940,636,19,/*spastic tetraplegia*/
1940,657,8,/*seizures*/
1940,670,17,/*cerebella atrophy*/
1940,833,11,/*argininemia*/
1940,1104,27,/*inborn errors of metabolism*/
1940,1176,11,/*argininemia*/
1941,62,14,/*retinoblastoma*/
1941,100,43,/*hereditary and nonhereditary retinoblastoma*/
1941,145,2,/*Rb*/
1941,188,28,/*copies of the retinoblastoma*/
1941,296,5,/*tumor*/
1941,421,2,/*Rb*/
1941,448,9,/*Rb tumors*/
1941,493,16,/*nonhereditary Rb*/
1941,704,6,/*tumors*/
1941,969,16,/*nonhereditary Rb*/
1941,1061,6,/*tumors*/
1941,1185,21,/*hereditary Rb display*/
1941,1235,2,/*Rb*/
1941,1717,14,/*retinoblastoma*/
1942,111,24,/*Wiskott-Aldrich syndrome*/
1942,141,24,/*Wiskott-Aldrich syndrome*/
1942,168,3,/*WAS*/
1942,179,33,/*X-linked immunodeficiency disease*/
1942,271,3,/*WAS*/
1942,450,3,/*WAS*/
1942,617,3,/*WAS*/
1942,672,3,/*WAS*/
1942,1309,25,/*isolated thrombocytopenia*/
1942,1400,3,/*WAS*/
1942,1698,3,/*WAS*/
1943,52,18,/*Huntington disease*/
1943,147,18,/*Huntington disease*/
1943,167,2,/*HD*/
1943,317,2,/*HD*/
1944,23,12,/*hemophilia B*/
1945,17,42,/*Schwartz-Jampel chondrodystrophic myotonia*/
1945,65,24,/*Schwartz-Jampel syndrome*/
1945,92,3,/*SJS*/
1945,98,26,/*chondrodystrophic myotonia*/
1945,191,8,/*myotonia*/
1945,202,13,/*short stature*/
1945,222,14,/*bone dysplasia*/
1945,737,8,/*myotonia*/
1945,803,14,/*bone dysplasia*/
1945,823,8,/*myotonia*/
1945,1057,23,/*moderate bone dysplasia*/
1945,1240,14,/*bone dysplasia*/
1945,1266,16,/*Kniest dysplasia*/
1945,1347,14,/*bone dysplasia*/
1945,1373,12,/*Pyle disease*/
1946,22,29,/*X-linked adrenoleukodystrophy*/
1946,109,29,/*X-linked adrenoleukodystrophy*/
1946,140,3,/*ALD*/
1946,165,21,/*adrenal insufficiency*/
1946,191,22,/*neurologic involvement*/
1946,294,3,/*ALD*/
1946,644,3,/*ALD*/
1947,105,13,/*breast cancer*/
1947,555,13,/*breast cancer*/
1947,808,3,/*PDB*/
1947,790,16,/*Protein Databank*/
1947,1188,16,/*brain metastasis*/
1947,1430,10,/*metastasis*/
1947,1528,18,/*infectious disease*/
1947,1551,10,/*metastasis*/
1947,1785,22,/*type of the metastasis*/
1948,46,18,/*myotonic dystrophy*/
1948,66,18,/*Myotonic dystrophy*/
1948,86,2,/*DM*/
1948,95,22,/*multi-systemic disease*/
1948,204,2,/*DM*/
1948,565,2,/*DM*/
1948,870,2,/*DM*/
1948,898,40,/*reduced lifespan, heart conduction block*/
1948,947,8,/*myotonia*/
1948,960,36,/*progressive skeletal muscle weakness*/
1948,1196,2,/*DM*/
1949,19,26,/*papillon-lef  vre syndrome*/
1949,70,25,/*Papillon-Lefevre syndrome*/
1949,97,3,/*PLS*/
1949,178,40,/*erythematous palmoplantar hyperkeratosis*/
1949,220,25,/*early-onset periodontitis*/
1949,307,3,/*PLS*/
1949,436,14,/*genetic defect*/
1949,454,3,/*PLS*/
1949,583,25,/*Papillon-lefevre syndrome*/
1950,0,19,/*Asperger's syndrome*/
1950,24,17,/*Tourette syndrome*/
1950,120,19,/*Asperger's syndrome*/
1950,141,2,/*AS*/
1950,230,6,/*autism*/
1950,241,21,/*personality disorders*/
1950,334,42,/*'atypical pervasive developmental disorder*/
1950,400,17,/*Tourette syndrome*/
1951,63,5,/*tumor*/
1951,181,30,/*breast and / or ovarian cancer*/
1951,849,41,/*hereditary breast and / or ovarian cancer*/
1952,18,35,/*familial restrictive cardiomyopathy*/
1952,67,35,/*Familial restrictive cardiomyopathy*/
1952,104,3,/*RCM*/
1952,169,26,/*inherited cardiomyopathies*/
1952,274,3,/*RCM*/
1952,334,27,/*hypertrophic cardiomyopathy*/
1952,363,3,/*HCM*/
1952,510,13,/*heart failure*/
1952,1307,14,/*cardiomyopathy*/
1952,1437,26,/*restrictive cardiomyopathy*/
1953,360,3,/*CO2*/
1953,420,39,/*complete   -ureidopropionase deficiency*/
1953,581,29,/*b-ureidopropionase deficiency*/
1954,349,20,/*adrenoleukodystrophy*/
1954,920,33,/*Fatty acid oxidation measurements*/
1955,112,13,/*Fabry disease*/
1955,353,13,/*Fabry disease*/
1955,368,2,/*FD*/
1955,439,2,/*FD*/
1955,569,2,/*FD*/
1955,776,2,/*FD*/
1955,1001,2,/*FD*/
1956,31,28,/*congenital chloride diarrhea*/
1956,62,3,/*CLD*/
1956,74,28,/*Congenital chloride diarrhea*/
1956,105,3,/*CLD*/
1956,254,3,/*CLD*/
1956,656,3,/*CLD*/
1956,916,3,/*CLD*/
1956,989,16,/*Pendred syndrome*/
1957,0,12,/*Wilms' tumor*/
1957,89,18,/*nephrotic syndrome*/
1957,126,12,/*Wilms' tumor*/
1957,192,36,/*steroid-resistant nephrotic syndrome*/
1957,244,11,/*Denys-Drash*/
1957,259,16,/*Frasier syndrome*/
1957,230,4,/*SRNS*/
1957,574,18,/*nephrotic syndrome*/
1958,62,17,/*Friedreich ataxia*/
1958,93,17,/*Friedreich ataxia*/
1958,112,4,/*FRDA*/
1958,124,28,/*autosomal recessive disorder*/
1958,278,4,/*FRDA*/
1958,431,4,/*FRDA*/
1958,478,4,/*FRDA*/
1958,834,4,/*FRDA*/
1958,1072,11,/*limb ataxia*/
1958,1088,20,/*lower limb areflexia*/
1958,1157,40,/*extensor plantar response and dysarthria*/
1958,1236,8,/*diabetes*/
1958,1283,24,/*eye movement abnormality*/
1958,1534,4,/*FRDA*/
1958,1599,4,/*FRDA*/
1959,80,35,/*McLeod neuroacanthocytosis syndrome*/
1959,117,35,/*McLeod neuroacanthocytosis syndrome*/
1959,154,3,/*MLS*/
1959,169,28,/*X-linked multisystem disease*/
1959,265,26,/*neurological abnormalities*/
1959,625,3,/*MLS*/
1959,908,23,/*paranodal demyelination*/
1959,1036,31,/*neuropathological abnormalities*/
1959,1271,18,/*mild abnormalities*/
1959,1367,31,/*neuropathological abnormalities*/
1960,0,17,/*Neonatal jaundice*/
1960,22,44,/*glucose-6-phosphate dehydrogenase deficiency*/
1960,138,8,/*jaundice*/
1960,148,63,/*erythrocyte glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
1960,278,19,/*hyperbilirubinaemia*/
1960,329,14,/*G6PD-deficient*/
1960,662,15,/*G6PD deficiency*/
1960,767,24,/*severe neonatal jaundice*/
1960,824,15,/*G6PD deficiency*/
1961,15,25,/*alveolar rhabdomyosarcoma*/
1961,115,25,/*Alveolar rhabdomyosarcoma*/
1961,142,4,/*ARMS*/
1961,218,5,/*tumor*/
1961,340,4,/*ARMS*/
1961,741,19,/*nasopharyngeal mass*/
1961,771,15,/*lymphadenopathy*/
1961,792,24,/*multiple bone metastases*/
1961,967,5,/*tumor*/
1961,1067,5,/*tumor*/
1961,1187,5,/*tumor*/
1961,1290,5,/*tumor*/
1961,1373,4,/*ARMS*/
1961,1482,42,/*nasopharyngeal small blue round cell tumor*/
1961,1526,4,/*ARMS*/
1962,27,14,/*hepatoblastoma*/
1962,62,30,/*Simpson-Golabi-Behmel syndrome*/
1962,121,30,/*Simpson-Golabi-Behmel syndrome*/
1962,162,19,/*overgrowth syndrome*/
1962,262,24,/*congenital abnormalities*/
1962,288,23,/*intellectual disability*/
1962,351,21,/*craniofacial features*/
1962,374,12,/*macrocephaly*/
1962,471,16,/*embryonal tumors*/
1962,506,20,/*overgrowth syndromes*/
1962,633,30,/*Simpson-Golabi-Behmel syndrome*/
1962,751,14,/*hepatoblastoma*/
1962,842,5,/*tumor*/
1962,1015,14,/*hepatoblastoma*/
1962,1040,7,/*cancers*/
1962,1104,5,/*tumor*/
1962,1339,14,/*hepatoblastoma*/
1962,1524,14,/*hepatoblastoma*/
1963,79,21,/*ataxia-telangiectasia*/
1963,102,3,/*A-T*/
1963,1576,11,/*A-T disease*/
1964,32,21,/*Prader-Willi syndrome*/
1964,354,21,/*Prader-Willi syndrome*/
1965,102,27,/*myeloproliferative diseases*/
1965,688,12,/*colon cancer*/
1965,727,24,/*chronic myeloid leukemia*/
1965,753,4,/*aCML*/
1965,770,3,/*CML*/
1966,374,16,/*DMT1 dysfunction*/
1966,435,23,/*iron overload disorders*/
1966,463,26,/*neurodegenerative diseases*/
1967,50,37,/*dermatofibrosarcoma protuberans tumor*/
1967,139,31,/*Dermatofibrosarcoma protuberans*/
1967,172,4,/*DFSP*/
1967,277,5,/*tumor*/
1967,426,4,/*DFSP*/
1967,492,5,/*tumor*/
1967,569,4,/*DFSP*/
1967,612,2,/*DF*/
1967,596,14,/*dermatofibroma*/
1967,712,2,/*DF*/
1967,862,5,/*tumor*/
1967,877,2,/*DF*/
1967,1143,4,/*DFSP*/
1967,1463,4,/*DFSP*/
1968,150,6,/*cancer*/
1968,209,23,/*cancer-specific targets*/
1968,411,6,/*cancer*/
1968,488,5,/*tumor*/
1968,533,22,/*cancer-specific target*/
1968,1105,21,/*ataxia-telangiectasia*/
1968,1193,34,/*cancer specificity in animal tumor*/
1968,1396,6,/*cancer*/
1969,49,23,/*amelogenesis imperfecta*/
1969,74,23,/*Amelogenesis imperfecta*/
1969,270,58,/*autosomal recessive hypomaturation amelogenesis imperfecta*/
1969,416,31,/*generalized brown discoloration*/
1970,45,17,/*retinal dystrophy*/
1970,206,17,/*retinal dystrophy*/
1970,557,17,/*retinal dystrophy*/
1970,1035,29,/*macular nummular pigmentation*/
1970,1112,20,/*retinitis pigmentosa*/
1970,1138,19,/*macular involvement*/
1970,1268,17,/*retinal dystrophy*/
1970,1356,20,/*retinitis pigmentosa*/
1970,1474,31,/*heterogeneous retinal dystrophy*/
1971,77,36,/*paroxysmal nocturnal haemoglobinuria*/
1971,115,3,/*PNH*/
1971,532,20,/*completely deficient*/
1971,602,36,/*paroxysmal nocturnal haemoglobinuria*/
1971,640,3,/*PNH*/
1971,673,3,/*DAF*/
1971,756,3,/*DAF*/
1971,984,3,/*PMN*/
1971,1105,3,/*PNH*/
1971,1148,7,/*anaemia*/
1971,1215,3,/*PMN*/
1971,1363,3,/*PNH*/
1971,1458,3,/*PNH*/
1971,1597,3,/*PNH*/
1971,1715,3,/*PNH*/
1971,1763,29,/*PNH-I and PNH-II erythrocytes*/
1972,169,20,/*Classic Galactosemia*/
1972,1419,14,/*Cerebral edema*/
1972,1810,20,/*Classic Galactosemia*/
1973,37,15,/*G6PD deficiency*/
1973,175,51,/*glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
1973,615,15,/*G6PD deficiency*/
1973,694,15,/*G6PD deficiency*/
1974,0,16,/*Bipolar disorder*/
1974,20,16,/*Pendred syndrome*/
1975,1693,36,/*loss-, neutral, and gain-of-function*/
1975,2311,20,/*chromatin remodelers*/
1976,77,20,/*Denys-Drash syndrome*/
1977,0,22,/*Coronary heart disease*/
1977,162,22,/*coronary heart disease*/
1977,186,3,/*CHD*/
1977,361,3,/*CHD*/
1977,617,3,/*CHD*/
1977,863,3,/*CHD*/
1977,1059,3,/*CHD*/
1977,1230,3,/*CHD*/
1977,1515,3,/*CHD*/
1978,74,24,/*Mandibuloacral dysplasia*/
1978,100,3,/*MAD*/
1978,115,28,/*autosomal recessive disorder*/
1978,161,16,/*postnatal growth*/
1978,191,22,/*craniofacial anomalies*/
1978,215,22,/*skeletal malformations*/
1978,251,22,/*cutaneous pigmentation*/
1978,275,36,/*Hutchinson-Gilford Progeria Syndrome*/
1978,313,4,/*HGPS*/
1978,401,3,/*MAD*/
1978,409,4,/*HGPS*/
1978,532,3,/*MAD*/
1978,540,4,/*HGPS*/
1979,166,14,/*ovarian cancer*/
1979,290,13,/*SCCOHT tumors*/
1980,62,22,/*neuromuscular diseases*/
1980,251,25,/*gain-of-function diseases*/
1980,422,22,/*neuromuscular diseases*/
1980,567,29,/*facioscapulohumeral dystrophy*/
1980,809,25,/*myotonic dystrophy type 1*/
1980,1381,34,/*gain of function muscular diseases*/
1981,0,11,/*Skin tumors*/
1981,139,6,/*tumors*/
1981,346,13,/*pilomatricoma*/
1981,459,6,/*tumors*/
1981,477,13,/*pilomatricoma*/
1981,535,6,/*tumors*/
1981,563,6,/*tumors*/
1981,720,6,/*tumors*/
1981,738,13,/*pilomatricoma*/
1981,792,6,/*tumors*/
1981,882,19,/*Five pilomatricomas*/
1981,956,6,/*tumors*/
1981,976,10,/*carcinomas*/
1981,990,22,/*melanocytic matricomas*/
1981,1052,6,/*tumors*/
1981,1088,33,/*trichoepithelioma/trichoblastomas*/
1981,1437,6,/*tumors*/
1981,1562,6,/*tumors*/
1982,107,9,/*polyposis*/
1982,301,24,/*adenomatous colon polyps*/
1982,438,26,/*adenomatous polyposis coli*/
1982,411,3,/*APC*/
1982,1046,21,/*adenomatous polyposis*/
1983,57,22,/*cancer cell malignancy*/
1983,97,5,/*tumor*/
1983,165,7,/*cancers*/
1983,197,5,/*tumor*/
1983,275,6,/*cancer*/
1983,517,6,/*cancer*/
1983,745,13,/*breast cancer*/
1983,1420,7,/*cancers*/
1984,277,22,/*coronary heart disease*/
1984,302,3,/*CHD*/
1984,869,3,/*CHD*/
1984,968,3,/*CHD*/
1984,1041,3,/*CHD*/
1984,1245,3,/*CHD*/
1984,1388,3,/*CHD*/
1984,1420,15,/*CETP deficiency*/
1984,1481,3,/*CHD*/
1984,1514,3,/*CHD*/
1985,102,22,/*X-linked retinoschisis*/
1985,332,13,/*retinoschisis*/
1986,84,12,/*lipoblastoma*/
1986,98,12,/*Lipoblastoma*/
1986,133,15,/*benign neoplasm*/
1986,263,12,/*lipoblastoma*/
1986,317,17,/*lipomatous tumors*/
1986,341,12,/*lipoblastoma*/
1986,466,12,/*lipoblastoma*/
1986,662,18,/*lipoblastoma tumor*/
1986,707,6,/*tumors*/
1986,1256,17,/*lipomatous tumors*/
1986,1331,18,/*lipoblastoma tumor*/
1986,1405,13,/*lipoblastomas*/
1986,1494,6,/*lipoma*/
1986,1579,12,/*lipoblastoma*/
1986,1680,17,/*lipomatous tumors*/
1987,247,15,/*G6PD deficiency*/
1987,2266,15,/*G6PD deficiency*/
1988,0,11,/*Wilms tumor*/
1988,24,11,/*Wilms tumor*/
1988,37,2,/*WT*/
1988,60,22,/*neoplasm of the kidney*/
1988,105,17,/*embryologic tumor*/
1988,150,19,/*renal embryogenesis*/
1988,327,2,/*WT*/
1988,413,19,/*renal embryogenesis*/
1988,592,6,/*tumors*/
1988,944,20,/*syndromic conditions*/
1988,973,4,/*WAGR*/
1988,982,21,/*Denys-Drash syndromes*/
1988,1045,6,/*tumors*/
1988,1258,27,/*Beckwith-Wiedemann syndrome*/
1988,1303,20,/*isolated hypertrophy*/
1988,1382,2,/*WT*/
1988,1400,3,/*WTX*/
1988,1540,14,/*poor prognosis*/
1988,1611,2,/*WT*/
1989,140,44,/*familial neurohypophyseal diabetes insipidus*/
1989,186,44,/*Familial neurohypophyseal diabetes insipidus*/
1989,233,4,/*FNDI*/
1989,246,26,/*autosomal dominant disease*/
1989,471,4,/*FNDI*/
1989,1197,4,/*FNDI*/
1990,251,20,/*anti-atherosclerosis*/
1991,27,20,/*neurological disease*/
1991,189,25,/*lysosomal storage disease*/
1991,225,39,/*deficiency of lysosomal b-galactosidase*/
1991,476,22,/*deep cerebellar nuclei*/
1991,619,21,/*brain and spinal cord*/
1991,881,13,/*gait deficits*/
1991,1144,26,/*lysosomal storage disorder*/
1992,0,37,/*Blepharo-cheilo-dontic (BCD) syndrome*/
1992,121,13,/*lagophthalmia*/
1992,136,41,/*euryblepharon, ectropion of lower eyelids*/
1992,193,30,/*bilateral cleft lip and palate*/
1992,255,37,/*blepharo-cheilo-dontic (BCD) syndrome*/
1992,391,28,/*autosomal dominant condition*/
1992,515,12,/*BCD syndrome*/
1992,569,12,/*BCD syndrome*/
1992,595,37,/*eyelids, lip, and teeth abnormalities*/
1992,669,3,/*BCD*/
1992,754,28,/*lumbosacral meningomyelocele*/
1993,45,28,/*spondyloepiphyseal dysplasia*/
1993,75,14,/*hypothyroidism*/
1993,91,53,/*neovascularization and tractional retinal detachments*/
1993,281,43,/*unclassifiable spondyloepiphyseal dysplasia*/
1993,326,14,/*hypothyroidism*/
1993,388,35,/*retinal and iris neovascularization*/
1994,184,42,/*hereditary persistence of fetal hemoglobin*/
1994,238,21,/*beta zero thalassemia*/
1994,228,4,/*HPFH*/
1994,295,21,/*beta zero thalassemia*/
1994,427,25,/*HPFH and beta thalassemia*/
1995,45,35,/*paroxysmal nocturnal hemoglobinuria*/
1995,82,35,/*Paroxysmal nocturnal hemoglobinuria*/
1995,119,3,/*PNH*/
1995,130,17,/*acquired disorder*/
1995,178,16,/*hemolytic anemia*/
1995,253,3,/*PNH*/
1995,312,28,/*autologous plasma complement*/
1995,398,3,/*PNH*/
1995,565,12,/*aberrant PNH*/
1996,166,18,/*inherited disorder*/
1996,596,2,/*HC*/
1996,732,16,/*haemochromatosis*/
1996,991,31,/*Cardiac and endocrine disorders*/
1996,1274,16,/*haemochromatosis*/
1996,1370,2,/*HC*/
1997,55,17,/*colorectal tumors*/
1997,112,40,/*Classical familial adenomatous polyposis*/
1997,155,3,/*FAP*/
1997,254,19,/*colorectal adenomas*/
1997,278,9,/*carcinoma*/
1997,362,3,/*FAP*/
1997,489,37,/*Attenuated adenomatous polyposis coli*/
1997,645,3,/*FAP*/
1997,691,8,/*adenomas*/
1997,942,17,/*colorectal tumors*/
1997,981,8,/*adenomas*/
1997,1089,9,/*carcinoma*/
1997,1322,3,/*APC*/
1997,1530,3,/*APC*/
1997,1586,19,/*colorectal adenomas*/
1997,1610,9,/*carcinoma*/
1997,1668,3,/*FAP*/
1997,1707,17,/*colorectal cancer*/
1999,36,21,/*peroxisomal disorders*/
1999,124,21,/*Peroxisomal disorders*/
1999,158,16,/*genetic diseases*/
1999,185,23,/*peroxisomal dysfunction*/
1999,336,18,/*Zellweger syndrome*/
1999,356,29,/*neonatal adrenoleukodystrophy*/
1999,387,24,/*infantile Refsum disease*/
1999,542,23,/*Zellweger-like syndrome*/
1999,625,29,/*X-linked adrenoleukodystrophy*/
1999,677,72,/*deficiency, bifunctional protein deficiency, acyl-CoA oxidase deficiency*/
1999,775,20,/*hyperoxaluria type I*/
1999,800,13,/*acatalasaemia*/
1999,939,38,/*hyperoxaluria type I and acatalasaemia*/
1999,1050,21,/*peroxisomal disorders*/
1999,1235,27,/*rhizomelic chondrodysplasia*/
1999,1282,29,/*X-linked adrenoleukodystrophy*/
2000,5,19,/*May-Hegglin anomaly*/
2001,34,20,/*colon adenocarcinoma*/
2001,62,23,/*familial polyposis coli*/
2001,156,25,/*colorectal adenocarcinoma*/
2001,200,23,/*familial polyposis coli*/
2001,225,3,/*FAP*/
2001,400,21,/*colorectal carcinomas*/
2001,501,30,/*sporadic colorectal carcinomas*/
2001,539,3,/*FAP*/
2002,197,50,/*von Willebrand factor, complement factors B and C2*/
2002,253,16,/*epidermal growth*/
2002,1183,14,/*von Willebrand*/
2003,0,16,/*Aarskog syndrome*/
2004,54,21,/*ataxia telangiectasia*/
2004,184,21,/*ataxia telangiectasia*/
2004,207,3,/*A-T*/
2004,605,3,/*A-T*/
2004,780,3,/*A-T*/
2004,795,3,/*A-T*/
2004,928,15,/*prolonged delay*/
2004,1155,3,/*A-T*/
2005,60,26,/*adenomatous polyposis coli*/
2005,88,26,/*Adenomatous polyposis coli*/
2005,124,29,/*dominantly inherited disorder*/
2005,116,3,/*APC*/
2005,300,9,/*polyposis*/
2008,23,26,/*polycystic kidney diseases*/
2008,51,26,/*Polycystic kidney diseases*/
2008,105,16,/*common disorders*/
2008,79,4,/*PKDs*/
2009,106,18,/*myotonic dystrophy*/
2009,139,18,/*myotonic dystrophy*/
2009,159,2,/*DM*/
2009,194,18,/*muscular dystrophy*/
2009,329,2,/*DM*/
2009,459,2,/*DM*/
2009,594,2,/*DM*/
2009,819,28,/*chronic lymphocytic leukemia*/
2009,993,2,/*DM*/
2009,1156,2,/*DM*/
2010,0,14,/*Norrie disease*/
2010,167,14,/*Norrie disease*/
2010,483,14,/*Norrie disease*/
2010,1054,14,/*Norrie disease*/
2011,110,21,/*Prader-Willi syndrome*/
2011,656,21,/*Prader-Willi syndrome*/
2011,679,3,/*PWS*/
2011,691,17,/*mentally retarded*/
2011,855,3,/*PWS*/
2011,1008,3,/*PWS*/
2011,1275,22,/*chromosomal aneuploidy*/
2011,1350,3,/*PWS*/
2011,1685,3,/*PWS*/
2012,25,27,/*inherited metabolic disease*/
2013,0,28,/*Hypervariable microsatellite*/
2014,17,14,/*IgA deficiency*/
2014,142,14,/*IgA deficiency*/
2014,161,32,/*common variable immunodeficiency*/
2014,262,18,/*immunodeficiencies*/
2014,580,13,/*IgA-deficient*/
2014,654,18,/*immunodeficiencies*/
2014,880,50,/*common variable immunodeficiency or IgA deficiency*/
2014,959,32,/*common variable immunodeficiency*/
2014,1043,14,/*IgA deficiency*/
2014,1418,14,/*IgA deficiency*/
2014,1471,51,/*common variable immunodeficiency and IgA deficiency*/
2015,39,26,/*familial adenomatosis coli*/
2015,67,36,/*Abnormalities of jaw bones and teeth*/
2015,204,30,/*Osteomatous radiopaque lesions*/
2015,267,3,/*FAC*/
2015,359,8,/*osteomas*/
2015,407,29,/*supernumerary unerupted teeth*/
2015,462,3,/*FAC*/
2015,547,22,/*Combined abnormalities*/
2015,665,8,/*Osteomas*/
2015,689,8,/*osteomas*/
2015,800,7,/*osteoma*/
2015,978,18,/*radiopaque lesions*/
2015,1052,3,/*FAC*/
2016,48,17,/*myasthenia gravis*/
2017,22,35,/*familial central diabetes insipidus*/
2017,298,34,/*crude posterior pituitary extracts*/
2017,451,35,/*familial central diabetes insipidus*/
2017,1213,23,/*isolated AVP deficiency*/
2017,1255,17,/*congenital defect*/
2018,738,2,/*ND*/
2020,0,32,/*Pediatric oncology: model tumors*/
2020,78,6,/*tumors*/
2020,558,18,/*Burkitt's lymphoma*/
2020,581,14,/*retinoblastoma*/
2020,668,6,/*tumors*/
2020,725,6,/*cancer*/
2023,124,29,/*subacute G(M2) gangliosidosis*/
2023,289,17,/*Tay-Sachs disease*/
2023,309,3,/*TSD*/
2023,1251,5,/*Hex A*/
2023,1504,3,/*TSD*/
2023,1956,16,/*Hex A deficiency*/
2024,40,27,/*Duchenne muscular dystrophy*/
2024,69,3,/*DMD*/
2025,87,26,/*bipolar affective disorder*/
2025,304,26,/*bipolar affective disorder*/
2026,0,23,/*Emery-Dreifuss syndrome*/
2026,25,33,/*Emery-Dreifuss muscular dystrophy*/
2026,102,70,/*contractures of the elbows, Achilles tendons, and postcervical muscles*/
2026,197,14,/*muscle wasting*/
2026,328,11,/*heart block*/
2026,805,23,/*Emery-Dreifuss syndrome*/
2027,40,21,/*Ataxia-telangiectasia*/
2027,63,3,/*A-T*/
2027,72,18,/*inherited disorder*/
2027,124,16,/*cancer-proneness*/
2027,343,3,/*A-T*/
2027,395,3,/*A-T*/
2027,437,6,/*cancer*/
2027,595,16,/*cancer-proneness*/
2028,0,20,/*Lesch-Nyhan syndrome*/
2028,123,20,/*Lesch-Nyhan syndrome*/
2028,231,21,/*involuntary movements*/
2028,822,20,/*Lesch-Nyhan syndrome*/
2030,151,56,/*congenital hypertrophy of the retinal pigment epithelium*/
2030,209,5,/*CHRPE*/
2030,368,5,/*CHRPE*/
2030,396,16,/*small microvilli*/
2030,789,5,/*CHRPE*/
2030,1075,5,/*CHRPE*/
2031,11,16,/*Wolfram syndrome*/
2031,102,7,/*DIDMOAD*/
2031,125,16,/*genetic disorder*/
2031,159,18,/*diabetes insipidus*/
2031,179,17,/*diabetes mellitus*/
2031,198,13,/*optic atrophy*/
2031,216,8,/*deafness*/
2031,260,17,/*diabetes mellitus*/
2031,500,16,/*Wolfram syndrome*/
2032,13,14,/*Coats' disease*/
2033,0,25,/*Benign muscular dystrophy*/
2033,177,18,/*muscular dystrophy*/
2033,367,34,/*X linked Becker muscular dystrophy*/
2033,405,50,/*autosomal recessive limb girdle muscular dystrophy*/
2034,61,14,/*retinoblastoma*/
2034,115,14,/*retinoblastoma*/
2034,147,6,/*tumors*/
2034,173,14,/*retinoblastoma*/
2034,191,12,/*osteosarcoma*/
2034,435,6,/*tumors*/
2035,58,22,/*aspartylglycosaminuria*/
2037,214,3,/*PPS*/
2037,184,28,/*popliteal pterygium syndrome*/
2037,295,3,/*PPS*/
2037,309,8,/*lip pits*/
2037,319,26,/*clefts, gingival synechiae*/
2037,367,10,/*syndactyly*/
2037,382,18,/*genital hypoplasia*/
2037,639,8,/*lip pits*/
2037,681,3,/*PPS*/
2037,750,8,/*lip pits*/
2037,775,6,/*clefts*/
2039,23,25,/*Becker muscular dystrophy*/
2039,50,3,/*BMD*/
2039,107,25,/*Becker muscular dystrophy*/
2039,134,3,/*BMD*/
2039,174,24,/*Proximal muscle weakness*/
2039,718,3,/*BMD*/
2039,811,7,/*DMD/BMD*/
2040,39,27,/*Duchenne muscular dystrophy*/
2041,62,10,/*hemostasis*/
2042,0,22,/*Ankylosing spondylitis*/
2042,168,22,/*ankylosing spondylitis*/
2042,192,2,/*AS*/
2042,490,11,/*arthropathy*/
2042,655,20,/*Peripheral arthritis*/
2042,805,9,/*stiffness*/
2042,967,6,/*anemia*/
2042,978,22,/*hypergammaglobulinemia*/
2042,1123,2,/*AS*/
2043,440,5,/*C7-C9*/
2044,11,29,/*congenital myotonic dystrophy*/
2044,90,29,/*congenital myotonic dystrophy*/
2044,134,6,/*autism*/
2044,193,18,/*myotonic dystrophy*/
2044,270,25,/*bilateral talipes equinus*/
2044,394,17,/*autistic behavior*/
2044,625,18,/*mental retardation*/
2044,712,6,/*autism*/
2044,783,18,/*mental retardation*/
2044,851,15,/*facial diplegia*/
2044,893,18,/*high-arched palate*/
2044,930,63,/*percussion myotonia of the tongue, generalized muscular atrophy*/
2044,998,8,/*weakness*/
2044,1008,8,/*lordosis*/
2044,1018,9,/*areflexia*/
2044,1033,20,/*congenital cataracta*/
2044,1519,22,/*Ventricular dilatation*/
2044,1659,29,/*congenital myotonic dystrophy*/
2044,1751,6,/*autism*/
};
}
static void init14() {
a14 = new int[] {
2045,80,30,/*Familial adenomatous polyposis*/
2045,199,14,/*cancer control*/
2045,276,17,/*colorectal cancer*/
2045,524,5,/*tumor*/
2045,612,5,/*tumor*/
2045,693,3,/*FAP*/
2045,770,17,/*colorectal cancer*/
2045,840,20,/*Knudson's hypothesis*/
2045,925,3,/*FAP*/
2047,18,12,/*hemophilia A*/
2047,221,12,/*hemophilia A*/
2048,116,8,/*lymphoma*/
2048,126,26,/*breast, and ovarian cancer*/
2048,224,6,/*cancer*/
2048,432,6,/*tumour*/
2048,447,6,/*cancer*/
2049,43,12,/*Wilms' tumor*/
2049,60,8,/*aniridia*/
2049,94,12,/*Wilms' tumor*/
2049,112,8,/*aniridia*/
2049,378,4,/*WAGR*/
2049,543,17,/*familial aniridia*/
2049,570,12,/*Wilms' tumor*/
2049,689,8,/*aniridia*/
2049,699,12,/*Wilms' tumor*/
2049,717,12,/*hypogonadism*/
2049,819,8,/*aniridia*/
2049,842,12,/*Wilms' tumor*/
2049,878,8,/*aniridia*/
2049,952,12,/*Wilms' tumor*/
2049,969,8,/*aniridia*/
2049,1036,4,/*WAGR*/
2049,1067,8,/*aniridia*/
2050,20,31,/*cytochrome c oxidase deficiency*/
2050,91,37,/*cytochrome c oxidase (CCO) deficiency*/
2050,637,18,/*encephalomyopathic*/
2050,662,3,/*RRF*/
2051,367,29,/*simian sarcoma virus p28v-sis*/
2052,71,19,/*Lesch-Nyhan disease*/
2054,52,27,/*X-linked muscular dystrophy*/
2055,129,27,/*X linked muscular dystrophy*/
2055,265,27,/*X linked muscular dystrophy*/
2055,508,37,/*Duchenne or Becker muscular dystrophy*/
2055,626,3,/*DMD*/
2055,803,3,/*DMD*/
2055,811,3,/*BMD*/
2055,983,3,/*DMD*/
2055,1082,3,/*DMD*/
2056,544,27,/*X-linked muscular dystrophy*/
2056,727,27,/*Duchenne muscular dystrophy*/
2056,756,3,/*DMD*/
2056,847,33,/*Emery Dreifuss muscular dystrophy*/
2057,12,37,/*X-linked lymphoproliferative syndrome*/
2057,55,37,/*X-linked lymphoproliferative syndrome*/
2057,109,28,/*Epstein-Barr virus infection*/
2057,159,13,/*mononucleosis*/
2057,174,51,/*immunodeficiency, and lymphoproliferative disorders*/
2057,278,37,/*X-linked lymphoproliferative syndrome*/
2057,657,37,/*X-linked lymphoproliferative syndrome*/
2057,826,37,/*X-linked lymphoproliferative syndrome*/
2061,13,40,/*Duchenne and Becker muscular dystrophies*/
2062,22,25,/*hereditary retinoblastoma*/
2063,15,27,/*Duchenne muscular dystrophy*/
2063,44,27,/*Duchenne muscular dystrophy*/
2063,73,3,/*DMD*/
2063,90,26,/*X-linked muscular disorder*/
2063,122,18,/*biochemical defect*/
2063,411,3,/*DMD*/
2063,752,3,/*DMD*/
2063,1077,3,/*DMD*/
2064,85,20,/*abetalipoproteinemia*/
2064,107,20,/*Abetalipoproteinemia*/
2064,129,3,/*ABL*/
2064,139,18,/*recessive disorder*/
2065,150,20,/*Huntington's disease*/
2065,172,2,/*HD*/
2065,334,2,/*HD*/
2065,920,2,/*HD*/
2065,1112,2,/*HD*/
2066,10,10,/*meningitis*/
2066,79,33,/*acute bacterial meningitis caused*/
2066,116,22,/*Neisseria meningitidis*/
2066,178,16,/*acute meningitis*/
2066,572,20,/*complement-deficient*/
2066,809,21,/*complement deficiency*/
2066,898,19,/*Neisseria infection*/
2067,44,14,/*ovarian cancer*/
2067,172,6,/*tumors*/
2067,354,14,/*ovarian tumors*/
2067,449,6,/*tumors*/
2067,505,5,/*tumor*/
2067,668,14,/*ovarian cancer*/
2069,38,34,/*nonpapillary renal cell carcinomas*/
2069,234,20,/*renal cell carcinoma*/
2069,256,3,/*RCC*/
2069,342,5,/*tumor*/
2069,745,17,/*nonpapillary RCCs*/
2071,4,46,/*golden tapetal sheen reflex in retinal disease*/
2071,113,16,/*retinal reflexes*/
2071,138,16,/*Oguchi's disease*/
2071,190,29,/*X-linked retinitis pigmentosa*/
2071,248,14,/*cone dystrophy*/
2071,301,25,/*golden reflex in each eye*/
2072,206,15,/*phenylketonuria*/
2072,223,3,/*PKU*/
2073,661,22,/*deficiency of activity*/
2073,829,15,/*GM2 ganglioside*/
2073,977,9,/*Tay-Sachs*/
2074,26,9,/*fragile X*/
2074,108,9,/*fragile X*/
2075,19,18,/*Huntington disease*/
2075,73,18,/*Huntington disease*/
2075,93,2,/*HD*/
2075,113,40,/*autosomal dominant neurological disorder*/
2075,201,11,/*HD-affected*/
2075,310,2,/*HD*/
2075,385,2,/*HD*/
2075,549,2,/*HD*/
2075,591,2,/*HD*/
2076,81,17,/*Tay-Sachs disease*/
2077,51,20,/*Huntington's disease*/
2077,99,20,/*Huntington's disease*/
2077,121,2,/*HD*/
2077,463,2,/*HD*/
2077,729,2,/*HD*/
2077,913,2,/*HD*/
2077,973,2,/*HD*/
2078,50,20,/*Huntington's disease*/
2078,75,19,/*Alzheimer's disease*/
2078,207,2,/*HD*/
2078,452,10,/*HD disease*/
2078,543,2,/*HD*/
2078,705,42,/*psychiatric symptoms of emotional lability*/
2078,801,2,/*HD*/
2078,884,8,/*dementia*/
2078,894,8,/*seizures*/
2078,977,2,/*AD*/
2078,984,2,/*HD*/
2078,1425,2,/*AD*/
2078,1432,2,/*HD*/
2079,106,18,/*glomerulonephritis*/
2080,917,21,/*feline leukemia virus*/
2080,940,4,/*FeLV*/
2080,1088,4,/*PRCA*/
2080,1065,21,/*pure red cell aplasia*/
2080,1503,4,/*PRCA*/
2080,1519,6,/*anemia*/
2081,172,24,/*Dictyostelium discoideum*/
2082,24,19,/*deficiency syndrome*/
2087,0,26,/*Adult adrenoleucodystrophy*/
2087,32,17,/*hypercortisolemia*/
2087,159,21,/*adrenomyeloneuropathy*/
2087,365,20,/*adrenoleucodystrophy*/
2087,389,26,/*adrenoleucomyeloneuropathy*/
2087,605,27,/*elevated in the final stage*/
2088,770,18,/*fragile X syndrome*/
2089,60,39,/*B-lymphocytes and lymphoid dissociation*/
2090,20,15,/*cystic fibrosis*/
2090,108,15,/*cystic fibrosis*/
2090,125,2,/*CF*/
2090,508,2,/*CF*/
2090,605,2,/*CF*/
2090,1009,2,/*CF*/
2093,0,17,/*Primary dystonias*/
2094,8,27,/*Duchenne muscular dystrophy*/
2095,1,22,/*Emery-Dreifuss disease*/
2095,72,24,/*Emery-Dreifuss dystrophy*/
2095,248,7,/*wasting*/
2095,305,16,/*atrial paralysis*/
2095,556,12,/*myosclerosis*/
2095,578,20,/*rigid spine syndrome*/
2095,672,22,/*muscular abnormalities*/
2096,52,41,/*Duchenne's progressive muscular dystrophy*/
2097,38,13,/*breast cancer*/
2097,149,13,/*breast cancer*/
2097,362,6,/*tumour*/
2097,698,6,/*tumour*/
2097,753,13,/*breast cancer*/
2098,90,31,/*pyruvate carboxylase deficiency*/
2098,165,31,/*pyruvate carboxylase deficiency*/
2098,318,14,/*hyperammonemia*/
2098,334,18,/*hypercitrullinemia*/
2098,358,14,/*hyperlysinemia*/
2098,468,17,/*liver dysfunction*/
2098,496,10,/*septicemia*/
2098,511,8,/*seizures*/
2098,808,33,/*intracellular oxaloacetate levels*/
2098,908,17,/*deficiency in ATP*/
2099,1716,3,/*PMA*/
2099,1746,3,/*PMA*/
2099,1689,25,/*phorbol myristate acetate*/
2100,0,23,/*Norrie-Warburg syndrome*/
2101,9,25,/*von Willebrand's syndrome*/
2101,75,50,/*von Willebrand's factor in polycythemia rubra vera*/
2101,151,25,/*von Willebrand's syndrome*/
2101,193,12,/*polycythemia*/
2101,1081,23,/*von Willebrand's factor*/
2102,35,14,/*von Willebrand*/
2102,97,30,/*nephrogenic diabetes insipidus*/
2102,212,14,/*von Willebrand*/
2102,282,30,/*nephrogenic diabetes insipidus*/
2102,314,3,/*NDI*/
2102,566,3,/*NDI*/
2102,620,3,/*NDI*/
2103,0,29,/*Beta-glucuronidase deficiency*/
2103,94,29,/*beta-glucuronidase deficiency*/
2103,310,15,/*peculiar facies*/
2103,334,6,/*cornea*/
2103,342,18,/*hepatosplenomegaly*/
2103,370,8,/*kyphosis*/
2103,380,20,/*recurrent infections*/
2103,402,13,/*short stature*/
2103,421,19,/*developmental delay*/
2104,1,28,/*Systemic lupus erythematosus*/
2104,59,17,/*myasthenia gravis*/
2105,63,26,/*von Hippel-Lindau syndrome*/
2105,91,26,/*von Hippel-Lindau syndrome*/
2105,124,27,/*autosomal dominant disorder*/
2105,191,27,/*benign and malignant tumors*/
2105,233,26,/*von Hippel-Lindau syndrome*/
2105,316,28,/*cancer-prone genetic disease*/
2105,479,26,/*von Hippel-Lindau syndrome*/
2105,595,33,/*detectable chromosome abnormality*/
2105,839,26,/*von Hippel-Lindau syndrome*/
2105,1144,5,/*tumor*/
2105,1163,26,/*von Hippel-Lindau syndrome*/
2106,5,15,/*retinoblastomas*/
2106,22,13,/*osteosarcomas*/
2106,46,15,/*tissue sarcomas*/
2106,137,13,/*osteosarcomas*/
2106,207,14,/*retinoblastoma*/
2106,279,2,/*RB*/
2106,318,2,/*RB*/
2106,361,14,/*retinoblastoma*/
2106,389,13,/*osteosarcomas*/
2106,411,15,/*tissue sarcomas*/
2106,513,16,/*epithelial tumor*/
2106,541,16,/*One osteosarcoma*/
2106,738,2,/*RB*/
2106,787,13,/*osteosarcomas*/
2106,810,15,/*tissue sarcomas*/
2106,837,15,/*retinoblastomas*/
2107,92,12,/*pigmentation*/
2107,525,14,/*pigmented eyes*/
2107,774,33,/*pigmentation of the eumelanosomes*/
2108,109,15,/*iron deficiency*/
2108,703,2,/*KD*/
2109,22,15,/*phenylketonuria*/
2109,142,15,/*phenylketonuria*/
2109,196,25,/*phenylalanine intolerance*/
2109,251,25,/*classical phenylketonuria*/
2109,491,25,/*phenylalanine intolerance*/
2109,544,15,/*phenylketonuria*/
2109,805,15,/*phenylketonuria*/
2112,36,5,/*tumor*/
2112,88,14,/*ovarian cancer*/
2112,125,14,/*ovarian cancer*/
2112,274,5,/*tumor*/
2112,509,6,/*tumors*/
2112,564,9,/*II tumors*/
2112,606,10,/*III tumors*/
2112,941,14,/*carcinomatosis*/
2112,1003,6,/*sepsis*/
2112,1019,9,/*pneumonia*/
2112,1059,6,/*sepsis*/
2112,1070,9,/*pneumonia*/
2114,0,19,/*Leukoencephalopathy*/
2114,23,28,/*HTLV-I-associated myelopathy*/
2114,191,27,/*T-lymphotropic virus type I*/
2114,239,10,/*myelopathy*/
2114,251,3,/*HAM*/
2114,613,30,/*abnormalities on the brain MRI*/
2114,683,18,/*greater disability*/
2114,800,19,/*minor abnormalities*/
2114,844,3,/*HAM*/
2114,898,20,/*cerebral involvement*/
2114,1044,3,/*HAM*/
2116,8,19,/*collagen deficiency*/
2117,1,30,/*Cerebrotendinous xanthomatosis*/
2118,41,20,/*adrenoleukodystrophy*/
2118,63,3,/*ALD*/
2118,69,30,/*cerebrotendinous xanthomatosis*/
2118,101,3,/*CTX*/
2118,125,10,/*myelopathy*/
2118,137,3,/*HAM*/
2120,99,63,/*absence of the human gene for the fifth component of complement*/
2121,30,21,/*ataxia telangiectasia*/
2121,158,21,/*ataxia telangiectasia*/
2122,0,20,/*Pyoderma gangrenosum*/
2122,32,20,/*Pyoderma gangrenosum*/
2122,156,11,/*skin ulcers*/
2122,245,16,/*systemic disease*/
2122,281,20,/*pyoderma gangrenosum*/
2122,414,17,/*systemic diseases*/
2122,500,20,/*pyoderma gangrenosum*/
2123,48,12,/*galactosemia*/
2124,0,21,/*Prader-Willi syndrome*/
2124,201,21,/*Prader-Willi syndrome*/
2124,224,3,/*PWS*/
2124,460,3,/*PWS*/
2125,14,27,/*Duchenne muscular dystrophy*/
2126,142,3,/*CHO*/
2127,50,22,/*familial mixed cancers*/
2127,121,6,/*cancer*/
2127,195,5,/*tumor*/
2127,248,7,/*cancers*/
2127,313,12,/*adult cancer*/
2127,535,6,/*cancer*/
2127,590,14,/*retinoblastoma*/
2127,609,12,/*osteosarcoma*/
2127,732,5,/*tumor*/
2127,949,5,/*tumor*/
2128,0,33,/*Familial neonatal hemochromatosis*/
2128,76,24,/*neonatal hemochromatosis*/
2128,102,3,/*NHC*/
2128,426,21,/*neonatal hypoglycemia*/
2128,449,12,/*coagulopathy*/
2128,472,18,/*hyperbilirubinemia*/
2128,529,19,/*multisystem failure*/
2128,565,9,/*cirrhosis*/
2128,637,20,/*giant cell hepatitis*/
2128,684,29,/*idiopathic neonatal hepatitis*/
2128,715,4,/*INHP*/
2129,0,13,/*C5 deficiency*/
2129,18,10,/*meningitis*/
2130,23,32,/*non-spherocytic hemolytic anemia*/
2130,104,6,/*anemia*/
2130,290,41,/*deficiencies and 2 of unstable hemoglobin*/
2130,333,32,/*Abnormalities of pyruvate kinase*/
2130,391,9,/*hemolysis*/
2130,701,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
2130,779,37,/*pyrimidine 5'-nucleotidase deficiency*/
2130,831,30,/*phosphate isomerase deficiency*/
2130,885,51,/*deficiency in 2, phosphoglycerate kinase deficiency*/
2130,947,33,/*glutathione synthetase deficiency*/
2131,15,40,/*deficiency and N-acetylaspartic aciduria*/
2131,73,15,/*Canavan disease*/
2131,225,28,/*cerebral spongy degeneration*/
2131,255,15,/*Canavan disease*/
2131,817,15,/*Canavan disease*/
2131,1010,15,/*Canavan disease*/
2132,63,42,/*partial deficiency of galactocerebrosidase*/
2132,311,82,/*cerebrospinal protein concentration and partial deficiency of galactocerebrosidase*/
2132,530,17,/*febrile infection*/
2133,104,41,/*cerebro-hepato-renal (Zellweger) syndrome*/
2134,0,71,/*Riboflavin-responsive multiple acyl coenzyme A dehydrogenase deficiency*/
2134,88,17,/*proximal myopathy*/
2135,158,22,/*lipid storage myopathy*/
2135,182,11,/*fatty liver*/
2135,234,16,/*Jordans' anomaly*/
2135,267,8,/*deafness*/
2135,1394,16,/*metabolic defect*/
2135,1595,25,/*triacylglycerol synthesis*/
2136,66,43,/*glucose-6-phosphate-dehydrogenase-deficient*/
2136,333,14,/*G6PD-deficient*/
2136,451,11,/*G6PD-normal*/
2136,485,14,/*G6PD-deficient*/
2137,110,18,/*chronic bronchitis*/
2137,130,2,/*CB*/
2137,397,13,/*such diseases*/
2137,414,18,/*chronic bronchitis*/
2137,437,16,/*bronchial asthma*/
2137,531,2,/*CB*/
2137,608,2,/*CB*/
2137,776,2,/*CB*/
2137,1160,2,/*CB*/
2138,32,15,/*hemochromatosis*/
2138,146,15,/*hemochromatosis*/
2138,362,9,/*cirrhosis*/
2138,375,8,/*diabetes*/
2138,777,9,/*cirrhosis*/
2138,790,8,/*diabetes*/
2138,1114,17,/*diabetes mellitus*/
2138,1373,15,/*hemochromatosis*/
2138,1481,9,/*Cirrhotic*/
2138,1562,12,/*liver cancer*/
2140,261,13,/*iron overload*/
2140,568,27,/*idiopathic haemochromatosis*/
2140,597,3,/*IHC*/
2140,1330,13,/*iron overload*/
2141,55,38,/*X chromosome-linked muscular dystrophy*/
2141,190,38,/*X chromosome-linked muscular dystrophy*/
2141,587,18,/*Duchenne dystrophy*/
2143,329,2,/*XS*/
2143,574,2,/*XS*/
2143,811,2,/*XS*/
2143,952,2,/*XS*/
2144,4,27,/*autosomal dominant syndrome*/
2144,43,27,/*craniofrontonasal dysplasia*/
2144,72,27,/*Craniofrontonasal dysplasia*/
2144,103,30,/*distinct malformation syndrome*/
2144,174,21,/*frontonasal dysplasia*/
2144,197,16,/*craniosynostosis*/
2144,228,92,/*extracranial abnormalities--in particular, brittle nails with prominent longitudinal grooves*/
2144,622,27,/*autosomal dominant syndrome*/
2144,667,27,/*craniofrontonasal dysplasia*/
2144,763,16,/*craniosynostosis*/
2144,783,18,/*nail abnormalities*/
2144,984,16,/*Aarskog syndrome*/
2145,19,18,/*Wolfram's syndrome*/
2146,0,16,/*Growth disparity*/
2146,53,21,/*chronic renal disease*/
2146,150,13,/*renal disease*/
2146,197,13,/*renal disease*/
2146,337,13,/*renal disease*/
2147,160,55,/*specificity for the fifth component of mouse complement*/
2147,307,22,/*C5-dependent hemolysis*/
2147,1082,12,/*C5-deficient*/
2147,1409,23,/*immunological tolerance*/
2148,593,6,/*G6PD A*/
2149,22,26,/*hereditary hemochromatosis*/
2149,124,26,/*hereditary hemochromatosis*/
2149,262,26,/*hereditary hemochromatosis*/
2149,689,15,/*hemochromatosis*/
2149,775,15,/*hemochromatosis*/
2149,805,15,/*hemochromatosis*/
2149,991,15,/*hemochromatosis*/
2149,1256,15,/*hemochromatosis*/
2149,1355,15,/*hemochromatosis*/
2151,0,22,/*Machado-Joseph disease*/
2152,1,44,/*Glucose-6-phosphate dehydrogenase deficiency*/
2152,320,16,/*hemolytic anemia*/
2152,368,51,/*glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
2153,20,13,/*breast cancer*/
2154,15,24,/*Wiskott-Aldrich syndrome*/
2154,104,24,/*Wiskott-Aldrich syndrome*/
2154,130,3,/*WAS*/
2154,159,25,/*immunodeficiency diseases*/
2154,233,3,/*WAS*/
2154,313,3,/*WAS*/
2154,416,3,/*WAS*/
2154,549,3,/*WAS*/
2154,663,3,/*WAS*/
2154,796,3,/*WAS*/
2154,912,3,/*WAS*/
2154,961,3,/*WAS*/
2155,37,24,/*adrenocortical carcinoma*/
2155,103,24,/*adrenocortical carcinoma*/
2155,372,6,/*cancer*/
2155,408,21,/*adrenocortical tumors*/
2157,28,7,/*cancers*/
2158,69,22,/*ankylosing spondylitis*/
2158,148,22,/*ankylosing spondylitis*/
2158,172,2,/*AS*/
2158,408,2,/*AS*/
2158,557,2,/*AS*/
2158,624,2,/*AS*/
2159,275,23,/*malignant glioma biopsy*/
2159,892,7,/*gliomas*/
2159,1483,6,/*glioma*/
2160,12,22,/*ankylosing spondylitis*/
2160,36,19,/*psoriatic arthritis*/
2160,60,17,/*Reiter's syndrome*/
2161,31,14,/*von Willebrand*/
2161,237,24,/*von Willebrand's disease*/
2161,263,3,/*vWD*/
2161,289,29,/*platelet storage pool disease*/
2161,320,3,/*SPD*/
2161,337,10,/*thrombosis*/
2161,765,3,/*vWD*/
2161,796,38,/*capillary thrombometer thrombosis time*/
2161,997,22,/*capillary thrombometer*/
2161,1232,14,/*von Willebrand*/
2161,1341,14,/*von Willebrand*/
2162,10,49,/*deficiency of the seventh component of complement*/
2162,76,9,/*nephritis*/
2162,185,14,/*pyelonephritis*/
2162,683,21,/*neutrophil chemotaxis*/
2162,1310,12,/*C7-deficient*/
2162,1757,28,/*chronic nephritis lacking C7*/
2162,2072,3,/*C56*/
2164,13,67,/*deficiency of the third component of complement, C3, in guinea pigs*/
2164,82,58,/*Hereditary deficiency of the third component of complement*/
2164,181,13,/*C3 deficiency*/
2164,360,24,/*hereditary C3 deficiency*/
2164,388,20,/*strain 2 guinea pigs*/
2164,784,12,/*C3-deficient*/
2164,1028,27,/*inbred strain 2 guinea pigs*/
2164,1075,9,/*C3 defect*/
2164,1176,23,/*C3a receptor deficiency*/
2164,1388,28,/*hypercatabolism of normal C3*/
2164,2053,12,/*C4-deficient*/
2164,2171,20,/*bacterial infections*/
2165,31,19,/*Lesch-Nyhan disease*/
2166,602,7,/*atrophy*/
2167,10,14,/*Coats' disease*/
2167,221,14,/*Coats' disease*/
2167,296,16,/*advanced disease*/
2167,426,32,/*interendothelial cell separation*/
2167,494,30,/*isolated vascular malformation*/
2168,41,10,/*hemorrhage*/
2168,56,10,/*thrombosis*/
2168,168,10,/*hemorrhage*/
2168,183,10,/*thrombosis*/
2168,245,24,/*von Willebrand's disease*/
2168,286,18,/*von Willebrand pig*/
2168,332,16,/*arteriosclerosis*/
2168,629,21,/*factor/von Willebrand*/
2168,708,10,/*thrombosis*/
2169,26,13,/*breast cancer*/
2170,16,44,/*glucose-6-phosphate dehydrogenase deficiency*/
2170,147,44,/*glucose-6-phosphate dehydrogenase deficiency*/
2170,273,25,/*hereditary blood disorder*/
2170,364,44,/*glucose-6-phosphate dehydrogenase deficiency*/
2171,80,28,/*Pelizaeus-Merzbacher disease*/
2172,97,14,/*Gyrate atrophy*/
2172,128,26,/*chorioretinal degeneration*/
2172,740,39,/*X-linked recessive retinitis pigmentosa*/
2173,0,20,/*Lesch-Nyhan syndrome*/
2173,60,26,/*Lesch-Nyhan (L-N) syndrome*/
2173,229,17,/*mentally retarded*/
2173,337,12,/*L-N syndrome*/
2173,372,12,/*L-N syndrome*/
2173,495,12,/*L-N syndrome*/
2173,671,12,/*L-N syndrome*/
2173,911,12,/*L-N syndrome*/
2174,238,15,/*atherosclerosis*/
2174,558,10,/*catabolism*/
2175,559,50,/*elevated plasma concentration of cholesteryl ester*/
2175,799,4,/*DTNB*/
2175,1483,4,/*DTNB*/
2175,1668,4,/*DTNB*/
2176,70,28,/*systemic lupus erythematosus*/
2176,202,28,/*systemic lupus erythematosus*/
2176,384,19,/*complement factor B*/
2177,24,18,/*myotonic dystrophy*/
2177,63,18,/*myotonic dystrophy*/
2177,83,2,/*DM*/
2177,268,17,/*myotonic features*/
2177,326,2,/*DM*/
2177,393,2,/*DM*/
2177,557,2,/*DM*/
2177,642,2,/*DM*/
2177,672,32,/*inherited neuromuscular disorder*/
2178,26,17,/*Tay-Sachs problem*/
2179,41,33,/*Emery-Dreifuss muscular dystrophy*/
2179,77,33,/*Emery-Dreifuss muscular dystrophy*/
2179,117,28,/*X-linked recessive condition*/
2179,168,17,/*muscular weakness*/
2179,362,19,/*cardiac involvement*/
2179,395,16,/*bradyarrhythmias*/
2179,443,12,/*sudden death*/
2179,536,12,/*sudden death*/
2179,895,28,/*Supraventricular arrhythmias*/
2179,1040,26,/*cardiac rhythm abnormality*/
2179,1087,17,/*muscular weakness*/
2179,1198,20,/*muscular involvement*/
2179,1231,30,/*arrhythmias of variable degree*/
2179,1369,16,/*bradyarrhythmias*/
2179,1423,33,/*Emery-Dreifuss muscular dystrophy*/
2179,1581,12,/*sudden death*/
2179,1701,16,/*bradyarrhythmias*/
2180,0,47,/*Deficiency of the sixth component of complement*/
2180,70,33,/*Neisseria meningitidis infections*/
2180,153,34,/*Complement component C6 deficiency*/
2180,268,23,/*meningococcal infection*/
2180,791,23,/*meningococcal infection*/
2180,880,32,/*Neisseria meningitidis infection*/
2180,1099,18,/*primary meningitis*/
2180,1230,23,/*meningococcal infection*/
2181,0,44,/*Glucose-6-phosphate dehydrogenase deficiency*/
2181,46,22,/*neutrophil dysfunction*/
2181,73,32,/*Chromobacterium violaceum sepsis*/
2182,68,14,/*Kniest disease*/
2182,169,14,/*Kniest disease*/
2182,225,32,/*rhizomelic short limbed dwarfism*/
2182,279,12,/*cleft palate*/
2182,293,8,/*deafness*/
2182,369,14,/*Kniest disease*/
2182,564,14,/*Kniest disease*/
2183,1080,27,/*deficiencies of the enzymes*/
2185,48,18,/*muscular dystrophy*/
2185,179,27,/*Duchenne muscular dystrophy*/
2186,0,36,/*Atypical sector pigmentary dystrophy*/
2186,96,20,/*pigmentary dystrophy*/
2187,0,20,/*Acromicric dysplasia*/
2187,40,49,/*type of bone dysplasia, the "acromicric dysplasia*/
2187,236,18,/*growth retardation*/
2188,0,42,/*Autosomal dominant humeroperoneal myopathy*/
2188,44,33,/*Emery-Dreifuss muscular dystrophy*/
2188,207,8,/*weakness*/
2189,0,22,/*Machado-Joseph disease*/
2189,54,22,/*Machado-Joseph disease*/
2189,78,3,/*MJD*/
2189,89,44,/*autosomal dominant motor system degeneration*/
2189,320,14,/*Type I disease*/
2189,450,15,/*Type II disease*/
2189,523,24,/*true cerebellar deficits*/
2189,674,60,/*pancerebellar deficits with motor and sensory polyneuropathy*/
2189,772,21,/*parkinsonian features*/
2189,799,24,/*mild cerebellar deficits*/
2189,830,31,/*distal motor sensory neuropathy*/
2189,917,3,/*MJD*/
2190,171,19,/*Bedlington terriers*/
2190,1070,27,/*Bedlington terrier disorder*/
2191,76,14,/*retinoblastoma*/
2191,278,14,/*retinoblastoma*/
2191,879,14,/*retinoblastoma*/
2192,67,15,/*cystic fibrosis*/
2192,265,15,/*cystic fibrosis*/
2192,282,2,/*CF*/
2192,987,2,/*CF*/
2192,1108,27,/*autosomal recessive disease*/
2193,1,18,/*Muscular dystrophy*/
2194,210,20,/*cone-rod dystrophies*/
2194,232,20,/*rod-cone dystrophies*/
2194,310,21,/*fundus flavimaculatis*/
2194,345,17,/*macular dystrophy*/
2194,368,28,/*Leber's congenital amaurosis*/
2194,947,21,/*retinal layer disease*/
2195,0,43,/*Acetazolamide-responsive myotonia congenita*/
2195,96,35,/*autosomal dominant form of myotonia*/
2195,176,50,/*autosomal dominant or recessive myotonia congenita*/
2195,521,18,/*myotonia congenita*/
2196,1,22,/*Emery-Dreifuss disease*/
2196,27,22,/*syndrome of amyotrophy*/
2196,55,18,/*early contractures*/
2196,145,23,/*Emery-Dreifuss myopathy*/
2196,214,19,/*muscle contractures*/
2196,235,56,/*atrophy predominant on the scapulohumeroperoneal muscles*/
2196,339,17,/*X-linked heredity*/
2196,646,16,/*muscle anomalies*/
2196,708,19,/*amyotrophy syndrome*/
2196,733,18,/*early contractures*/
2197,20,33,/*cholesterol ester storage disease*/
2197,122,66,/*lysosomal storage of neutral lipids with deficiency of acid lipase*/
2197,236,14,/*Wolman disease*/
2197,340,33,/*cholesteryl ester storage disease*/
2197,375,4,/*CESD*/
2197,435,24,/*hereditary enzymopathies*/
2197,582,33,/*Epstein-Barr Virus transformation*/
2198,0,21,/*Adenomatoid leiomyoma*/
2198,26,39,/*papillary cystadenoma of the epididymis*/
2199,69,17,/*enzyme deficiency*/
2199,183,42,/*congenital nonspherocytic hemolytic anemia*/
2199,231,16,/*mental disorders*/
2200,0,26,/*Familial myasthenia gravis*/
2200,83,26,/*familial myasthenia gravis*/
2200,203,31,/*familial limb-girdle myasthenia*/
2200,323,30,/*familial congenital myasthenia*/
2200,606,26,/*familial myasthenia gravis*/
2201,14,12,/*histidinemia*/
2201,129,12,/*histidinemia*/
2201,482,12,/*histidinemia*/
2201,552,12,/*histidinemia*/
2204,143,21,/*ataxia-telangiectasia*/
2205,1,22,/*Van der Woude syndrome*/
2206,1,22,/*Van der Woude syndrome*/
2208,41,20,/*Bechterew's syndrome*/
2208,63,22,/*ankylosing spondylitis*/
2208,147,18,/*sacro-iliac joints*/
2208,435,22,/*ankylosing spondylitis*/
2208,459,2,/*AS*/
2208,508,18,/*sacro-iliac joints*/
2208,711,30,/*ankylosis of apophyseal joints*/
2208,1251,27,/*ankylosed apophyseal joints*/
2208,1390,18,/*sacro-iliac joints*/
2208,1581,9,/*psoriasis*/
2208,1594,22,/*acute anterior uveitis*/
2208,1618,22,/*Definite sacro-iliitis*/
2208,1836,13,/*sacro-iliitis*/
2208,2029,2,/*AS*/
2208,2102,2,/*AS*/
2208,2200,2,/*AS*/
2208,2251,44,/*ankylosis of the spine or sacro-iliac joints*/
2209,16,22,/*acute anterior uveitis*/
2209,40,22,/*Acute anterior uveitis*/
2209,64,3,/*AAU*/
2209,222,3,/*AAU*/
2209,322,3,/*AAU*/
2209,340,22,/*ankylosing spondylitis*/
2210,0,16,/*Hyperinsulinemia*/
2210,20,18,/*myotonic dystrophy*/
2210,93,27,/*myotonic dystrophy syndrome*/
2210,188,17,/*neonatal syndrome*/
2210,230,18,/*muscular hypotonia*/
2210,339,18,/*myotonic dystrophy*/
2210,521,20,/*physical deformities*/
2210,546,18,/*mental retardation*/
2210,592,18,/*myotonic dystrophy*/
2210,686,18,/*myotonic dystrophy*/
2210,836,25,/*severe muscular hypotonia*/
2210,1022,18,/*myotonic dystrophy*/
2211,32,24,/*carboxylase deficiencies*/
2211,590,2,/*PC*/
2211,816,14,/*PCC-deficiency*/
2211,963,22,/*carboxylase deficiency*/
2213,27,21,/*ataxia-telangiectasia*/
2213,118,21,/*ataxia-telangiectasia*/
2214,0,19,/*Dyslipoproteinemias*/
2214,42,22,/*coronary heart disease*/
2214,231,22,/*coronary heart disease*/
2214,255,3,/*CHD*/
2214,300,18,/*dyslipoproteinemia*/
2214,320,3,/*DLP*/
2214,575,3,/*CHD*/
2214,740,3,/*CHD*/
2214,748,3,/*DLP*/
2214,1115,3,/*CHD*/
2214,1185,3,/*CHD*/
2214,1220,3,/*CHD*/
2214,1277,7,/*type IV*/
2214,1441,3,/*CHD*/
2214,1592,3,/*CHD*/
2214,1646,8,/*hyperHDL*/
2214,1719,3,/*CHD*/
2214,1796,3,/*CHD*/
2214,2036,3,/*CHD*/
2215,40,25,/*alveolar rhabdomyosarcoma*/
2217,18,30,/*acetylcholinesterase-deficient*/
2217,62,35,/*paroxysmal nocturnal hemoglobinuria*/
2217,122,35,/*paroxysmal nocturnal hemoglobinuria*/
2217,159,3,/*PNH*/
2217,810,16,/*PNH IIIb, of PNH*/
2217,907,3,/*PNH*/
2217,984,19,/*PNH II erythrocytes*/
2218,29,18,/*sacro-iliac joints*/
2218,51,22,/*ankylosing spondylitis*/
2218,78,9,/*psoriasis*/
2218,130,9,/*arthritis*/
2218,214,18,/*sacro-iliac joints*/
2218,332,22,/*ankylosing spondylitis*/
2218,356,2,/*AS*/
2218,458,9,/*psoriasis*/
2218,496,2,/*AS*/
2218,542,2,/*AS*/
2218,641,39,/*Radiographic abnormalities of the spine*/
2218,908,4,/*SABS*/
2218,1231,26,/*abnormalities of the spine*/
2218,1456,22,/*grade IV sacro-iliitis*/
2218,1570,2,/*AS*/
2218,1654,2,/*AS*/
2218,1836,13,/*Sacro-iliitis*/
2218,1904,13,/*sacro-iliitis*/
2218,1965,2,/*AS*/
2220,209,28,/*familial Mediterranean fever*/
2220,239,3,/*FMF*/
2220,271,25,/*arterial branch occlusion*/
2220,406,29,/*retinal circulatory disorders*/
2221,27,14,/*ovarian cancer*/
2221,117,14,/*ovarian cancer*/
2221,224,19,/*cancer of the ovary*/
2221,742,8,/*stage IV*/
2221,900,5,/*tumor*/
2222,0,21,/*Adrenomyeloneuropathy*/
2222,113,21,/*adrenomyeloneuropathy*/
2222,136,3,/*AMN*/
2222,207,25,/*biochemical abnormalities*/
2222,416,3,/*AMN*/
2223,35,26,/*Von Hippel-Lindau syndrome*/
2224,0,20,/*Adrenoleukodystrophy*/
2224,25,20,/*psychiatric disorder*/
2225,19,22,/*fundic gland polyposis*/
2225,59,45,/*familial adenomatosis coli/Gardner's syndrome*/
2225,147,22,/*fundic gland polyposis*/
2225,188,45,/*familial adenomatosis coli/Gardner's syndrome*/
2225,338,19,/*gastric radiography*/
2225,385,19,/*Fundic gland polyps*/
2225,558,6,/*polyps*/
2225,827,19,/*fundic gland polyps*/
2225,892,22,/*fundic gland polyposis*/
2225,932,45,/*familial adenomatosis coli/Gardner's syndrome*/
2225,1081,6,/*polyps*/
2225,1139,6,/*polyps*/
2225,1215,22,/*fundic gland polyposis*/
2226,0,13,/*Renal failure*/
2226,17,56,/*familial lecithin-cholesterol acyltransferase deficiency*/
2226,75,56,/*Familial lecithin-cholesterol acyltransferase deficiency*/
2226,137,39,/*hereditary disorder of lipid metabolism*/
2226,364,11,/*Proteinuria*/
2226,523,22,/*terminal renal failure*/
2226,622,12,/*renal damage*/
2227,57,31,/*spontaneous retinal hemorrhages*/
2227,154,19,/*retinal hemorrhages*/
2227,526,19,/*Retinal hemorrhages*/
2227,807,31,/*spontaneous retinal hemorrhages*/
2227,882,29,/*retinal arteriolar tortuosity*/
2228,23,13,/*liver disease*/
2228,171,13,/*liver disease*/
2228,254,21,/*various liver disease*/
2228,1175,13,/*liver disease*/
2228,1239,13,/*liver disease*/
2228,1376,13,/*liver disease*/
2232,0,35,/*Familial cranial diabetes insipidus*/
2232,145,26,/*cranial diabetes insipidus*/
2232,388,26,/*cranial diabetes insipidus*/
2232,1129,26,/*cranial diabetes insipidus*/
2235,18,21,/*myotonic disturbances*/
2236,51,18,/*myotonic dystrophy*/
2237,32,21,/*neuromuscular disease*/
2238,42,38,/*congenital tapeto-retinal degeneration*/
2238,97,11,/*keratoconus*/
2238,113,11,/*nephropathy*/
2239,0,43,/*Red cell phosphoglycerate kinase deficiency*/
2239,60,32,/*non-spherocytic hemolytic anemia*/
2240,0,6,/*Cancer*/
2240,19,26,/*hereditary cancer syndrome*/
2241,0,42,/*Carcinoma of the breast and ovary in three*/
2242,0,24,/*Familial hyperlipidemias*/
2243,1,42,/*Congenital nonspherocytic hemolytic anemia*/
2243,45,8,/*cataract*/
2243,58,44,/*glucose-6-phosphate dehydrogenase deficiency*/
2244,15,16,/*hemolytic anemia*/
2246,286,48,/*inactivator of the third component of complement*/
2248,68,27,/*tapeto-retinal degeneration*/
2249,23,28,/*familial mediterranean fever*/
2250,1,16,/*Norrie's disease*/
2252,15,28,/*familial Mediterranean fever*/
2253,31,24,/*Wiskott-Aldrich syndrome*/
2253,133,24,/*Wiskott-Aldrich syndrome*/
2253,974,24,/*Wiskott-Aldrich syndrome*/
2254,14,13,/*xanthomatosis*/
2255,24,17,/*Cowden's syndrome*/
2255,140,17,/*Cowden's syndrome*/
2255,177,14,/*facial lesions*/
2255,210,14,/*trichilemmomas*/
2255,274,13,/*trichilemmoma*/
2255,311,26,/*benign verrucous acanthoma*/
2255,434,15,/*benign fibromas*/
2255,537,16,/*benign keratosis*/
2255,555,23,/*Multiple trichilemmomas*/
2255,611,17,/*Cowden's syndrome*/
2255,743,30,/*multiple facial trichilemmomas*/
2255,793,17,/*Cowden's syndrome*/
2255,840,21,/*facial trichilemmomas*/
2255,863,13,/*oral fibromas*/
2255,929,17,/*Cowden's syndrome*/
2256,0,43,/*Cold urticaria and complement C2 deficiency*/
2257,15,14,/*retinoblastoma*/
2257,75,14,/*retinoblastoma*/
2257,237,14,/*retinoblastoma*/
2258,107,20,/*Lesch-Nyhan syndrome*/
2258,169,20,/*Lesch-Nyhan syndrome*/
2259,1,14,/*Bisalbuminemia*/
2261,76,18,/*cat's-eye syndrome*/
2262,27,14,/*retinoblastoma*/
2264,42,35,/*pigmentary tapeto-retinal dystrophy*/
2265,72,16,/*hemolytic anemia*/
2268,75,14,/*Lange syndrome*/
2269,13,56,/*erythrocyte glucose-6-phosphate dehydrogenase deficiency*/
2270,40,38,/*glucose-phosphate-isomerase deficiency*/
2270,84,42,/*hereditary nonspherocytic hemolytic anemia*/
2271,36,43,/*glucose-6-phosphate dehydrogenase-deficient*/
2272,14,12,/*galactosemia*/
2274,0,44,/*Glucose-6-phosphate dehydrogenase deficiency*/
2274,49,17,/*neonatal jaundice*/
2274,79,51,/*Glucose-6-phosphate dehydrogenase (G6PD) deficiency*/
2274,223,8,/*jaundice*/
2274,768,14,/*G6PD deficient*/
2274,946,29,/*spontaneous neonatal jaundice*/
2274,1042,8,/*jaundice*/
2274,1108,14,/*G6PD deficient*/
2274,1178,14,/*G6PD deficient*/
2274,1242,15,/*G6PD deficiency*/
2274,1282,8,/*jaundice*/
2275,12,18,/*diabetes insipidus*/
2276,26,44,/*glucose-6-phosphate dehydrogenase deficiency*/
2278,17,22,/*ankylosing spondylitis*/
2278,152,22,/*ankylosing spondylitis*/
2278,350,22,/*ankylosing spondylitis*/
2279,13,6,/*cancer*/
2279,42,14,/*retinoblastoma*/
2279,97,14,/*retinoblastoma*/
2279,168,14,/*retinoblastoma*/
2279,188,6,/*cancer*/
2279,466,15,/*retinoblastomas*/
2279,534,18,/*Poisson statistics*/
2279,649,5,/*tumor*/
2279,679,17,/*unilateral tumors*/
2279,720,16,/*bilateral tumors*/
2279,782,6,/*tumors*/
2279,835,6,/*tumors*/
2280,0,30,/*X-linked haematological traits*/
2281,0,22,/*Von Wllebrands disease*/
2281,104,10,/*hemophilia*/
2284,244,28,/*somatic and anxiety symptoms*/
2285,1358,12,/*galactosemic*/
2286,93,43,/*congenital nonspherocytic hemolytic disease*/
2287,20,17,/*Thomsen's disease*/
2288,4,28,/*hereditary torsion dystonias*/
2288,34,8,/*dystonia*/
2289,1,16,/*Hemolytic anemia*/
2289,28,44,/*glucose-6-phosphate-dehydrogenase deficiency*/
2290,0,23,/*Perifollicular fibromas*/
2290,25,35,/*Pure periadnexal adventitial tumors*/
2291,0,27,/*Autoimmune hemolytic anemia*/
2292,1,12,/*Alkaptonuria*/
2293,93,10,/*leucocoria*/
2293,187,23,/*retrolental fibroplasia*/
2293,212,14,/*retinoblastoma*/
2293,228,14,/*Coats' disease*/
2293,244,20,/*von Hippel's disease*/
2293,266,25,/*inflammatory pseudoglioma*/
2293,293,16,/*Norrie's disease*/
2293,325,23,/*intraocular haemorrhage*/
2295,1,24,/*Chronic hemolytic anemia*/
2296,55,18,/*glomerulonephritis*/
2298,23,57,/*familial lecithin: cholesterol acyltransferase deficiency*/
2298,238,64,/*familial lecithin: cholesterol acyltransferase (LCAT) deficiency*/
2299,79,22,/*ankylosing spondylitis*/
2299,128,22,/*ankylosing spondylitis*/
2299,152,2,/*AS*/
2299,314,19,/*degree of deformity*/
2299,510,2,/*AS*/
2299,733,22,/*acute anterior uveitis*/
2299,857,2,/*AS*/
2299,965,2,/*AS*/
};
}
static int[] a0;
static int[] a1;
static int[] a2;
static int[] a3;
static int[] a4;
static int[] a5;
static int[] a6;
static int[] a7;
static int[] a8;
static int[] a9;
static int[] a10;
static int[] a11;
static int[] a12;
static int[] a13;
static int[] a14;
static {
init0();
init1();
init2();
init3();
init4();
init5();
init6();
init7();
init8();
init9();
init10();
init11();
init12();
init13();
init14();
}
int[] annotate() {
int[] ans = new int[44721];
int idx = 0;
for (int i:a0) ans[idx++] = i;
for (int i:a1) ans[idx++] = i;
for (int i:a2) ans[idx++] = i;
for (int i:a3) ans[idx++] = i;
for (int i:a4) ans[idx++] = i;
for (int i:a5) ans[idx++] = i;
for (int i:a6) ans[idx++] = i;
for (int i:a7) ans[idx++] = i;
for (int i:a8) ans[idx++] = i;
for (int i:a9) ans[idx++] = i;
for (int i:a10) ans[idx++] = i;
for (int i:a11) ans[idx++] = i;
for (int i:a12) ans[idx++] = i;
for (int i:a13) ans[idx++] = i;
for (int i:a14) ans[idx++] = i;
return ans; }}

